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ABSTRACT 
There is an increase in the prevalence of physical symptoms in military veterans who 
have deployed to combat zones compared to those who have not been deployed. These 
symptoms can be distressing, disabling, and negatively impact quality of life. Current 
paradigms regarding the effects of traumatic deployment exposures on military personnel 
tend to consider non-specific physical symptoms (that are not due to injury) as simply a 
comorbidity of psychological disorder following trauma, rather than independent 
sequelae. For example, the diagnostic criteria for a condition specifically caused by 
traumatic exposures, posttraumatic stress disorder (PTSD), do not include physical 
symptoms.  Uncertainty surrounding the aetiology of physical symptoms has led to some 
fierce controversies, such as the existence of Gulf War Syndrome. 
The aim of this thesis was to examine how physical and psychological symptoms occur 
independently as well as co-occur in veterans post-deployment, and to examine the 
strength of associations between traumatic deployment exposures (TDEs) and these 
profiles of physical and psychological symptom presentation. A further aim was to 
explore how well a checklist of physical symptoms could identify concurrent PTSD. The 
final aim was to examine whether inflammation mediated associations between TDEs and 
physical symptoms. 
Data used in this thesis were from several related studies of Australian Defence Force 
(ADF) members who deployed to the Middle East Area of Operations (MEAO) from 
2001 to 2012. These studies were commissioned by the Australian Government’s 
Department of Defence to explore the impact of increased operational tempo on the 
health of military personnel. These large-scale correlational studies surveyed tens of 
thousands of personnel using self-reported questionnaires which included gold-standard 
measures of psychological distress and PTSD, as well as checklists of trauma exposure 
and physical symptoms. 
This thesis substantiated prior findings of high rates of comorbidity between PTSD and 
physical symptoms in veterans. While results confirmed that physical and psychological 
symptoms can co-occur, analyses identified a subgroup of veterans who exhibited 
physical symptoms without psychological distress; this ‘physical only’ presentation was 
as common as the ‘psychological only’ and comorbid symptom presentations.  Moreover, 
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this presentation was associated with lower quality of life, and as such is worthy of 
clinical attention.  Importantly, TDEs showed similar associations with both ‘physical 
only’ and ‘psychological only’ symptom presentations.  
As with First Gulf War research, there did not appear to be a particular post-deployment 
physical ‘syndrome’; while symptoms often co-occurred, it was symptom number and 
intensity rather than type that identified affected veterans. A list of 10 physical symptoms 
demonstrated good diagnostic utility for predicting cases of concurrent PTSD. The 
findings also suggest that sub-types of PTSD exist, differentiated by the level of somatic 
symptoms. While a relationship was found between some individual physical symptoms 
and inflammation, the hypothesis that inflammation mediates the relationship between 
trauma and physical symptoms was not supported. 
These findings validate physical symptoms as a discrete symptom outcome following 
deployment, and this presentation had a similar prevalence to co-occurring physical and 
psychological symptoms. Therefore, physical symptoms should not be regarded simply as 
a comorbidity of an underlying psychological disorder for all veterans.  As physical 
symptoms are just as likely to occur as psychological symptoms following TDEs and they 
impact quality of life, they should be assessed during post-deployment screening and 
considered in civilian treatment of veterans. Furthermore, the inclusion of physical 
symptoms in PTSD screening checklists may improve PTSD identification rates and 
better describe the patient experience.  
ABSTRACT 
 
Page | xv 
THESIS DECLARATION 
I certify that this work contains no material which has been accepted for the award of any 
other degree or diploma in my name, in any university or other tertiary institution and, to 
the best of my knowledge and belief, contains no material previously published or written 
by another person, except where due reference has been made in the text. In addition, I 
certify that no part of this work will, in the future, be used in a submission in my name, 
for any other degree or diploma in any university or other tertiary institution without the 
prior approval of the University of Adelaide and where applicable, any partner institution 
responsible for the joint-award of this degree.  
I acknowledge that copyright of published works contained within this thesis resides with 
the copyright holder(s) of those works.  
I also give permission for the digital version of my thesis to be made available on the 
web, via the University’s digital research repository, the Library Search and also through 
web search engines, unless permission has been granted by the University to restrict 
access for a period of time.  
I acknowledge the support I have received for my research through the provision of an 
Australian Government Research Training Program Scholarship. 
 
Kristin Graham 
Signed:_______         Date: 11 June 2019 
I believe this thesis is properly presented and conforms to the specifications for the degree 
of sufficient standard to be, prima facie, worthy of examination 
 
Signed:_________                                 Date:   11 June 2019 
Professor Alexander Cowell McFarlane 
Principal Supervisor 
      ACKNOWLEDGMENTS 
Page | xvi 
ACKNOWLEDGEMENTS 
I would like to gratefully acknowledge the financial support I have received through an 
Australian Rotary Health ANZAC Scholarship. They have also provided me with 
wonderful extracurricular opportunities that have greatly enriched my learning 
experience. The Medical School and the Centre for Traumatic Stress Studies at the 
University of Adelaide have been generous with funding, enabling me to broaden my 
education through conference and workshop attendance.   
My sincere thanks to a number of people who have contributed significantly to this 
project. First, my deepest gratitude to my outstanding supervisors, Prof. Alexander 
McFarlane, Dr Miranda Van Hooff, Dr Amelia Searle, and the ring-in Dr Ellie Lawrence 
Woods who have supported me throughout my thesis with their patience, encouragement, 
and wisdom. You have all made this an extraordinary experience. I will miss working 
with you but hope we have the opportunity to cross paths in the future. 
Thanks also to my fantastic office colleagues at CTSS. Your office banter always 
brightened my day. Jody, thanks for always knowing the answers. To Blair, Susan, and 
Tom I am extremely thankful for your statistical guidance, and particularly to Dr Jo 
Dipnall for her help with the machine learning analyses.  
I would like to especially thank all the Australian Defence Force members, serving and 
ex-serving, who generously took the time to participate in these studies. Without them 
this research could not have happened. 
Finally, a huge thank you to my family and friends. Alison and Vanessa thanks for 
encouraging me to keep going. My parents Mary and Frank and my siblings Luke, Angus, 
and Katherine who have been wonderfully supportive. Paul for his exceptional listening 
skills and wise advice, and Jo for reminding me to celebrate. The biggest thanks of course 
must go to my partner Tim and my children Mitchell and Alex. Thank you for stepping 
up and taking on the extra work to allow me the freedom to pursue a change of career, 
being my cheer squad, being extremely patient with the number of weekends I’ve spent at 
my desk and reminding me to have fun along the way. You’re the best.
 
 









 Reader navigation & overview 
 
 
       
Page | 2 
1.1 Navigation 
This thesis incorporates a combination of written text in the form of introduction, 
methods, and discussion chapters (Chapters 2, 3, and 9), and five manuscripts that have 
received approval for publication from the Department of Defence and have subsequently 
been submitted to peer-reviewed journals for consideration (Chapters 4 to 8). Each paper 
is formatted as a stand-alone peer-reviewed article and thus there is some repetition of 
background information across chapters in order to contextualise each study. To avoid 
repetition, the literature review in the thesis introduction (Chapter 1) provides an 
overview of the history of physical symptoms and posttraumatic syndromes. The reader is 
directed to the individual manuscripts for specific literature reviews or methods material. 
Formatting varies between the manuscripts based on the requirements of the different 
journals. All references relevant to all chapters of this thesis are at the end of the thesis. 
1.2 Overview 
Researchers and the medical profession are yet to establish a definitive explanation for 
the aetiology of post-deployment physical symptoms. The tendency in psychiatry has 
been to ascribe the aetiology of physical symptoms to psychological mechanisms such as 
somatisation or PTSD. However, some veterans feel that such explanations are a moral 
judgment that belittles the severity of their symptoms and places blame for the symptoms 
on a weakness in the individual. This can leave veterans distressed and disengaged from 
the medical profession. Many veterans believe their physical symptoms are the result of 
exposures experienced on deployment, but there is little empirical evidence to support 
this. 
Research exploring the association between deployment and physical health is growing, 
but few studies have examined the relationship between traumatic deployment exposures 
(TDEs) and physical symptoms in the absence of psychological symptoms. Therefore, the 
comparative strength of the relationship of TDEs to physical only and psychological only 
symptom presentations has not been explored, nor has the belief that psychological 
symptoms deserve to be regarded as the primary trauma exposure outcome. To explore 
this relationship, this thesis takes an atheoretical approach to examining the independence 
of physical and psychological symptoms as well as their co-occurrence and their 
relationship to trauma. A key strength of this study is the use of large military samples, 
      READER NAVIGATION & OVERVIEW 
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which provides the power to statistically examine differences between the various 
symptom presentation subgroups.  
The aim of Study 1 (Chapter 4) was to examine the differentiation and overlap of three 
post-deployment symptom profiles: physical symptoms only, psychological symptoms 
only, and comorbid (i.e. physical and psychological) symptoms.  The study examined the 
prevalence of each profile, as well as the relative strength of association of each profile 
(compared with no symptoms) with TDEs.  TDEs were examined as a count variable, 
reflecting the total number of different exposures that members had experienced. Three 
TDE sub-scales (subjective, objective, and human death and degradation) were also 
examined in order to explore the relationship of different exposure types with the 
symptom profiles.  
In Study 2 (Chapter 5), similar analyses to that of Study 1 were conducted, but with a 
difference in the psychological symptoms variable; profiles were created including: 
physical symptoms only, PTSD symptoms only, and comorbid symptoms. Using the 
same method as Study 1, comparisons were made between the prevalence of symptom 
profiles and strength of association of each profile with TDEs. The move to examine 
PTSD specifically (as opposed to non-specific psychological distress) was to compare the 
major diagnosis for traumatic experiences (PTSD) with the physical symptom profile, 
rather than the broader emotional distress variable used in Study 1.  
In study 3 (Chapter 6), the data-driven machine learning statistical technique of self-
organised maps was used to identify and describe clusters of self-reported physical 
symptoms, and then the association of these clusters with probable PTSD was examined. 
In addition, the association of these clusters with TDEs was examined.  
Study 4 (Chapter 7) explores whether the strong relationship identified between physical 
symptoms and PTSD symptoms in the previous studies would enable physical symptoms 
to be used to identify veterans with concurrent PTSD. To achieve this, two physical 
symptom scales were constructed (one 9-item and one 10-item) from a 67-item health 
symptom checklist (HSC) that showed good diagnostic utility for predicting 30-day 
PTSD (measured using a gold standard diagnostic interview).   
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The final study (Chapter 8) explores inflammation as a possible biological mechanism 
for the association between trauma and physical symptoms. This was examined using a 
mediation model to test whether inflammation (measured using C-reactive protein) may 
be a mediator in the relationship between deployment trauma and physical symptoms.   
The thesis concludes with a general discussion (Chapter 9) which summarises the main 
findings, incorporates these with recent research in the field, discusses clinical 
implications, considers study limitations, and presents suggestions for future research.  
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2.1 Overview 
This thesis explores the relationship between traumatic deployment exposures (TDEs) 
experienced by Australian Defence Force (ADF) personnel and post-deployment physical 
and psychological symptoms. The relationship between physical and psychological 
symptoms is an area of medical practice that has failed to develop a coherent narrative, 
with different medical specialties adopting contradictory approaches.  Additionally, 
physical symptoms that do not conform to established diagnostic criteria can be 
challenging for practitioners.  The non-specific nature of symptoms may result in the 
practitioner dismissing them as unimportant, despite the level of distress patients 
experience, and thereby create the potential for conflict. This combination of 
inconsistency in approach and the patient feeling that their symptoms have not been 
acknowledged can leave the patient confused, angry, disengaged from medical personnel, 
and struggling to understand and manage the impact of their symptoms. Developing a 
better understanding of the relationship between presenting physical and psychological 
symptoms is important as it has the potential to enable a unified approach by various 
professionals and result in better health outcomes for patients. 
The aim of this introduction is to provide a broad outline of the background 
content needed to justify the questions and aims addressed in the subsequent chapters. 
The introduction begins with a description of physical symptoms and discusses the 
difficulty with terminology and therefore defining, researching, and treating physical 
symptoms. This is followed by an explanation of the lack of common approach between 
medical specialties, then the factors that influence symptom experience and reporting. 
Next, physical symptoms occurring in military personnel are discussed, followed by the 
association between physical symptoms and psychological disorder with a focus on 
posttraumatic stress disorder (PTSD). Subsequently, the role of trauma as a predictor of 
both physical and psychological symptoms is discussed. The introduction concludes with 
a review of the genesis of the diagnostic classification of physical symptoms and related 
syndromes. This history demonstrates the complex intertwining of physical and 
psychological symptoms and reveals the origins of the inconsistency in medical 
approaches. The questions and aims of the thesis are then stated.  
  
   INTRODUCTION 
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2.2 Physical symptoms 
Physical symptoms have traditionally been defined by the medical profession as either 
medically explained, where there is an organic explanation for symptoms, or medically 
unexplained where no organic cause is found (Kroenke & Mangelsdorff, 1989). Both 
categories of physical symptoms may be transitory; consequently individuals may not 
seek medical consultation (Banks, Beresford, Morrell, Waller, & Watkins, 1975; Green, 
Fryer Jr, Yawn, Lanier, & Dovey, 2001; Kroenke & Price, 1993). However, it is 
estimated that one-fifth of the general population suffer from serious, disabling, and 
frequently chronic physical symptoms (Hiller, Rief, & Brähler, 2006; Jackson & 
Passamonti, 2005; Kroenke, Koslowe, & Roy, 1998).  
Physical symptoms are the most common reasons patients visit a medical practitioner, 
accounting for up to half of primary care consultations (Haller, Cramer, Lauche, & 
Dobos, 2015; Komaroff, 1990; Kroenke, 2003; Kroenke & Mangelsdorff, 1989; Kroenke 
& Price, 1993; Schappert, 1992).  Military research in the United States of America (US) 
shows similar patterns of consultation, with non-specific health symptoms a leading 
category for medical encounters in military members (Armed Forces Health Surveillance 
Center, 2013).  
Physical symptoms constitute an important public health problem as they can cause 
considerable personal suffering. The effects of this suffering on individuals and the 
community include reduced quality of life, poor health status, functional impairment, high 
health care utilisation, psychosocial distress, disability, lost days from work, and 
mortality (Barsky, Ettner, Horsky, & Bates, 2001; Barsky, Orav, & Bates, 2005; Creed et 
al., 2012; Katon & Russo, 1992; Katon, Sullivan, & Walker, 2001; Kelsall et al., 2009; 
Kirmayer, 2004; Kisely & Simon, 2006; Konnopka et al., 2012; Lowe et al., 2008; St Cyr, 
McIntyre-Smith, Contractor, Elhai, & Richardson, 2014; Thompson et al., 2013; 
Tomenson et al., 2013).  An important clinical factor associated with outcome severity is 
the number of symptoms; the higher the symptom count, the more likely it is that 
symptoms will persist and the greater the impact on the individual (Chou & Shekelle, 
2010; Ladwig et al., 2010; Rief & Rojas, 2007).  Research suggests that outcomes are 
similar regardless of whether physical symptoms are explained or unexplained (Duddu, 
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Husain, & Dickens, 2008; Jackson & Passamonti, 2005; Kisely & Simon, 2006; Klaus et 
al., 2013).  
There is a plethora of research in the area of physical symptoms, including a study 
conducted by Kroenke and Mangelsdorff (1989) that summarises our understanding of 
physical symptoms. This study involved an audit of 1000 patient records in a primary 
care outpatient clinic for active and retired military personnel and their dependants, 
examining the 3-year incidence of 14 of the most common physical symptoms (chest 
pain, fatigue, dizziness, headache, oedema, back pain, dyspnoea, insomnia, abdominal 
pain, numbness, impotence, weight loss, cough, and constipation).  A total of 567 new 
complaints of one or more of these symptoms were identified. Results of the study 
showed that only 16% of patients had physical symptoms that could be organically 
explained, identifying an organic cause was often expensive, only 55% of patients with 
physical symptoms were provided with treatment, and when an outcome was 
documented, 53% of symptoms improved (Kroenke & Mangelsdorff, 1989).  This 
research highlights that most physical symptoms presenting to primary care can be 
difficult to explain, assess, and treat.  
One difficulty for clinicians is that modern medicine has placed an emphasis on 
explaining and curing disease by focusing on measurable, objective pathology, which is 
an inadequate approach when dealing with many symptom-prompted encounters (Kroenke, 
2014). However, knowing when symptoms require further exploration without over-
investigating can be difficult.  Unnecessary investigations may unwittingly potentiate 
illness behaviour (Baker, 2014; Kanton & Rosen, 1982; Louis, 1987; Rolfe & Burton, 
2013; Wright & Morgan, 1990), particularly as the efficiency of modern diagnostic 
techniques frequently identify asymptomatic and irrelevant pathology (Wiener, Schwartz, 
& Woloshin, 2013), which can progress to unwarranted, unhelpful or harmful treatment 
including surgical measures (Black, 2013; Nelson et al., 2013). The clinician’s role can be 
further complicated in the context of the current medico-legal framework, which has been 
demonstrated to motivate defensive medical practices (Bishop, Federman, & Keyhani, 
2010). 
With poor treatment outcomes being common for many individuals suffering with 
physical symptoms, this is an area of research worthy of further attention. Improved 
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understanding would have considerable positive impact on patient outcomes and reduce 
economic and social burden. 
 Physical symptom terminology  
The plethora of terms for medically unexplained physical symptoms found in the 
literature includes medically unexplained (Engel, Adkins, & Cowan, 2002; Iversen, 
Chalder, & Wessely, 2007), somatic (Sirri & Fava, 2013; St Cyr et al., 2014), bodily 
distress (Fink, Toft, Hansen, Ørnbøl, & Olesen, 2007), non-specific (Mendell, 1993), 
idiopathic (Engel Jr, Liu, Hoge, & Smith, 2002), and functional (Barsky & Borus, 1999; 
Bourke, Langford, & White, 2015).  However, research focus is slowly moving away 
from whether symptoms are explained or unexplained, as this has been found to have 
little impact on patient outcomes (Duddu, Isaac, & Chaturvedi, 2006; Jackson & 
Passamonti, 2005; Kisely & Simon, 2006; Klaus et al., 2013). In line with this change and 
as suggested by Rief and Martin (2014), for most of the following thesis chapters, the 
term ‘physical symptoms’ is used to encompass all reported physical symptoms. This 
terminology was chosen as it makes no assumptions regarding aetiology but merely 
reflects documented patient symptoms. When discussing past research and historical 
perspectives, to accurately represent the context of the research and beliefs of the times, 
the term ‘medically unexplained physical symptoms’ (MUPS) is used. In Chapter 6, due 
to the choice of journals to which manuscripts were submitted, the term ‘somatic 
symptoms’ is used. Both of these terms are used interchangeably with ‘physical 
symptoms’. 
 Factors that influence symptom experience and reporting  
The way in which symptoms are expressed and reported by individuals is not only a 
product of pathological processes, but includes various other environmental, social and 
cultural factors, such as the doctor-patient relationship (Kleinman, 1978).  Michael Balint 
(1896–1970), a general practitioner, psychoanalyst, and educator, believed that the doctor 
has a powerful influence over how symptoms and illness develop (Johnson, Brock, & 
Zacarias, 2014). Balint believed that the doctor-patient interaction must address the 
patient’s suffering, such that the patient feels understood and engaged. Within the context 
of treating physical symptoms, a finding that supports Balint's belief is that if all of the 
symptoms that are distressing the patient are not adequately addressed by the doctor, the 
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illness schema a patient develops may not be consistent with the doctor’s diagnosis 
(McFarlane, Ellis, Barton, Browne, & Van Hooff, 2008). This lack of a common illness 
schema can result in doctor-patient conflict, a situation that is common when physical 
symptoms exist with no medically known cause (Engel et al., 2002; Kroenke, 2001; 
Rosendal, Fink, Bro, & Olesen, 2005; Stone, 2014).   
The importance of the doctor-patient relationship in shaping the patient’s understanding 
and experience of their symptoms highlights the need for frameworks of disease that 
encompass the patient’s experience and symptoms. The focus of modern medicine on 
finding a curable diagnosis can create a false mind-body dichotomy that we need to move 
beyond.  By adopting Balint’s suggestion that doctors treat the whole person and consider 
the patient’s perspective of their symptoms in treatment, patient outcomes may improve. 
Having such concordance can assist the patient to develop an illness schema that enables 
them to engage in constructive treatment choices. 
 Physical symptoms and the medical specialties 
Physical symptoms are not only seen in primary care, but are also common in the medical 
specialties (Reid et al., 2001; Reid, Wessely, Crayford, & Hotopf, 2002). Every specialty 
of medicine has developed its own functional somatic syndrome diagnosis used to explain 
symptoms in patients presenting with symptom constellations for which there is no 
medical explanation (Amital et al., 2006; Sharpe & Carson, 2001); for example, irritable 
bowel syndrome in gastroenterology, fibromyalgia in rheumatology, and tension 
headache in neurology (Han, Kim, Han, & Joo, 2016; Nimnuan, Hotopf, & Wessely, 
2001a; Nimnuan, Rabe-Hesketh, Wessely, & Hotopf, 2001b; Wessely, Nimnuan, & 
Sharpe, 1999). Most of these syndromes have idiosyncratic and overlapping 
conceptualisations (Aaron & Buchwald, 2001; Barsky & Borus, 1999; Burton, 2002; 
McFarlane et al., 2008; Nimnuan et al., 2001b; Sharpe & Carson, 2001; Wessely et al., 
1999; Whitehead, Palsson, & Jones, 2002; Wolfe et al., 1990).   
The overlap between such syndromes was demonstrated in a study that examined 282 
individuals who had 10 or more hospital admissions over an 8-year period (Fink, 1992). 
This study found that the description of a patient’s illness varied depending on which 
specialty department patients were admitted to, and that such differences could be 
attributed to the clinicians focusing on symptoms that were relevant to their specialty 
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(Fink, 1992).  Such findings have led to suggestions that these syndromes may either 
represent a continuum of physical distress or are different manifestations of the same 
condition, highlighting considerable gaps in our understanding of physical symptoms 
(Aaron & Buchwald, 2001; Buchwald & Garrity, 1994; Burton, 2002).  
Two broad and competing classifications for physical symptoms have developed in 
parallel: in medicine, such symptoms are attributed to functional somatic syndromes - 
diagnosed predominantly on the basis of constellations of unexplained symptoms 
(Kroenke, 2003); in psychiatry, such symptoms are attributed to somatisation, defined as 
the tendency to express psychological distress through physical symptoms and to seek 
medical help (Lipowski, 1988; Strassniga, Stowella, Firstc, & Pincu, 2006; Swartz, 
Blazer, George, & Landerman, 1986). However, the use of the term somatisation to 
describe the psychopathological process, while popular and broadly used, has been 
criticised for its lack of empirical support (Hotopf & Wessely, 2005).  
The functional somatic syndrome diagnosis, while lacking empirical evidence, is usually 
better accepted by patients (Brooks, Rimes, & Chalder, 2011) because the nosology is 
typically based around symptoms that are relatable to the patients’ experience; for 
example, tension headache to explain headaches with no organic pathology. Additionally, 
patients are less likely to feel stigmatised by the diagnosis of a physical symptom-based 
syndrome than a psychological one, as psychological diagnoses are often perceived 
negatively by the patient (Kirmayer, 1988; Lai, Hong, & Chee, 2001; Mahajan & 
Banerjee, 2015).  However, functional somatic syndromes have high rates of comorbidity 
with psychological symptoms and diagnoses, a complicating factor for research (Afari et 
al., 2014; Arguelles et al., 2006).  The concern with having these two competing 
functional somatic and somatisation perspectives is that the biases this creates have 
resulted in uncoordinated research that has limited advancements in our understanding 
(Wessely et al., 1999).  
2.3 Association between physical and psychological symptoms   
The high rate of comorbidity of physical symptoms with psychological disorder may 
elucidate why current explanatory frameworks typically treat physical symptoms as 
secondary to or a somatic comorbidity of psychological disorder (Asmundson, Coons, 
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Taylor, & Katz, 2002a; Bekhuis, Boschloo, Rosmalen, de Boer, & Schoevers, 2016; de 
Waal, Arnold, Spinhoven, Eekhof, & van Hemert, 2005; Hoge, Terhakopian, Castro, 
Messer, & Engel, 2007; Jakupcak et al., 2006; Kroenke, 2003; Kroenke et al., 1994; 
McKenzie et al., 2015; Outcalt et al., 2015; Quartana, Wilk, Balkin, & Hoge, 2015; 
Simon, Gater, Kisely, & Piccinelli, 1996; Simon, VonKorff, Piccinelli, Fullerton, & 
Ormel, 1999).  The co-occurrence of physical and psychological symptoms complicates 
presentation, delays the recognition of psychological disorder, and is usually seen with 
greater levels of impairment, greater symptom severity, and lower response to treatment, 
which reinforces the need to better understand this presentation (Hirschfeld, Mallinckrodt, 
Lee, & Detke, 2005; Huijbregts et al., 2013; Karp, Scott, Houck, Kupfer, & Frank, 2005; 
Kisely & Simon, 2006; Magruder et al., 2004; Rona et al., 2012).  
Reflecting this, physical symptom count (either explained or unexplained) is strongly 
predictive of psychological disorder (Kroenke et al., 1997; Kroenke et al., 1994). 
Interestingly, while physical symptoms are often dismissed as secondary to psychological 
disorder, in clinical practice those presenting with physical symptoms often have their 
underlying psychological disorder overlooked (Clarke, Piterman, Byrne, & Austin, 
2008b; Gates, Petterson, Wingrove, Miller, & Klink, 2016; Goldberg, 1984). Such 
findings demonstrate the complex clinical presentation and diagnostic intertwining of 
physical and psychological symptoms. 
However, it has been identified that physical symptoms can also occur as a discrete 
diagnosis without psychological symptoms. For example, a community meta-analysis by 
Henningsen, Zimmermann, and Sattel (2003) identified that medically unexplained 
physical symptoms can present in the absence of comorbid depression and anxiety. 
Similarly, Wolfe et al. (1999) found that almost two-thirds of the Gulf War veterans who 
participated in their study who had moderate to high physical symptom counts had no 
psychological diagnosis. Such findings demonstrate that while psychological and physical 
symptoms are associated, they are not perfectly interrelated and thus may also occur 
independently.  
Major gaps exist in the literature around the prevalence of physical symptoms as an 
independent presentation, specifically the within person presentation of physical 
symptoms when they are a discrete outcome and when comorbid with psychological 
symptoms. Therefore, there is a gap in our understanding of the prevalence and shared or 
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unique factors associated with these three different presentation types: physical, 
psychological, or comorbidity of the two.  Exploration of these presentation types may 
help identify alternate pathological mechanisms rather than assuming that physical 
symptoms are secondary to psychological processes.  
Before a discussion of the physical and psychological symptoms in the military context, 
which is the focus of this thesis, a discussion of the historical context of this complex 
inter-relationship of physical and psychological symptoms and associated diagnoses is 
useful for understanding the need for progress in this area of research. 
2.3.1 Posttraumatic stress disorder  
Posttraumatic stress disorder is a condition that may develop after experiencing or 
witnessing a traumatic event such as a death, serious injury, or sexual assault.  As well as 
exposure to a trauma, the presence of all the following symptoms for more than a month 
is also needed to meet the diagnosis: intrusion (e.g. nightmares or flashbacks), avoidance 
(e.g. thoughts or feelings), negative alterations in cognitions or mood (feeling isolated, 
exaggerated blame of self or others for causing the trauma), and alterations in arousal or 
reactivity (e.g. irritability or difficulty sleeping; American Psychiatric Association, 2013). 
The presentation of symptoms in PTSD varies widely between affected individuals, with 
initial presentation often confounded by physical and psychiatric comorbidities (Galatzer-
Levy & Bryant, 2013; Kelmendi et al., 2016; Orcutt, Erickson, & Wolfe, 2004).  In fact, 
PTSD has a stronger association with physical symptoms than any other psychological 
disorder (Andreski, Chilcoat, & Breslau, 1998). 
2.4 History of physical symptoms and associated syndromes 
Physical symptoms have a long and complex history. Vacillations about the origin and 
classification of physical symptoms have generated recurrent conflict among clinicians, 
academics, philosophers, politicians, and veterans that are still relevant today. The 
following section of this thesis presents background regarding physical symptoms to 
provide perspective for the questions answered in this thesis.  
This section includes a summary of several significant features of the early origins of 
diagnoses involving physical symptoms and discusses three prominent diagnoses that 
       
Page | 14 
have shaped physical symptom syndromes: hysteria, neurosis, and neurasthenia. The term 
‘multiple unexplained physical symptoms’ (MUPS) is used frequently as many of these 
syndromes were developed to provide a theory for physical symptoms that the medical 
profession could not explain at the time. Firstly, syndromes are discussed as they 
developed in the medical profession, then as they influenced military medical practices, 
and lastly how they influenced the development of diagnostic categories.  
2.4.1 Physical symptoms before World War I 
The origins of attempts to classify MUPS can be traced back to the ancient Egyptian text 
the Kahun Papyri (1900 BC) where ‘spontaneous uterus movement’ was blamed for the 
female emotional hysteria (Tasca, Rapetti, Carta, & Fadda, 2012). Remarkably, ancient 
Greek physicians such as Hippocrates (460–370 BC) had formed the sophisticated 
understanding that psychological conditions were due to disorders of the brain (Kleisiaris, 
Sfakianakis, & Papathanasiou, 2014). However, the rise in power of the Roman Catholic 
Church through Europe in the middle ages (5th to 15th century), saw the Church take 
ownership of many areas of health (Finger, 2001).  Conditions such as hysteria, 
hypochondriasis, and convulsive fits came to be seen as witchcraft, demonology and 
sorcery, and their study by scientific medicine was forbidden, thereby limiting medical 
advancement (Veith, 1993; Westerink, 2014).   
During the Renaissance and Enlightenment, philosophers and scientists again began 
exploring the nature of the mind. Charles Darwin's (1809–1882) evolutionary theory of 
natural selection, although not an attempt to be irreligious, challenged the theological 
position of the time (Richards, 2005). Such challenges assisted the return of medical 
study to the domain of the mind (Butler, 1914). Medical specialisation began to emerge in 
Europe in the early 1800s, including the two overlapping fields of psychiatry (treating 
inpatient populations of hospitals and asylums) and neurology (treating conditions of the 
nervous system).  
2.4.1.1 Hysteria 
Work by Thomas Willis (1621–1675), an anatomist and neurologist, and Thomas 
Sydenham (1624–1689), a clinician, advanced the diagnosis of hysteria from being seen 
as caused by the uterus, possession, toxins, or disturbances of the Mesmer, to an 
emotional condition characterised by unexplained physical symptoms and behavioural 
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disturbance (North, Ryall, Ricci, & Wetzel, 1993). The French physician Paul Briquet 
(1796–1881) advanced the concept of hysteria, viewing it as a physical neurodegenerative 
process (Bogousslavsky, 2011; Chodoff & Lyons, 1958; Mai & Merskey, 1980, 1981). 
Briquet described hysteria as occurring in women, characterised by multiple physical 
complaints, frequent hospitalisation, and poly surgery (Bogousslavsky, 2011; Chodoff & 
Lyons, 1958; Mai & Merskey, 1980, 1981). 
Influential practitioners such as the French clinical neurologist Jean-Martin Charcot 
(1825–1893), and psychologist Pierre Janet (1859–1947), also saw hysteria as a 
neurodegenerative complaint (Chodoff, 1974). Hysteria had previously been seen as a 
solely female complaint, but Charcot identified ‘traumatic hysteria’, a condition found in 
men where a traumatic accident or injury acted as a trigger in individuals with an 
inherited predisposition (Jones & Wessely, 2007; Libbrecht & Quackelbeen, 1995; 
Micale, 1994). Charcot believed that predisposition played a greater role than the trauma, 
therefore placing blame on a weakness in the individual (Holdorff & Dening, 2011). 
Charcot observed motor and sensory disturbance with symptoms such as fatigue, 
headaches, back pain, palpitations, dizziness, and sleep disorders (Lerner, 2003).  
The work of Charcot and Janet influenced the theories of Austrian neurologist Sigmund 
Freud (1856–1939) and Viennese physician Josef Breuer (1842–1925), the founding 
fathers of psychoanalysis. Freud and Breuer described the aetiology of hysteria as an ego 
defence mechanism where traumatic memories were repressed and converted to physical 
symptoms in the unconscious mind (hysterical conversion; Chodoff & Lyons, 1958; Ford 
& Folks, 1985; Hafeiz, 1980; Kroll, Chamberlain, & Halpern, 1979; Ziegler, Imboden, & 
Meyer, 1960). Freud and Breuer also felt that hysteria only occurred in individuals who 
were predisposed to the condition, again blaming weakness in the individual (Breuer & 
Freud, 1956). 
2.4.1.2 Neurasthenia 
American influence in the MUPS field included neurologist George Beard (1839–1893) 
who in 1876 suggested that emotion could produce disease (Arieti, 1959; Gijswijt-Hofstra 
& Porter, 2001). Beard's suggestion saw an exploration of the psychological determinants 
of almost every somatic illness including asthma, tuberculosis, and arthritis (Arieti, 
1959). Beard was also known as the father of 'neurasthenia', a condition he described as a 
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weakness of the nerves due to the fast pace of modern living that could create bodily 
dysfunction (Arieti, 1959; Gijswijt-Hofstra & Porter, 2001). Neurasthenia was used to 
describe a wide range of psychological and physical symptoms including anxiety, 
insomnia, inattention, fatigue, palpitations, migraine, and indigestion (Gijswijt-Hofstra & 
Porter, 2001).  
2.4.1.3 Neurosis 
Similar to Willis and Sydenham, the Scottish physician William Cullen (1710–1790) 
moved away from religious thinking by suggesting psychiatric conditions were 
endogenous and not due to an external force (Knoff, 1970). Cullen was the first to 
describe 'neurosis', which he defined as irritability of the nervous system that could 
induce symptoms such as palpitations, fainting, convulsions, or vomiting (Arieti, 1959; 
Knoff, 1970).  
In 1884 the German neurologist Hermann Oppenheim (1858–1919) introduced a third 
traumatic neurosis, a condition typically seen in working class men following railway or 
workplace accidents (Holdorff & Dening, 2011; Lerner, 2003).  Oppenheim described 
symptoms very similar to those of Charcot’s traumatic hysteria, however he viewed the 
pathology as a physical reaction to terror, fright, or shock that caused lesions on the 
central nervous system and not attributable to internal weakness as described by Charcot 
and others who studied hysteria (Holdorff & Dening, 2011; Lerner, 2003).  
Another possible explanation for MUPS was provided in 1884 by English physician 
Clifford Allbutt (1836–1925) when he proposed the concept of ‘visceral neuroses’, 
exhaustion of the general vitality of the patient that could produce symptoms in all tissues 
controlled by the neuroendocrine system (Allbutt, 1884; Lichtwitz, 1930). 
2.4.1.4 Railway spine 
Another development of interest to MUPS came in the mid-1850s with industrialisation 
and the rapid rise of railway travel and accidents. The condition ‘railway spine’ was 
characterised by a variety of physical symptoms in otherwise healthy uninjured railway 
accident victims (Harrington, 2007). Symptoms included sleep disturbances, dreams of 
collisions, tinnitus, vasomotor instability, intolerance of railway travel, headache, spinal 
pain, and spinal tenderness (Hall, 1868). Initially, railway spine was seen as a physical 
disorder caused by damage to the spine (Erichsen, 1867), but was progressively seen as 
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hysteria, traumatic neurosis, or traumatic neurasthenia (Cohen & Quintner, 1996; 
Gasquoine, 1998; Keller, 1995).   
Railway spine became an important medical and medico-legal issue (Harrington, 2007). 
By the early 1860s, railway companies were paying considerable personal injury 
compensation (Harrington, 2007) and due to there being no visible pathology, the 
question of malingering arose (Hall, 1868; Reynolds, 1869; Walton, 1890). This was 
exacerbated by disagreement over the pathophysiology between medical specialists, with 
some supporting physical models of damage to spinal, neural, or musculoskeletal tissues, 
some supporting psychological or emotional disturbance (Cohen & Quintner, 1996; 
Crocq & Crocq, 2000), and others supporting deliberate malingering associated with the 
prospects of compensation (Prince, 1891). The debate of body-brain-mind relations of 
disease is similar to present concepts, and provides an example of the conflict caused by 
different views from different specialisations of medicine (Cohen & Quintner, 1996; 
Holdorff & Dening, 2011).  
The success of the railway spine claims through the court systems led to the establishment 
of workers' compensation on a wider scale. The first workers' compensation program, 
Workmen's Accident Insurance, was introduced by Bismarck in Germany in 1885 
(Kleeberg, 2003). Soon after, Oppenheim published a book on traumatic neurosis, 
strengthening the recognition of on-the-job injury in the aetiology of anxiety, depression, 
and physical symptoms (Bellamy, 1997). This debate over whether Oppenheim’s ideas of 
trauma as aetiological would shape the debate of traumatic neurosis through World War I 
(WWI; 1914–1918; Holdorff & Dening, 2011). 
This history demonstrates that the origins of diagnostic categories were based on patients 
who suffered at the extreme end of symptoms and disability, and it is this perspective that 
continues to influence clinicians’ thinking today. One disadvantage of this is that there are 
many patients whose disability is not extreme, so their condition may be perceived as 
medically insignificant, regardless of the significant impact it may have on their quality of 
life.  
To summarise, at the outbreak of WWI the medical profession was still an undisciplined 
area with anarchic literature that included many variations on symptomatology and 
nosology resulting in cataloguing hundreds of syndromes with little consensus (Arieti, 
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1959; Butler, 1914; Jones & Wessely, 2007). Generally accepted criteria for hysteria, 
neurosis, and neurasthenia were yet to be achieved and were the subject of considerable 
intense debate and controversy, with psychoanalysts, neurologists and psychiatrists 
offering conflicting views (Asnaani, Reddy, & Shea, 2014; Cohen & Quintner, 1996; 
Holdorff & Dening, 2011; Lerner, 2003). 
2.4.2 Wartime History 
Descriptions of debilitating physical symptoms in military personnel have been reported 
as early as the Crimean War (1853–1856) and the American Civil War (1861–1865). 
Records describe general debility with extreme fatigue (Jones & Wessely, 1999) and 
‘functional disorder of the heart’, ‘irritable heart’, ‘soldier’s heart’ or ‘Da Costa 
syndrome’ characterised by palpitations, chest discomfort, breathlessness with and 
without exertion, dizziness, faintness, and fatigue. These terms were also used in WWI 
along with a rapidly broadening selection of diagnoses such as ‘gas effect’, ‘shell-shock’, 
‘trench spine’, and ‘effort syndrome’, all of which described very similar presentations 
(Lewis, 1919). The different labels reflect the various medical theories of causation, as 
medical nosology traditionally classifies disorders according to their cause. Such names 
demonstrate that at the outbreak of WWI physiology dominated aetiology, diagnosis, and 
therapy; the importance of the ‘mind’ in combat pathology, while recognised in the 
Russo-Japanese War (1904 – 1905), had not been integrated into medical use (Bailey, 
1918; Butler, 1914; Crocq & Crocq, 2000; Jones & Wessely, 2007; Lewis, 1919; Scott, 
1990; Wood, 1941).  
In WWI, shell-shock was seen as brain damage induced by exposure to shell explosions 
and was a well-accepted diagnosis by both medical staff and soldiers (Bailey, 1918; 
Butler, 1914; Jones & Wessely, 1999). However, as the war progressed concerns over the 
cost of military pensions were raised due to the large number of affected soldiers. Many 
military leaders and physicians began to consider shell-shock a form of cowardice or 
malingering, thus it changed from being considered a legitimate physical injury to a sign 
of weakness of character (Crocq & Crocq, 2000; Scott, 1990).   
The term ‘war neurosis’, an extension of Oppenheim’s traumatic neurosis, was also used 
in WWI (Holdorff & Dening, 2011). Although Oppenheim saw traumatic neurosis as 
undetectable molecular alterations, these symptoms quickly came to be seen as a 
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weakness of the individual, similar to Charcot’s traumatic hysteria (Holdorff & Dening, 
2011; Lerner, 2003; MacCurdy, 2013; Smith & Pear, 1917). 
By the end of WWI, the need for standardised definitions was recognised. War neurosis 
gained popularity as a diagnosis; while there were still those that ascribed a physical 
cause, there was a paradigm shift toward psychological origins (Bailey, 1918; Butler, 
1914; Buzzard, 1923; Scott, 1990). The view that weakness of individuals was the cause 
of war neurosis was so entrenched that at the beginning of World War II (WWII; 1939–
1945) both the British and German forces declared they would not pay war pensions to 
anyone who suffered nervous conditions or breakdowns (Shephard, 1999). This view 
divided the medical profession (Bellamy, 1997). By 1941, with the help of community 
outrage, the British had reversed their position (Shephard, 1999). 
War neurosis maintained popularity throughout WWII , the Korean War (1950 – 1953), 
and early into the Vietnam War (1961–1975; Bourne, 1970; Scott, 1990). The theories 
current during those times were that the outcomes of traumatic stress were short-term.  
There was no concept of delayed onset or the impact of cumulative combat exposure. 
Therefore, part of the enduring use of the diagnosis was a lack of any appropriate 
alternative to describe post-war presentations (Crocq & Crocq, 2000).  
At the end of WWII Abram Kardiner, an American anthropologist and psychoanalyst 
who had been a student of Sigmund Freud, published his seminal book The Traumatic 
Neuroses of War (Kardiner, 1941).  Kardiner (1941) speculated that combat-associated 
symptoms stemmed from psychological injury rather than a soldier’s flawed character. He 
described a body-based disorder that he termed a ‘physio-neurosis’, stressing the overlap 
of both physical and psychological symptoms. 
A major development following the Vietnam War was the introduction of post-traumatic 
stress disorder (PTSD) as a diagnosis that considered exposure to combat trauma as 
having a causal role in these symptoms, and recognised that symptoms could have 
delayed onset and result in chronic clinical disorder in normal individuals (Figley, 1978; 
Yehuda & McFarlane, 1995) . This new diagnosis moved away from previous diagnostic 
categories that viewed psychiatric reactions to extreme trauma as abnormal behaviour 
caused by premorbid vulnerability, and instead acknowledge that PTSD may be a 
normative or adaptive response to trauma (Scott, 1990; Yehuda & McFarlane, 1995). 
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Following Kardiner’s, influence most of the early PTSD research focused on 
physiological disruption and acknowledged that it is often difficult to differentiate 
between the psychological and physical origins of symptoms (van der Kolk & McFarlane, 
1996). 
2.4.3 Somatisation in the Diagnostic and Statistical Manual of Mental Disorders  
At the end of WWII, the lack of systematic nomenclature for psychological disorders was 
recognised as problematic for the scientific advancement of medicine. This led to the 
introduction of formal classificatory systems such as the American Psychiatric 
Association's (APA) Diagnostic and Statistical Manual of Mental Disorders (DSM).  
The DSM is arranged into categories of ‘disorder’ grouped by related psychiatric 
syndromes. In the first two editions of the DSM (released in 1952 and 1968) diagnostic 
classification was based on psychodynamic theory, demonstrating the wide influence of 
the work of Freud in Europe and Meyer in the United States (Grob, 1991; Kawa & 
Giordano, 2012). Since the third edition, classification has been increasingly based on 
clusters of symptoms identified from clinical observation and epidemiological research 
(Kroenke & Rosmalen, 2006). The DSM has been criticised for the fact that expert 
consensus drives diagnosis rather than empirical knowledge (Clark, Cuthbert, Lewis-
Fernández, Narrow, & Reed, 2017).  
Across the many editions of the DSM, possible diagnostic criteria and terminology for 
syndromes based on physical symptoms have varied, reflecting the difficulties in their 
classification and in establishing valid diagnostic criteria (Fink, Rosendal, & Olesen, 
2005; Martin, 1999; Mayou, Kirmayer, Simon, Kroenke, & Sharpe, 2005). Some of the 
important changes in DSM categories that impact physical symptom syndromes are 
highlighted in the following section, and a flow diagram is provided in Figure 2.1 listing 
the psychiatric syndromes associated with each category and the changes across the many 
editions of the DSM.  
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Figure 2.1 Changes across editions of the American Psychiatric Association’s Diagnostic and 
Statistical Manual that impact syndromes involving physical symptoms 
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o dissociation or conversion 
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 other neurosis 
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 Divided into 10 body 
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Somatoform Disorder  
 somatisation disorder 
 pain disorder  
 hypochondriasis 
Somatic Symptom and Related Disorders  
 somatic symptom disorder  
 illness anxiety disorder  
 conversion disorder (functional neurological symptom disorder)  
 factitious disorder 
 psychological factors affecting other medical conditions 
 other specified somatic symptom and related disorder 
 unspecified somatic symptom and related disorder 
Somatoform Disorder  
 Somatoform Disorder  
 conversion disorder  
 hypochondriasis  
 somatoform pain disorder  
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1968 
DSM-I 
     1952 
     1952 
       
Page | 22 
The first edition, the DSM-I (American Psychiatric Association, 1952) published in 1952, 
included two categories significant to physical symptoms: Psychoneurotic Disorders, and 
Psychophysiologic Autonomic and Visceral Disorders. The latter category was divided 
into body systems and was specifically included to cover psychosomatic disorders which 
were described as ‘disturbance of innervation or of psychotic control’. This edition did 
not include any combat-specific diagnoses. It was believed that ‘gross stress reaction’ in 
the Transient Situational Personality Disorders category would encompass both combat 
and non-combat trauma as well as move away from negative reactions suffered by many 
veterans after combat (Houts, 2000). This reflected the belief that the impact of trauma 
was short-lived and, similar to Charcot’s ideas of hysteria, the emphasis remained on the 
individual not the event (Jones & Wessely, 1999). This definition emphasises the lack of 
understanding that the impact of trauma on an individual can be cumulative.  
In the 1968 DSM-II (American Psychiatric Association, 1968), the Psychoneurotic 
Disorders category was renamed ‘Neuroses’ and the psychosomatic disorders were now 
named ‘Psychophysiologic Disorders’ (physical disorders of presumably psychogenic 
origin). The diagnosis of ‘gross stress reaction’ was removed, as a consequence of which 
the DSM-II had no diagnosis that adequately described post-war syndromes (Crocq & 
Crocq, 2000). 
The DSM-III (American Psychiatric Association, 1980), released in 1980, introduced a 
descriptive classification, with a focus on the measurable features of disorders (Merskey, 
2009; North, 2015). The ‘Somatoform Disorder’ category was introduced and included 
‘somatization disorder’, modelled on Briquet’s syndrome. Diagnosis required a lifetime 
history of 14 symptoms for men and 16 symptoms for women from a list of 37 possible 
symptoms. Psychophysiologic disorders became ‘Psychological factors affecting physical 
condition’. Despite the attempt to be descriptive, there were many criticisms of the term 
‘somatoform disorder’. For example, it was considered inherently dualistic, implying that 
‘psychological’ illnesses are distinct from physical illnesses (Creed & Barsky, 2004; 
Kroenke et al., 1997; Spitzer et al., 1995).  
The fourth edition, the DSM-IV (American Psychiatric Association, 1994), released in 
1995, maintained the Somatoform Disorder category, but criteria were simplified to 
require only eight symptoms (from a list of 32) distributed among four designated organ 
systems. Somatoform disorder criteria were criticised for being over-restrictive in both 
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clinical and research settings (Creed, 2006; Kroenke, Sharpe, & Sykes, 2007; Lowe et al., 
2008). This may be valid considering the high prevalence of physical symptoms 
presenting to clinicians with a low rate of use of the diagnosis (Rief & Martin, 2014). 
Additionally, concerns were raised over stigma and patients’ distress at receiving a 
psychological diagnosis for their physical symptoms (Kirmayer, 2004; Mayou et al., 
2005; Rief & Isaac, 2007; Sharpe & Carson, 2001).  
The concept of MUPS has been a cornerstone criterion for the somatic group of 
conditions. However, research has identified several concerns with this symptom 
definition. These symptoms can be difficult to define and measure (Fink et al., 2005), and 
they demonstrate low interrater reliability (Kroenke et al., 1992; Rosendal, Bro, Fink, 
Christensen, & Olesen, 2003), show poor validity of physicians’ judgments (Fink et al., 
2005), may transform back and forth between being considered medically explained or 
unexplained (Duddu et al., 2008; Jackson & Passamonti, 2005; Kisely & Simon, 2006; 
Klaus et al., 2013), and there is limited variation in outcomes whether explained or 
unexplained (Kisely & Simon, 2006; Klaus et al., 2013). An additional criticism of the 
DSM-IV is that the diagnosis of somatisation disorder is based on the exclusion of 
organic disease and not any positive psychological criteria (Fink et al., 2005). 
These concerns saw the disorder again revised in the DSM-V (American Psychiatric 
Association, 2013), released in 2013. Somatoform Disorder was renamed ‘Somatic 
Symptom and Related Disorders’, characterised by an intense focus on physical 
symptoms which cause significant distress and/or interfere with daily functioning, thereby 
introducing a positive psychological criterion. Somatic Symptom Disorder now requires 
one or more physical symptoms that can be medically explained or unexplained. There 
are still critics of the current definition; for example, that the broadening of the definition 
has considerably increased the numbers of those who would qualify for diagnosis, and 
that it has made research using previous DSM definitions not comparable to DSM-V 
defined research (Rief & Martin, 2014).  
The changes in the DSM over time highlights the lack of knowledge and clinician 
agreement, the lack of utility of many diagnostic separations, and the arbitrary distinction 
between cases and non-cases (Kroenke & Rosmalen, 2006).  The significant directional 
changes seen in diagnostic classifications can have far-reaching ramifications for both 
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diagnostic practice and research. The move toward a more descriptive reflection of 
diagnostic criteria in the most recent DSM-V demonstrates that regardless of a long 
history and extensive research, we are still no closer to having a clear conceptualisation of 
physical symptoms and related syndromes. 
The question remains, to what extent can we separate the physical and psychological axes 
of distress (i.e. is distress a dimensional construct)? The large observational databases 
available in modern research, such as military databases, with their large numbers and 
depth of detail make them ideal for exploring such questions. 
2.5 Physical and psychological symptoms: The modern military context 
Many veterans believe their physical symptoms are physical in cause and related to their 
experiences and environmental exposures on deployment.  This belief can cause conflict 
with the medical profession and military who often believe the cause is related to the 
psychological stress of the deployment environment or weakness of the individual (Haley, 
1997; Hyams, Wignall, & Roswell, 1996; Kilshaw, 2008; Landrigan, 1997). This research 
aims to determine whether there is a causal nexus between deployment and physical 
symptoms, and therefore the focus of this thesis is on military personnel who have 
deployed to an area of conflict.  
Compared to the general community, deployed military personnel are at higher risk for 
both physical and psychological symptoms, and these symptoms (and their interrelations) 
must be considered within the context of the unique work environment and broader 
culture of the military. In this section, the significance of physical and psychological 
symptoms in the military and the uniqueness that traumatic military deployment 
exposures introduce to these diagnoses are discussed.  
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2.5.1 Physical symptoms following military deployment 
Military personnel deployed to an area of conflict have high documented rates of physical 
symptoms (Cherry et al., 2001; de Silva, Jayasekera, & Hanwella, 2013b; Everitt, Ismail, 
David, & Wessely, 2002; Hoge et al., 2007; Kelsall et al., 2004b; Killgore, Stetz, Castro, 
& Hoge, 2006; Kroenke et al., 1998; Schwartz, Doeddeling, Merchant, & Barrett, 1997; 
Toblin et al., 2012; Unwin et al., 1999b; Vanderploeg et al., 2012; Waller et al., 2012; 
Wolfe, Proctor, Davis, Borgos, & Friedman, 1998). Most major military conflicts in 
modern history have an associated post-war syndrome described by clusters of physical 
symptoms. For example, shell-shock was first documented after WWI, Agent Orange 
Syndrome after the Vietnam War, and Gulf War Syndrome after the first Gulf War 
(Hyams et al., 1996; Jones et al., 2002). While the labels and explanations of aetiology for 
these syndromes differ, there is remarkably little variability between their symptom 
presentation (Hoge et al., 2007; Hyams et al., 1996; Jones et al., 2002; Jones & Wessely, 
2004; Killgore et al., 2006; Vanderploeg et al., 2012). This is exemplified in a review of 
military records from the Boer War to the first Gulf War (Jones et al., 2002), where the 
authors’ conclusion about symptom presentation in post-war syndromes was:  
The form that these assume, the terms used to describe them, and the explanations 
offered by servicemen and doctors seem to be influenced by advances in medical 
science, changes in the nature of warfare, and underlying cultural forces (Jones et 
al., 2002, p. 324)  
The lack of variability in symptoms across post-war syndromes suggests that one or more 
factors common across all deployments may contribute to post-war syndromes and 
similar to functional somatic syndromes, raises the question of whether they are separate 
syndromes or one single war-related syndrome (Hyams et al., 1996). 
Given the high rates of physical symptoms among veterans and the significant negative 
impact of those symptoms, it may be that physical symptoms represent a significant threat 
to military fitness, member retention, force readiness, and civilian workforce participation 
as members transition out of the military. As a case in point, even though the military 
forces require high levels of health and fitness at entry, there is evidence that veterans 
returned from deployment experience faster physical health declines than age-matched 
civilians (Falvo et al., 2012). The reason for such declines is not known. One suggestion 
is that PTSD is an intermediary between trauma exposure and ill health (Schnurr, 2015). 
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The medical profession has historically either dismissed such symptoms or assigned the 
cause to somatisation, a diagnosis that often leaves members dissatisfied. Labelling 
veterans who suffer from physical symptoms with a psychological condition (e.g. 
somatisation) may be perceived negatively in military cultures as psychological labels 
may brand an individual as weak, and thus negatively impact career opportunities or 
progression (Friedman, 2006; Iversen et al., 2007; Kirmayer, 1988).  In the military 
setting, physical symptoms that are left without an explanation that is acceptable to the 
patient have been found to increase patients’ focus on symptoms and their level of 
distress, as well as to impact how patients view their health and the types of treatments 
they pursue (Clarke et al., 2008; Fiedler et al., 2004; Wright, McFarlane, Clarke, Sim, & 
Kelsall, 2015b).  The lack of what patients and advocacy groups perceive as an adequate 
diagnosis, explanation, and treatment for physical symptom syndromes has seen the 
development of alternate theories for symptom causation, usually based around 
environmental or toxic exposures. Such contested causation of symptoms can contribute 
to an increasing focus on the need for compensation and assigning blame (Engel Jr et al., 
2002).  
Conflict arises because, while members may attribute their symptoms to a physical cause, 
PTSD and other psychiatric disorders associated with trauma can also be associated with 
physical symptoms.  A greater understanding of the association between physical 
symptoms, psychological symptoms, and deployment could improve explanatory 
frameworks used by clinicians, which has the potential to improve doctor-patient 
relationships and therefore patient outcomes.  
A major methodological limitation concerning physical symptom reporting is the lack of 
definition of physical symptoms and therefore difficulty in operationalisation, a problem 
also identified in the non-military physical symptom literature (Kroenke, 2016; Mayou et 
al., 2005; Rief, Mewes, Martin, Glaesmer, & Brahler, 2011). This lack of clarity of 
definition has resulted in a wide variety of measurement tools. Some military studies used 
the somatic scale from the Patient Health Questionnaire (PHQ), which provides a total 
score that is diagnostic of somatisation (Hoge et al., 2007; Kroenke, Spitzer, & Williams, 
2002). Other studies created original lists of symptoms that are commonly reported by 
veterans and measured a count of the number of symptoms present (Kelsall et al., 2004; 
Unwin et al., 1999). Others used lists from civilian assessments, such as the Hopkins 
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Symptom Checklist (Derogatis, Lipman, & Rickels, 1974) with the addition of some 
veteran-specific symptoms (Ismail et al., 1999; Knoke, 2000).  Most of these approaches 
contain a mix of both psychological and physical symptoms without differentiation or 
subscales, making it unclear what is in fact being measured (appearing to vary between 
somatisation, general health symptoms, or a combination of physical and psychological 
symptoms). This lack of continuity of definition and measures makes comparison across 
studies difficult. 
2.5.2 Posttraumatic stress disorder following deployment 
Originally termed to describe a psychiatric disorder recognising the morbidity 
experienced by veterans of the Vietnam War (Scott, 1990), posttraumatic stress disorder 
(PTSD) has become the primary focus when addressing psychological injuries resulting 
from military combat  (Adler & Sipos, 2018). The potentially extreme circumstances of 
deployment places military members at high risk of meeting PSTD’s unique diagnostic 
criterion of exposure to a traumatic or stressful event. The presentation of symptoms in 
PTSD varies widely between affected individuals, with initial presentation often 
confounded by physical and psychiatric comorbidities (Galatzer-Levy & Bryant, 2013; 
Kelmendi et al., 2016; Orcutt et al., 2004).   
The exact prevalence of PTSD in military personnel is a matter of debate. For example, a 
recent review of prevalence studies of military veterans of the Iraq conflict found rates 
between 1.4% and 31%, which the authors suggested may be the result of methodological 
and sample differences (Sundin, Fear, Iversen, Rona, & Wessely, 2010). One factor that 
can have a major influence on PTSD prevalence is the roles of a member’s unit on 
deployment, which can vary widely within and between services and nations (Kok, 
Herrell, Thomas, & Hoge, 2012). For example, one study found that the higher 
prevalence of PTSD in US veterans compared to UK veterans of Iraq and Afghanistan 
conflicts could be explained by differences in combat exposure (Sundin et al., 2014). This 
result demonstrates that examining prevalence alone does not always provide an accurate 
reflection.  
The 12-month prevalence of PTSD in ADF members is estimated at 8.3% (McFarlane & 
Hodson, 2011), and even higher amongst members who have transitioned out of the ADF 
within the last 5 years (17.7%; Van Hooff et al., 2018). The long-term effects of PTSD 
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can be devastating in military personnel, including substance abuse, suicide ideation, 
physical health problems, significant medical illness, mortality, diminished productivity, 
disability, relationship disruption, and unemployment  (Elliott, Gonzalez, & Larsen, 2011; 
Friedman & McEwin, 2004; Holdeman, 2009; Krysinska & Lester, 2010; Monson, Taft, 
& Fredman, 2009; Pietrzak, Goldstein, Southwick, & Grant, 2012; Shipherd, Stafford, & 
Tanner, 2005; Zatzick et al., 1997). Kessler (2000) estimated the annual cost to US 
society of lost productivity due to PTSD to be approximately $3 billion, a cost that would 
have increased due to inflation and the involvement of the US military in conflicts in the 
Middle East. 
PTSD is currently underdiagnosed in the military and treatment outcomes are poor (Rona 
et al., 2012; Steenkamp, Litz, Hoge, & Marmar, 2015). These factors combined with the 
high personal, military, and community costs validate the need for research that may 
improve detection and treatment. 
2.5.3 Physical symptoms and posttraumatic stress disorder in the military 
Veterans with diagnosed PTSD are more likely to report physical symptoms than those 
without a diagnosis of PTSD (de Silva et al., 2013; Grieger et al., 2006; Litz, Keane, 
Fisher, Marx, & Monaco, 1992; Shalev, Bleich, & Ursano, 1990; Wolfe et al., 1999). For 
example, a study of US Iraq veterans found that the prevalence of multiple physical 
symptoms one year after deployment to Iraq was 34% in those who met screening criteria 
for PTSD, compared to 5.2% in those who did not (Hoge et al., 2007). A civilian study 
showing similar findings examined firefighters and found that those who screened 
positive for PTSD were more likely to report cardiovascular, respiratory, musculoskeletal, 
and neurological problems than firefighters who were also exposed to a devastating 
bushfire but were not screened positive for PTSD (McFarlane, Atchison, Rafalowicz, & 
Papay, 1994). 
PTSD demonstrates a strong association with physical symptoms across various civilian 
and military samples, more so than other psychological disorders (Andreski et al., 1998; 
Asmundson, Coons et al., 2002; Beckham et al., 1998; Beckham et al., 2005; Benyamini 
& Solomon, 2005; Friedman & McEwin, 2004; McFarlane et al., 1994; Runnals et al., 
2013; Schnurr, Spiro, & Paris, 2000; Shalev et al., 1990; van der Kolk et al., 1996; Wolfe 
et al., 1999).  This strong association was recognised by the forefathers of the PTSD 
   INTRODUCTION 
 
                                                                                                                                                                                         Page | 29 
diagnosis, Kardiner (1941) and Kolb (1989), who both described psychophysiological 
reactivity as a core component of the disorder. However, current diagnostic criteria 
greatly underplay this aspect of presentation.   
While this strong relationship between physical symptoms and PTSD has been identified, 
the association of specific individual physical symptoms with psychological disorder is 
generally found to be low (Simon et al., 1999; Wessely et al., 1999).  However, two small 
studies of refugee populations identified a small group of self-reported physical 
symptoms (headache, appetite change, dizziness or fatigue, and sleep problems) that 
demonstrated reasonable prediction of PTSD status (Gulden et al., 2010; Westermeyer et 
al., 2010). While these studies made a valuable contribution there is the possibility that 
this research could be extended. For example, revisions could consider that: these studies 
used small specific samples; only a few symptoms were examined, and these were chosen 
through clinical opinion, leaving room for a more objective examination of a broader 
range of symptoms; PTSD was measured using a self-report measure, so this could be 
improved by the use of a clinical interview; and the cut-offs for the physical symptom 
measures could have been identified with more sophisticated diagnostic validity 
measures. Exploration of whether these results could be replicated in other high-risk 
populations, such as military members deployed to an area of conflict, could provide a 
valuable resource in PTSD screening. Additionally, identifying patterns of symptom 
association could be suggestive of the pathological mechanisms involved in PTSD. 
2.6 Risk factors for physical symptoms and PTSD  
Exposure to trauma is a requirement for a PTSD diagnosis, and exposure to combat-zone 
stressors is generally accepted as playing a causal role (Fontana & Rosenheck, 1994; 
Helzer, Robins, & McEvoy, 1987; Shore, Tatum, & Vollmer, 1986). Furthermore, it has 
been recognised that cumulative exposure to traumatic events are related to PTSD in a 
‘dose-response’ manner in both civilian (Kolassa et al., 2010; Mollica, McInnes, Poole, & 
Tor, 1998; Neuner et al., 2004; Rona et al., 2009a) and military research (Hoge et al., 
2004; Iversen et al., 2008; Phillips, LeardMann, Gumbs, & Smith, 2010; Pietrzak, 
Johnson, Goldstein, Malley, & Southwick, 2009b; Smith et al., 2008; Vogt, Proctor, 
King, King, & Vasterling, 2008; Xue et al., 2015). The finding that despite exposure to 
trauma being common, only a small proportion of people develop PTSD suggests that 
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individual vulnerabilities may exist (Yehuda & McFarlane, 1995). Several factors that 
may increase vulnerability to PTSD in military members have been identified. These can 
be divided into: pre-deployment factors including low motivation to serve, prior trauma 
exposure, prior psychological problems, female gender, ethnic minority status, and low 
education (Kaplan et al., 2002; Xue et al., 2015); deployment factors including non-
officer ranks, army service, combat specialization, high numbers of deployments, 
comradeship, group cohesion, and longer cumulative length of deployments (Kaplan et 
al., 2002; Rona et al., 2009b; Xue et al., 2015); and post-deployment factors including 
lack of post-deployment social support (Xue et al., 2015). 
Exposure to traumatic events has also been recognised as associated with physical 
symptoms, but unlike PTSD, trauma is not recognised as having a major causal role in 
post-trauma physical symptoms (Afari et al., 2014). In military studies the association of 
physical symptoms with psychological disorder has continued to be a dominant area of 
physical symptom research, however findings have been contradictory. For example, 
research by Quartana et al. (2015) supports the role of psychological disorder in physical 
symptom causation. This group examined the hypothesis that mental health conditions are 
essential to fully explain the association between combat exposure and physical 
symptoms (Quartana et al., 2015).  This small study of US soldiers, conducted three 
months after return from a 15-month deployment to Iraq in 2003-2004, used a multiple 
indirect effects model and found no direct effect of combat exposure and physical 
symptoms but a significant indirect association through PTSD, depression, and insomnia 
symptoms (Quartana et al., 2015). Other earlier research among British and Danish 
military personnel deployed in Iraq and Afghanistan also failed to find an association 
between combat participation and physical symptoms (Hotopf et al., 2003; Nissen, 
Marott, Gyntelberg, & Guldager, 2011).  In contrast, findings using data from the large 
longitudinal US Millennium Cohort Study demonstrated that even after adjusting for 
psychological morbidity, there was a consistent and robust longitudinal association 
between reported combat exposures during deployment and multiple physical symptoms, 
suggesting that the most important risk factor for physical symptoms was combat 
exposure (McCutchan et al., 2016). This study did not examine the number of 
deployments or cumulative duration of deployment, nor did it differentiate types of 
trauma (McCutchan et al., 2016).  
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Variations in research findings may be due to the inclusion of different confounders, 
definitions of physical symptoms, or other differences in methodology. For example, the 
inclusion of correlated factors such as depression, or negative affectivity may artificially 
weaken associations.    
Some additional causal mechanisms have been investigated for both PTSD and physical 
symptoms. For example, mild traumatic brain injury (mTBI) has been explored as a 
possible mechanism for the association between combat deployment and both PTSD and 
physical symptoms. However, most research findings have not supported an association 
between mTBI and physical symptoms (Fear et al., 2009; Hoge et al., 2007; Quartana et 
al., 2015; Vanderploeg et al., 2012; Wilk, Herrell, Wynn, Riviere, & Hoge, 2012). PTSD 
and mTBI are highly comorbid, but the pathological relationship is not well understood 
(Santhanam et al., 2018). Other deployment exposures have also been explored, such as 
Agent Orange in the Vietnam War and, in more recent deployments, the anti-malaria 
medication Mefloquine (Eick-Cost, Hu, Rohrbeck, & Clark, 2017; Nevin, 2017; Stellman 
& Stellman, 2018). Some of the interest in exploring these exposures is that personnel are 
often looking for an organic cause for some of the neurocognitive or physical symptoms 
they experience post-deployment.  
The difficulty in understanding the aetiology of both PTSD and physical symptoms, like 
many health conditions, stems from the fact that their aetiology is likely multifactorial. 
For example, there is some evidence that genetics influence both physical symptoms and 
PTSD (Ball et al., 2011; Daskalakis, Rijal, King, Huckins, & Ressler, 2018; Gillespie, 
Zhu, Heath, Hickie, & Martin, 2000; Kato, Sullivan, Evengård, & Pedersen, 2009; 
Kendler et al., 2011). While genetics is a factor that may create some vulnerability, 
environmental factors (Ball et al., 2011; Fink et al., 2007), particularly early life adversity 
(Creed, Barsky, & Leiknes, 2011; Essau, 2007; Hotopf, Mayou, Wadsworth, & Wessely, 
1999) and exposure to trauma (Katon et al., 2001) show more promise in providing 
possible pathological mechanisms.  
A Norwegian study (N = 2776) that included 449 twin pairs found that trauma exposure 
had a direct association with psychological disorder. However, among twins discordant 
for trauma exposure, the findings suggest that familial effects may account for some of 
the relationship between trauma and major depressive disorder but no significant effect 
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for other axis 1 disorders were seen (Brown et al., 2014). Studies have also found that 
trauma is associated with the reporting of physical symptoms post-deployment 
(Asmundson et al., 2002a; Benyamini & Solomon, 2005; Engel Jr, Liu, McCarthy, Miller, 
& Ursano, 2000; Friedman & McEwin, 2004; Jakovljević, Sarić, Nad, Topić, & Vuksan-
Cusa, 2006; Killgore et al., 2006; Krause, Shaw, & Cairney, 2004; Maia, McIntyre, 
Pereira, & Ribeiro, 2011; McCutchan et al., 2016; North, Kawasaki, Spitznagel, & Hong, 
2004; Petkus, Gum, King-Kallimanis, & Wetherell, 2009).   
2.6.1 Deployment trauma 
In the military profession, regardless of deployment status or role, the nature of training 
and everyday duties can place members at high risk of exposure to stressful and traumatic 
events.  Military trauma is multifaceted, with personnel exposed to many diverse, 
potentially traumatic, high-magnitude combat and operational stressors as well as 
malevolent working environments and stressful environmental exposures (King, King, 
Gudanowski, & Vreven, 1995; Stein et al., 2012; Wright et al., 2015a).  The impact of 
cumulative trauma has been acknowledged by the inclusion of the stressor criterion 
’experiencing repeated or extreme exposure to aversive details of traumatic event(s)’ in 
the recent DSM-V revision of PTSD (American Psychiatric Association, 2013; 
Benyamini & Solomon, 2005; Clancy et al., 2006; McFarlane, 2017; Nelson et al., 2011; 
Wisco et al., 2014).  
Relatively little research exists on how to best quantify and assess the extent of trauma 
exposure (Weathers & Keane, 2007; Wilker et al., 2015).  Therefore, the assessment 
techniques used to explore trauma exposure in military research vary widely, including 
qualifying trauma as having any combat experience (McCutchan et al., 2016); assessment 
of the total frequency of TDEs (Quartana et al., 2015; Toblin et al., 2012); counting 
variables of the number of different types of trauma, which may include non-military 
trauma (Searle et al., 2017); examining the one worst traumatic event meeting criterion A 
for PTSD (Kilpatrick et al., 2013; Prigerson, Maciejewski, & Rosenheck, 2001); 
examination of specific traumatic events (Maguen et al., 2010; Osorio et al., 2018; 
Phillips et al., 2010; Pietrzak, Whealin, Stotzer, Goldstein, & Southwick, 2011; Rona et 
al., 2009a; Shea, Walsh, Macmillan, & Steiner, 2005; Watkins, Sudom, & Zamorski, 
2016); or using principal component analysis, factor analysis or other techniques to 
reduce a list of exposures to factors or categories for analysis (Osorio et al., 2018; Searle 
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et al., 2017; Waller et al., 2012). The assessment of trauma is further complicated by 
changes in the way trauma exposure has been conceptualised and operationalised in 
revisions of the DSM. This lack of consistent approach makes cross-comparisons between 
studies difficult.   
Regardless of the inconsistencies in how trauma is operationalised and measured, there is 
a considerable body of research demonstrating a strong association between military 
trauma and PTSD. It has been suggested that some specific deployment exposures may 
have more impact on the risk of PTSD or even the symptoms associated with PTSD 
(Clancy et al., 2006; Osorio et al., 2018; Smith et al., 2008; Stein et al., 2012); for 
example, increased combat exposure has consistently been shown to be a risk factor for 
PTSD (Pietrzak et al., 2011; Xue et al., 2015).  A recent meta-analysis of 32 articles 
related to military PTSD found that deployment exposures such as discharging a weapon, 
witnessing someone being wounded or killed, severe trauma, and deployment-related 
stressors, were all risk factors for PTSD (Xue et al., 2015). Additionally,  objective 
degree of trauma exposure may be less predictive of PTSD than the individual’s 
subjective appraisals of the trauma, particularly the appraisal of threat-to-self (Ehlers & 
Clark, 2000; Halligan, Michael, Clark, & Ehlers, 2003; Ozer, Best, Lipsey, & Weiss, 
2003; Phillips et al., 2010; Rona et al., 2009a; Shea et al., 2005; Solomon, Zur-Noah, 
Horesh, Zerach, & Keinan, 2008).  
Specific traumatic deployment exposures and physical symptoms have received 
comparably less attention and findings are inconsistent. Studies exploring this association 
have found that combat exposure is a risk factor for physical symptoms (de Silva et al., 
2013; Hotopf et al., 2006; McAndrew et al., 2013; McCutchan et al., 2016), but a small 
study by Quartana et al. (2015) found no direct association between combat exposure and 
physical symptoms. The association of specific exposures and physical symptoms also 
has inconsistent findings. For instance, a large study of US military personnel from the 
first Gulf War found no association between specific exposures and individual physical 
symptoms (Kroenke et al., 1998). However, a study of Danish soldiers deployed to Iraq 
found subjective appraisal (e.g. fear of being physically harmed, feeling of insecurity 
outside of camps, feeling of meaninglessness) and human death and degradation 
exposures (e.g. witnessing atrocities, and having been in touch with prisoners) were 
associated with physical symptoms (Nissen et al., 2011). Another study conducted with a 
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sample of 259 Special Forces and 412 regular Sri Lankan navy personnel who had served 
for 12 months in a combat area between 2006 and 2009 found that threat-to-self 
exposures were associated with physical symptoms (de Silva et al., 2013). This study 
found that the subjective assessment of ‘thought I might be killed’ was associated with 
multiple physical symptoms. A study by Vanderploeg et al. (2012) included assessment 
of injury and found that, with or without physical injury, ‘seeing others wounded or 
killed’ or ‘experiencing the death of a buddy or leader’ were associated with indigestion 
and headaches. In summary, there is not a large body of research in this area but a theme 
that appears to be emerging is that, similar to PTSD, subjective appraisals and human 
death and degradation may be associated with physical symptoms.  
The impact that subjective appraisal of TDEs can have on risk highlights the importance 
of cognitive and emotional responses to traumatic experiences. The DSM-IV (American 
Psychiatric Association, 1994) criteria for PTSD included that responses to a trauma 
involved ‘fear, helplessness or horror’. While this was removed for the DSM-V 
(American Psychiatric Association, 2013) criteria, other intense emotions such as disgust, 
grief, anger, guilt, and shame have also been suggested as significant factors in PTSD 
(Bernat, Patrick, Benning, & Tellegen, 2006; Crocker, Haller, Norman, & Angkaw, 2016; 
Engelhard, Olatunji, & de Jong, 2011; Hathaway, Boals, & Banks, 2010; Peterson, 
Luethcke, Borah, Borah, & Young-McCaughan, 2011). The autonomic nervous system 
(ANS) plays a critical role in both emotional and stress responses through providing 
physiological responses for adaptive action, but also by providing visceral sensations that 
can shape the subjective emotional experience (Levenson, 2003; McEwen, 1998). Thus, it 
is plausible to consider that the physiological arousal to TDEs via the ANS may also play 
a causal role in the experience of physical symptoms. 
Studies examining the prevalence of physical and psychological symptoms often use 
correlations or regression to explore the association of physical symptoms with 
exposures, demographics or psychological disorder. For example, a study examining 
ADF members involved in two different warlike peacekeeping deployments to 
Bougainville or East Timor used separate logistic regression to examine emotional 
distress (measured with the K10), PTSD (measured with the PCL), and health symptom 
outcomes for objective and subjective traumatic exposures (examined as quartiles) 
(Waller et al., 2012). The findings show that higher levels of subjective exposures were 
   INTRODUCTION 
 
                                                                                                                                                                                         Page | 35 
significantly associated with PCL scores and health symptoms for Bougainville but only 
health symptoms for the East Timor group (Waller et al., 2012). Few have examined how 
TDEs predict physical and psychological presentation within the same individual. One 
study that examined this was conducted with a sample of US soldiers just prior to combat 
deployment during Operation Iraqi Freedom (Killgore et al., 2006). The researchers used 
ANOVA to examine affective and somatic complaints as within-subject variables and 
whether a member had combat experience as a between-subjects variable. They found 
that soldiers with previous combat experience had lower affective and greater somatic 
complaints relative to combat-naive soldiers (Killgore et al., 2006). These approaches are 
valuable for providing information on the average levels of symptoms across all 
participants across a sample.   
Research for this thesis is interested in exploring whether the association between 
physical symptoms and TDEs is similar to the association between psychological 
symptoms and TDEs.  Examining the association that different symptomatic presentations 
(i.e. physical, psychological, or their overlap) have with TDEs may provide insight into 
the mechanisms involved in symptom development. 
2.7 Theorised mechanisms for the link between trauma and symptoms  
While the relationship between trauma and physical symptoms has long been realised 
(Shorter, 2008), dominant explanatory models have been based around psychological 
processes such as somatisation, dissociation, conversion, and other cognitive models (see 
Roelofs and Spinhoven, 2007 for review).  However, these theories do not integrate well 
with emerging findings of neurobiological alterations.   
Studies over the past few decades have provided evidence that stress impacts the 
complex interactions of the central nervous system (CNS), the endocrine system and 
the immune system, finding that dysregulation of these systems can provoke health 
changes (Glaser & Kiecolt-Glaser, 2005). Chronic stress is increasingly theorised as a 
catalyst to accelerated aging, ill-health, and disease (Boscarino, 1997, 2004; Friedman & 
McEwin, 2004; Juster et al., 2011; McEwen, 1998; Schnurr & Green, 2004).   
The hypothalamic–pituitary–adrenal (HPA) axis and the sympathetic nervous system 
(SNS) provide the body’s response to stress by assisting in physiological adaptions to 
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maintain homeostasis (allostasis; Chrousos, 2009; Smith & Vale, 2006; Tsigos & 
Chrousos, 2002) . Whereas acute response to stress is adaptive, chronic activation of the 
system is thought to damage the feedback loops that return hormones to their normal 
levels. When stress exceeds the ability of the individual to cope, dysregulation of the 
stress system can result. Allostatic load is a conceptual framework developed  to describe 
the wear and tear that repeated or chronic stress incurs on the body (Friedman & McEwin, 
2004; McEwen, 1998).   
The stress response involves a complex bidirectional relationship between the nervous, 
endocrine and immune systems. As well as the HPA axis, stress can also activate the 
sympathetic–adrenal–medullary (SAM) axis, stimulating the release of pituitary 
(adrenocorticotropic ATCH)  and adrenal hormones (glucocorticoid hormones) which 
can begin a cascade of stress hormones such as catecholamines (adrenaline and 
noradrenaline), cortisol, growth hormone and prolactin, all of which impact immune 
function (Glaser & Kiecolt-Glaser, 2005). There are two ways these stress hormones 
may impact the  immune response: directly, by binding to the appropriate receptor on 
the surface of immune cells l; or indirectly, for example, by dysregulation of cytokines 
such as interferon-γ (IFN-γ), interleukin-1 (IL-1), IL-2, IL-6 and tumour-necrosis 
factor (TNF; Glaser & Kiecolt-Glaser, 2005). These hormones and cytokines can act as 
negative feedback mechanisms on all levels of the system including the CNS (Glaser & 
Kiecolt-Glaser, 2005). For example, the HPA axis is involved in a negative feedback 
loop that regulates cortisol release. The release of corticotropin releasing hormone 
(CRH) by the hypothalamus stimulates the release of ACTH from the pituitary which in 
turn stimulates the adrenal gland to release glucocorticoids such as cortisol. Cortisol then 
exerts negative feedback on the pituitary and the hypothalamus to restore homeostasis. 
An interesting anomaly to this stress response demonstrating the impact of allostatic load 
and HPA dysregulation can be seen in PTSD. Contrary to the expected elevated stress 
hormones in individuals with PTSD, most studies find low levels of cortisol (Yehuda et 
al., 2015; Zoladz & Diamond, 2013). 
Stress induced dysregulation of the immune system and the production of cytokines 
creates a link between stress, inflammation, and ill-health. One important pro-
inflammatory cytokine is IL-6, an acute phase responder produced by T cells, B 
lymphocyte cells, and monocytes in response to other inflammatory cytokines (Black, 
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2003). IL-6 is an important inducer of C-reactive protein (CRP) by the liver, and 
elevated levels of CRP and IL-6 predict mortality in the elderly independently of 
conventional risk factors (Black, 2002; Black, 2003; Reuben et al., 2002). Elevated 
CRP predicts hypertension, future coronary heart disease, and cardiac mortality (Sesso 
et al., 2003; Solak et al., 2016), and IL-6 and TNF-α are associated with subclinical 
atherosclerosis and coronary heart disease (Amar et al., 2006; Cesari et al., 2003; 
Larsen, Laughlin, Cummins, Barrett-Connor, & Wassel, 2017).  
Inflammation is showing promise for improving our understanding of many somatic 
diseases, as well as a diverse range of psychological disorders including PTSD, 
depression and schizophrenia (Baune et al., 2012; Iwata, Ota, & Duman, 2013; 
Khandaker et al., 2015; Lindqvist et al., 2017a; Lindqvist et al., 2017b; Spitzer et al., 
2010a; von Känel et al., 2007; Zalli, Jovanova, Hoogendijk, Tiemeier, & Carvalho, 2016).  
The role of inflammation in the aetiology of depression has received considerable 
research attention (see Miller and Raison, 2016 for review), with physical symptoms 
found to be a major driver of this association (Duivis, Vogelzangs, Kupper, de Jonge, & 
Penninx, 2013). Similarly, the HPA axis has been found to have a central role in the 
development and maintenance of PTSD (Yehuda et al., 1998). However, the difficulty in 
this area of research is that biomarker levels are impacted by almost every area of life 
from activity levels to childhood experiences, creating many covariates to consider as 
well as considerable variability within and between individuals. As a result, findings are 
often inconsistent. For example, in reference to PTSD several civilian and military studies 
have reported higher concentrations of various pro-inflammatory cytokines (Groer, Kane, 
Williams, & Duffy, 2015; Heath et al., 2013; Lindqvist et al., 2017b; Lindqvist et al., 
2014), but others have not (Bonne et al., 2011). 
HPA axis dysfunction has also been explored as a biological risk marker in functional 
somatic disorders and physical symptoms, but again findings with inflammatory markers 
are inconsistent, and when found, effect sizes are usually small (Houtveen, Kavelaars, 
Heijnen, & van Doornen, 2007; Tak & Rosmalen, 2010). For instance, in a population-
based study of 741 male and female adults, Tak et al. (2009) assessed 24-hour urinary 
free cortisol as a measure of HPA-axis function and found no association with total 
number of symptoms or symptom clusters (musculoskeletal, gastrointestinal, 
cardiorespiratory, or general). Another study by Tak et al. (2011) examined the 
    
Page | 38 
relationship of CRP with total symptom count and the same symptom clusters as the 
previous study, but again found no association with physical symptom count and only a 
small association with musculoskeletal symptoms. This line of research offers alternative 
aetiological explanations for physical symptoms and suggests that the term ‘somatisation’ 
may be too reductionist (Burton, 2002; McFarlane et al., 2008; Sharpe & Carson, 2001).  
Advancement in the ability of medicine to capture biological components of the stress 
response such as measures of cardiac vagal tone or functional magnetic resonance 
imaging (fMRI) show promise in improving understanding of the neurophysiological 
dysregulation that occurs with traumatic exposures (Henningsen & Creed, 2010). These 
new developments raise the controversial question: how to best classify physical 
symptoms? If biological changes are found to be a key mechanism, a review of physical 
symptoms to conceptualise them as a systemic reaction to trauma rather than a secondary 
somatic symptom may be needed, in which case a re-medicalisation of these symptoms 
may better serve the patient (Rief & Isaac, 2007; Sharpe & Carson, 2001). Such changes 
may be less stigmatising and therefore more acceptable to patients, make treatment more 
accessible, and even be suggestive of new treatment targets (Mayou et al., 2005; Rief & 
Isaac, 2007).  
2.8 Recent military deployment research 
For most wars throughout history, disease has been a major risk factor to the health of 
military personnel; for example, the influenza pandemic during WWI killed thousands in 
military camps and the trenches (Summers, 2013; Wever & van Bergen, 2014). However, 
recent conflicts such as the first Gulf War are unique in their concern about modern 
environmental exposures such as chemical and biological weapons (Ferguson, 1997).  
Veterans of the first Gulf War (1990–1991) are highly relevant to the study of physical 
symptom reporting as the strong beliefs that their physical symptoms were related to 
exposures experienced on deployment gained considerable research interest (Brown et al., 
2001; Kilshaw, 2008). The high prevalence of physical symptoms in these veterans has 
led to extensive research in most coalition forces ranging from large population-based 
studies to small cross-sectional studies of specific military units or branches of service 
(e.g. (Chesbrough et al., 2002; Kelsall et al., 2004b; Unwin et al., 1999b; Van Hooff et 
al., 2014).  
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Large population-based epidemiological studies have explored the association between 
both physical and psychological symptoms reported by first Gulf War veterans and the 
various threatened (e.g. chemical and biological weapons; Holloway, Norwood, Fullerton, 
Engel, & Ursano, 1997) and actual environmental exposures (e.g. smoke from oil-fires; 
Lange, Schwartz, Doebbeling, Heller, & Thorne, 2002) and depleted uranium 
(McDiarmid et al., 2004). To date, independent review committees have not identified 
any specific exposures or risk factors to explain Gulf War veterans’ symptoms (Barrett, 
Gray, Doebbeling, Clauw, & Reeves, 2002b; Cherry et al., 2001; Fukuda et al., 1998; 
Gray, Reed, Kaiser, Smith, & Gastañaga, 2002; Schwartz et al., 1997), except deployment 
to the Gulf (Landrigan, 1997; Lashof, Knox, & Baldeschwieler, 1997) and a relationship 
with psychological health (Bartone, Ursano, Wright, & Ingraham, 1989; Horn et al., 
2010; Proctor et al., 1998; Wolfe et al., 1999). Nevertheless, as demonstrated by the 
volume of research and the extent of public interest, this absence of cause does nothing to 
resolve veterans’ concerns.  
Some of the Gulf War studies used control groups of military-era personnel who were not 
deployed to the Gulf, or personnel deployed to other conflict areas (Kelsall et al., 2004b; 
Unwin et al., 1999b). For example, an ADF study compared first Gulf War veterans with 
ADF veterans of other conflicts and found a significantly higher mean number of self-
reported symptoms for Gulf War veterans (14.7) compared with other conflict veterans 
(11.3; Kelsall et al., 2004b). Despite the differences in the number of symptoms between 
the two groups, there were no significant differences in the specific symptoms reported. 
The most commonly endorsed symptoms were sleep problems, fatigue, headaches, 
myalgia and arthralgia, skin irritation, and itchy or painful eyes (Kelsall et al., 2004).  
Similar prevalence rates of physical symptoms have been found in American (Kroenke et 
al., 1998; Smith et al., 2014), British (Unwin et al., 1999), and Canadian (Robinson, 
1995) Gulf War military veterans, as well as in personnel in the more recent Australian 
(Dobson et al., 2012) and British Middle Eastern conflict cohorts (Hoge et al., 2007; 
Hotopf et al., 2006).  Most studies have found no unique constellation of symptoms that 
would identify a specific Gulf War syndrome (Barrett et al., 2002b; Cherry et al., 2001; 
Everitt et al., 2002; Ismail et al., 1999; Knoke, 2000; Shapiro, Lasarev, & McCauley, 
2002). However, two studies found differences between Gulf War and non-Gulf War 
veterans. (Kang et al., 2002) used exploratory factor analysis to identify six symptom 
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clusters. Of the six factors identified, a neurological impairment factor (including the 
symptoms of blurred vision, loss of balance/dizziness, tremors/shaking, and speech 
difficulty) was more common in Gulf War veterans (Kang et al., 2002). Similarly, Haley, 
Kurt, and Hom (1997) used principal factor analysis and found six factors explaining 71% 
of the variance between the groups, also based around neurologic injury. Overall, the 
concordant findings across studies suggest that physical symptom reporting by first Gulf 
War veterans is a valid phenomenon and not the result of malingering or compensation 
seeking (Landrigan, 1997).  
As the last two examples show, factor analysis is a popular statistical technique utilised 
for investigating the symptoms reported by Gulf War veterans (Barrett et al., 2002a; 
Cherry et al., 2001; Doebbeling et al., 2000; Everitt et al., 2002; Forbes et al., 2004; 
Fukuda et al., 1998; Haley, 1997; Ismail et al., 1999; Kang et al., 2002; Kelton et al., 
2010; Knoke, 2000; Wagner, Wolfe, Rotnitsky, Proctor, & Erickson, 2000). Factor 
analysis is a method used in data reduction, developing scales, and identifying otherwise 
latent relations among multiple variables (Costello & Osborne, 2005). In another Gulf 
War example, Fukuda et al. (1998) used a combination of exploratory factor analysis and 
clinical and epidemiological reasoning to examine whether they could identify a case 
definition for the symptoms experienced by Gulf War veterans.  The case definition they 
derived was the patient having one or more chronic symptoms present for more than six 
months from at least two of three symptom categories: fatigue, mood-cognition problems 
and musculoskeletal problems (Fukuda et al., 1998). This case definition was labelled 
‘Multisymptom Illness’.  Australian, British, and other US military studies have identified 
similar factor structures in Gulf War veterans’ symptoms (Cherry et al., 2001; Forbes et 
al., 2004; Fukuda et al., 1998; Ismail et al., 1999; Kang et al., 2002; Kelsall et al., 2009; 
Knoke, 2000).  While Multisymptom Illness has been found to be more common in Gulf 
War veterans than in non-deployed and groups deployed elsewhere (Ismail et al., 1999; 
Kelsall et al., 2004; Knoke, 2000; Unwin et al., 1999), it has also been identified that the 
symptom patterns are not unique to Gulf War veterans (Everitt et al., 2002; Unwin et al., 
1999).  Thus, there is still no syndrome identified as unique to Gulf War veterans, which 
has left veterans without any explanation or treatment for their distress. 
The first Gulf War ended 28 years ago but the ADF has been involved in ongoing conflict 
in the Middle East, making this the conflict region in which the ADF has been actively 
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involved for the longest time (McFarlane, 2017).  Research on more recent Middle East 
deployments has continued to find higher rates of physical symptoms in deployed than 
non-deployed members (McCutchan et al., 2016; Toblin et al., 2012; Vanderploeg et al., 
2012). The ADF involvement in the Middle East has seen an increased tempo of 
deployments for ADF members with many completing multiple deployments in the space 
of a few years. The associated increased risk of TDEs may result in an increased risk of 
physical and psychological symptoms in members, creating some urgency for improving 
medical understanding of these symptoms.  
2.8.1 Reflections on deployment research  
A limitation of data-analytic methods such as factor analysis is that they may lack 
consideration of the different mechanisms involved in the aetiology of individual 
symptoms or groups of symptoms as they occur within the individual (Barrett, Gray et al., 
2002). There is a long-standing debate about whether lumping (condensing similar 
constructs under as few categories as possible, like Multisymptom Illness) or splitting 
(using distinctions in signs and symptoms to classify unique conditions separately) is the 
better approach, with the current DSM-V tending toward a lumping approach (Leventhal, 
2012). In the case of physical symptoms, the tendency to lump limits understanding of 
heterogeneity, such that the existence of subgroups with unusual patterns of symptom 
presentation will not be recognised (McFarlane et al., 2008).  
For capturing heterogeneity (splitting approach), the focus is more on the individual so 
person-centred approaches such as cluster analysis (e.g. k means clustering, machine 
learning, latent class analysis) are better suited because they organise data into groups by 
exploring how symptoms cluster together within the individuals when the nature of these 
groups in unknown (Bauer & Shanahan, 2007; Wilks, 2011). These person-centred or 
pattern-centred approaches can be more suggestive of different pathophysiological 
mechanisms and therefore may provide greater understanding of the pathogenesis, yet 
they are less commonly applied (Bergman & Magnusson, 1997; Bergman & Wångby, 
2014; von Eye & Bergman, 2003).  
One study of physical symptoms combined both variable-centred and person-centred 
approaches using a list of 95 health symptoms in both Gulf War and non-Gulf War 
veterans seven years after the first Gulf War (N= 11914; Cherry et al., 2001).  Principle 
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component analysis identified seven factors: psychological, peripheral, neurological, 
respiratory, gastrointestinal, concentration, and appetite; with five factors having higher 
scores in the Gulf War veterans (psychological, peripheral, respiratory, gastrointestinal, 
and concentration). Cluster analysis of the 95 symptoms then found six clusters that could 
be interpreted by use of the seven factors. Cluster analysis allowed estimation of the size 
of the groups, the six clusters were arranged in order of decreasing numbers of subjects 
and increasing overall severity, and then mean scores for each factor for the six clusters 
were calculated. Cluster 1 was a large (n = 4808) healthy cluster and cluster 6 was small 
(n = 374) with high symptom severity. The clusters showed subtle differences in which 
factors were more prominent; for example, Cluster 4, with high scores on respiratory and 
gastrointestinal problems and Cluster 6 with high symptom scores on all factors but 
predominantly the neurological factor (Cherry et al., 2001). More Gulf War than non-
Gulf War veterans belonged to the smaller clusters. This example shows that the two 
techniques provide quite different information about symptom presentation. The factors 
allow the reduction of large numbers of variables to a more manageable number, while 
the clusters show how symptoms occur within the individual.  
Other limitations of first Gulf War research have been widely discussed (see Hotopf and 
Wessely, 2005).  For example, most of the studies were cross-sectional, did not 
commence until many years after the war had finished, and were instigated as a reaction 
to veterans’ and community concerns over veterans’ health (Brown et al., 2001; Hotopf & 
Wessely, 2005). Such delays make it difficult to examine causation. Delay may also 
exacerbate the exclusion of ex-servicemen in studies as military members can be difficult 
to locate once discharged (Fukuda et al., 1998; Gray et al., 2002; Haley, 1997), a factor 
that can introduce a healthy worker bias as the most symptomatic are more likely to be 
discharged or choose to leave the military (Baker et al., 2009). Delayed data collection 
also adds the complication of retrospective recall of exposures and self-reported health 
outcomes (Barrett, Gray et al., 2002).  For example, the mental state of participants can 
influence reporting (Brewin, Andrews, & Valentine, 2000; Ozer et al., 2003; Wessely et 
al., 2003); those who are ill may ruminate over exposures, and those who are healthy may 
be more likely to downplay exposures. Furthermore, the media may reinforce inaccurate 
narratives about causation (Burkett & Whitley, 1998). First Gulf War research also 
suffered from low response rates (Hotopf & Wessely, 2005).  The impact of non-response 
bias is difficult to measure; one concern is that those who participate may be those most 
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likely to be unwell or to attribute symptoms to traumatic deployment exposures (Hotopf 
& Wessely, 2005). 
The absence of early, proactive, population-based research programmes in the past has 
left a vacuum for the development of uncertainty and therefore unsubstantiated and often 
emotive claims about causation, most of which have since been contradicted by 
epidemiological research (Brown et al., 2001; Hotopf & Wessely, 2005; Iversen et al., 
2007). A constructive outcome of such uncertainty has been the development of 
proactive, longitudinal, population-based research programmes within many military 
services, often including physical and psychological health screening pre-deployment, in-
theatre, and on return from deployment (Chesbrough et al., 2002; Davy et al., 2012; 
Kelton et al., 2010). Such longitudinal studies have the advantage of allowing 
examination of causal mechanisms and therefore may, in time, greatly improve our 
understanding. 
This collection of findings demonstrates the recurring cycle for military physical 
symptoms. Following military conflicts it is common for concerns about the health 
consequences of war on veteran’s health to emerge which is often met a lack of 
recognition of the members’ distress. However, as community support for veterans grows, 
often with great emotion, this can motivate a military or government response. It also 
illustrates that researchers and the medical profession are yet to establish a sound 
explanation for the aetiology of post-deployment physical symptoms.  
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2.9 Thesis aims, hypotheses, and structure 
To improve the medical framework for the understanding and treatment of veterans’ 
symptoms, it is important to examine the prevalence and pattern of physical and 
psychological symptoms. It is also important to determine whether psychological 
symptoms are more strongly associated with TDEs than physical symptoms and thus 
whether psychological symptoms deserve to be considered as the primary trauma 
exposure outcome. These questions are the basis of this thesis and will be addressed in 
relation to ADF members, incorporating the Army, Air Force, and Navy.  
Within this thesis, TDEs are those experienced by members during their deployment to 
the Middle East Area of Operations (MEAO) from 2001 to 2009. A better understanding 
of the epidemiology of physical symptoms and the role of predisposing factors would 
assist in addressing health outcomes associated with future deployments and in planning 
for future medical service needs, particularly with the recent high rates of deployment 
tempo in the ADF. 
The broad aim of the research for this thesis is to examine how post-deployment physical 
and psychological symptoms occur independently as well as how they co-occur. To 
achieve this, an atheoretical approach to symptom presentation is taken, with no 
assumptions made regarding aetiology but merely reflecting documented patient 
symptoms to explore the prevalence of these different symptom presentations. The second 
aim is to examine the link between TDEs and physical symptoms to explore whether the 
strength of their association is similar to that between TDEs and psychological symptoms. 
The third aim explores the relationship between PTSD and physical symptoms, initially 
by testing how well physical symptoms define PTSD through examining the clinical 
utility of physical symptoms for PTSD. The fourth aim is to explore whether clusters of 
physical symptoms can be identified and how these clusters relate to PTSD. The final aim 
is to explore potential inflammatory mechanisms by which TDEs are associated with 
symptoms. 
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In particular, the research questions addressed in this thesis regarding MEAO deployed 
ADF personnel are: 
 What is the prevalence of each of three possible symptomatic profiles: (1) 
physical symptoms only, (2) psychological symptoms only, and (3) comorbid 
physical and psychological symptoms? 
 Does the association between TDEs and physical symptoms have a similar 
strength to that between TDEs and psychological symptoms? 
 Will a checklist of physical symptoms have diagnostic validity adequate to be 
used as a screen for 30-day PTSD? 
 Do clusters of physical symptoms exist and if so, what relationship does 
probable PTSD share with these clusters? 
 Does the inflammatory biomarker C-reactive protein mediate the relationship 
between TDEs and physical symptoms? 
To address these hypotheses, five separate analyses were conducted, and these analyses 
compose the body of this thesis. Following is a brief synopsis for each of the studies. 
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3.1 Data Sources 
This thesis extends the research conducted as part of the Military Health Outcomes 
Program (MilHOP), a body of research commissioned by the Department of Defence 
(Defence) to determine the impact of Australia’s increased operational commitments 
overseas. The MilHOP was an umbrella term that incorporated two studies: 
 Mental Health Prevalence and Well-being Study, to determine the prevalence of 
mental health conditions across all areas of the ADF. 
 Middle East Area of Operations (MEAO) Health Study, which measured the 
current health of ADF members who were deployed to the MEAO.  
The MEAO Health Study had four components:  
 The MEAO Preliminary Study: Conducted to gain stakeholder input into the 
development of the measurements and method of data collection for the Census 
and Prospective Studies. ADF units, ex-service organisations and other veterans’ 
groups were involved in meetings and focus groups.  
 The MEAO Census Study: A retrospective, self-report survey covering health and 
deployment experiences of ADF members who deployed to the MEAO from 2001 
to 2009.  
 The MEAO Mortality and Cancer Incidence Study: Death and cancer incidence 
data from the Australian Institute of Health and Welfare were linked with the 
MEAO nominal roll, and the cancer and mortality rates of MEAO veterans were 
compared with standardised Australian rates.  
 The MEAO Prospective Study: A longitudinal cohort study collecting pre- and 
post-deployment data on members deploying in 2010 and 2011.  
   There was some overlap between the studies in the MilHOP, as Defence expanded the 
original terms of the study from just MEAO deployed to include the whole of the regular 
ADF members (McFarlane & Hodson, 2011). This change was implemented following 
recommendations of the Dunt report (Dunt, 2009). As a result, the sample size varies with 
the cut-off date applied.
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3.2 Thesis samples  
The MEAO Health Study was the focus of this thesis. Chapter 4, Chapter 5, and Chapter 
6 samples were from the MEAO Census Study data, Chapter 7 captured participants who 
completed both the MEAO census and the Mental Health Prevalence and Well-being 
Study (MHPWS) as shown by the darkest shading in Figure 3.1, and Chapter 8 used the 
MEAO Prospective Study data.  
 
 
Figure 3.1 Overlap between participants in the MEAO Census Study and the Mental Health 
Prevalence and Well-being Study (McFarlane, 2017) 
3.2.1 Chapter 4, 5, & 6 sample: MEAO Census Study  
The MEAO Census Study is the first large-scale Australian study to investigate the 
association between deployment exposures and the health of ADF members who 
deployed to Iraq, Afghanistan and supporting locations. All ADF members on the ADF 
nominal roll who deployed to the MEAO from 1 October 2001 to 31 December 2009 
were invited to participate (N = 26915) including serving regular, reserve, and ex-serving 
ADF members. With a response rate of 53% (n = 14032), this study compared favourably 
with similar recent Australian and international studies: response rate of 49% for the 2010 
MEAO Census Health Study 
  Regular, currently 
serving members, 
deployed to MEAO 
in 2001-2009 who 
responded in 2010 
   N = 9520 
 Regular, currently 
serving members 
 Not deployed to 
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2010 Mental Health Prevalence 
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ADF Mental Health Prevalence and Well-being Study (McFarlane & Hodson, 2011); 
56% for studies in the UK (Garfield, 2012); and 37% for studies in the USA (Pinder et al., 
2012). Data were collected from March 2010 to August 2011 and participation was 
voluntarily (Dobson et al., 2012).  
The survey had three main components:  
 Brief Deployment History: This included questions about MEAO and other 
deployments covering operation, year deployment started, number of times 
deployed in that year, and total time deployed (months). For MEAO deployments, 
three additional questions asked about pressure to deploy and whether members 
deployed with their parent unit. 
 Health questionnaire: This included questions about background details, recent 
health symptoms, current health, lifestyle behaviours, life experiences, respiratory 
health, reproductive history, recreation and social activities, and open-ended 
questions.  
 Deployment experiences: This included questions that covered deployment details 
relating to chemical and environmental exposures, work on deployment, health on 
deployment, other deployment experiences, post-deployment experiences, open-
ended questions.  
Response rates were lower among members aged under 35 years, males, Army and Navy 
personnel (compared to RAAF), lower ranks, and active and inactive reserves and ex-
serving members. To minimise bias created in groups that were under-represented, the 
data were weighted based on service, sex, rank and employment (regular, active reserve, 
or inactive/ex-serving) as at the completion of the survey.  
3.2.2 Chapter 7 sample: MEAO census and MHPWS Studies 
The sample of interest to Chapter 7 consisted of those who had completed both the 
MEAO Census Study survey as described for Chapter 4, 5, & 6, as well as the Composite 
International Diagnostic Interview (CIDI) as part of the Prevalence and Well-being Study.  
The CIDI was required as the reference standard for PTSD diagnosis in the analyses for 
Chapter 7. This included 598 members who were then weighted to represent the 16991 
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currently-serving regular ADF members who, as at 11th December 2009, had previously 
deployed to the MEAO. For accuracy of the diagnostic reference only those who could be 
interviewed within 60 days of completing their questionnaire were eligible. 
The difference in the number of participants for Chapter 4, 5, & 6 compared to Chapter 7 
is due to differences in the cut-off dates applied to completion of the survey, and because 
later analyses were more inclusive representations of MEAO deployment numbers due to 
a secondary assessment of survey results which improved the accuracy of recorded 
results. 
Who completed the CIDI? 
A total of 50049 ADF members excluding trainees and reservists were considered eligible 
for Phase 1 participation, the self-report survey, of whom approximately half (49%, n = 
24481) completed the survey. Phase 2 was designed as a time- and cost-efficient means of 
establishing ADF mental health prevalence estimates. A stratified sub-sample of 3688 
(15% of the Phase 1 sample) were offered an interview, and approximately half of those 
(n = 1798, 49% response rate) completed the Phase 2 CIDI interview via telephone.  
Stratification procedure 
The selection of the sub-sample invited to complete the CIDI (Phase 2) was 
stratified by demographic and mental health characteristics, specifically: service, 
sex (oversampling for females to ensure sufficient numbers in each service), and 
the combination of members’ Phase 1 screening scores (oversampling those 
identified as being more likely to have a psychological disorder based on Phase 1 
screening). 
 
The 60th and 80th percentiles of the PCL and AUDIT distributions from the surveys 
were used as cut-offs for each measure to form three bands (high - 80th percentile cut-
off, moderate – 60th percentile cut-off, and low scores) to stratify the sample for 
subsequent interview. The resulting scores on the PCL and AUDIT for each of these 
bands were: 
 
Band 3 (high scorers): PCL > 33 or AUDIT > 10 
 
Band 2 (moderate scorers): PCL between 25 & 33 and AUDIT ≤ 10 or PCL ≤ 33 and 
AUDIT between 7 and 10 
 
Band 1 (low scorers): PCL ≤ 25 and AUDIT ≤ 7. 
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This stratification strategy was utilised to over-represent those with mental disorders to 
reduce the possibility of error in prevalence estimates that can occur with low prevalence 
rates. Because the interviewees were drawn from the large proportion of the ADF 
population who provided responses to the Phase 1 survey, the potential for sampling error 
was further reduced. Moreover, the demographic and health status of the ADF members 
who did not respond at each phase was known and therefore could be considered when 
weighting the data from the interviews.  
Weighting  
Weighting was applied to obtain prevalence estimates for the entire ADF population 
while correcting for differential non-response. Data were weighted by sex, service, rank 
and medical employment classification (MEC) status. In each section of the 
questionnaire, responses were only used if the participant responded to all the questions 
from that section. As a result, a separate weight was calculated for each section of the 
questionnaire. For both survey and CIDI results, within each stratum the weight was 
calculated as the population size divided by the number of stratum respondents. A finite 
population correction was also applied to adjust variance estimates for the reasonably 
large sampling fraction within each stratum. 
3.2.3 Chapter 8 sample: MEAO Prospective Study 
The MEAO Prospective Study was the first study to consider the health of deployed ADF 
personnel from a longitudinal perspective. Data were collected at two time points; at pre-
deployment not more than four months prior to their deployment, and again at post-
deployment, on average 4.2 months after they returned home. The structure of the survey 
completed both pre- and post-deployment was similar to the MEAO Census Study. In 
addition, a sub-sample of primarily combat personnel were invited to provide objective 
health measures, which included physical tests and blood samples. This design avoided 
relying solely on self-reported symptoms and allowed the exploration of possible causes 
for onset of health concerns. 
ADF members who deployed to the MEAO after June 2010 and returned from that 
deployment by June 2012 were eligible to participate (n = 3074). Response rates were 
60.9% for the pre-deployment self-report survey, of whom 70.8% also completed the 
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post-deployment survey. A total of 655 of these responders also supplied blood samples 
at pre-deployment, and 60.9% of those (n = 357) again at post-deployment.  
Demographic and service characteristics for the samples used in the papers are shown in 
Table 3.1. 
Table 3.1 Demographic characteristics of the study samples from each chapter 
Variable Chapter 4, 5, & 
6 
Chapter7 Chapter8 
N 14032 16991 357 
Sex, Male % 87.5 90.5 98.6 
Age, Mean (SD) 36.54 (8.51) 38.26 (0.54) 27.14 (6.80) 
Service %    
Army 47.1 52.3 95.0 
Navy 22.4 18.6 5.0 
Airforce 30.5 29.1 nil 
Rank %    
Commissioned officer 28.2 28.7 5.3 
Non-commission officer 51.1 54.2 30.8 
Other ranks 20.7 17.1 67.9 
 
3.3 Measures 
The following section describes the measures that were used in the thesis. Firstly, the 
psychological measures are described, namely the posttraumatic stress list (PCL), the 
Kessler 10 (K10), the Composite International Diagnostic Interview and the Health 
Symptom checklist (HSC); followed by a brief description of covariates. This is followed 
by a description of the trauma exposure scale. Copies of all the survey measures from the 
Census Studies used in this thesis can be found in Appendix A. 
3.3.1 Psychological measures  
The psychological measures from the MiLHOP study used in this thesis are the Post-
traumatic Stress Disorder Checklist (PCL; Weathers, Litz, Herman, Huska, & Keane, 
1993), the Kessler Psychological Distress Scale (K10; Kessler et al., 2002), and the CIDI 
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(Kessler et al., 2004). The PCL and the K10 were chosen as they are both used in ADF 
mental health screening. Two mandatory screening procedures in the ADF are the Return 
to Australia Psychological Screen (RtAPS), given when departing an area of operations, 
and the Post-operational Psychological Screen (POPS), given three to six months after 
returning (Dunt, 2009; O’Donnell, Dell, Fletcher, Couineau, & Forbes, 2014). These 
screenings are conducted by a mental health professional and utilise the PCL and the 
K10.  
3.3.1.1 Posttraumatic Stress Checklist (PCL) 
The PCL (Weathers et al., 1993) is a self-report scale for assessing the Diagnostic and 
Statistical Manual (DSM; American Psychiatric Association, 1994) diagnostic criteria for 
PTSD. The PCL was developed for Vietnam combat veterans, and has three versions that 
differ slightly. The PCL-M is a military version which refers to the traumatic event as “a 
stressful military experience”. The PCL-S can be used for any traumatic event nominated 
by the participant, with the questions referring to “the stressful experience”. The PCL-C 
is a general civilian version that is not linked to a specific event but refers to “a stressful 
experience from the past”. The PCL-C is used in the MiLHOP studies as well as the ADF 
RtAPS and POPS as it allows members’ tests to be based on any trauma, not just trauma 
experienced during military service (Nicholson, 2006).  
The studies in this thesis used the PCL-C based on DSM-IV PTSD diagnostic criteria, a 
17-item version with the diagnostic criteria defined by the three DSM-IV symptom 
clusters: re-experiencing, avoidance, and hyperarousal. Respondents rate each item from 
1 ("not at all") to 5 ("extremely") to indicate the degree to which they have been bothered 
by a particular symptom over the past month. Total scores range from 17 to 85. With the 
DSM-V release in 2013, a new 20-item PCL-C was developed, based on DSM-V criteria, 
incorporating the additional symptom cluster of negative thoughts or feelings. However, 
as the PCL-V was developed after the MiLHOP studies were conducted, this thesis is 
limited to DSM-IV criteria. 
The PCL is the most commonly used self-report PTSD questionnaire (Elhai, Gray, 
Kashdan, & Franklin, 2005; McDonald & Calhoun, 2010), most likely because it is easy 
to administer and has strong psychometric properties. Test-retest reliability has been 
reported as .96 at 2-3 days and .88 at one week (Blanchard, Jones-Alexander, Buckley, & 
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Forneris, 1996; Ruggiero, Del Ben, Scotti, & Rabalais, 2003). Estimates of internal 
consistency (Cronbach's alpha) range from .94 (Blanchard et al., 1996) to .97 (Weathers 
et al., 1993).  Although self-report measures should not be used for diagnosis, the PCL 
has demonstrated good diagnostic accuracy in primary care and veteran samples 
(McDonald & Calhoun, 2010; Weathers et al., 1993). The PCL correlates strongly with 
other measures of PTSD, such as the Mississippi Scale (convergent validity ranging from 
r = .85 to .93; Weathers et al., 1993), the MMPI-2 Keane PTSD Scale (.77), IES (.77 to 
.90),  and the CAPS (.92; Blanchard et al., 1996). It also correlates moderately with level 
of combat exposure (Forbes, Creamer, & Biddle, 2001).  
A cut-off score of 50 was originally recommended as an epidemiological cut-off for 
PTSD (Weathers et al., 1993).  However, the cut-offs used vary widely depending on the 
sample and the purpose. Testing in ADF members found the optimal screening cut-
off was 29, with a sensitivity of 0.79 (95% CI 0.65–0.92) and specificity of 0.80 (95% CI 
0.77–0.82), and the optimal epidemiological cut-off was 53, with a specificity of 0.97 
(95% CI 0.97–0.98), but a sensitivity of 0.25 (95% CI 0.15–0.35; Searle et al., 2015b). In 
comparison, a study of 724 US Army soldiers reported an optimal PCL screening cut-off 
of 32 (Bliese et al., 2008). The ADF uses a screening cut-off of 30, indicating the need for 
psychologist follow-up, and scores above 50 trigger an automatic referral (Nicholson, 
2006; O’Donnell et al., 2014).  
3.3.1.2 Kessler Psychological distress scale (K10) 
The K10 is a 10-item questionnaire designed to provide a global measure of non-specific 
psychological distress based on ten questions related to levels of nervousness, agitation, 
psychological fatigue, and depression in the past four weeks (Kessler et al., 2002). 
Population-level studies have shown the K10 to have high levels of overall diagnostic 
accuracy, with areas under the curve from 0.80 to 0.96 (Andrews & Slade, 2001; 
Furukawa, Kessler, Slade, & Andrews, 2003; Kessler et al., 2002; Oakley Browne, Wells, 
Scott, McGee, & Team, 2010). The K10 has been found to be comparative to other global 
psychological measures including the general health questionnaire (GHQ), SF Health 
Survey short form (SF-12), and the CIDI (Andrews & Slade, 2001).  
Testing in ADF members has found the optimal cut-off for the K10 for detecting any 30-
day ICD-10 anxiety or affective disorder was 19, with a sensitivity of 0.59 (95% CI 0.44–
0.73) and specificity of 0.81 (95% CI 0.78–0.84), and the optimal epidemiological cut-off 
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was 25, with a specificity of 0.93 (95% CI 0.92–0.95) and sensitivity of 0.30 (95% CI 
0.21–0.39; Searle et al., 2015). In this thesis, a cut-off of 20 was used as it was close to 
that found to be optimal and replicated the ADF cut-off used to indicate the need for 
follow-up and  potential referral (McFarlane & Hodson, 2011). 
3.3.1.3 Composite International Diagnostic Interview 3.0 (CIDI) 
The computerised CIDI version 3.0 was used in the MilHOP study and is the reference 
standard used to generate the DSM-IV defined diagnoses of 30-day PTSD in Chapter 4. 
The CIDI is a comprehensive, fully-standardised, structured interview developed by the 
World Health Organization and designed to be used by trained lay interviewers for the 
assessment of mental disorders according to the definitions and criteria of ICD-10 and the 
DSM-IV (Robins et al., 1988). The instrument has been widely used worldwide in 
community-based and healthcare settings to obtain information about the prevalence and 
correlates of mental disorders (Kessler et al., 2004; Robins et al., 1988). In addition, the 
CIDI is currently the most widely used fully structured diagnostic interview in psychiatric 
epidemiological research (Kessler & Ustun, 2004) and shows high convergent and 
predictive validity (Haro et al., 2006) .The validity of the CIDI has been shown to be 
excellent when compared to trained clinical interview (Haro et al., 2006; Kessler et al., 
2004).  
The CIDI modules administered in this study were depression, mania, panic disorder, 
specific and social phobia, agoraphobia, generalised anxiety disorder, obsessive-
compulsive disorder, PTSD, alcohol use, tobacco, and separation anxiety.  
3.3.2 Health symptom checklist (HSC)  
The health symptom checklist is a 67-item questionnaire developed specifically for the 
MilHOP studies (Dobson et al., 2012). Development and scoring of the HSC is discussed 
in Chapter 4.  
Some of the chapters in this thesis examined overlaps between the HSC and the PCL and 
K10 psychological measures. To avoid construct overlap, items that were repeated 
between measures or that resembled the DSM-IV diagnostic category of the 
psychological diagnoses being considered were excluded. As such the number of items 
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used from the HSC varied between chapters, as outlined in Table 3.2, and the full 
questionnaires are available in Appendix A. 
Operationalisation of the HSC in Chapter 5 and 7 
Paper 2 divided the sample into four groups based on HSC and PCL scores and Chapter 7 
addressed the utility of physical symptoms in PTSD screening. Therefore, these chapters 
excluded 10 items that overlapped with the PCL: irritability / outbursts of anger, sleeping 
difficulties, feeling jumpy / easily startled, feeling distant / cut off from others, 
forgetfulness, loss of concentration, difficulty finding the right word, increased sensitivity 
to noise, avoiding doing things or situations, distressing dreams. 
Operationalisation of the HSC in Chapter 4  
Chapter 4 used HSC and K10 scores to define the four groups. The K10 measures a 
broader range of emotional distress states, therefore physical symptoms that overlapped 
with PTSD, depression, or anxiety were excluded. These included the 10 items from 
studies 2 and 4 plus an additional four items: fatigue, feeling unrefreshed after sleep, loss 
of interest in sex, loss of or decrease in appetite. 
Operationalisation of the HSC in Chapter 6 and 8 
For Chapters 6 and 8 there was no overlap with psychological measures, therefore all 67 
items of the HSC were included in the analyses. 
Table 3.2 Analysis of HSC items and how they overlap with psychological measures, and the 
items that were excluded from papers  




4  5 & 7  
1 Chest pain    
2 Headaches    
3 Rapid heartbeat    
4 Irritability / outbursts of anger PCL   
5 Unable to breathe deeply enough    
6 Faster breathing than normal    
7 Feeling short of breath at rest    
8 Wheezing    
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9 Sleeping difficulties PCL   
10 Feeling jumpy / easily startled PCL   
11 Feeling unrefreshed after sleep    
12 Fatigue K10   
13 Double vision    
14 Intolerance to alcohol    
15 Itchy or painful eyes    
16 Rash or skin irritation    
17 Skin infections, e.g. boils    
18 Skin ulcers    
19 Shaking    
20 Tingling in fingers and arms    
21 Tingling in legs and toes    
22 Numbness in fingers / toes    
23 Feeling distant / cut off from others PCL   
24 Constipation    
25 Flatulence or burping    
26 Stomach cramps     
27 Diarrhoea    
28 Indigestion    
29 Dry mouth    
30 Pain in the face, jaw, in front of the ear, or in the ear    
31 Persistent cough    
32 Lump in throat    
33 Sore throat    
34 Forgetfulness    
35 Dizziness, fainting or blackouts    
36 Seizures or convulsions    
37 Feeling disorientated    
38 Loss of concentration PCL   
39 Difficulty finding the right word    
40 Pain on passing urine    
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41 Passing urine more often    
42 Burning sensation in the sex organs    
43 Loss of interest in sex    
44 Problems with sexual functioning    
45 Increased sensitivity to noise PCL   
46 Increased sensitivity to light    
47 Increased sensitivity to smells or odours    
48 Ringing in the ears    
49 Avoiding doing things or situations PCL   
50 Pain, without swelling or redness, in several joints    
51 Joint stiffness    
52 Feeling that your bowel movement is not finished     
53 Changeable bowel function     
54 General muscle aches or pains    
55 Loss of balance or coordination    
56 Difficulty speaking    
57 Low back pain    
58 Night sweats which soak the bed sheets    
59 Feeling feverish    
60 Tender or painful swelling of lymph glands in neck, 
armpit or groin 
   
61 Loss of or decrease in appetite    
62 Nausea     
63 Vomiting    
64 Distressing dreams PCL   
65 Stomach bloating    
66 Unintended weight gain > 4kg    
67 Unintended weight loss > 4kg    
3.3.3 Trauma measure 
Trauma exposure was a variable used in Chapters 4, 5 & 6. The MiLHOP study included 
a deployment experiences questionnaire covering environment, chemical and traumatic 
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experiences. Chapters 4 and 5 utilised the 27-item traumatic exposures questionnaire, and 
Chapter 7 used the environmental exposure items as well, so included all 59 items from 
the questionnaire. Details of the origins of the measure and how the studies were used are 
described in the Chapters 4 to 8. A copy of the questionnaire is available in Appendix A. 
3.4 How the symptom profiles were developed for Chapters 4 and 5  
Chapters 4 & 5 examined how physical and psychological symptoms occurred 
independently as well how they co-occur. The difference between the two chapters was in 
defining the symptom profiles. For Chapter 4, the four profiles were defined by 
distributional splits of the K10 and HSC scores, as described in detail in the chapter. 
Figure 3.2 (not included in the chapter) provides a graphical representation of the group 
distributions. In Chapter 5 the groups were defined using the same method but using the 
PCL and HSC. 
 
Figure 3.2 Chapter  4 four symptom groups defined by K10 and HSC score: low-symptom, 
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4.1 Abstract 
Current paradigms regarding the effects of traumatic exposures on military personnel do 
not consider physical symptoms (unrelated to injury or illness) as independent outcomes 
of trauma, characteristically dealing with these symptoms as comorbidities of 
psychological disorders.  Our objective was to ascertain the proportions of deployed 
military personnel that experienced predominantly physical symptoms, predominantly 
psychological symptoms, and comorbidity of the two, and to examine the strength of the 
relationship between traumatic deployment exposures (TDEs) and these symptomatic 
profiles.   
Data were from a cross-sectional study of Australian Defence Force personnel who were 
deployed to the Middle East Area of Operations from 2001 to 2009 (N = 14,032).  Four 
groups were created based on distributional splits of a physical and a psychological 
symptom scale: low-symptom, psychological, physical, and comorbid.  Multinomial 
logistic regression models assessed the probability of symptom group membership 
(compared with low-symptom) as predicted by self-reported TDEs. Group proportions 
were low-symptom 78.3%, physical 5.0%, psychological 9.3%, and comorbid 7.5%.  
TDEs were significant predictors of all symptom profiles.  For subjective, objective and 
human death and degradation exposures respectively, the largest relative risk ratios were 
for the comorbid profile (1.47, 1.19, 1.48), followed by the physical profile (1.27, 1.15, 
1.40), then the psychological profile (1.22, 1.07, 1.22).   Almost half of those with 
physical symptoms did not have comorbid psychological symptoms suggesting physical 
symptoms can occur as a discrete outcome of exposure to trauma. The similar dose-
response relationship between TDEs and the physical and psychological profiles suggests 
trauma is similarly associated with both outcomes.
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4.2 Introduction 
There is a long history of military members deployed to conflict zones reporting 
distressing and disabling non-specific physical symptoms that occur across many health 
domains (Unwin et al., 1999).  Research from the first Gulf War as well as more recent 
conflicts in Iraq and Afghanistan has provided evidence of elevated rates of physical 
symptoms in deployed compared to non-deployed military members (McCutchan et al., 
2016; Unwin et al., 1999; Vanderploeg et al., 2012).  
Many military studies have found an association between physical symptoms and 
psychological disorders, often concluding that psychological disorder is a major driver of 
physical symptoms (Quartana, Wilk, Balkin, & Hoge, 2015; Nissen, Marott, Gyntelberg, 
& Guldager, 2011).  However, a few studies have identified that physical symptoms can 
occur as discrete outcomes (Wolfe et al., 1999).  Most veterans contest a psychological 
aetiology for physical symptoms, believing that these symptoms are associated with 
deployment exposures and that psychological aetiologies place blame on veterans and 
diminish their unique deployment experiences (Kilshaw, 2008).  This clash of beliefs over 
causation has led to much controversy over the existence of post-war syndromes such as 
shell shock after the First World War, Agent Orange exposure after the Vietnam War, and 
more recently, Gulf War Syndrome following the Gulf War, with broad-reaching 
implications such as the validity of pension entitlements for such invisible injuries 
(Hyams et al., 1996; Miley & Read, 2017).  
When researching non-specific physical symptoms (that are not a result  of injury or 
illness), determining their pathophysiology can be difficult, particularly as post-
deployment physical and psychological health outcomes often co-occur and overlap 
(McFarlane, Ellis, Barton, Browne, & Van hooff, 2008).  Moreover, while traumatic 
deployment exposures (TDEs) have been well established as a major risk factor for 
psychological distress in veterans, along with demographic factors such as lower 
education and non-officer rank (Xue et al., 2015), the associations found between TDEs 
and physical symptoms are inconsistent.  Importantly, one study examining the physical 
and psychological health effects of military deployment experiences identified that 
combat exposure was associated with physical symptoms with or without physical injury, 
suggesting that combat exposure may have a mechanistic association with physical 
symptoms (Vanderploeg et al., 2012).   
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Reid et al. (2001) suggest that physical symptoms in military personnel may be caused by 
functional somatic disorders, such as chronic fatigue syndrome.  However, the symptoms 
of such disorders have high levels of overlap with those of psychological disorders, and 
as such do not allow for differentiation of physical symptoms when exploring symptom 
profiles.  A fundamental challenge of medicine has been the inability to determine the 
specificity and overlap of the symptoms of somatic disorders and functional syndromes 
such as chronic fatigue syndrome (Sharpe & Carson, 2001).  This challenge is reflected in 
the removal of functional somatic disorders from the recently released DSM-5, which 
also suggests that this diagnosis is unsuitable (Sharpe & Carson, 2001).  Current 
treatment recommendations for non-specific physical symptoms include cognitive 
behaviour therapy and antidepressant medication, which suggests an assumption of 
psychological aetiology (olde Hartman et al., 2017).  However, the effect sizes for these 
treatments are generally small, highlighting the need to explore alternate causal 
mechanisms that may suggest new treatment targets (olde Hartman et al., 2017).   
In the psychiatric domain, somatization has traditionally been used to explain the 
aetiology of physical symptoms, suggesting that psychological processes are the 
predominant causal factors of those physical symptoms (Sharpe & Carson, 2001).  
However, modern theories of the impact of stress, such as the influence of allostatic load, 
highlight the complex nature of neurobiological processes that occur in response to stress, 
and posit the possibility of bidirectional or synergistic associations between physical and 
psychological processes in the stress reaction (McEwen, 1998; Taylor, 2010).  Such 
theories highlight that psychological disorders may not be the sole mechanism in the 
development of physical symptoms for some veterans (Bai, Chiou, Su, Li, & Chen, 
2014).  The first step in exploring these theories is to determine whether any veterans 
have experienced physical symptoms without psychological distress. 
Several military studies suggest that certain TDEs may be associated with negative 
physical and psychological outcomes (Killgore, Stetz, Castro, & Hoge, 2006; Kroenke, 
Koslowe, & Roy, 1998; Searle et al., 2017).  Subjective threat-to-self exposures and 
witnessing human atrocities have been found to be predictors of both physical and 
psychological symptoms, whereas objective combat exposures appear to have less impact 
(de Silva, Jayasekera, & Hanwella, 2013; Nissen, et al., 2011; Waller et al., 2012).  Other 
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studies have found that deployment rather than combat is associated with physical 
symptoms (de Silva et al., 2013; Hotopf et al., 2006; McCutchan et al., 2016).   
This variability in findings may be due to the wide range of tools used to measure 
physical symptoms.  Additionally, some measures contain symptoms such as ‘anger and 
irritability’ or ‘fatigue’, which share construct overlap with psychological symptoms.  
The ambiguity in how to conceptualize physical symptoms has further impeded research 
(Khan, Khan, Harezlak, Tu, & Kroenke, 2003).  As such, there are still many gaps in our 
understanding of the association between TDEs and physical symptoms independent of 
psychological disorders.  
Determining whether sufferers can be separated into physical, psychological, and 
comorbid profiles, apart from having significant prognostic implications, may help in the 
development of alternate theories regarding pathological mechanisms.  Consequently, this 
study examined the degree of overlap and differentiation of physical and psychological 
symptoms in a large cohort of deployed Australian Defence Force (ADF) personnel who 
served in the Second Gulf War from 2001 to 2009.  Our aim was to identify symptom 
profiles of personnel who had experienced high levels of physical symptoms alone, high 
levels of psychological symptoms alone, and a pattern of comorbid physical and 
psychological symptoms.  As this is a unique approach, we have no hypotheses regarding 
the prevalence of the different profiles.     
An additional aim was to examine potential correlates of these symptom profiles, 
including demographic and service characteristics, and various deployment trauma 
exposures.  We hypothesized that total trauma exposure would be positively associated 
with symptom counts and therefore all profile memberships.  Like the previous research 
discussed above, we also examined different trauma types to determine whether stressors 
for physical and psychological distress differ.  However, as findings regarding the 
correlates of physical symptoms are equivocal, these analyses were exploratory with no 
hypotheses.   
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4.3 Method 
4.3.1 Participants  
Data came from the Middle East Area of Operations (MEAO) Census Study (Dobson et 
al., 2012), a retrospective, self-report survey of current, ex-serving, and Reserve 
Australian Defence Force (ADF) members who were deployed to Iraq, Afghanistan, or 
supporting operations between October 2001 and December 2009.  
The full nominal roll of 26,915 ADF members deployed to the MEAO during this period 
were invited to participate, with 14,032 (53%) accepting the invitation.  Data were 
collected in 2010 and 2011 using online surveys or hard copy questionnaires that included 
questions on deployment history, current health, and deployment experiences based on 
the participants’ most recent MEAO deployment. Participation was voluntary and all data 
were de-identified.  Further details of the data collection methods have been described 
elsewhere (Dobson et al., 2012). Non-response rates were significantly higher among 
females, older ADF members, Air Force members, Officers, and current serving members 
(Dobson et al., 2012). This study received appropriate Research Ethics Committee 
approval.  
4.3.2 Measures  
The Kessler Psychological Distress Scale (K10) is a global measure of non-specific 
psychological distress (Kessler et al., 2002), with strong psychometric properties and the 
capacity to discriminate psychiatric caseness in both civilians and military personnel 
(Kessler et al., 2002; Searle et al., 2017; Searle et al., 2015b). Participants rate 10 items 
with reference to the last four weeks on a five-point Likert-type scale, with sum scores 
ranging from 10 to 50.  Higher scores are indicative of higher psychological distress. For 
this study, psychological distress was defined by a cut-off of 20, representing the post-
operational screening cut-off used by the ADF (McFarlane & Hodson, 2011).  This cut-
off also aligns with that used in the 2007 Australian National Mental Health and 
Wellbeing Survey (Slade, Johnston, Oakley Browne, Andrews, & Whiteford, 2009).  The 
K10 had high internal consistency in our sample (alpha = 0.92). 
Physical symptoms were assessed with a 67-item self-report Health Symptom Checklist 
(HSC; provided in the supplementary material) adapted from the King's College Gulf 
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War Survey (Unwin et al., 1999) and the Australian Gulf War Veterans Health Study 
(Kelsall et al., 2004).  As this instrument contains symptoms that could be considered 
psychological (e.g. ‘distressing dreams’) or physical (e.g. ‘joint stiffness’), any items 
appearing in the DSM-IV diagnostic criteria for PTSD or depression were excluded in 
order to avoid construct overlap between the HSC and the K10. This resulted in a final 
list of 53 physical symptoms.  Participants were asked to indicate the severity of each 
symptom over the past month on a four-point scale selecting never, mild, moderate, or 
severe.  Each symptom was further dichotomized as ‘No’ (‘never’) or ’Yes’ (‘mild’, 
‘moderate’ or ‘severe’), as per previous military studies (Kelsall et al., 2004; Unwin et al., 
1999).  We assigned physical distress caseness as endorsing 16 or more physical 
symptoms. This represented the top 12.4% of our sample, which was comparable to cut-
offs established in previous military research (de Silva et al., 2013; Hoge, Terhakopian, 
Castro, Messer, & Engel, 2007; Hotopf et al., 2006; McCutchan et al., 2016). The HSC 
had high internal consistency in our sample (alpha = 0.92). 
Four symptom groups were defined based on combinations of these dichotomised K10 
and HSC scores: a ‘low-symptom’ group (< 16 physical symptoms and K10 score < 20), 
a ‘physical only’ group (≥ 16 physical symptoms and K10 score < 20), a ‘psychological 
only’ group (< 16 physical symptoms and K10 score ≥ 20), and a ‘comorbid’ group (≥ 16 
physical symptoms and K10 score ≥ 20).  
A traumatic exposures questionnaire adapted from the Deployment Risk and Resilience 
Inventory (King, King, Vogt, Knight, & Samper, 2006), the King's College Gulf War 
Survey (Unwin et al., 1999), and the Traumatic Stressors Exposure Scale (TSES-R; 
Swann & Hodson, 2004) was used to measure the frequency of 27 deployment exposures 
from participants’ most recent MEAO deployment, which were rated as occuring: never, 
once, 2-4 times, 5-9 times, 10+ times.  Two items were excluded from our analysis: ‘Did 
you clear/search caves?’ as this item only related to Afghanistan deployments, and ‘Were 
you present when a loved one was injured or killed?’ as the prevalence rate for this item 
was less than 1%.  The items were dichotomised into ‘no exposure’ or ‘exposed’, then 
added to provide a count of total combat exposure types.  The number of different types 
of TDEs has been found to have more impact on health outcomes than frequency of 
exposure in military studies (Killgore et al., 2006; Kroenke et al., 1998b; Searle et al., 
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2017).  The total trauma type count had high internal consistency in our sample (alpha = 
0.9). A full list of the trauma items is available in the supplementary material. 
We divided the traumatic exposure items into three subscales that are described in the 
literature as influencing physical and psychological symptoms: ‘subjective combat’ (i.e. 
perceived threat) which included eight items (e.g. ‘Were you in danger of being 
injured?’); ‘objective combat’ (i.e. measurable events) which included 11 items (e.g. ‘Did 
you experience a landmine strike?); and ‘human death or degradation’ which included six 
items (e.g. ‘Did you handle dead bodies?’ (de Silva et al., 2013; Nissen  et al., 2011; 
Waller et al., 2012).  Each subscale score was the total number of subscale items to which 
participants were exposed.   
The functional outcome of health related quality of life was measured with the twelve 
item Short-Form Health Survey (SF-12), version two was used (Kosinski, Ware, Turner-
Bowker, & Gandek, 2007). The SF-12 has been validated for use in Australia (Sanderson 
& Andrews, 2002). The SF-12 comprises 12 questions measuring 8 domains that are used 
to calculate two summary scales: the Physical Component Score (PCS), and the Mental 
Component Score (PCS). Both scores range from 0 to 100 with a mean of 50 and a 
standard deviation of 10, and higher scores indicative of better self-perceived quality of 
life.  Both scores are valid and reliable and widely used (Cheak-Zamora, Wyrwich, & 
McBride, 2009). Comparative data for the Australian population were based on 
population norms produced by the Department of Human Services, South Australia 
(Avery, Dal Grande, & Taylor, 2004).  
Demographic and military covariates included those previously found to influence 
symptom reporting (de Silva et al., 2013; Horn et al., 2006; Hotopf et al., 2006; Kroenke, 
et al., 1998; Storzbach et al., 2000).  Covariates that related to participants’ most recent 
MEAO deployment included gender, age, service (Navy, Army, Air Force), service status 
(current serving, active Reserve, ex-Serving, inactive Reserve), rank (Commissioned 
Officer: Lieutenant to General equivalents; Non-Commissioned Officer: Sergeant to 
Warrant Officer equivalents; or Other Rank: Private to Corporal equivalents), number of 
times deployed to the MEAO, time since last MEAO deployment, and education (high 
school, certificate, graduate [diploma or degree], and postgraduate).  Another two items 
were included as covariates to adjust for their possible confounding effects on symptom 
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reporting: injury sustained on MEAO deployment that required attendance at sick parade, 
and doctor diagnosed medical conditions (‘Since returning from your last MEAO 
deployment, has a medical doctor diagnosed you with, or treated you for any of the 
following medical problems or conditions?’). 
4.3.3 Data Analysis 
All analyses were conducted using Stata 14 (Stata Corporation, College Station, TX, 
USA).  Missing values in outcome and exposure variables were addressed using multiple 
imputation implemented under a ‘missing at random’ assumption, which was deemed 
plausible since we were unable to find any predictor of missingness outside of these 
variables.  Multiple imputation (MI) was carried out using fully conditioned specification, 
with 20 complete datasets created based on the rule of thumb that the number of 
imputations should be at least equal to the percentage of incomplete cases (White, 
Royston, & Wood, 2011).  Estimates were combined across imputed datasets using 
Rubin’s rules (Amital et al., 2006).  As well as analysis model variables, the imputation 
model included two auxiliary variables that demonstrated moderate correlation with the 
outcome variable; imputed outcomes were therefore retained in the analysis (Sullivan, 
Salter, Ryan, & Lee, 2015).  Complete case analyses showed only minimal differences to 
the imputed analysis, so only the imputed results have been reported.  Multinomial 
logistic regression (MLR) was chosen for the imputation and analysis of the outcome as it 
has been shown to perform well in simultaneously modelling estimates for the probability 
of multiple diagnoses (Bertens et al., 2016).  Effect size was measured using relative risk 
ratios (RRR), which in MLR is the exponentiated coefficient calculated relative to a base 
category. Wald statistics were used for hypothesis testing as these are superior with 
imputed data (White et al., 2011). The results from MI models were pooled using Rubin’s 
rules. However, pooling goodness-of-fit test statistics such as log likelihood or chi 
squared tests of difference across imputations is not recommended with Rubin’s rules 
(White et al.,2011). As an alternative F-test were used to test the same hypothesis that all 
coefficients were identically zero.  
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4.4 Results  
Most participants were male, with a mean age of 36.9 years (SD 8.56).  Half had been 
deployed to the MEAO more than once, with 61% having been deployed to Afghanistan, 
72% to Iraq, and 35% to both areas.  The mean time since last deployment to the MEAO 
was 4.28 years (SD 2.46).  The Army was the largest Service, ‘current serving’ the 
predominant service status, and Non-Commissioned Officers the most common rank.  
Table 4.1 shows the proportion of personnel in each of the four symptom groups 
including the mean K10 and the HSC scores used to define our symptom groups.  Most 
respondents were in the low-symptom group (78.3%) and reported the lowest mean 
number of total trauma type exposures (4.10).  The physical only was the smallest profile 
(5.0%) and the psychological only profile the largest (9.3%).  The comorbid group (the 
most symptomatic) had a prevalence of 7.5% and the highest mean total trauma type 
exposures (4.32).  The correlation between physical and psychological symptom severity 
was moderate (r = 0.61). 
Table 4.1 Frequency of Service and Demographic Characteristics by the Four Symptom 
Groups, Including Mean Scale Scores with Standard Deviations (SD), N=14032 
Characteristic Symptom groups 
Low-
symptom 
Physical Psychological Comorbid 
Group size: N (%) 11435 
(81.5) 
723(5.2) 1353(9.6) 1088 (7.7) 
HSC: mean score (SD) 4.26 (4.1) 19.37 (5.2) 7.94 (4.8) 24.51 (8.8) 
K10: mean score (SD) 12.64 (2.7) 15.4 (3.1) 23.69 (5.3) 26.94 (7.2) 
Age: mean years (SD) 36.54 (8.5) 40.31 (9.6) 36.21 (8.0) 39.68 (6.7) 
Total trauma types: mean (SD) 4.1 (4.8) 6.09 (5.6) 5.34 (5.4) 7.32 (6.0) 
Gender: Male (%) 87.8 88.1 85.9 85.6 
Service (%) 
   Army 
   Navy 

















Service status (%)     
    






















   Commissioned 
   Non-Commissioned 

















Number of deployments: mean 
(SD) 
1.96 (1.93) 2.09 (1.84) 1.83 (1.52) 2.11 (6.33) 
Years since MEAO:  mean (SD) 4.15 (2.43) 4.58 (2.45) 4.64 (2.51) 5 (2.44) 
Education (%) 
   High school 
   Certificate 
   Graduate 





















Injury at MEAO: N (%) 2161 (18.9) 223 (30.9) 316 (23.4) 405 (37.3) 
Dr diagnosed medical:  mean 
(SD) 
6061 (53.0) 862 (77.8) 870 (64.3) 830 (76.3) 
N = number, SD = standard deviation 
We initially tested the demographic and service characteristics as well as total trauma 
exposure simultaneously in Model 1 using multivariate MLR to determine which 
variables were predictors of symptom group membership.  Model 1 predicted a 
significant amount of variance, F(5120066.1) = 26.80, p > 0.001.  Table 2 shows that 
‘years since deployment to MEAO’ and ‘number of deployments to the MEAO’ did not 
predict group membership, whereas ‘total trauma exposure’, ‘being female’, ‘in the 
Navy’, or ‘having a doctor diagnosed medical condition’ increased the risk of 
membership in all symptomatic groups. Some differences in risk were found between the 
groups.  The physical only group were likely to be slightly older, of lower rank (Non-
Commissioned Officers), and have completed only high school education.  Psychological 
only group membership was associated with being ex-serving or an inactive Reserve and 
having sustained an injury at the MEAO.  Comorbid group membership was associated 
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with being slightly older, in the RAAF, an inactive Reserve or ex-serving, lower rank 
(Non-Commissioned Officer or Other Rank), and having an injury. 
The Army is reputed to have the worst post-deployment health outcomes of the three 
services (Van Hooff, et al., 2014).  Univariate analyses in this data found little difference 
between the Army (reference group, RRR of 1), the Navy (physical RRR = 1.01, CI 
[0.83, 1.24]; psychological RRR = 1.21 CI [1.03, 1.42]; comorbid RRR = 1.00 CI [0.85, 
1.19]), and the RAAF (physical RRR = 0.82 CI [0.67, 1.01]; psychological RRR = 0.81 
CI [0.69, 0.94]; comorbid RRR = 0.71 CI [0.59, 0.84]).  However, being in the Navy 
showed the highest risk of belonging to all symptom groups in the multivariate analysis.  
We conducted a number of sensitivity analyses. Firstly, we analysed Model 1 with 
‘physical’ as the reference category and found that the total trauma exposure was 
associated with a slightly reduced and statistically significant risk of belonging to the 
psychological profile (RRR = 0.97; CI 0.94, 0.99).  Next, we examined the total frequency 
of TDEs (i.e. retaining each trauma’s original Likert scaling).  This did not change the 
pattern of association beyond that expected by a measure with a range of 0 to 140 
compared to the original trauma type range of 1 to 27.  For cross-comparison with similar 
research we retained total trauma type.  Lastly, we examined whether injury would 
impact symptom group membership.  The likelihood of symptomatic group membership 
only increased by 3% for the physical and comorbid groups and not at all for the 
psychological group. Given that there were only non-significant differences seen, we 
have reported analyses on the total population and not the groups stratified by injury. 
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Table 4.2 Four Separate Multivariate MLR Models Testing Predictors of Symptom Group Membership. The Baseline Category is ‘Low-Symptom’ 
Predictor 
Physical vs low-symptom 
RRR (95% CI) 
Psychological vs low-
symptom RRR (95% CI) 
Comorbid vs low-symptom 
RRR (95% CI) 
p 
Model 1: Demographic and Service characteristics 
Age 1.05 (1.04, 1.06) 0.99 (0.98, 1.00) 1.05 (1.04, 1.06) < .001 





1.44 (1.11, 1.87) 
1.13 (0.88, 1.46) 
 
1.48 (1.21, 1.81) 
1.14 (0.95, 1.37) 
 
1.69 (1.31, 2.19) 
1.30 (1.03, 1.65) 
< .001 




current serving (ref) 
1.04 (0.78, 1.37) 
1.08 (0.73, 1.59) 
0.73 (0.52, 1.02) 
 
1.05 (0.86, 1.30) 
2.07 (1.61, 2.69) 
1.30 (1.04, 1.62) 
 
1.26 (0.98, 1.61) 
3.77 (2.88, 4.93) 
1.67 (1.29, 2.15) 
< .001 
Rank on deployment 
   Non-Commissioned 
   Other 
Commissioned (ref) 
1.77 (1.32, 2.37) 
1.44 (0.95, 2.19) 
 
1.03 (0.85, 1.26) 
0.95 (0.74, 1.24) 
 
1.57 (1.23, 2.01) 
1.93 (1.39, 2.69) 
< .001 
No deployments  1.03 (0.99, 1.06) 0.98 (0.94, 1.02) 1.03 (1.00, 1.06) .124 
Years since 1.01 (0.97, 1.06) 1.04 (1.01, 1.08) 1.02 (0.98, 1.06) .112 
Education  High school (ref)   .013 
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   Certificate 
   Graduate 
   Postgraduate 
1.4 (1.10, 1.19) 
1.01 (0.79, 1.30) 
0.89 (0.60, 1.32) 
1.11 (0.94, 1.33) 
0.89 (0.74, 1.07) 
0.83 (0.63, 1.08) 
1.12 (0.91, 1.38) 
0.97 (0.78, 1.20) 
0.65 (0.46, 0.91) 
Injury 1.14 (0.99, 1.31) 1.14 (1.02, 1.27) 1.36 (1.23, 1.50) < .001 
Dr diagnosed Medical 1.28 (1.24, 1.32) 1.10 (1.07, 1.14) 1.30 (1.23, 1.50) < .001 
Total trauma types 1.10 (1.08, 1.12) 1.05 (1.03, 1.07) 1.14 (1.12, 1.16) < .001 
Model 2: Subjective* 1.27 (1.20, 1.33) 1.22 (1.17, 1.28) 1.47 (1.40, 1.53) < .001 
Model 3: Objective*   1.15 (1.10, 1.19) 1.07 (1.04, 1.10) 1.19 (1.15, 1.24) < .001 
Model 4: Human death and 
degradation*  
1.40 (1.30, 1.51) 1.22 (1.14, 1.30) 1.48 (1.40, 1.57) < .001 
*Adjusted for age, sex, service, service status, rank, education, number of deployments to the MEAO, years since deployment to the 
MEAO, injury, and Dr diagnosed medical conditions. 
RRR = Relative Risk Ratio; ref = ref reference group; CI = confidence interval. 
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We then tested the three TDE scales separately (subjective, objective, and human death 
and degradation) rather than simultaneously to determine whether the influence of trauma 
type varied across our symptom profiles. Examining the TDE scales separately avoids 
diminishing the constructs of interest, which can occur when removing large proportions 
of shared variance within a combined model. Correlations between TDE scales were 
moderate to high, ranging from 0.61 to 0.72, yet tests of collinearity were negative. For 
completeness we also conducted subsidiary analyses with the three TDE scales in one 
model.  Results (see supplementary material) showed little difference in the impact of the 
three scales on the physical profile, and slightly attenuated their impact on the comorbid 
profile. The association between subjective trauma scale and the psychological profile 
became non-significant, suggesting a suppression effect, but due to the loss of 
significance and small effect size interpretation should be considered with caution. 
The F-ratios in Models 2, 3, and 4 indicate that the null hypothesis that all coefficients 
were zero can be rejected: Model 2: F(51, 20030.7)  = 27.75, p > 0.001; Model 3: 
F(51,20133.0)  = 24.79, p > 0.001; and Model 4: F(51,19968.8)  = 25.88, p > 0.001. The 
results in Table 4.2 demonstrate that all three TDE scales were predictive of increased 
risk of all symptom profiles. The comorbid profile had the highest RRR, followed by the 
physical profile, and the lowest RRR was for the psychological profile. Patterns of 
association were very similar; the human death and degradation scale was the most 
predictive of all symptom profiles and the objective scale the least predictive.  The RRR 
of 1.48 for the comorbid group with the human death and degradation scale indicates that 
for each additional exposure there was a 48% increase in the risk of comorbid profile 
membership relative to the low-symptom profile.  
Table 4.3 shows the mean SF-12 MCS scores for the resilient group of 52.7  was similar 
to the Australian norm of 52.4, and the PCS of 49.9 was similar to the Australian norm of 
48.9 (Avery et al., 2004). All three symptomatic profile had statistically significantly 
lower scores than the resilient profile. The effect size for the physical profile was larger 
on the PCS than the MCS, and the reverse was found for the psychological profile, while 
the comorbid profile was well below the Australian norms on both scales. A difference of 
≥ 3 points for the PCS or the MCS is considered clinically meaningful (Stewart et al., 
1989; Warkentin et al., 2014; Wyrwich, Tierney, Babu, Kroenke, & Wolinsky, 2005), 
suggesting all profiles, except the PCS for psychological profile, have poor self-perceived 
mental and physical well-being.
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Table 4.3 Associations between SF-12 and symptom group membership: adjusted relative risk ratios and 95% confidence intervals. The reference 
predictor variable is ‘Resilient’ 
SF-12 component Low-symptom Physical Psychological Comorbid P value 
Physical Component Score (PCS) 
Mean score (SD) 49.9 (7.00) 42.58 (9.80) 48.63 (9.98) 40.21 (11.49) < .001 
Coefficient (95% CI) reference -6.45 (-6.58, -6.32) -1.12 (-1.2, 1.02) -8.68 (-8.80, -8.57)  
Mental Component Score (MCS) 
Mean score (SD) 52.69 (0.08) 48.15 (0.33) 35.48 (0.32) 32.78 (0.37) 
 
<.001 
Coefficient (95% CI) reference -4.70 (-4.84, -4.57) -16.83 (-16.93, -16.73) -20.09 (-20.20, -19.98)  
    Adjusted for age, Service status, rank, years since deployment, injury, and Dr diagnosed medical conditions 
    CI = confidence interval; RRR = relative risk ratios
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4.5  Discussion 
While TDEs have been accepted as a key risk factor for psychological symptoms, there is 
continued conceptual uncertainty regarding how to account for the many physical 
symptoms experienced by veterans (Iversen et al., 2008; McFarlane et al., 2008; Xue et 
al., 2015).  To explore this question, four symptom profiles were identified: a low-
symptom group and three symptomatic profiles incorporating physical only, 
psychological only, and comorbid.  The physical profile was the smallest (4.9%), 
psychological the largest (9.3%), and comorbid the most symptomatic.  Despite the 
stringent requirement of 16 physical symptoms to be considered symptomatic, we found 
that physical symptoms without comorbid psychological symptoms was a sizable 
symptom profile, representing almost half of those with any physical symptoms.   
Identifying the physical symptom only profile independent of psychological symptoms 
corroborates the concerns expressed by veterans that their physical health could have a 
direct relationship with TDEs rather than being of psychological origin. Despite this, 
clinicians struggle to explain or treat these symptoms effectively and clinical management 
of this group is not well developed (Kilshaw, 2008; McFarlane, Lawrence-Wood, Van 
Hooff, Malhi, & Yehuda, 2017; olde Hartman et al., 2017).  This may be indicative of a 
significant burden of distress and impairment, although more longitudinal research is 
needed to confirm the health progression of this group.  Thus, identifying the prevalence 
of this symptom profile is an important step in characterising a group that requires further 
investigation regarding the mechanisms of symptom formation and treatment.  
The predictive probabilities generated from our regressions (see Figure 1 of the 
supplementary material) showed a dose-response association between total trauma type 
and all symptom profiles.  Moreover, the comorbid group, which had the highest 
symptom count, also experienced the highest levels of TDEs.  The increased rate of ADF 
deployments during the MEAO may have increased levels of TDEs (McFarlane & 
Hodson, 2011). As our findings suggest that TDEs may be associated with an increase in 
poor health outcomes, military planners may need to account for greater levels of ill-
health for this cohort.   
Comorbidity of physical and psychological conditions is recognised as a clinically 
important marker of illness severity and presents a significant challenge in treatment 
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management, often resulting in poorer outcomes (Hruska, Irish, Pacella, Sledjeski, & 
Delahanty, 2014; Librero, Peiró, & Ordiñana, 1999).  If physical symptoms are dismissed 
as a secondary somatic complaint or insignificant in nature, the true severity of a patient’s 
disorder may be overlooked by clinicians.  Research into major depressive disorder has 
found that rates of relapse are higher if physical symptoms are not considered (Trivedi, 
2004).  Such findings demonstrate the clinical importance of how physical symptoms are 
conceptualised.   
Our findings do not remove the ambiguity around demographic and service risk factors.  
We found that the non-military characteristics of ‘sex’, ‘age’, and ‘education’ were 
predictive of symptomatic outcomes, whereas others have found no impact of 
demographic variables (Kroenke et al., 1998).  In addition, we found that females were at 
an increased risk of all symptom profiles, yet others have found that female veterans are 
more likely to suffer from depression and males are more likely to report pain (Haskell et 
al., 2010).  These results should be interpreted with caution as the number of females 
involved in combat roles does not provide the statistical power required to examine these 
effects.  We also found a small increase in the risk of belonging to the physical profile 
with increasing age. In contrast, de Silva et al. (2013) found no association with age, 
while Killgore et al. (2006) found that the risk decreased with age.  Interestingly, lower 
education only predicted physical profile membership.  
The military factors of rank, service, and service status differed between the profiles.  We 
found that lower rank, a factor often associated with poor psychological outcomes (Xue et 
al., 2015), was only associated with physical or comorbid profiles, whereas de Silva et al. 
(2013) found no association between rank and physical symptoms.  However, the 
increased risk of belonging to the comorbid profile, the profile most likely to include 
those with PTSD, supported other research findings linking PTSD with lower rank 
(Iversen et al., 2008).  We found that ex-serving and inactive Reserves had an increased 
risk of psychological and comorbid profiles which supports the findings of Hotopf et al. 
(2006), but unlike Hotopf et al. (2006), our findings did not support an increased risk of 
physical symptoms for these service status groups.  We identified that serving in the Navy 
was predictive of all symptomatic profiles and being in the RAAF was predictive of the 
comorbid profile.  These results may reflect the specific roles that these groups perform, 
which has been found to be an important consideration when assessing health outcomes 
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(Kok et al., 2012).  However, as roles were not specifically examined in this research, we 
are unable to generalise our findings. 
We assessed the risk of symptomatic profile membership for three types of TDEs: 
objective, subjective, and human death and degradation. Of the three trauma exposure 
types objective exposure showed the smallest associations with all symptomatic profiles, 
a finding consistent with other research (de Silva et al., 2013; Waller et al., 2012).  The 
subjective and human death and degradation exposures predicted all three symptom 
profiles, a finding also supported by previous research (de Silva et al., 2013; Nissen et al., 
2011).  The similar patterns of association with all profiles suggests that there may be 
similar underlying mechanisms in the development of all symptomatic outcomes.   
This study found that the physical only profile showed a stronger relationship with TDEs 
than did the psychological only profile (this difference was small but statistically 
significant).  While the differences in RRR were small and the cross-sectional nature of 
the data do not provide evidence of causation, this finding suggests that TDEs play a role 
in both physical and psychological symptom development, at least partly independent of 
each other.  Therefore, assuming that all physical symptoms share a dimensional 
association with psychological disorders may be invalid.   
If both the physical and psychological profiles share a similar association with trauma, it 
may be time to reflect on the current paradigm that TDEs result in psychological 
disruption which results in ill-health (for example the model of Schnurr and Green, 2004).  
If there is a shared mechanism of trauma in both physical and psychological symptoms, a 
possible alternative theory is that trauma leads to neurobiological shifts which in turn play 
a role in the physical and psychological outcomes associated with trauma.  Exploring 
alternative causal mechanisms may assist in advancing treatment options and developing 
explanatory frameworks.  
 A potential explanation for physical symptoms being a substantial consequence of TDEs 
is that physiological arousal in high threat situations may be an indicator of long-term 
dysregulation of physiological homeostasis (disruption of the body’s ability to maintain 
physiological parameters within a range to allow optimal health).  A prospective study of 
WWII veterans found that physiological reactivity during combat exposure was a 
significant predictor of later health outcomes (Lee, Vaillant, Torrey, & Elder, 1996).  This 
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suggests that physical symptoms during combat may represent a long-term signature of 
how later combat-related distress is re-experienced.  Subtle changes in physiological 
reactivity are not assessed in clinical settings as they are not indicators of frank 
pathology.  However, reported physical symptoms may provide an early indicator of 
physiological dysregulation, and may be a marker for those at increased risk of future ill 
health, a possibility requiring further investigation.   
To our knowledge, this is the first study to examine the comparative strength of 
association between TDEs and physical and psychological symptoms.  Physical 
symptoms are often dismissed by health professionals as having psychological sources 
and tend to receive negative evaluations, or their legitimacy as a ‘medical’ condition is 
questioned (McFarlane et al., 2008; Salmon, 2000).  The findings of this research 
demonstrate that, after controlling for other known risk factors such as gender and rank, 
previous deployment is a significant independent risk factor for both physical and 
psychological symptoms.   
Recognising that there may be an independent association between physical symptoms 
and trauma rather than physical symptoms being secondary to psychological disorder is 
important in validating patients’ experience of these symptoms.  The lack of a coherent 
narrative for patients to make sense of distressing symptoms creates a potential for 
conflict between clinician and patient (Engel et al., 2002; Stone, 2014).  In attempting to 
deal with physical symptoms, both patients and clinicians often express high levels of 
dissatisfaction with the lack of a shared illness schema, with practitioners often 
classifying these patients as ‘difficult’ (Steinmetz & Tabenkin, 2001; Stone, 2014) .  The 
lack of an adequate explanatory framework motivates patients to find alternate theories of 
causality, which can contribute to an increasing focus on the need for compensation and 
blame (Engel et al., 2002).  Identifying that the physical profile can be associated with 
TDEs independent of psychological distress is a crucial first step in research and 
identifies the need to improve our understanding of the pathophysiology of physical 
symptoms and develop explanatory frameworks that better validate the patients’ suffering 
(Engel et al., 2002; Stone, 2014).  
One limitation of this study is that our data were derived from self-reported measures 
which, although economical in large-scale studies, are prone to recall bias.  Research 
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suggests that the reporting of deployment exposures can change over time (Southwick, 
Morgan III, Nicolaou, & Charney, 1997).  However, we found no association between 
‘time since deployment’ and symptom reporting, which suggests minimal amplification 
of traumatic memory in our sample.  Additionally, we were unable to differentiate non-
specific physical symptoms from those caused through disease, injury, or age.  However, 
by controlling for injury and doctor diagnosed medical conditions, we have accounted for 
some factors which may impact symptom reporting.  The utility of the cut-off of 16 
chosen for physical symptoms was conservative.  Sensitivity analyses conducted with the 
lower cut-offs of 15 and 14 demonstrated good construct validity for our physical 
symptom profile.  We limited the covariates included in the study for parsimony and 
because we were limited to information collected by the survey.  Lastly, the cross-
sectional nature of the data limits conclusions about causation.  Key strengths of our 
study include our large, non-treatment seeking sample. Longitudinal studies examining 
the temporal and causal relationships between trauma exposure, physical symptoms, and 
psychological disorder, and the impact of demographic and military factors, with a 
particular focus on physiological mechanisms are needed in the future.  
In conclusion, this research identified a physical symptom only profile (without 
psychological comorbidity), a group that is not adequately conceptualized in clinical 
settings.  It is noteworthy that the association of the physical and psychological symptom 
profiles with TDEs suggests that these exposures are similarly significant in the aetiology 
of both symptom types.  These findings highlight the need to understand causal 
mechanisms for this physical symptom profile as well as develop adequate explanatory 
frameworks and expand available treatments.  
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4.6  Supplementary material 
Table 4.4. Multivariate MLR models with three trauma scales as predictors of symptom group membership N = 14032. The baseline category is 
‘low-symptom’  
Predictor 
Physical vs low-symptom 
RRR (95% CI) 
Psychological vs low-
symptom RRR (95% CI) 
Comorbid vs low-symptom 
RRR (95% CI) 
p 
Model 2: Traumatic deployment exposure scales* 
Subjective 1.19 (1.11, 1.27) 1.25 (1.18, 1.32) 1.48 (1.25, 1.52) < .001 
Objective   0.97 (0.91, 1.04) 0.92 (0.88, 0.97) 0.94 (0.86, 0.99) < .001 
Human death and 
degradation 
1.29 (1.16, 1.43) 1.14 (1.05, 1.23) 1.24 (1.15, 1.35) < .001 
*Adjusted for age, sex, service, service status, rank, education, number of deployments to the MEAO, years since deployment 
to the MEAO, injury, and Dr diagnosed medical conditions. 
RRR = Relative Risk Ratio; ref = ref reference group; CI = confidence interval 
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Figure 4.1. Predictive probabilities with error bars demonstrating a dose-response effect of total 
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5.1  Abstract  
Background: Current paradigms of posttraumatic stress disorder (PTSD) and the effects 
of trauma exposure on military personnel do not adequately account for the significance 
of trauma as an independent cause of physical distress. Physical distress is generally 
treated as a comorbidity of psychological disorder, whereas a subgroup of personnel may 
experience it independently. This study aims to identify distinct posttraumatic stress and 
physical distress profiles in deployed veterans and explore their relationship with 
traumatic exposures. 
Methods: Data were from a cross-sectional study of Australian Defence Force personnel 
who were deployed to the Middle East Area of Operations from 2001 to 2009 (N = 
14,032). Four groups were defined using distributional splits of a physical symptom scale 
and a PTSD scale: low-symptom, physical, PTSD, and comorbid. Multinomial logistic 
regression models were used to assess the ability of three self-reported trauma exposures: 
objective, subjective, and human death/degradation to predict group membership.   
Results: The three symptomatic groups demonstrated similar prevalence: physical 7.1%, 
PTSD 6.3%, and comorbid 7.7%. Traumatic exposures were significant predictors of all 
symptomatic groups. For objective, subjective, and human death/degradation traumas, the 
largest relative risk ratios predicted comorbid group membership (1.5, 1.23, and 1.58), 
followed by PTSD group membership (1.34, 1.16, and 1.45), and physical group 
membership (1.18, 1.09, and 1.26).  
Conclusion: Similar patterns of association of traumatic exposures with both PTSD and 
physical symptoms suggests a shared influence of trauma on both outcomes in veterans. 
Specific trauma exposure categories differ in their impact on symptom development.  
Keywords: trauma, multinomial logistic regression, posttraumatic stress, comorbidity, 
physical symptoms. 
Acronyms: PTSD = posttraumatic stress disorder; MLR = multinomial logistic 
regression; MEAO = Middle East Area of Operations; ADF = Australian Defence Force; 
HSC = health symptom checklist; SMH = somatic marker hypothesis; CI = confidence 
interval.  
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5.2  Introduction  
Every major conflict has been followed by fierce controversies over the existence of post-
war syndromes, such as Gulf War Syndrome (Ismail et al., 1999), which typically present 
as clusters of non-specific physical symptoms such as fatigue, headaches, or bodily aches 
and pains (Jones et al., 2002). The nomenclature applied to these symptoms is varied and 
may include physical symptoms, medically unexplained symptoms, or somatic symptoms. 
It has been well-established that regardless of whether the cause of symptoms is known, it 
is the number of  symptoms that most strongly impacts upon long-term health outcomes 
(Chou & Shekelle, 2010; Huijbregts et al., 2013; Rief & Rojas, 2007). Thus, when 
referring to the symptoms of somatic distress, we have chosen to use the simple 
descriptive term ‘physical symptoms’ (Rief & Martin, 2014) as this term makes no 
assumptions concerning pathogenesis. 
Physical symptoms are major drivers of patients’ perceptions of ill health for which they 
seek medical help; for example, the diagnostic category ‘symptoms, signs, and other ill-
defined conditions’ is the most common reason for consultation in the US military 
(Armed Forces Health Surveillance Center, 2013; Khan, Khan, Harezlak, Tu, & Kroenke, 
2003; McFarlane et al., 1994). A study of Canadian military veterans by Thompson et al. 
(2013) found that physical health status appeared to have a greater effect on overall 
health-related quality of life than mental health status. Physical symptoms have also been 
associated with increased healthcare utilisation (Andersen, Eplov, Andersen, Hjorthoj, & 
Birket-Smith, 2013), functional impairment (Kroenke et al., 1994), and mortality (Engel 
Jr et al., 2002).  
An ongoing conundrum for the traumatic stress field is how to characterise such non-
specific physical symptoms, and how to deal with their substantial burden. For veterans 
experiencing these symptoms, the lack of a coherent explanatory framework often leads 
to conflict with clinicians and disagreements about causation (Engel et al., 2002; Stone, 
2014). For example, veterans commonly attribute their physical symptoms to hazardous 
environmental battlefield exposures such as exposure to depleted uranium, multiple 
vaccinations, or dioxin, yet research has found little empirical evidence to support such 
aetiologies (Hotopf et al., 2000; Kang et al., 2006; Kroenke et al., 1998; War, 2000).  
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Physical symptoms commonly co-occur with psychological disorder, particularly 
posttraumatic stress disorder (PTSD), which can complicate presentation, delay diagnosis, 
and result in greater levels of impairment and poorer treatment outcomes (Andreski et al., 
1998; Katon et al., 2001; Magruder et al., 2004; Simon et al., 1999). The diagnosis for 
PTSD was first introduced in the American Psychiatric Association's (APA) third edition 
of its Diagnostic and Statistical Manual of Mental Disorders (DSM-III), and was largely 
inspired to normalise the traumatic response seen in Vietnam veterans, and to move away 
from the diagnosis of war neurosis (Scott, 1990; Yehuda & McFarlane, 1995). Given the 
extensive evidence relating combat exposure to the development of PTSD, it is now 
considered the main trauma-related disorder (Baker et al., 2012a; Wisco et al., 2014; Xue 
et al., 2015). However, the DSM-V diagnostic criteria for PTSD do not address physical 
symptomatic distress, except in the broad criterion ‘B5’ of unspecified ‘marked 
physiological reaction’ (American Psychiatric Association, 2013). Thus, physical 
symptoms are not considered a core component of trauma-related disorders, requiring 
clinicians to deal with them as a somatoform comorbidity.  
The strong association between physical symptoms and PTSD explains why a large 
proportion of research exploring post-deployment physical symptoms has focused on 
their co-occurrence (de Silva et al., 2013; Hoge et al., 2007; Maia et al., 2011; Nillni et 
al., 2014; Nissen et al., 2011; Osorio, Carvalho, Fertout, & Maia, 2012; Quartana et al., 
2015; Wolfe et al., 1999; Wolfe, Schnurr, Brown, & Furey, 1994). The association of 
physical symptoms with combat exposure independent of psychological disorder has 
received comparatively little attention, despite being identified as a possible post-
deployment symptom profile in subgroups of veterans (Graham, Searle, Van Hooff, 
Lawrence-Wood, & McFarlane, 2018; Wolfe et al., 1998). Research in our group has 
identified that post-deployment physical symptoms can exist without psychological 
distress for a significant subgroup of the population. They also have a similar prevalence 
to psychological distress, are similarly related to deployment trauma, and have a similar 
impact on health-related quality of life (Graham et al., 2018). Thus, the potential of 
physical symptoms as an independent outcome of combat exposure has been neglected in 
both the research and diagnostic spheres. In addition, the fact that physical symptoms are 
considered a somatic comorbidity may negatively affect the identification and treatment 
of at-risk personnel. 
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Despite the links that have been identified between combat exposure and physical 
symptoms, the literature is inconsistent. Several studies have found that combat exposure 
is a risk factor for physical symptoms, some suggest that deployment rather than combat 
is influential, and others suggest that deployment has no impact (de Silva et al., 2013; 
Horn et al., 2006; Hotopf et al., 2006; McCutchan et al., 2016; Waller et al., 2012). 
Methodological differences may explain this discrepancy, particularly the poor definition 
of physical symptoms and the wide variety of measurement tools available. Thus, despite 
the high incidence of post-deployment physical symptoms and their significant negative 
impact, little is definitively understood about their association with traumatic deployment 
exposure as a discrete outcome. 
The purpose of this study is to extend our previous findings concerning the relationship 
between deployment trauma and physical symptoms (Graham et al., 2018), to specifically 
focus on PTSD symptoms rather than the broader emotional distress, and to explore the 
overlap with and differentiation between physical symptoms following traumatic 
deployment exposures. Our sample was a large cohort of deployed Australian Defence 
personnel who served in the Iraq and Afghanistan conflicts from 2001 to 2009. Our aim 
was to identify discrete post-deployment outcome profiles of: (1) high physical symptoms 
alone, (2) high PTSD symptoms alone, or (3) comorbidity. Subsequently, this study aims 
to explore correlates of these profiles including traumatic exposures, and demographic 
and service characteristics to delineate whether stressors for our three symptom profiles 
differ meaningfully. We separated traumatic exposures into different categories, as some 
trauma types may have greater impact on veterans’ symptoms (Searle et al., 2017; Waller 
et al., 2012).  
5.3  Method 
5.3.1 Study design and participants  
The data for this study came from the Middle East Area of Operations (MEAO) Census 
Study (Dobson et al., 2012), a survey of current and ex-serving, regular, and Reserve 
Australian Defence Force (ADF) members who were deployed to Iraq, Afghanistan, or 
supporting operations from 1 October 2001 to 31 December 2009.  
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All 26,239 ADF members who were deployed to the MEAO in this period (determined 
from Defence records) were invited to participate, with a response rate of 53% (n = 
14,032). Data collection occurred in 2010 and 2011 using either online or hard-copy 
questionnaires. The retrospective, self-report survey included questions on deployment 
history, current health, and deployment experiences for participants’ most recent MEAO 
deployment. Participation was voluntary, and all data were de-identified. Further details 
about the data collection methods are described elsewhere (Dobson et al., 2012). This 
study was approved by the Australian Defence Human Research Ethics Committee, the 
University of Queensland Behavioural and Social Sciences Ethical Review Committee, 
the Department of Veterans’ Affairs Human Research Ethics Committee, and the 
University of Adelaide Human Research Ethics Committee. 
5.3.2 Measures  
5.3.2.1 Outcome variable  
The posttraumatic checklist (PCL) assesses self-reported PTSD symptoms (Weathers et 
al., 1993). Participants rate 17 questions on a 5-point Likert scale from ‘not at all’ to 
‘extremely’ with relevance to the last month. Total scores range from 17 to 85, with 
higher scores indicative of higher symptomatology. A cut-off of 33 was used in this study 
as this has been found to represent a moderate risk of PTSD and may capture some sub-
syndromal PTSD in military populations, a condition that has been demonstrated to have 
an impact on functional impairment and comorbidity similar to that of PTSD, as well as 
being a risk factor for delayed onset PTSD (Andrews, Brewin, Philpott, & Stewart, 2007; 
Dickstein et al., 2015; Smid, Mooren, van der Mast, Gersons, & Kleber, 2009; Stein, 
Walker, Hazen, & Forde, 1997). Additionally, it has been found that lower PCL cut-off 
scores may be of value in military samples as they may have a stigma against reporting 
PTSD symptoms (Hoge et al., 2004). This cut-off represented the top 13% of individuals 
with PTSD symptoms in our sample. The PCL displays high validity and reliability 
(McDonald and Calhoun, 2010). Our sample demonstrated excellent internal consistency 
(alpha = 0.96).  
Self-reported physical symptoms were assessed with a 67-item health symptom checklist 
(HSC) adopted from the King's College Gulf War Survey (Unwin et al., 1999), and the 
Australian Gulf War Veterans Health Study (Kelsall et al., 2004). This instrument 
contained psychological (e.g. ‘forgetfulness’) and physical (e.g. ‘joint pain’) symptoms. 
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To avoid construct overlap between the HSC and the PCL, items that were repeated on 
both measures, such as ‘distressing dreams’, were excluded, resulting in a final list of 57 
physical symptoms. The HSC had excellent internal consistency in our sample (alpha = 
0.93). 
Members were asked to indicate the presence or absence of these symptoms over the past 
month, rated as: never, mild, moderate, or severe. To assess prevalence, physical 
symptoms were dichotomised into no (‘never’) or yes (‘mild’, ‘moderate’, or ‘severe’), 
providing a count of the number of physical symptoms. Physical symptom count scores 
have been associated with deployment in veteran samples (de Silva et al., 2013; Hotopf et 
al., 2006; Unwin et al., 1999). We derived our definition for physical symptom caseness 
as endorsing 16 or more physical symptoms, based on previous studies using the physical 
symptom scale from the King's College Gulf War Survey (de Silva et al., 2013; Hotopf et 
al., 2006). This cut-off represented the top 12.4% of our sample.  
To generate our outcome variable of symptom group membership, four symptom groups 
were defined using these dichotomised PCL and HSC scores: (1) a low-symptom group 
(< 16 physical symptoms and a PCL score < 33); (2) a physical only group (≥ 16 physical 
symptoms and PCL score < 33); (3) a PTSD only group (< 16 physical symptoms and 
PCL score ≥ 33); and (4) a comorbid group (≥ 16 physical symptoms and PCL score ≥ 
33). 
5.3.2.2 Explanatory variable 
A traumatic exposures questionnaire was adapted by the Census Study developers 
(Dobson et al., 2012) from a number of sources including the Deployment Risk and 
Resilience Inventory, the Traumatic Stressors Exposure Scale, and the King's College 
Gulf War Survey (King, King, Vogt, Knight, & Samper, 2006; Swann & Hodson, 2004; 
Unwin et al., 1999). The questionnaire assessed the frequency of 27 self-reported 
deployment exposures from participants’ most recent MEAO deployment, rated as: never, 
once, 2-4 times, 5-9 times, or 10+ times. Two items were excluded from our analysis: 
‘Did you clear/search caves?’ as this item was limited to Afghanistan deployments; and 
‘Were you present when a loved one was injured or killed?’ as the rate was less than 1%. 
Items were categorised into three sub-scales that have been found to be associated with 
PTSD or physical symptom development: ‘subjective trauma’ (i.e. perceived threat) 
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included eight items (e.g. ‘Were you in danger of being injured?); ‘objective trauma’ (i.e. 
measurable events) included 11 items (e.g. ‘Did you come under small arms or anti-
aircraft fire?’); and ‘human death/degradation’ included six items (e.g. ‘Did you handle 
dead bodies?’; Stein et al., 2012; Waller et al., 2012). Items were first dichotomised into 
‘not exposed’ or ‘exposed’, then added to provide a total count of the number of trauma 
types, as well as separate counts for each of the three sub-scales. Rather than frequency, a 
count of the number of trauma types was assessed, as this measure appears to be more 
strongly associated with PTSD and physical symptoms (Kroenke et al., 1998; Searle et 
al., 2017; Waller et al., 2012). The trauma type count had excellent internal consistency in 
our sample (alpha = 0.9). 
5.3.2.3 Covariates  
The demographic and military covariates used were consistent with those previously 
reported in the literature to be associated with either physical or PTSD symptoms (de 
Silva et al., 2013b; Horn et al., 2006; Hotopf et al., 2006; Kroenke et al., 1998; Storzbach 
et al., 2000). These were: sex, age, Service (Navy, Army, Air Force), current service 
status (actively serving, active Reserve, ex-serving, inactive Reserve), current/discharge 
Rank (Commissioned Officer: Lieutenant to General equivalents; Non-Commissioned 
Officer: Sergeant to Warrant Officer equivalents; or Other Rank: Private to Corporal 
equivalents), number of times deployed to the MEAO, and time since last MEAO 
deployment. Other covariates included were: injury sustained on MEAO deployment that 
required attendance at sick parade, and doctor-diagnosed medical condition (‘Since 
returning from your last MEAO deployment, has a medical doctor diagnosed you with, or 
treated you for any of the following medical problems or conditions?’).  
5.3.2.4 Statistical analysis  
Analyses were conducted using Stata 14 (StataCorp LP, 2015b). Missing values in 
outcome and exposure variables were addressed using multiple imputation implemented 
under a missing at random assumption, which was deemed plausible since outside of 
these analysis variables we were unable to find any predictors of missingness. Multiple 
imputation was carried out using fully conditioned specification, with 20 complete 
datasets created based on the rule of thumb that the number of imputations should at least 
equal the percentage of incomplete cases (White, Royston, & Wood, 2011). Estimates 
were combined across imputed datasets using Rubin’s rules (Amital et al., 2006). As well 
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as analysis model variables, the imputation model included two auxiliary variables (‘In 
general, how would you rate your: overall health; quality of life?’) that demonstrated 
moderate correlation with the outcome variable; imputed outcomes were therefore 
retained in the analysis (Sullivan, Salter, Ryan, & Lee, 2015). As complete case analyses 
showed only minimal differences from the imputed analysis, only the imputed results are 
reported.  
Multinomial logistic regression (MLR) was used to examine associations between trauma 
exposure and symptom group membership, as it has been shown to perform well in 
simultaneously modelling estimates for the probability of multiple diagnoses (Bertens et 
al., 2016). The effect size measure used was relative risk ratios (RRR), which in MLR is 
the exponentiated coefficient calculated relative to a base category. Wald statistics were 
used for hypothesis testing as these are considered superior with imputed data (White et 
al., 2011). All the measures used are provided in Appendix A. 
5.4  Results 
Table 5.1 shows the demographic and service characteristics for the 14,032 survey 
participants. The majority were male, with a mean age of 36.9 years, in the Army, active 
serving, Non-Commissioned officers, with 61% deployed to Afghanistan, 72% to Iraq, 
and 35% deployed to both areas. Survey response rates were lower among males, 
veterans under 35 years, Army and Navy members, lower ranks, and members who were 
in the Reserves or ex-serving (Dobson et al., 2012).  
As expected in a healthy deployed sample, most personnel reported low symptom levels. 
The mean PCL score was 23.85 (SD 10.53), and the mean HSC score was 7.54 (SD 8.03), 
so the majority were below the symptom group cut-offs. 
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Table 5.1 Demographic and service characteristics for survey responders, with prevalence (and 
n) or mean (and standard deviation), n = 14032 
Characteristic Prevalence  
Age: mean (SD) 36.9 years (8.6) 
Sex: n (%)  
   Male 




Service: n (%) 
   Army  
   Navy  




30.5%  (4,280) 
 Service status at survey commencement: n (%)      
Active regular  
Active Reserve 







Rank on deployment: n (%) 
   Commissioned officer  
   Non-commissioned officer 
   Other Rank 
 
28.2% (3,957) 
51.1% (7,170)  
20.7% (2,905) 
Number of deployments: mean (SD) 2.5 (2) 
Time since last deployed to the MEAO: mean (SD) 4.3 years (2.5) 
MEAO = Middle East Area of Operations 
 
Table 5.2 describes the proportion of personnel in each of the four symptom groups as 
well as their mean PCL scores, HSC scores, and the total number of trauma exposure 
types. Most participants were in the low-symptom group, reporting low levels of trauma 
exposures, PTSD, and physical symptoms. The remaining participants were 
approximately equally as likely to be part of the physical, PTSD, and comorbid groups. 
The comorbid group had the highest mean count of total trauma exposures and were the 
most symptomatic. 
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Table 5.2 Mean (SD) symptom scale scores and trauma counts for the four symptom groups, n 
= 14,032 




Mean count for total 
deployment trauma 





4.76 (4.27) 20.13 (4.48) 3.99 (4.65) 
Physical 999 (7.1) 19.99 (5.74) 25.12 (6.65) 4.93 (5.01) 
PTSD 884 (6.3) 9.24 (4.73) 40.53 (10.1) 6.85 (5.96) 
Comorbid 1,077 (7.7) 25.93 (9.1) 47.4 (13.82) 8.15 (6.09) 
 
HSC = health symptoms checklist; PCL posttraumatic check list; PTSD posttraumatic 
stress disorder 
 
5.4.1 Multivariate multinomial logistic regression models 
5.4.1.1 Model 1: Demographic and service characteristics with trauma type count 
Table 5.3 shows the multivariate MLR Model 1, the demographic and service 
characteristics, with trauma type count and all service and demographic variables entered 
simultaneously. The number of deployments to the MEAO, years since most recent 
deployment to the MEAO, and Service were not significantly associated with group 
membership. When compared to the low-symptom group, the physical group were more 
likely to be older, female, and Non-Commissioned Officer or Other Rank. The PTSD 
group were more likely to be active Reserves or ex-serving. The comorbid group were 
more likely to be older, female, ex-serving or inactive Reserves, and Non-Commissioned 
Officer or Other Rank. All symptomatic groups had elevated RRR with injuries; however, 
doctor-diagnosed medical condition was only associated with physical and comorbid 
group membership.  
Interestingly, in the multinomial MLR in Table 5.3, with all other variables controlled for, 
including trauma type count, the Army were at the lowest risk of symptomatic group 
membership. However, in the univariate MLR analyses (available in the supplementary 
material), the Army was at the highest risk of all symptomatic group membership as is 
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usually expected (Van Hooff et al., 2014), except for physical, where the Navy was the 
most at risk. This suggests that the Army may have worse outcomes as they experience 
more traumatic deployment exposures. 
Sensitivity analyses were conducted using total trauma frequency; this made no 
appreciable difference to the outcomes. As injury can influence physical symptoms 
reporting and increase the risk of PTSD (Macgregor, Tang, Dougherty, & Galarneau, 
2013), the sample was divided into those with and those without an injury and analysed 
separately. This analysis found only small differences in RRR: no difference in physical, 
a 2% increase in PTSD, and a 3% increase in comorbid membership. Thus, the results 
reported are for the total sample.
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Table 5.3 Multinomial logistic regression models for symptom group membership, n=14,032 







RRR (95% CI)  RRR (95% CI)    RRR (95% CI)    p 
Model 1: Demographic and service characteristics 
Age   1.05 (1.04, 1.06) 1.00 (0.99, 1.01) 1.05 (1.04, 1.06) < .001 
Gender: Male (ref) 
   Female 
 
1.65 (1.33, 2.06) 
 
1.09 (0.84, 1.42) 
 
1.49 (1.14, 1.94) 
< .001 
Service: Army (ref) 
   Navy  
   RAAF 
 
1.45 (1.15, 1.82) 
1.18 (0.96, 1.46) 
 
1.43 (1.11, 1.85) 
1.17 (0.93, 1.48) 
 
1.49 (1.13, 1.96) 
1.17 (0.92, 1.51) 
.002 
Service status: Active regular (ref)  
Active Reserve 
Ex-Serving 
Inactive Reserve                                                                                                                                                                                                                                                                                                                                                                          
 
1.06 (0.83, 1.35) 
1.00 (0.70, 1.42) 
0.82 (0.61, 1.08)
 
1.38 (1.06, 1.85) 
2.57 (1.88, 3.52) 
1.41 (1.08, 1.86)
 
1.32 (1.01, 1.71) 
3.91 (2.96, 5.17) 
1.72 (1.34, 2.20)
< .001 
Rank on deployment: 
Commissioned officer (ref) 
   NCO 
   Other Rank 
 
 
1.77 (1.47, 2.13)  
1.94 (1.48, 2.53) 
 
 
1.23 (1.04, 1.58) 
1.19 (0.86, 1.66) 
 
 
1.90 (1.51, 2.40) 
2.08 (1.53, 2.83) 
< .001 
Number of deployments  1.06 (1.01, 1.1) 1.01 (0.95, 1.07) 1.06 (1.02, 1.11) .023 
    












*Adjusted for age, sex, service, service type, rank, years since deployment, number of deployments, injury, and doctor diagnosed medical 
conditions. Model 1 demographic, service characteristics, and total trauma types are the predictors. Models 2, 3 & 4 deployment exposure scales 
are the predictors. The baseline category is ‘low-symptom’. 
RRR = Relative Risk Ratio; ref = reference group; CI = confidence interval; NCO = Non-Commissioned officer
Years since deployed 1.03 (0.99, 1.06) 1.04 (1.00, 1.09) 0.99 (0.95, 1.03) .081 
Injury  1.16 (1.03, 1.30) 1.23 (1.09, 1.39) 1.35 (1.21, 1.50) < .001 
Dr diagnosed medical conditions 1.26 (1.22, 1.3) 1.03 (0.99, 1.07) 1.18 (1.14, 1.21) < .001 
Total trauma types 1.07 (1.05, 1.09) 1.12 (1.1, 1.14) 1.16 (1.14, 1.18) < .001 
Model 2, 3, & 4:  Deployment trauma exposure subscales * 
Model 2: Subjective trauma 1.18 (1.12, 1.24) 1.34 (1.28, 1.41) 1.5 (1.43, 1.58) < .001 
Model 3: Objective trauma 1.09 (1.05, 1.13) 1.16 (1.12, 1.21) 1.23 (1.19, 1.27) < .001 
Model 4: Human 
death/degradation trauma 
1.26 (1.16, 1.36) 1.45 (1.35, 1.56) 1.58 (1.48, 1.68) < .001 
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5.4.1.2 Models 2, 3, & 4: Deployment trauma exposure scales 
Three multivariate MLR models were run, each testing a different deployment trauma 
exposure sub-scale as the predictor of symptom group membership compared to the base 
low-symptom group: Model 1 subjective trauma; Model 2 objective trauma; and Model 3 
human death/degradation. Each model was adjusted for all the demographic and service 
characteristics listed in Model 1. 
The results in Table 5.3 demonstrate that all three trauma exposure scales were predictive 
of increased RRR for all symptomatic group membership. All three models showed a 
similar pattern of results, with the strongest association being with comorbid group 
membership, followed by the PTSD group, and the weakest association with physical 
group membership. The human death/degradation exposure scale was the most predictive 
of symptom group membership and the objective scale the least. The RRR of 1.58 for the 
comorbid group with the human death/degradation exposure scale shows that, for every 
one-point increase in this exposure scale score, there is a 58% increase in risk of 
comorbid group membership relative to the low-symptom group.  
5.5  Discussion  
This study investigated patterns of physical and posttraumatic stress symptoms in 
veterans and their relationship to deployment trauma. We created four symptom profiles: 
a low-symptom, high physical symptoms only, high PTSD symptoms only, and a 
comorbid profile. The large size of the low-symptom profile reflects that most veterans 
maintain a good standard of post-deployment health. This is  most likely the result of the 
‘healthy warrior effect’, where members selected for deployment have better pre-
deployment health (Kang  & Bullman 1996). Interestingly, the comparable size of the 
three symptom profiles demonstrates that a physical symptoms profile is not only a 
possible discrete outcome of trauma exposure, but also an equally plausible manifestation 
as the PTSD symptoms only or comorbid profiles.  
The finding that physical symptoms can have an association with trauma independent of 
psychological disorder is significant because such symptoms have been found to 
negatively impact upon the quality of life of sufferers, as well as creating a considerable 
economic burden (Thompson et al., 2013). However, the fact that we are yet to 
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understand the neurobiological mechanisms of these symptoms underscores the need for 
further research in this area. This finding also highlights the importance of clinicians 
focusing on physical symptoms as an area for clinical intervention (McFarlane, 
Lawrence-Wood, Van Hooff, Malhi, & Yehuda, 2017). An improved understanding of 
the aetiology of post-deployment physical symptoms, whether co-occurring with PTSD or 
as a discrete outcome of trauma exposure, may help in the development of an explanatory 
framework that meets the requirements of both clinicians and patients. Such a framework 
could help avoid the adversarial relationship that often develops with contested causation 
that can arise with patients if this axis of distress is not addressed (Engel et al., 2002; 
Stone, 2014).  
In addition to creating our symptom profiles, we explored the strength of association of 
each profile with a count of trauma types that members were exposed to. Higher trauma 
type count predicted membership of all three symptomatic profiles, demonstrating that 
increased trauma exposure results in an increased risk of belonging to a symptom profile. 
The comorbid profile exhibited the highest mean trauma type count, the strongest 
association with trauma type count, and the highest mean number of all symptoms, 
supporting the premise that impact of trauma should be viewed on a continuum, with 
comorbid physical and PTSD symptoms at the extreme end (McFarlane et al., 2017).  
To advance this finding, further research could identify the processes that link 
deployment trauma with both physical and psychological symptoms. One possible 
neurobiological mechanism is activation of the insula.  The insula is a small structure in 
the cerebral cortex, and is located in the lateral sulcus of each hemisphere that is involved 
in conciseness (Vago, & David, 2012).  This vital brain structure is suggested to be 
involved in visceral-somatic processing, autonomic function, and interoception, (i.e., the 
sense of the physiological condition of the body), thereby facilitating our concept of self-
awareness the self-registration of physical and emotional states (Uddin, Nomi, Hebert-
Seropian, Ghaziri, & Boucher, 2017).  These functions make it an area of interest in 
physical psychological overlap, and in fact the insula has been implicated in both PTSD 
and physical symptom generation and severity (Garfinkel & Liberzon, 2009; Hillert, 
Musabasic, Berglund, Ciumas, & Savic, 2007; Kaczkurkin et al., 2016; Simmons, Strigo, 
Matthews, Paulus, & Stein, 2009).  Another possibility is genetic phenotypes that may be 
associated with different symptom expression. For example, research with adolescents 
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has identified a genetic factor that accounts for somatic distress but not anxiety or 
depression (Hansell et al., 2012).  
We also assessed the association between symptom profiles and three sub-types of 
traumatic deployment exposure (subjective, objective, and human death/degradation). 
Again, the comorbid profile demonstrated the strongest association with all trauma sub-
types, followed by PTSD, and then physical profiles. All symptom profiles shared a 
similar pattern of association with each trauma sub-type; that is, human death/degradation 
showed the strongest association with all symptom profiles, followed by the subjective 
and then the objective trauma sub-types.  
Techniques used to measure trauma exposure on deployment vary considerably, but 
studies have found that some trauma types have a stronger impact on both physical and 
psychological symptom development. Other research supports our findings that exposure 
to human trauma has the strongest association with psychological disorder and that 
subjective but not objective exposures were associated with higher physical symptom 
count and higher PCL scores (Pietrzak et al., 2011; Sareen et al., 2007; Waller et al., 
2012).  
The similar patterns of association of trauma sub-types to our three symptomatic groups 
suggests that similar neurobiological pathological mechanisms may be involved in 
symptom development for all groups. Identifying the differences in the neurobiological 
signatures of different traumatic exposure types could help to identify the mechanisms 
involved in symptom development which, in turn, may provide models for the 
development of new interventions that target specific pathological processes. One 
supposition may be that the horror of human death/degradation exposures, or the fear of 
the subjective threat-to-self, may be linked with symptom development via physiological 
dysregulation (i.e., the body’s ability to maintain physiological parameters, such as blood 
pressure, within a range to allow optimal health is disrupted). The premise that 
physiological dysregulation is a core mechanism in symptom development would support 
findings such as those by Schlenger et al. (2015) showing that the level of exposure to 
war zone stress is a significant predictor of mortality, even after adjusting for PTSD. 
Thus, physical symptoms may be a marker of those at risk of poor long-term health 
outcomes, a supposition worthy of further exploration. 
    
Page | 104 
The findings of our study are consistent with past research showing that PTSD is 
associated with physical symptoms (Solomon & Mikulincer, 1987). The relative size of 
the comorbid and PTSD only groups highlights that more than half of those with high 
levels of PTSD symptoms also have high levels of physical symptoms. Early definitions 
of PTSD proposed physical symptoms as a central feature of PTSD, a proposition 
supported by our results (Kardiner, 1941; Kolb, 1989).    
One possible interpretation of our results is that the current DSM-5 PTSD diagnostic 
criteria do not fully describe the ‘illness’ experience of many patients. The fact that 
physical symptoms are usually viewed as a comorbidity of PTSD (Jakupcak et al., 2006) 
highlights an inconsistency in the treatment of psychopathologies. For example, both 
major depressive disorder (decrease in appetite, fatigue) and generalised anxiety disorder 
(fatigue, muscle tension) have physical symptoms as part of their DSM-5 diagnostic 
criteria. This inconsistency is particularly important in the clinical realm as research on 
depression has found higher rates of relapse in patients when physical symptoms remain 
unresolved (Paykel et al., 1995). Exploring if there is a similar relationship between 
PTSD and physical symptoms could be important in understanding the efficacy of 
treatments and rates of relapse. 
Our analyses controlled for demographic and service characteristics which may offer 
alternative explanations for physical and PTSD symptoms. A strong association was seen 
between the PTSD profile and ex-Serving and inactive Reserves, which is most likely 
indicative of delayed expression of PTSD being higher in Reserve and transitioned 
members, a result that has also been found in other military studies (Andrews, Brewin, 
Stewart, Philpott, & Hejdenberg, 2009). However, even accounting for these covariates, 
the relationship between traumatic exposures in our three symptomatic groups remained 
significant. 
The limitations of our research include the data being self-reported and collected in some 
instances several years after returning from deployment, which could introduce recall 
bias. However, we found no statistically significant association between time since 
deployment and symptom reporting, even in the high symptoms groups, suggesting no 
amplification of memory for traumatic events (Southwick, Morgan, Nicolaou, & Charney, 
1997; Wilson, Hoge, McGurk, Thomas, & Castro, 2010). The data were also cross-
sectional which limits conclusions about causation. Additionally, we were unable to 
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determine whether the origin of our physical symptoms was through disease, injury, or 
age. However, by controlling for such variables, we have accounted for specific somatic 
diseases which may impact symptom reporting. The utility of the cut-off chosen for 
physical symptoms was conservative. Sensitivity analyses were also run with a cut-off of 
15 and 14 physical symptoms, and although the relative risk ratios decreased slightly, the 
results were otherwise consistent, demonstrating good construct validity for our somatic 
distress group.  
A strength of our study was that it was a large, non-treatment seeking sample of the 
population of interest. Further studies that elucidate the temporal and causal relationships 
between trauma exposure, physical symptoms, and PTSD are needed, with a focus on 
informing our understanding of the neurobiological processes involved. Additionally, 
research that explores the association between physical symptoms and PTSD over the 
course of treatment may help to improve clinical outcomes for veterans. 
In conclusion, this research highlights that physical symptoms are an important correlate 
of deployment trauma, regardless of PTSD symptoms. Specifically, physical symptoms 
without comorbid PTSD symptoms is a discrete health outcome as common as 
posttraumatic manifestations, but also high levels of physical symptoms commonly co-
occur with PTSD symptoms. Thus, we propose that physical symptoms are an integral 
experience for a significant sub-group of veterans, and highlight the importance of 
assessing, monitoring, and treating these symptoms in veterans both with and without 
PTSD symptoms. Further research to improve the understanding of the neurobiological 
mechanisms involved in symptom development in veterans may improve our 
understanding of the variability in responses to trauma and may help to identify new 
targeted interventions to improve patient outcomes.  
5.6  Supplementary material 
The univariate multinomial logistic regression models in Table 5.4 show that when 
compared with the low-symptom group, gender and number of deployments were not 
significantly associated with group membership. The physical group are likely to be older 
or in the Navy. The PTSD group are less likely to be in the RAAF. The comorbid group 
are likely to be older and not from the RAAF or the Navy. For service status, active 
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Reserves and ex-serving were more likely to belong to all symptomatic groups, while 
inactive Reserves were more likely to belong to the PTSD or comorbid group. Non-
Commissioned Officer Rank was associated with all symptomatic groups, but Other Rank 
with only the PTSD and comorbid groups. Years since deployment to the MEAO had a 
small increased relative risk ratio for all symptomatic group membership.  
Table 5.4 Univariate MLR between symptom group membership and demographic and service 
characteristics (Model 1) and deployment exposure scales (Models 2, 3 & 4). The baseline 
category is ‘low-symptom’, n=14032 







RRR (95% CI)  RRR (95% CI)    RRR (95% CI)     
Age 1.05 (1.04, 1.06) 1.01 (1, 1.02) 1.04 (1.04, 1.05) < .001 
Gender: Male (ref) 
   Female 
 
1.3 (1.06, 1.59) 
 
0.99 (0.78, 1.25) 
 
1.05 (0.85, 1.29) 
.094 
Service: Army (ref) 
   Navy  
   RAAF 
 
1.30 (1.1, 1.54) 
1.04 (0.88, 1.23) 
 
0.92 (0.77, 1.11) 
0.63 (0.52, 0.76) 
 
0.78 (0.65, 0.94) 
0.56 (0.47, 0.67) 
< .001 




Inactive Reserve                                                                                                                                                                                                                                                                                                                                                                          
 
 
1.51 (1.22, 1.88) 




1.66 (1.3, 2.11) 




1.83 (1.8, 2.27) 
7.03 (5.78, 8.54) 
2.46 (2.03, 2.99)
< .001 
Rank on deployment: 
   Commissioned Officer  
   Non-Commissioned 
   Other 
 
(ref) 
1.55 (1.59, 2.43)  




1.41 (1.07, 1.85) 
 
 
1.88 (1.55, 2.27) 
1.6 (1.29, 1.91) 
< .001 
No deployments  1.02 (1, 1.05) 0.95 (0.9, 1.01) 1.03 (1, 1.05) .049 
Years since 1.1 (1.06, 1.13) 1.12 (1.08, 1.16) 1.14 (1.11, 1.17) < .001 
Injury  1.48 (1.33, 1.65) 1.4 (1.25, 1.57) 1.95 (1.79, 2.13) < .001 
Dr diag. medical  1.37 (1.33, 1.4) 1.19 (1.15, 1.23) 1.44 (1.41, 1.48) < .001 
Subjective scale 1.16 (1.11, 1.2) 1.37 (1.32, 1.43) 1.56 (1.51, 1.62) < .001 
Objective scale 1.04 (1.01, 1.07) 1.15 (1.12, 1.18) 1.21 (1.18, 1.24) < .001 
Human 1.19 (1.12, 1.27) 1.46 (1.39, 1.54) 1.61 (1.54, 1.69) < .001 
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6.1 Abstract  
Objective: Among military personnel posttraumatic stress disorder is strongly associated 
with non-specific health symptoms and can have poor treatment outcomes. This study 
aimed to use machine learning to identify and describe clusters of self-report health 
symptoms and examine their association with probable PTSD, other psychopathology, 
traumatic deployment exposures, and demographic factors. 
Method: Data were from a large sample of military personnel who deployed to the 
Middle East (n = 12,566) between 2001 and 2009. Participants completed self-report 
measures including health symptoms and deployment trauma checklists, and several 
mental health symptom scales. The data driven machine learning technique of self-
organised maps identified health symptom clusters and logistic regression examined their 
correlates. 
Results: Two clusters differentiated by number and severity of health symptoms were 
identified: a small ‘high health symptom cluster’ (HHSC; n = 366) and a large ‘low health 
symptom cluster’ (LHSC; n = 12,200). The HHSC had significantly higher proportions of 
(1) scaled scores indicative of PTSD (69% compared with 2% of LHSC members), (2) 
scores on other psychological scales that were indicative of psychopathology, and (3) 
deployment trauma. HHSC members with probable PTSD had a stronger relationship 
with subjective (OR 1.25; 95% CI 1.12, 1.40) and environmental (OR 1.08; 95% CI 1.03, 
1.13) traumatic deployment exposures than LHSC members with probable PTSD.  
Conclusion: These findings highlights that health symptoms are not rare in military 
veterans, and that PTSD is strongly associated with health symptoms. Results suggest that 
there may be subtypes of PTSD, differentiated by health symptoms. 
Key words:  Posttraumatic stress disorder, somatic symptoms, machine learning, military, 
trauma
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6.2  Introduction 
Deployment places military personnel at-risk of exposure to traumatic events and 
subsequent negative health outcomes, including posttraumatic stress disorder (PTSD) and 
non-specific health symptoms across many domains (independent of injury and illness) 
(Gates et al., 2012; Graham, Searle, Van Hooff, Lawrence-Wood, & McFarlane, in press; 
Schlenger et al., 2015; C. Unwin et al., 1999).  Some traumatic deployment exposures 
(TDEs) have been identified as more strongly associated with negative health outcomes, 
specifically, the perception of threat-to-self, military combat, and exposure to human 
death and suffering (Graham et al., in press; Waller et al., 2012; Xue et al., 2015).   
Additional risk factors associated with PTSD include: non-officer rank, army service, 
high number of deployments, longer cumulative length of deployment, prior trauma 
exposure, female, low education, and prior psychological problems (Xue et al., 2015).  
However, the risk factors associated with non-specific health symptoms in military 
members are not as well defined (Graham et al., in press; Steenkamp, Litz, Hoge, & 
Marmar, 2015).   PTSD in military personnel is associated with increased risk of 
morbidity and mortality, reduced functional capacity, decreased quality of life, difficulty 
maintaining relationships, and suicidality (Boscarino, 2006; Gerlock, Grimesey, & Sayre, 
2014; Litz, 2007; Nock et al., 2014).  Consequently, PTSD can result in considerable 
personal, financial, and resource costs not only for the individuals affected but also the 
military, families, and the broader community.  For example, a 2008 study estimated the 
costs of PTSD and depression in deployed US soldiers at somewhere between 4 and 6 
billion dollars a year (Tanielian & Jaycox, 2008).  Yet PTSD remains underdiagnosed in 
military personnel and treatment outcomes can be poor (Hoge et al., 2004; Magruder et 
al., 2005; O’Donnell, Dell, Fletcher, Couineau, & Forbes, 2014; Outcalt, Hoen, Yu, 
Franks, & Krebs, 2016; Rona et al., 2012; M. M. Steenkamp & Litz, 2013; Steenkamp et 
al., 2015). 
While PTSD and health symptoms can be independent outcomes of TDEs, they often co-
occur (Andreski, Chilcoat, & Breslau, 1998; Asmundson, Stein, & McCreary, 2002; 
Graham et al., in press).  For example, a study of US Iraq War veterans research found 
the prevalence of multiple somatic symptoms was 34% in those with probable PTSD, and 
5.2% in those without, and members with PTSD also had greater somatic symptoms 
severity (Hoge, Terhakopian, Castro, Messer, & Engel, 2007). The co-occurrence of 
health symptoms with psychopathologies are a concerning clinical pattern as they 
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complicate presentation, delay diagnosis, and are usually associated with worse severity 
and outcomes (Kisely & Simon, 2006; Magruder et al., 2004).  The strong association 
between PTSD and health symptoms could plausibly contribute to under-diagnosis as 
many patients with psychopathology initially present with physical complaints, a factor 
that can bias diagnosis (Clarke, Piterman, Byrne, & Austin, 2008; Simon, VonKorff, 
Piccinelli, Fullerton, & Ormel, 1999). 
Machine learning (ML) is a subset of artificial intelligence where computer systems 
perform analyses without explicit programming, instead learning from patterns in the data 
(Louridas & Ebert, 2016).  ML has revolutionised data analysis by equipping researchers 
with sophisticated learning algorithms able to detect patterns and relationships in large 
data sets (Alpaydin, 2014; Bishop, 2006).  There are two different strategies commonly 
applied in ML: supervised learning, where there is prior knowledge of what the output 
should be and the goal is to build a model that can predict the output in new data based on 
the training example; and unsupervised learning where the output is not known and the 
goal is to identify the inherent structure present in the data (Louridas & Ebert, 2016).  ML 
is increasingly being used in health (Chekroud et al., 2016).  For example, in community 
samples to   predict PTSD from pre-trauma risk factors (Kessler et al., 2014), and to 
improve PTSD identification from early symptoms and event characteristics (Karstoft, 
Galatzer-Levy, et al., 2015).  In military data ML has been used in a prospective study of 
Danish soldiers to identify predictors of PTSD at pre-deployment (Karstoft, Statnikov, 
Andersen, Madsen, & Galatzer-Levy, 2015), and in a group of US Army soldiers to 
identify members at risk of a suicide attempt amongst those who denied suicidal ideation 
(Bernecker et al., 2018). 
The data-driven ML technique of self-organizing maps (SOMs) use a simple and effective 
unsupervised algorithm to visualize and cluster large complex high dimensional data 
without strict distribution assumptions.  SOM was chosen for this study due to its ability 
to handle different types of data (e.g. ordinal and binary) and produced visual 
representation that make the data easy to interpret, and an unsupervised algorithm as we 
had no a priory information to guide analyses.  SOMs have been used in community 
samples to identify clusters of lifestyle factors (Dipnall et al., 2017) and medical 
symptoms associated with depression (Dipnall et al., 2016), and to detect affective states 
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(Arnrich, Setz, La Marca, Tröster, & Ehlert, 2010).  Therefore, it may be particularly 
useful in the identification of health symptom clusters in veterans. 
Factor analysis, which uses correlations between symptoms across all participants to 
reduce symptoms to a smaller number of factors, has been widely used to explore health 
symptoms in military personnel.  Observation-based clustering techniques are not so 
commonly used.  One example applied k-class clustering in a study of UK Gulf and non-
Gulf veterans exploring whether clusters of somatic and psychological symptoms could 
identify a unique syndrome in Gulf veterans (Everitt, Ismail, David, & Wessely, 2002).   
An advantage of clustering techniques is rather than reduce symptoms to factors across 
participants they provide information on how symptoms occur within the person.   
This research aimed to use the data-driven ML approach of SOM to identify and describe 
clusters of self-reported health symptoms in military personnel that had deployed to the 
Middle East. Additionally, to identify military and non-military factors that may 
differentiate cluster membership.  Due to the strong association of PTSD with health 
symptoms, we were also interested in exploring how cluster membership was associated 
with PTSD.  A greater understanding of the clustering of health symptoms and their 
association with PTSD has the potential to improve diagnostic rates and the 
understanding of pathological mechanisms.  To our knowledge the current study is the 
first to utilise ML clustering techniques to identify health symptom clusters in a military 
sample.   
6.3  Method 
6.3.1 Study design and participants 
Data were from the Australian Defence Force (ADF) Middle East Area of Operations 
(MEAO) Census Study (Dobson et al., 2012), a retrospective, self-report survey of 
current, ex-serving, regular, and Reserve Australian Defence Force (ADF) members who 
deployed to Iraq, Afghanistan, or supporting operations between 1 October 2001 and 31 
December 2009. The survey included questions on deployment history, current health, 
and deployment experiences for participants’ most recent MEAO deployments. All ADF 
members who deployed to the MEAO in this period were invited to participate (N = 
26,239). The response rate was 53% (n = 14,032). Data was collected between 2010 and 
2011, participation was voluntary, and all data were de-identified. A full description of 
data collection methods is provided elsewhere (Dobson et al., 2012). 
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For this study observations with 50% or less missing data across all somatic symptom 
variables were retained (n=13,638; i.e. 2.8% missing rate). Then only those with a PTSD 
score were kept resulting in a final analysis sample size of 12,613. 
This study was approved by the Australian Defence Human Research Ethics Committee, 
the University of Queensland Behavioural and Social Sciences Ethical Review 
Committee, the Department of Veterans’ Affairs Human Research Ethics Committee, and 
the University of Adelaide Human Research Ethics Committee. 
6.3.2 Measures 
6.3.2.1 Somatic symptoms 
Somatic symptoms were assesses using a 67-item Health Symptom Checklist (HSC) 
adapted from the King's College Gulf War Survey (Unwin et al., 1999b), and the 
Australian Gulf War Veterans’ Health Study (Kelsall et al., 2004b). Members indicated 
the presence or absence of symptoms (e.g. ‘sore throat’) over the past month on an 
ordinal scale: ‘never’,’ mild’, ‘moderate’, or ‘severe’. Symptoms were then dichotomised 
into no (never) or yes (‘mild’, ‘moderate’, or ‘severe’) to provide a total symptom count. 
Symptom counts have been shown to be associated with military deployment in veteran 
samples (Hotopf et al., 2006; Unwin et al., 1999b). A full list of HSC items is provided in 
Appendix A. 
6.3.2.2 PTSD symptoms 
PTSD symptoms were assessed using the posttraumatic checklist (PCL) (Weathers et al., 
1993), which displays high validity and reliability (Searle et al., 2015b). Participants rate 
17 questions on a 5-point Likert scale from ‘not at all’ to ‘extremely’ with relevance to 
the last month. Total scores range from 17 to 85 with higher scores indicative of higher 
symptomatology. We examined two cut-offs: 50 to replicate the ADF post-operational 
screening and to allow comparison with the broader military literature (O’Donnell et al., 
2014; Searle et al., 2015b), and 29 which has demonstrated good utility as a screening 
cut-off in a large ADF sample (Searle et al., 2015b). The internal consistency for the PCL 
score for this study sample was considered excellent, with a Cronbach alpha of 0.96.  
6.3.2.3 Depression symptoms 
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Depression symptoms were assessed using the self-reported Patient Health Questonnaire-
9 (PHQ-9; (Kroenke et al., 2002). The PHQ-9 has been found to have good validity and 
reliability (Kroenke et al., 2002). Participants rate 9 questions on a 4-point Likert scale 
(from ‘not at all’ to ‘nearly every day). Total scores range from 0 to 27, with higher 
scores indicative of higher symptomatology. The internal consistency for the PHQ-9 
score for this study sample was considered excellent, with a Cronbach alpha of 0.91. 
6.3.2.4 Psychological Distress symptoms 
Psychological distress symptoms were assessed using the Kessler psychological self-
report 10-item distress scale (K10; Kessler et al., 2002), which has demonstrated 
reasonable reliability validity (Searle et al., 2015b). Items relate to anxiety and depressive 
symptoms experienced in the last 4 weeks, rated on a 5-pont Likert scale (from ‘none of 
the time’ to ‘all of the time’). Total scores range from 10 to 50, with higher scores 
indicative of higher symptomatology. The ADF uses a screening cut off of 20 to indicate 
a high risk of psychological pathology (Searle et al., 2015b). The internal consistency for 
the K10 score for this study sample was considered excellent, with a Cronbach alpha of 
0.92.  
6.3.2.5 Traumatic deployment exposures  
Traumatic deployment exposures from participants most recent MEAO deployment were 
assessed using a questionnaire of the frequency of 59 self-reported deployment exposures 
rated as: never, once, 2-4 times, 5-9 times, 10+ times. This questionnaire was adapted 
from a number of sources including: the Deployment Risk and Resilience Inventory, the 
Traumatic Stressors Exposure Scale, and the King's College Gulf War Survey (King et 
al., 2006; Swann & Hodson, 2004; Unwin et al., 1999b).  Two items were excluded from 
our analysis: ‘did you clear/search caves?’ as this item was limited to Afghanistan 
deployments, and ‘were you present when a loved one was injured or killed?’ as the rate 
was less than 1%, leaving 57 items. To provide a count of total trauma exposure, items 
were dichotomised into ‘not exposed’ or ‘exposed’ then summed.  
We created four subscales of different trauma exposure types used within military 
literature (Kroenke et al., 1998; Searle et al., 2017; Waller et al., 2012): 8 ‘subjective 
combat’ (i.e. perceived threat) items (e.g. ‘were you in danger of being injured?’); 11 
‘objective combat’ (i.e., measurable events) items (e.g. ‘did you experience a landmine 
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strike); 6 ‘human death or degradation’ items (e.g. ‘did you handle dead bodies’); and 32 
environmental items (e.g. ‘Were you exposed to diesel exhaust’). A full list of trauma 
items is provided in Appendix A. 
6.3.2.6 Demographic and Military Variables 
Demographic and military variables assessed were drawn from the military literature 
(Horn et al., 2006; Hotopf et al., 2006), including: gender, age, Service (Navy, Army, Air 
Force), service status (current serving, active Reserve, ex-serving, inactive Reserve), 
number of deployments, cumulative months deployed, years since deployment and Rank 
(Commissioned Officer: Lieutenant to General equivalents; Non-Commissioned Officer: 
Sergeant to Warrant Officer equivalents; or Other Rank: Private to Corporal equivalents). 
Injury sustained on MEAO deployment that required attendance at sick parade, and 
doctor diagnosed medical conditions (‘ever been diagnosed by a medical doctor and 
treated in the last 12 months’) were included as covariates to adjust for their probable 
confounding effects on symptom reporting.  
6.3.3 Statistical analysis  
For this study an extensive set of systematic ML analyses were conducted using R 
statistical software (R Foundation for Statistical Computing, (2016); Wehrens & 
Buydens, 2007).  The data were initially randomly split approximately 50:50 equal groups 
and then analysed in parallel in order to test consistency of the SOM results generated.  
The two groups had approximately the same representation with respect to demographics 
and PCL binary measure (see supplementary Table 6.3).  For each group, the SOM 
analysis was performed separately on all 67 HSC items in both their binary and Likert-
scaled format, to establish which response scale created meaningful clusters.  Within this 
analysis, both 300 iterations and 600 iterations were performed to check consistency.  
Within the iteration analysis five sets of SOM hexagonal map topology (i.e. grids) were 
tested to establish a map with suitable nodes: 6x6, 8x8, 9x9, 10x10, 15x15.  The 10x10 
hexagon grid was selected as the best fitting based on the learning rate, count, distance 
neighbour grids, and the meaningfulness of clusters.  Hierarchical clustering used the 
complete linkage method (Köhn & Hubert, 2006) to group nodes with similar final 
weights, identifying the clusters within each SOM.  Two to six cluster solutions were 
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considered, and the two-cluster solution was selected based on the most differentiation 
across the grid.  Figure 6.1 provides a flowchart of the analyses performed. 
 
 
Figure 6.1. Description of SOM analysis 
Note: Final grid hexagon selection 10x10 in bold italic. Final 2-cluster solution selected 
in bold italic. 
Once the clusters were identified, post hoc analyses including descriptive statistics of 
clusters, and binary logistic regression analyses were conducted using Stata version 15 
(StataCorp LP, 2017).   
Quantitative and qualitative investigation of the final 2-cluster solution from the final 
10x10 SOM was performed.  Chi-square test of association and t-tests and two-sample 
Wilcoxon rank-sum (Mann-Whitney) tests were used to test whether the clusters varied 
with respect to the demographic, health, military variables, and the key scales of PTSD, 
K10, and PHQ-9.  Median values of data were used as some data were non-normally 
distributed. Statistical significance was set at a stricter value of 1% to reduce the risk of 
Type I error. 
Five logistic regressions were conducted on only individuals who were identified as 
having probable PTSD by a PCL score over 50.  This strategy was employed as we had 
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an interest in identifying whether PTSD differed between the clusters as well as whether 
predictors differed.  Predictive accuracy for these logistic regressions was estimated using 
Area Under the Receiver Operating Characteristic (ROC) Curve (AUC).  The ROC curve 
plots sensitivity against 1-specificity of a classification system and measures the 
accuracy.  A model with an AUC over 0.9 is considered to have excellent discriminatory 
ability, 0.7 – 0.9 moderate, 0.5–0.7 low, and 0.5 a non-discriminating test (Swets, 1988; 
Tape, 2013).  
6.4  Results 
Table 6.1 presents demographic and service characteristics. The majority of participants 
were male, of active regular service status, Non-Commissioned Officers, and in the 
Army.  
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Figure 6.2. Mean iteration progress and SOM plots 
Note: yn refers to binary data and scale refers to scaled data. 
 
Due to larger base sizes in the smaller cluster of interest (i.e. 300 iterations: R0 n=205, R1 
n=67; 600 iterations: R0 n=160, R1 n=206), and similarity in demographic and military 
characteristics across iterations, the 600 iteration random data sets were selected for the 
main cluster validation. 
6.4.1 Cluster validation  
The two clusters identified demonstrated clear differentiation on demographic and service 
variables, health symptoms, psychological measures, and traumatic exposure counts, as 
shown in Table 6.1. 
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6.4.1.1 Demographic and service characteristics 
Individuals in Cluster 2 were statistically significantly older, more likely to be Army, less 
likely to be Air Force, less likely to be actively serving and more likely to be ex-serving, 
or inactive Reserves, and more likely to be of Non-Commissioned Officer rank. 
6.4.1.2 Health symptom Checklist (HSC)  
Cluster 2, the smaller cluster (2.9% of the sample) was labelled the ‘high health symptom 
cluster’ (HHSC) as members endorsed a median number of 44 HSC items, more than five 
times that of the median of Cluster 1 (8 HSC items), which was labelled the ‘low health 
symptom cluster’ (LHSC).  The severity of symptoms also varied between clusters with 
the HHSC exhibiting a high proportion of ‘moderate’ to ‘severe’ ratings on HSC items. 
Conversely, the LHSC had high proportions of ‘low’ or ‘no scoring’ HCS items. 
Supplementary Table 6.4 shows HSC item prevalence and severity.  
6.4.2 Psychological test scores  
For the HHSC, the median PCL score was 53, 56.6% had a PCL score above 50, and 
93.7% above 29, indicating members of this cluster experienced high levels of PTSD 
symptoms.  For the LHSC, the median PCL score was 19, with only 2.4% scoring above a 
PCL score of 50, and 17.5% above 29.  
Table 6.1 also shows HHSC members demonstrated PHQ-9 (depression) and K10 
(emotional distress) scores indicative of psychopathology, while LHSC members were in 
the normal range. 
6.4.3 Traumatic deployment exposure  
The median total trauma exposure count score for the HHSC was almost double that of 
the LHSC.  
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Table 6.1 Demographic and service characteristics and health measure scores for survey responders comparing clusters 1 & 2, n = 12566, as well as 
comparing cluster 1 and 2 with probable PTSD, n = 505. 
Demographic and military 
characteristics 

















Sample size 12566 12200 366  298 207  
Age: mean years (SD) 37.1 (8.6) 37 (8.6) 40.5 (8.7) p < .001 38.9 (8.8) 40.5 (9.2) p =.053 
Sex: Male % 87.4 87.5 86.1 p = .438 88.2 86.2 p = .515 
Service: % 
   Army  
   Navy  
























p = .173 
Service status:  n (%)      
Active regular  
Active Reserve 
Ex-serving  





























p = .506 
Rank:  % 
   CO 




















p = .078 
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   Other 20.2 20.2 16.9  25.6 15.8 
PCL: Median (IQR) 20 (17, 26) 19 (17, 25) 53 (40, 66) p < .001 56 (52, 62) 64 (57, 71) p < .001 
PHQ-9: Median (IQR) 1 (0, 4) 1 (0, 4) 13 (9, 19) p < .001 13 (9, 18) 17 (12, 22) p < .001 
K10: Median (IQR) 13 (11, 17) 13 (11 16) 29 (23, 35) p < .001 28 (22, 33) 34 (28, 38) p < .001 
HSC  median (IQR) 9 (3, 17) 8 (3, 16) 44 (39, 50) p < .001 27 (20, 34) 47 (41, 54) p < .001 
Total-trauma count, median (IQR) 15 (9, 22) 14 (9, 22) 25.5 (18, 33) p < .001 24 (16, 33) 28 (20, 37) p = .003 
Objective trauma count, median (IQR) 1 (0, 3) 1 (0, 3) 3 (1, 6) p < .001 3 (1, 6) 4 (1, 7) p = .048 
Subjective trauma count, median (IQR) 1 (0, 3) 1 (0, 3) 3 (2, 5) p < .001 3 (1, 5) 4 (2, 5) p < .001 
Human trauma count, median (IQR) 0 (0, 1) 0 (0, 1) 1 (0, 3) p < .001 1.5 (0, 3) 2.0 (0, 3) p = .207 
Environmental count, median (IQR) 12 (8, 16) 12 (8, 16) 18 (14, 21) p < .001 16 (13, 20) 19.5 (15, 22) p < .001 
Note: MEAO = Middle East Area of Operations, IQR = interquartile range, CO = Commissioned Officer, NCO = Non-Commissioned Officer.  
p-values taken from chi-square tests of association for categorical variables and parametric t-tests and non-parametric Mann-Whitney tests of 
differences. 
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6.4.3.1 Characteristic differentiation in probable PTSD 
The following results examine the differentiation of characteristics of individuals 
with probable PTSD who fall within the HHSC versus the LHSC.  In total 4% of the 
sample had a PCL over 50, or probable PTSD: 59% (298) in the LHSC and 41% (207) in 
the HHSC.  Table 6.1 shows that those with probable PTSD in the HHSC had almost 
twice as many physical symptoms as those with probable PTSD in the LHSC.  There 
were no significant differences between the clusters for those with probable PTSD in 
demographic and service variables.  
 Table 6.2 shows the results of five different logistic regression models among 
those with probable PTSD, with different trauma count scales as the predictors of HHSC 
membership (probable PTSD LHSC as the reference group): (1) total, (2) subjective, (3) 
objective, (4) Human death and degradation, and (4) environmental trauma scales.  We 
explored each trauma type separately to delineate whether stressors for cluster 
membership differ meaningfully.  All models were adjusted for demographic and service 
variables, only odds ratios for model 1 are presented as there was no appreciative 
difference between models.  The only variables associated with HHSC membership in all 
adjusted models were Dr diagnosed medical conditions, and higher total trauma count.  
The adjusted Models in Table 6.2 demonstrated that membership in the probable 
PTSD HHSC group was associated with higher subjective and environmental deployment 
exposures, while objective and human death and degradation exposures were no different 
between the groups.  The probability of having probable PTSD and belonging to the 
HHSC rather than the LHSC following different traumatic exposures, are shown in Figure 
6.3. 
The five models (total trauma and subjective, objective, environment, and human 
subscales) returned AUC’s of 0.73, 0.73, 0.71, 0.72 and 0.70 respectively, which 
represented a moderate level of accuracy for prediction of cluster membership in the 
probable PTSD participants. 
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Table 6.2 Logistic regression models testing association between traumatic and HSSC cluster 
membership for those with probable PTSD, N = 505 
Characteristic OR (95% CI) adjusted p 
Model 1: demographic and service characteristics, and total trauma type exposure 
Service: RAAF (ref) 
   Navy  
   Army 
 
0.72 (0.37, 1.40) 
0.51 (0.27, 0.97) 
 
p = .333 
p = .040 
Age 1.02 (0.99, 1.04) p = .284 
Sex: Male (ref) 
   Female    
 
1.77 (0.93, 3.37) 
 
p = .082 
Rank: CO (ref) 
   NCO 
   Other  
 
1.56 (0.90, 2.70) 
1.13 (0.50, 2.57) 
 
p = .116 
p = .773 
Type service: Active (ref) 
   Active Reserve 
   Ex-Serving 
   Inactive Reserve 
 
1.08 (0.57, 2.06) 
1.05 (0.61, 1.81) 
0.85 (0.47, 1.54) 
 
p = .809 
p = .847 
p = .595 
Doctor diagnosed medical condition 1.25 (1.14, 1.37) p = .000 
Injury 1.14 (0.89, 1.45) p = .306 
Total trauma count 1.05 (1.02, 1.07) p = .000 
Trauma count Models 2, 3, 4, & 5    
Subjective trauma count# 1.25 (1.12, 1.40) p = .000 
Objective trauma count# 1.10 (1.02, 1.20) p = .019 
Human death and degradation trauma 
count# 
1.12 (0.97, 1.28) p = .121 
Environmental trauma count# 1.08 (1.03, 1.13) p = .001 
#Adjusted for sex, age, Rank, and Service, type of Service, Dr diagnosed medical 
conditions, & injury 
Note: The reference group is ‘probable PTSD LSSC’. 
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Figure 6.3 The probability of probable HSSC membership for the 4 different trauma subscales. 
Reference group is probable PTSD low somatic symptom cluster (LSSC) 
 
6.5 Discussion 
Using a machine learning clustering technique, we explored the expression of health 
symptoms in a sample of ADF members who had deployed to the MEAO.  Two clusters 
were identified based on a 67-item Health Symptom Checklist. Both symptom count and 
severity were required to differentiate clusters.  Most of the sample was classified as 
members of Cluster 1 with low health symptom count and severity (low health symptom 
cluster; LHSC). Cluster 2 was a small cluster of individuals with high health symptom 
count and severity (high health symptom cluster; HHSC).  All 67 items of the Health 
Symptom Checklist had statistically significantly higher severity in the HHSC.  
Identifying a large low health symptom cluster is in keeping with research identifying a 
healthy warrior effect, theorised to exist as only the most healthy military members are 
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HHSC members demonstrated a high prevalence of PTSD symptoms, with over two 
thirds scoring above the PCL epidemiological cutoff of 50, and nearly all above the 
recommended ADF screening cutoff of 29 (O’Donnell et al., 2014; Searle et al., 2015).  
Scoring over 29 may be indicative of subsyndromal PTSD, which can have similar impact 
on functional status and wellbeing as PTSD (Pietrzak, Goldstein, Malley, Johnson, & 
Southwick, 2009).  One in four individuals with subsyndromal PTSD will later develop 
full PTSD (Cukor, Wyka, Jayasinghe, & Difede, 2010).  Importantly, low-intensity 
treatment may be effective in subsyndromal PTSD (Shiner et al., 2012), underscoring the 
importance of early identification and intervention as well as the value of identifying a 
highly at-risk group.  
Current Diagnostic and Statistical Manual of Mental Disorders (DSM-5) PTSD diagnostic 
criteria include: exposure to a trauma as well as the presence of four clusters of 
psychological symptoms: re-experiencing; avoidance and numbing; arousal; and 
alterations in mood and cognition (American Psychiatric Association, 2013).  Health 
symptoms only play a small role in these criteria with the item ‘B5’ - unspecified ‘marked 
physiological reaction’.  Our findings that health symptom counts were considerably 
higher in both clusters for those with probable PTSD suggests that the low priority of 
health symptoms in PTSD criteria may contribute to underdiagnoses (Rona et al., 2012) 
as it may create a clinical ‘blind spot’ for probable PTSD in patients who present 
complaining of physical symptoms.  
Mean scores on all mental health measures differed between the clusters.  LHSC 
member’s scores on PTSD, depression, and emotional distress were in the normal range, 
while members of the HHSC scored in the pathological range. This supports evidence that 
PTSD is highly comorbid with other psychopathologies in military personnel (Armour et 
al., 2015).   
Those with probable PTSD were distributed almost evenly between the two clusters.  This 
could suggest that PTSD has at least two subtypes: one associated with a high health 
symptom count and severity; and one that is not.  Mechanisms that may explain this 
finding should be investigated.  Considering  the demonstrated association between PTSD 
and disorders that involve inflammatory mechanisms (such as cardiovascular disease or 
metabolic syndrome; (Coughlin, 2011; Heppner et al., 2012) and that inflammation is 
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seen as a risk factor for PTSD itself (O’Donovan, 2016), the role of inflammation in 
PTSD subtypes requires further investigation.  
The finding of possible PTSD subtypes could have significant clinical and nosological 
importance, making replication of this study a priority.  Extending this study to include 
PTSD symptoms together with health symptoms would add greater validity to the 
existence of subtypes.  Latent profile analysis has been used to explore dissociation 
subtypes in PTSD, and therefore may be a useful technique to consider in this endeavour 
(Wolf, Lunney, et al., 2012; Wolf, Miller, et al., 2012).  Interestingly, one study found 
that the PTSD dissociated subtype scored higher in DSM-V criterion B (physiologic 
reactivity; Wolf, Miller, et al., 2012).  However, research with cancer symptom has found 
that machine learning clustering algorithms identified congruent clusters to latent class 
analysis and clinical observation, demonstrating that machine learning clusters can be 
meaningful (Papachristou et al., 2016).  The advantage of machine learning is the large 
amount of data that can be analysed (Wolf, Lunney, et al., 2012; Wolf, Miller, et al., 
2012). 
Higher total trauma exposure predicted HHSC membership for those with probable 
PTSD. When considering specific TDEs, only the subjective and environmental 
exposures were significantly associated with HHSC membership in those with probable 
PTSD. The environmental exposures included items which could be considered measures 
of the malevolence of the environment, e.g. ‘were you exposed to dust storms’ or ‘did you 
have contact with any chemical or biological weapons’. Malevolent environments have 
been found to contribute to PTSD in both civilian and military research and to heighten 
the sense of threat-to-self, particularly in a conflict zone (Brewin, Andrews, & Valentine, 
2000; Ikin et al., 2004; D. W. King, King, Gudanowski, & Vreven, 1995). Therefore, this 
constellation of environmental and subjective exposures may capture members who felt 
the greatest subjective threat-to-self. Damasio has argued that consciousness is based 
upon an awareness of the body’s homeostatic state (Damasio, 1999), offering an 
explanatory link between a heightened stress response and health symptoms. Therefore, 
health symptoms may be a physical representation of consciousness or a ‘feeling of what 
happened’. A ramification of this finding is that methods of training and management 
strategies for deployed personnel could be developed that focus on aspect of malevolence 
and threat-to-self. 
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The low success rate of PTSD treatments demonstrates the need for a broader range of 
treatment options (Steenkamp & Litz, 2013).  To date there is no established method of 
predicting treatment success rates or individualising treatment programs (Steenkamp & 
Litz, 2013).  Identifying subtypes of PTSD could suggest differences in pathophysiology 
which may provide avenues for new treatment options that allow improved prediction of 
treatment success and the possibility of individualising treatment. Identifying this as an 
area of research that should be prioritised. 
There are several strengths of this study, including the large non-treatment seeking 
sample of the population of interest.  In addition, the rigorous testing regime and running 
the ML on both scaled and dichotomous data sets demonstrated that severity was an 
important factor in the development of the clusters.  To obtain meaningful clusters in 
SOM sufficient data must be available. Our study had the advantage of having enough 
data to allow a random split into two groups to ensure that consistent clusters replicated 
across groups. Another disadvantage with SOM is that anomalies in the map can generate 
two similar groupings in different areas on the grid, but our results demonstrated 
consistent clear differentiation between clusters. 
However, these findings must be considered with limitations in mind, including that our 
measures were self-reported which are always prone to bias, particularly for traumatic 
deployment exposures (Bonanno et al., 2012). The PCL measure used in the analyses was 
based on DSM-IV diagnostic criteria, so our findings may not be generalisable to the 
recent DSM-V version. 
In conclusion, this study utilised a ML clustering technique to identify two health 
symptom-based clusters among a large group of ADF veterans.  These clusters were 
delineated by both health symptom count and severity.  These findings highlight that the 
reporting of health symptoms is not rare in military veterans and suggests that PTSD is 
associated with both physical and psychological dimensions, demonstrating the 
importance of examining both in trauma exposed military personnel.  Significantly these 
findings suggest that PTSD may have subtypes differentiated by health symptom count 
and severity. This finding is worthy of further exploration as the categorisation of PTSD 
into subtypes in diagnostic criteria has the potential to improve diagnosis and the 
prediction of treatment outcomes. 
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6.6 Supplementary material 
Table 6.3 Demographic and service characteristics and health measure scores for survey responders for clusters 1 & 2 for 600 with iterations random 
sets 0 and 1, n = 14032 





Random set 0 
N = 6291 
p-value Random set 1 
N = 6275 
p-value 
total HSSC LSSC total HSSC LSSC 
Sample size 14032 6291 160 6131  6275 206 6069  
Age: mean years (SD) 36.9 (8.6) 37.2 (8.6) 40.5 (8.9) 37.1 (8.6) p < .001 37 (8.6) 40.4 (8.5) 36.9 (8.6) p < .001 
Sex: Male % 86.8 87.5 88.0 87.4 p = .84 87.4 84.7 87.5 p = .22 
Service: % 
   Army  
   Navy  
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Active regular  
ctive reserve 






































Rank on deployment:  %  
   CO 
   NCO 
   Other 
 
28.7%  



























P L: Median (IQR) 0 (9) 20 (9) 54 (23.5) 19 (8) p < .001 20 (9) 53 (26) 19 ( ) p < .001 
PCL positive cut off 29: 
% 
19.8 19.5 95.0 17.  p < .001 19.9 92.  17.4 p < .001 
PCL positive cut off 53: 
% 
3.3 3.2 53.8 1.9 p < .001 3.3 50.5 1.7 p < .001 
PHQ-9: Median (IQR) 1 (4) 1 (4) 14 (11) 1 (4) p < .001 1 (4) 13 (10) 1 (4) p < .001 
K10: Median (IQR) 13 (6) 13 (6) 30 (10) 13 (5) p < .001 13 (6) 28 (15) 13 (5) p < .001 
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HSC Median (IQR) 8 (13) 8 (13) 45 (9) 8 (12) p < .001 8 (13) 44 (13) 8 (12) p < .001 
Total Trauma count: 
Median (IQR) 
3.0 (7.0) 3.0 (6.0) 7.0 (8.0) 2.0 (7.0) p < .001 3.0 (7.0) 7.5 (9.5) 2.0 (7.0) p < .001 
Note: MEAO = Middle East Area of Operations, HSC = health symptom checklist, MCS = PCS =  IQR = interquartile range,  CO = 
Commissioned officer, NCO = Non-commissioned officer. P-values taken from chi-square tests of association for categorical variables and 
parametric t-tests and non-parametric Mann-Whitney tests of differences.
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Table 6.4 Health symptom checklist items prevalence and severity in cluster 1 and 2 for 600 iterations random set 0  
Health symptom 
cluster 1 p cluster 2 p 
0 1 2 3  0 1 2 3  
Chest pain 5530 (90.5%) 462 (7.6%) 104 (1.7%) 16 (0.3%) < .001 66 (42.3%) 48 (30.8%) 38 (24.4%) 4 (2.6%) < .001 
Headaches 5519 (91.2%) 421 (7.0%) 95 (1.6%) 14 (0.2%) < .001 78 (38.6%) 73 (36.1%) 38 (18.8%) 13 (6.4%) < .001 
Rapid heartbeat 3225 (52.7%) 1974 (32.3%) 766 (12.5%) 155 (2.5%) < .001 13 (8.2%) 40 (25.2%) 82 (51.6%) 24 (15.1%) < .001 
Irritability / outbursts 
of anger 
3369 (55.0%) 1708 (27.9%) 866 (14.1%) 180 (2.9%) < .001 7 (4.4%) 14 (8.8%) 74 (46.3%) 65 (40.6%) < .001 
Unable to breathe 
deeply enough 
5512 (90.0%) 476 (7.8%) 125 (2.0%) 14 (0.2%) < .001 26 (16.5%) 57 (36.1%) 64 (40.5%) 11 (7.0%) < .001 
Faster breathing than 
normal 
5674 (92.8%) 356 (5.8%) 82 (1.3%) 5 (0.1%) < .001 26 (16.3%) 52 (32.5%) 72 (45.0%) 10 (6.3%) < .001 
Feeling short of breath 
at rest 
5599 (91.5%) 421 (6.9%) 86 (1.4%) 11 (0.2%) < .001 36 (22.5%) 56 (35.0%) 59 (36.9%) 9 (5.6%) < .001 
Wheezing 5589 (91.6%) 424 (6.9%) 81 (1.3%) 10 (0.2%) < .001 77 (48.7%) 47 (29.7%) 24 (15.2%) 10 (6.3%) < .001 
Sleeping difficulties 2838 (46.3%) 1728 (28.2%) 1263 (20.6%) 294 (4.8%) < .001 1 (0.6%) 7 (4.4%) 56 (35.0%) 96 (60.0%) < .001 
Feeling jumpy / easily 
startled 
4835 (79.1%) 839 (13.7%) 358 (5.9%) 79 (1.3%) < .001 10 (6.3%) 29 (18.1%) 57 (35.6%) 64 (40.0%) < .001 
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Feeling unrefreshed 
after sleep 
2964 (48.4%) 1867 (30.5%) 1044 (17.1%) 244 (4.0%) < .001 3 (1.9%) 14 (8.8%) 55 (34.4%) 88 (55.0%) < .001 
Fatigue 2747 (44.9%) 2217 (36.2%) 992 (16.2%) 163 (2.7%) < .001 0 (0.0%) 10 (6.3%) 75 (46.9%) 75 (46.9%) < .001 
Double vision 5843 (95.4%) 243 (4.0%) 33 (0.5%) 3 (<1%) < .001 73 (45.6%) 48 (30.0%) 34 (21.3%) 5 (3.1%) < .001 
Intolerance to alcohol 5533 (90.4%) 427 (7.0%) 114 (1.9%) 44 (0.7%) < .001 61 (38.6%) 39 (24.7%) 36 (22.8%) 22 (13.9%) < .001 
Itchy or painful eyes 4846 (79.1%) 990 (16.2%) 244 (4.0%) 43 (0.7%) < .001 35 (22.0%) 51 (32.1%) 55 (34.6%) 18 (11.3%) < .001 
Rash or skin irritation 4970 (81.2%) 849 (13.9%) 246 (4.0%) 54 (0.9%) < .001 61 (38.4%) 27 (17.0%) 51 (32.1%) 20 (12.6%) < .001 
Skin infections e.g. 
boils 
5781 (94.5%) 268 (4.4%) 55 (0.9%) 14 (0.2%) < .001 98 (61.3%) 31 (19.4%) 26 (16.3%) 5 (3.1%) < .001 
Skin ulcers 6032 (98.6%) 67 (1.1%) 11 (0.2%) 7 (0.1%) < .001 126 (79.2%) 21 (13.2%) 10 (6.3%) 2 (1.3%) < .001 
Shaking 5744 (93.8%) 312 (5.1%) 65 (1.1%) 3 (<1%) < .001 35 (22.0%) 66 (41.5%) 46 (28.9%) 12 (7.5%) < .001 
Tingling in fingers and 
arms 
5301 (86.7%) 635 (10.4%) 158 (2.6%) 21 (0.3%) < .001 41 (25.6%) 47 (29.4%) 56 (35.0%) 16 (10.0%) < .001 
Tingling in legs and 
toes 
5594 (91.7%) 405 (6.6%) 88 (1.4%) 14 (0.2%) < .001 62 (38.8%) 48 (30.0%) 37 (23.1%) 13 (8.1%) < .001 
Numbness in fingers / 
toes 
5547 (90.9%) 420 (6.9%) 115 (1.9%) 23 (0.4%) < .001 63 (40.6%) 45 (29.0%) 34 (21.9%) 13 (8.4%) < .001 
Feeling distant/cut off 4405 (72.0%) 1179 (19.3%) 444 (7.3%) 92 (1.5%) < .001 9 (5.6%) 21 (13.1%) 62 (38.8%) 68 (42.5%) < .001 
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from others 
Constipation 5585 (91.3%) 405 (6.6%) 108 (1.8%) 19 (0.3%) < .001 64 (40.3%) 51 (32.1%) 33 (20.8%) 11 (6.9%) < .001 
Flatulence or burping 4407 (72.0%) 1298 (21.2%) 350 (5.7%) 65 (1.1%) < .001 32 (20.0%) 42 (26.3%) 57 (35.6%) 29 (18.1%) < .001 
Stomach cramps 5353 (87.5%) 592 (9.7%) 135 (2.2%) 36 (0.6%) < .001 54 (33.8%) 52 (32.5%) 39 (24.4%) 15 (9.4%) < .001 
Diarrhoea 4969 (81.3%) 924 (15.1%) 186 (3.0%) 35 (0.6%) < .001 45 (28.3%) 48 (30.2%) 44 (27.7%) 22 (13.8%) < .001 
Indigestion 5148 (84.1%) 704 (11.5%) 227 (3.7%) 43 (0.7%) < .001 44 (27.5%) 47 (29.4%) 42 (26.3%) 27 (16.9%) < .001 
Dry mouth 5362 (87.8%) 629 (10.3%) 105 (1.7%) 8 (0.1%) < .001 25 (15.6%) 56 (35.0%) 63 (39.4%) 16 (10.0%) < .001 
Pain in the face, jaw, 
in front of the ear, or 
in the ear 
5487 (89.7%) 470 (7.7%) 128 (2.1%) 30 (0.5%) < .001 57 (35.8%) 53 (33.3%) 32 (20.1%) 17 (10.7%) < .001 
Persistent cough 5323 (86.9%) 576 (9.4%) 195 (3.2%) 30 (0.5%) < .001 69 (43.7%) 37 (23.4%) 38 (24.1%) 14 (8.9%) < .001 
Lump in throat 5924 (96.8%) 157 (2.6%) 36 (0.6%) 1 (<1%) < .001 88 (55.0%) 47 (29.4%) 22 (13.8%) 3 (1.9%) < .001 
Sore throat 5031 (82.2%) 941 (15.4%) 130 (2.1%) 17 (0.3%) < .001 68 (43.0%) 58 (36.7%) 28 (17.7%) 4 (2.5%) < .001 
Forgetfulness 3964 (64.8%) 1646 (26.9%) 458 (7.5%) 54 (0.9%) < .001 7 (4.4%) 36 (22.6%) 78 (49.1%) 38 (23.9%) < .001 
Dizziness, fainting or 
blackouts 
5720 (93.4%) 354 (5.8%) 46 (0.8%) 5 (0.1%) < .001 68 (42.8%) 58 (36.5%) 24 (15.1%) 9 (5.7%) < .001 
Seizures or 
convulsions 
6109 (99.8%) 7 (0.1%) 2 (<1%) 4 (0.1%) < .001 154 (96.3%) 2 (1.3%) 3 (1.9%) 1 (0.6%) < .001 
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Feeling disorientated 5852 (95.6%) 246 (4.0%) 22 (0.4%) 1 (<1%) < .001 
5848 
(96.2%) 
57 (35.6%) 76 (47.5%) 22 (13.8%) < .001 
Loss of concentration 4192 (68.6%) 1604 (26.2%) 282 (4.6%) 37 (0.6%) < .001 9 (5.7%) 36 (22.6%) 74 (46.5%) 40 (25.2%) < .001 
Difficulty finding the 
right word 
4080 (66.6%) 1645 (26.8%) 371 (6.1%) 31 (0.5%) < .001 19 (11.9%) 31 (19.4%) 84 (52.5%) 26 (16.3%) < .001 
Pain on passing urine 6037 (98.7%) 68 (1.1%) 8 (0.1%) 4 (0.1%) < .001 142 (88.8%) 13 (8.1%) 3 (1.9%) 2 (1.3%) < .001 
Passing urine more 
often 
5683 (92.8%) 335 (5.5%) 90 (1.5%) 13 (0.2%) < .001 83 (51.9%) 48 (30.0%) 22 (13.8%) 7 (4.4%) < .001 
Burning sensation in 
the sex organs 
6065 (99.1%) 48 (0.8%) 9 (0.1%) 1 (<1%) < .001 137 (86.7%) 17 (10.8%) 2 (1.3%) 2 (1.3%) < .001 
Loss of interest in sex 4832 (78.9%) 878 (14.3%) 309 (5.0%) 104 (1.7%) < .001 30 (18.8%) 33 (20.6%) 55 (34.4%) 42 (26.3%) < .001 
Problems with sexual 
functioning 
5544 (90.6%) 389 (6.4%) 141 (2.3%) 43 (0.7%) < .001 53 (33.3%) 40 (25.2%) 40 (25.2%) 26 (16.4%) < .001 
Increased sensitivity to 
noise 
5196 (84.9%) 603 (9.9%) 275 (4.5%) 45 (0.7%) < .001 31 (19.4%) 38 (23.8%) 60 (37.5%) 31 (19.4%) < .001 
Increased sensitivity to 
light 
5506 (89.9%) 492 (8.0%) 107 (1.7%) 19 (0.3%) < .001 41 (25.6%) 53 (33.1%) 53 (33.1%) 13 (8.1%) < .001 
Increased sensitivity to 5760 (94.2%) 262 (4.3%) 83 (1.4%) 12 (0.2%) < .001 75 (46.9%) 45 (28.1%) 25 (15.6%) 15 (9.4%) < .001 
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smells/odours 
Ringing in the ears 4458 (72.9%) 951 (15.5%) 
513 
(8.4%) 
195 (3.2%) < .001 35 (21.9%) 37 (23.1%) 40 (25.0%) 48 (30.0%) < .001 
Avoiding doing things 
or situations 
4646 (75.9%) 1101 (18.0%) 305 (5.0%) 68 (1.1%) < .001 13 (8.2%) 34 (21.4%) 58 (36.5%) 54 (34.0%) < .001 
Pain, without swelling 
or redness, in several 
joints 
5026 (82.2%) 658 (10.8%) 352 (5.8%) 78 (1.3%) < .001 23 (14.6%) 41 (25.9%) 53 (33.5%) 41 (25.9%) < .001 
Joint stiffness 4278 (70.0%) 1270 (20.8%) 481 (7.9%) 84 (1.4%) < .001 14 (8.8%) 40 (25.2%) 62 (39.0%) 43 (27.0%) < .001 
Feeling that your 
bowel movement is 
not finished 
5229 (85.5%) 706 (11.5%) 158 (2.6%) 22 (0.4%) < .001 38 (23.8%) 45 (28.1%) 52 (32.5%) 25 (15.6%) < .001 
Changeable bowel 
function 
5348 (87.4%) 585 (9.6%) 149 (2.4%) 34 (0.6%) < .001 51 (31.9%) 44 (27.5%) 43 (26.9%) 22 (13.8%) < .001 
General muscle aches 
or pains 
3911 (63.9%) 1704 (27.8%) 455 (7.4%) 55 (0.9%) < .001 2 (1.3%) 49 (30.6%) 74 (46.3%) 35 (21.9%) < .001 
Loss of balance or 
coordination 
5721 (93.4%) 356 (5.8%) 42 (0.7%) 4 (0.1%) < .001 37 (23.1%) 64 (40.0%) 50 (31.3%) 9 (5.6%) < .001 
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Difficulty speaking 5829 (95.3%) 262 (4.3%) 23 (0.4%) 4 (0.1%) < .001 51 (31.9%) 66 (41.3%) 35 (21.9%) 8 (5.0%) < .001 
Low back pain 3597 (58.8%) 1431 (23.4%) 840 (13.7%) 254 (4.1%) < .001 19 (11.9%) 35 (22.0%) 50 (31.4%) 55 (34.6%) < .001 
Night sweats which 
soak the bed sheets 
5388 (88.1%) 512 (8.4%) 184 (3.0%) 35 (0.6%) < .001 45 (28.1%) 40 (25.0%) 50 (31.3%) 25 (15.6%) < .001 
Feeling feverish 5777 (94.4%) 290 (4.7%) 46 (0.8%) 5 (0.1%) < .001 58 (36.3%) 56 (35.0%) 33 (20.6%) 13 (8.1%) < .001 
Tender or painful 
swelling of lymph 
glands in neck, armpit 
or groin 
5851 (95.7%) 222 (3.6%) 34 (0.6%) 9 (0.1%) < .001 93 (58.1%) 35 (21.9%) 25 (15.6%) 7 (4.4%) < .001 
Loss of or decrease in 
appetite 
5604 (91.4%) 419 (6.8%) 97 (1.6%) 8 (0.1%) < .001 65 (40.6%) 47 (29.4%) 27 (16.9%) 21 (13.1%) < .001 
Nausea 5766 (94.3%) 295 (4.8%) 42 (0.7%) 11 (0.2%) < .001 67 (42.1%) 54 (34.0%) 25 (15.7%) 13 (8.2%) < .001 
Vomiting 5943 (97.2%) 140 (2.3%) 23 (0.4%) 11 (0.2%) < .001 118 (74.2%) 26 (16.4%) 13 (8.2%) 2 (1.3%) < .001 
Distressing dreams 5043 (82.4%) 722 (11.8%) 286 (4.7%) 70 (1.1%) < .001 21 (13.1%) 28 (17.5%) 54 (33.8%) 57 (35.6%) < .001 
Stomach bloating 5393 (88.1%) 546 (8.9%) 154 (2.5%) 29 (0.5%) < .001 49 (30.6%) 51 (31.9%) 43 (26.9%) 17 (10.6%) < .001 
Unintended weight 
gain > 4kg 
5138 (84.1%) 571 (9.3%) 310 (5.1%) 90 (1.5%) < .001 65 (41.1%) 26 (16.5%) 35 (22.2%) 32 (20.3%) < .001 
Unintended weight 5854 (96.9%) 131 (2.2%) 40 (0.7%) 18 (0.3%) < .001 107 (72.8%) 15 (10.2%) 15 (10.2%) 10 (6.8%) < .001 
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7.1  Abstract  
Physical symptoms are highly comorbid with post-traumatic stress disorder (PTSD).  As 
PTSD is underdiagnosed, we explore the value of self-reported physical symptoms in 
screening for 30-day PTSD in military personnel.  Two physical symptom scales were 
constructed using items from a 67-item health symptom checklist, clinical interviews 
were used as the diagnostic reference standard, and diagnostic utility of physical 
symptoms was compared with the current gold standard screen, the post-traumatic stress 
checklist (PCL).  Receiver operating characteristic analyses showed that both a nine-item 
and a ten-item physical symptom scale were of value in predicting PTSD (areas under the 
curve 0.81 and 0.83).  Importantly, two-thirds of PTSD-positive personnel missed by the 
PCL were captured with physical symptom scales, and when physical symptoms were 
added to the PCL, prediction was improved (areas under the curve 0.90 to 0.92). Our 
findings highlight the value of assessing physical symptoms in PTSD screening.  
 
Keywords: military, physical symptoms, posttraumatic stress, receiver operating 
characteristic curve   
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7.2  Introduction 
Military personnel are a highly at-risk group for exposure to traumatic events and 
subsequent onset of posttraumatic stress disorder (PTSD; Schlenger et al., 2015). The 
prevalence rate for PTSD in deployed military members varies widely in the range of 2-
35% (Xue et al., 2015). The wide variation in findings may be partly influenced by 
factors such as measurement methods and sample characteristics like service role (Kok, 
Herrell, Thomas, & Hoge, 2012).  The prevalence of 12-month PTSD Australian Defence 
Force (ADF) is estimated at 8.3% in serving members (McFarlane, Hodson, Van Hooff, 
& Davies, 2011), and almost 18% in ADF members who have transitioned out of full-
time service (Van Hooff et al., 2018). 
PTSD is associated with a number of negative health outcomes for veterans including 
comorbid psychiatric and physical health problems (Green & Kimerling, 2004; Kessler, 
2000; O'Toole, Catts, Outram, Pierse, & Cockburn, 2009; Schnurr, 2015), and mortality 
(Boscarion 2006).  Functional impairments are also common and may include marital and 
family problems (Pereira, Pereira, & Pedras, 2019), poor occupational functioning 
(Kessler, 2000; Smith, Schnurr, & Rosenheck, 2005), and homelessness (Metraux, Clegg, 
Daigh, Culhane, & Kane, 2013). Such impairments have been linked to suicide and 
intimate partner violence, highlighting that PTSD can have broad reaching impact on 
family, military, and community resources (Bush et al., 2013; Harden & Murphy, 2018; 
Hyman, Ireland, Frost, & Cottrell, 2012).  Despite the high personal, social, and economic 
burden, PTSD continues to remain underdiagnosed in military settings (Hoge et al., 2004; 
Magruder et al., 2005; O’Donnell, Dell, Fletcher, Couineau, & Forbes, 2014; Outcalt, 
Hoen, Yu, Franks, & Krebs, 2016).  
Physical symptoms are a significant clinical feature of PTSD (see Gupta, 2013 for 
review) to a greater degree than other psychological disorders (Andreski et al., 1998).  
The association between PTSD and physical symptoms remains even after controlling for 
veteran-reported environmental exposures, degree of combat exposure, initial level of 
health problems, and comorbid medical conditions (Engel, Liu, McCarthy, Miller, & 
Ursano, 2000; Wagner et al., 2000).  While the specificity of physical symptoms or the 
reason for this association remains unclear (Quartana et al.,, 2015), the strength and 
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consistency of the association support that the presence of non-specific physical 
symptoms may be useful in screening for PTSD.  
One factor in the under diagnosis of PTSD may be that patients with psychological 
disorder often initially seek help for physical symptoms (Simon et al., 1999), which may 
bias diagnostic outcomes (Clarke, et al., 2008; Herran, Vazquez-Barquero, & Dunn, 
1999).  How patients present and attribute their health symptoms can be influenced by 
various factors with culture being one example (Landrine & Klonoff, 1992).  Military 
cultures reinforce the character traits of toughness and resilience, and military training 
uses psychological strategies such as emotional suppression as adaptive responses to the 
realities of combat (Bryan, Jennings, Jobes, & Bradley, 2012), which may bias 
individuals toward a somatic health attribution style.  In addition, psychological 
symptoms may be underreported by military members as a psychological diagnosis may 
imply a ‘weakness of character’, or negatively impact deployability and career promotion 
(Friedman, 2006; Iversen et al., 2007; Kilshaw, 2008; Kirmayer, 1988; Rona, Jones, 
French, Hooper, & Wessely, 2004).  Furthermore, the military requirement for mobility 
can be disruptive in developing relationships between members and medical professions.  
Somatic presentation is more common in patients who do not have an ongoing 
relationship with a primary care physician (Simon et al., 1999). 
Despite the ubiquitous association between PTSD and physical symptoms, these 
symptoms only play a minor role in the Diagnostic and Statistical Manual fourth edition 
(DSM-IV; American Psychiatric Association, 2013), contained within the broad PTSD 
criterion ‘B5’ of unspecified ‘marked physiological reactivity’ and criterion ‘D1’ 
‘difficulty falling and staying asleep’ (which in DSM-V has been changed to ‘sleep 
disturbance’).  As a result, physical symptoms may not be considered a component of 
PTSD by clinicians, a factor that may contribute to under diagnosis.   
 In summary, veterans are a high-risk population for PTSD, physical symptoms are 
strongly associated with PTSD, and military culture may bias individuals toward a 
somatic attribution style.  The fact that physical symptoms are a common first 
presentation in psychological disorder highlights the need for exploring whether the 
strength of association between physical symptoms and PTSD can improve diagnostic 
rates. This paper examines the value of physical symptoms in predicting 30-day 
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Diagnostic and Statistical Manual fourth edition (DSM-IV; American Psychiatric 
Association, 2000) defined PTSD in a non-treatment seeking military population. 
7.2.1 Physical symptoms for predicting PTSD 
One research group has explored the ability of physical symptoms to predict PTSD in two 
small refugee populations: 620 Somali and 512 Ethiopian (Gulden et al., 2010; 
Westermeyer et al., 2010).  An alternative to reporting standard PTSD symptoms was 
sought with the justification that refugees are reluctant to disclose past traumatic 
experiences due to a perceived lack of relevance, or suppression of traumatic memories 
due to emotional responses such as shame guilt remorse, grief, or rage (Westermeyer & 
Wahmenholm, 1989).  An advantage of physical symptoms is that they offer low face 
validity for PTSD and therefore maybe an alternative in environments where the stigma 
of mental illness is high, or when it is preferable not to confront the trauma or 
emotionally distressing diagnostic criteria of DSM-IV PTSD (American Psychiatric 
Association, 2000).   
The two refugee studies used a screening tool devised of dichotomous yes/no questions 
concerning four physical symptoms: headache, appetite change, dizziness or fatigue, and 
sleep problems.  In both studies a positive association was found between the number of 
physical symptoms and PTSD checklist (PCL) scores.  Cut-off scores of 2 (in the 
Somalian sample) and 3 (in the Ethiopian sample) physical symptoms were suggested due 
to their associated mean PCL scores (40 and 46 respectively) best resembling existing 
PCL clinical cut-points of between 44 and 50 (Blanchard, Jones-Alexander, Buckley, & 
Forneris, 1996; Weathers, Litz, Herman, Huska, & Keane, 1993).  However, these studies 
suffer from limitations including: small specific samples; the assessment of only four of 
the many physical symptoms known to be associated with PTSD; the index test used to 
determine cut-offs (the PCL) could not assess diagnosed PTSD but could only suggest 
probable PTSD; and importantly the technique used to determine cut-offs was overly 
simplistic.   
The diagnostic accuracy of any given cut-off value can be measured using several 
different indices, including the probability of true positive (sensitivity) and true negative 
(specificity) diagnoses (Altman & Bland, 1994; Honest & Khan, 2002).  A receiver 
operating characteristic curve, or ROC curve, is a plot of sensitivity by 1-specificity.  The 
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area under the curve (AUC; McFall & Treat, 1999) provides a global measure of 
diagnostic accuracy.  Relatedly, positive predictive value (PPV; the probability that 
subjects with a positive screening test truly have the disease) and negative predicative 
value (NPV; the probability that subjects with a negative screening test truly does not 
have the disease) are accepted measures for clinicians to clearly quantify the risk that a 
test result represents to the patient.  Without using such established diagnostic validity 
measures it is difficult to accurately calculate test utility and appropriate cut-off values 
(Brenner & Gefeller, 1997). 
It is important to recognise that predictive values are dependent on the prevalence of the 
disease in the population from which they are derived. Specifically, in screening 
asymptomatic healthy individuals, where disease prevalence is low, predictive values will 
be low compared to those found once a patient is referred for specialist consultation 
where disease prevalence will be higher (Brenner & Gefeller, 1997).  Therefore, it is 
important to have meaningful reference values for different populations.  For example, 
when analysing high-quality primary care studies of clinical features of cancers, Shapley, 
Mansell, Jordan, & Jordan (2010) used a PPV of 0.05 or more for a physical symptom 
(e.g. abdominal pain, or rectal bleeding) to be the maximum acceptable screening risk 
before warranting further examination.  This seemingly low cut-off is justifiable as (1) the 
lifetime rate of colorectal cancer is approximately 5% (but likely higher in treatment-
seeking samples), and (2) it was comparable to the 5% reduction in 10 year 
cardiovascular risk expected for primary prevention with statins in individuals with a 
Framingham risk score of 20% (Cooper & O’Flynn, 2008).   
7.2.2 Aim of the study  
This study aimed to explore whether physical symptoms could be of value in the 
identification of increased risk for 30-day PTSD caseness in a population of non-
treatment-seeking Australian Defence Force (ADF) personnel deployed to the Middle 
East Area of Operations (MEAO).  The utility of physical symptoms was compared with 
the ‘gold standard’ measure, a structured diagnostic interview using DSM-IV criteria.  
Considering the strong association of multiple physical symptoms with PTSD in deployed 
military personnel, we hypothesised that multiple physical symptoms would demonstrate 
good discrimination for 30-day PTSD caseness.  To our knowledge, this is the first study 
to examine the discrimination ability of physical symptoms in the prediction of 30-day 
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PTSD.  Improved detection of PTSD can assist with early intervention, enabling 
symptoms and disorders to be addressed before they become entrenched and cause 
broader negative outcomes.  
7.3  Method 
7.3.1 Participants  
The current sample was drawn from the ADF Military Health Outcomes Program 
(MilHOP), a broad program of research conducted from 2010 to 2012 examining the 
physical and mental health of all ADF members (McFarlane, Hodson, Van Hooff, & 
Davies, 2011).  Eligible members were 26915 current and ex-serving ADF members who 
had deployed to the MEAO from 2001 to 2009. Recruitment was conducted using a two-
phase design, the details of which have been reported previously (Davy C. et al., 2012; 
Dobson et al., 2012).  In Phase 1, all current-serving MEAO deployed personnel were 
contacted to complete a self-report survey of mental health and wellbeing, of which 
16991 participated (response rate 63%).  In Phase 2, a stratified sub-sample of Phase 1 
survey completers were invited to complete a structured diagnostic interview (CIDI; 
Kessler & Ustun, 2004), of whom 604 responded.  The Phase 2 sub-pool was stratified by 
Service, sex, Phase 1 mental health symptom scores on the PCL, and scores on the 
Alcohol Use Disorders Identification Test (AUDIT; Saunders, Aasland, Babor, de la 
Fuente, & Grant, 1993).  Higher mental health symptom scores (over the 60th percentile), 
females, and Navy and Air Force members, were oversampled to provide adequate power 
to reduce the error in prevalence estimates, and to account for the greater number of 
males and Army members in the ADF (McFarlane et al., 2011; Van Hooff et al., 2014). 
Participation was voluntary, all data were de-identified, and participants were informed 
that no study information would be provided to the Department of Defence or the 
Department of Veterans’ Affairs.  This study was approved by the Australian Defence 
Human Research Ethics Committee, the University of Queensland Behavioural and 
Social Sciences Ethical Review Committee, the Department of Veterans’ Affairs Human 
Research Ethics Committee, and the University of Adelaide Human Research Ethics 
Committee. 
7.3.2 Measures 
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7.3.2.1 Diagnostic reference standard - CIDI 
The reference standard used to generate DSM-IV defined diagnoses of 30-day PTSD was 
the World Health Organization Composite International Diagnostic Interview 3.0 (CIDI; 
Kessler & Ustun, 2004).  The CIDI is widely used for the evaluation of psychiatric 
disorders in epidemiologic studies (Magruder et al., 2015) and military research (Kessler 
et al., 2013). The CIDI shows reasonable concordance with several other clinical 
diagnostic interviews for identifying PTSD, including the Structured Clinical Interview 
for DSM-IV (SCID; Spitzer, Williams, Gibbon, & First, 1992) with an AUC of .69 (Haro 
et al., 2006), a semi-structured clinician-administered diagnostic interview the K‐SADS 
(Kaufman et al., 1997) with an AUC of 0.79, and the Clinician Administered PTSD Scale 
(CAPS; Blake et al., 1995) with a sensitivity of 0.71 and a specificity of 0.85 for past-year 
PTSD.   
This study used a computerised version of the CIDI administered via telephone by trained 
research personnel with a minimum qualification of a Psychology (Honours) degree.  
Recorded interviews were monitored weekly for quality and training purposes.   
7.3.2.2 Screening scales 
The PTSD Checklist (PCL) 
The PCL (Weathers et al., 1993) is a 17 item self-report measure, based on the DSM-IV 
diagnostic criteria for PTSD (American Psychiatric Association, 2000).  The civilian 
version (PCL-C) was used to duplicate ADF procedures. This version allows for the 
assessment of trauma from any source (Nicholson, 2006), an important consideration as 
non-military trauma has been identified as a significant issue in the mental health of ADF 
members (Van Hooff et al., 2012).  Items are rated on a 5-point Likert scale (1 = not at all 
to 5 = extremely), with possible scores ranging between 17 and 85.  A cut-off score of 29 
has been validated as the best screening cut-off in the ADF population (Searle et al., 
2015a). Internal consistency was excellent in our sample (alpha = 0.95). 
Physical symptoms 
Self-reported physical symptoms were assessed using a health symptom checklist (HSC) 
adapted from scales used in the King’s Centre for Military Health Research (King’s 
Centre for Military Health Research, 2010) and the Australian Gulf War Veterans Health 
Study (Sim et al., 2003). Internal consistency was excellent in our sample (alpha=0.94). 
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The HSC contains 67 items describing health symptoms reported in post-combat 
populations (Kelsall et al., 2004; Unwin et al., 1999).  Members were asked to indicate 
the presence and severity of symptoms over the past month (‘No’ or ‘yes’: ‘mild’, 
‘moderate’ or ‘severe’), giving a score of 0 to 3 for each symptom.   
HSC items that demonstrated construct overlap with PTSD were excluded.  These items 
included CIDI or DSM-IV diagnostic criteria for PTSD (e.g. loss of concentration), and 
items that assessed psychological characteristics similar to PCL or CIDI diagnostic 
criteria (e.g. increased sensitivity to noise).  While the item ‘feeling unrefreshed after 
sleep’ might be considered a psychological symptom, it does not overlap with any PCL or 
CIDI PTSD items so was retained within the context of a broader ‘physical’ screening 
scale. The final list contained 56 physical items.  
7.3.3 Statistical Analysis  
Data were analysed using Stata Software, version 14.1 (StataCorp LP, 2015).  All 
analyses were weighted to correct for differential non-response, and to obtain prevalence 
estimates for the entire MEAO-deployed ADF population.  The weighting methodology 
employed was the same as for the ADF Mental Health Prevalence and Wellbeing Study 
within the MilHOP (McFarlane et al., 2011; Van Hooff et al., 2014).  Survey responses 
were only used if the participant responded to all the questions from each scale, thus two 
different weights were calculated for each of the two screening scales (i.e. physical 
symptoms, and PCL).  Results were weighted using the interview selection strata 
(Service, sex, and Phase 1 screening scores).  Within each stratum the weight was 
calculated as the population size divided by the number of responders (i.e. Phase 2 CIDI 
responders) for that stratum.  A finite population correction was also applied to adjust 
variance estimates for the large sampling fraction within each stratum. Jackknife 
sampling was used for the estimation of 95% confidence intervals of measures. 
Receiver operator characteristic (ROC) curve analysis was used to obtain several 
diagnostic validity estimates regarding how well individual physical symptom items and 
multiple physical symptoms discriminated for 30-day PTSD caseness (Glas, Lijmer, 
Prins, Bonsel, & Bossuyt, 2003).  The area under the curve (AUC; McFall & Treat, 1999) 
was calculated as a global measure of diagnostic accuracy.  An AUC over 0.9 is 
        
Page | 150 
considered high accuracy, 0.7–0.9 moderate accuracy, 0.5–0.7 low accuracy, and 0.5 a 
non-discriminating test (Swets, 1988).  
Additional diagnostic accuracy measures were used to determine the optimal number of 
physical symptoms or cut-off values.  These measures included sensitivity (the proportion 
of individuals who are correctly identified as having PTSD), specificity (the proportion of 
individuals who are correctly identified as not having PTSD), positive predictive value 
(the proportion of those who screen positive and actually have PTSD), and negative 
predictive value (the proportion who screen negative and do not have PTSD).   
Cut-offs were selected based on the highest Youden’s index, which gives a single statistic 
to summarise test performance; zero indicates no utility and 1 indicates infallibility (i.e. 
sensitivity + specificity -1; Reiser, 2000; Youden, 1950).  The ability of multiple physical 
symptoms to predict PTSD was then compared with the diagnostic validity of the PCL.  
7.4  Results 
The demographic characteristics are provided in Table 7.1.  The majority of the 
population were male, non-commissioned officers, in the Army, married or in a 
significant relationship and deployed within the last 3 years. 
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Table 7.1 Demographic characteristics of MEAO-deployed ADF Members 
Variable MEAO-deployed 
(N = 16 991) 
Age – Mean (SE) 38.26 (.54)  
Male % 90.45 
Service %  
Army  52.34 
Navy  18.59 
Air Force  29.08 
Rank %  
Commissioned officer  28.71 
Non-commissioned officer  54.21 
Other ranks  17.08 
Time in ADF (years) – Mean (SE) 16.77 (.55) 
Married/partnered % 87.06 
Highest education level %  
High school or less  39.54 
Post high school qualification  60.46 
Time since last deployment %  
0-1 years  42.01 
2-3 years  30.56 
4-5 years  14.46 
6-9 years  16.28 
 
 
Table 7.2 shows the proportion of the population reporting each of the physical 
symptoms, including for those with PTSD and those without. Over half of the total 
population experienced feeling unrefreshed after sleep (53.96%), only 8.04% reported 
shortness of breath, and the least common physical symptom was seizures and 
convulsions (0.002%). Only the 11 most prevalent physical symptoms for the population 
overall are presented here (a full list can be provided upon request). The Mean PCL score 
of 22.83 (SE .37) was in the low category and only 19.45 % scored above the screening 
cut-off of 29 and 1.65 % above the epidemiological cut-off of 53. These cut-offs have 
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been identified to show the highest diagnostic utility in this population (Searle et al., 
2015b). The prevalence of 30-day DSM-IV PTSD diagnosed by the CIDI was 2.16%.  
The mean number of combat exposures for the sample was 4 (SE .04). Those with PTSD 
had higher levels of exposure (see Table 7.2), as expected with the dose-response 
relationship that has been identified between PTSD and combat exposure (Dohren 2006). 
Table 7.2 The Prevalence of physical symptom in members with and without PTSD, N = 16 991 
Variable Total PTSD No PTSD 
Physical symptoms % yes    
Feeling unrefreshed after sleep 53.96 97.09 51.71 
Low back pain 42.43 78.78 41.32 
General muscle aches or pains  36.99 79.85 36.00 
Flatulence and burping 28.82 63.35 28.08 
Unintended weight gain greater than 4kg 16.11 52.22 15.99 
Feeling that your bowel movement is not 
finished 
15.63 55.61 14.67 
Rapid heart beat                                                          14.87 66.75 14.24 
Pain in the face, jaw, in front of the ear, or in 
the ear 
13.02 43.80 11.17 
Loss of, or decrease in, appetite 10.80 53.66 8.69 
Faster breathing than normal                                     9.59 62.20 7.43 
Feeling short of breath at rest                                 10.47 57.21 8.79 
At least one physical symptom endorsed % 92.44 99.36 91.17 
Total number of physical symptoms endorsed: 
Mean (SE) 
8.07 (.52) 25.16 (.71) 6.30 (.06) 
Total number of combat exposures: Mean (SE) 4.00 (.04) 4.07 (.05) 9.44 (.38) 
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7.4.1 Diagnostic Accuracy of Individual Health Symptom Checklist (HSC) Items 
The AUC of each HSC item was calculated using the items HSC Likert scale score of 0 to 
3.  Table 7.3 shows the 11 physical symptom items of the HSC with the highest 
individual AUC values for PSD in order of descending AUC value (which were also the 
11 most prevalent items, see Table 7.2).  Not unexpectedly (given that all of the physical 
symptoms were unrelated to the diagnostic criteria for PTSD), AUCs for individual 
symptoms were in the in the low accuracy range (.61 to .68) for predicting PTSD.  In 
contrast, feeling unrefreshed after sleep, showed a moderately accurate AUC of .81 with a 
specificity .46 (CI .39, .53) of and a sensitivity of .28 (CI .05, .56), .22 (CI .16, .59), and 
.32 (CI .13, .51) for Likert scores of 1, 2, and 3 respectively.   
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Table 7.3 AUCs and 95% confidence intervals (CI) of the 11 highest scoring HSC physical 
symptom items for predicting DSM-IV 30-day PTSD  
 AUC 95% CI 
Individual physical symptoms    
Feeling unrefreshed after sleep .81 .73, .89 
Loss of, or decrease in appetite .68 .57, .79 
Unintended weight gain greater than 4kg .68 .56, .80 
General muscle aches or pains  .67 .52, .80 
Flatulence and burping .66 .53, .79 
Rapid heart beat                                                          .65 .53, .75 
Faster breathing than normal                                     .64 .53, .74 
Feeling short of breath at rest                                 .64 .53, .73 
Feeling that your bowel movement is not finished .64 .53, .75 
Low back pain .63 .53, .74 
Pain in the face, jaw, in front of the ear, or in the ear .61 .51, .70 
Screening measures    
9-item physical symptom scale  .81 .75, .89 
10-item physical symptom scale .83 .78, .90 
PCL  .90 .86, .95 
PCL plus 9-item physical symptom .92  
PCL: posttraumatic stress check list; AUC: area under the curve 
 
7.4.2 Diagnostic Accuracy of Physical Symptom Scales  
To address our aim of examining the ability of multiple physical symptoms to predict 
PTSD, HSC item responses were first recoded as dichotomous (i.e. present or absent).  
Dichotomous items were combined to create physical symptom scales as a count of the 
number of physical symptoms present (e.g. the 9-symptom scale scores ranged from 0 to 
9).  Two physical symptom scales were created from the most parsimonious combinations 
of symptoms (i.e. achieving relatively high AUCs using a relatively small number of 
items), as follows:   
 A 9-item physical symptom scale with: loss of or decrease in appetite; unintended 
weight gain greater than 4kg; general muscle aches and pains; flatulence and 
burping; faster breathing than normal; feeling short of breath at rest; rapid 
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heartbeat; feeling that your bowel movement is not finished; and pain in the face, 
jaw, in front of the ear, or in the ear.  
 A 10-item physical symptom scale with: the previous nine symptoms, plus feeling 
unrefreshed after sleep.  
We composed two scales to provide the option of a scale with no resemblance to PTSD 
measures, as while feeling unrefreshed after sleep is not a PCL or CIDI item, it resembles 
PCL/CIDI sleep items such as sleep difficulties.  
Diagnostic accuracy measures for these physical symptom scales are shown in Table 7.4, 
with values provided for optimal number of symptoms or cut-offs as well as one score 
above and below (full tables available on request).  The 9-item physical symptom scale 
demonstrated good diagnostic validity with an AUC of .83.  At the optimal screening cut-
off of 2, sensitivity was .81, indicating that 81% of those with 30-day PTSD scored above 
this cut-off point, and specificity was .67, indicating that 67% of those without PTSD 
scored below this cut-off.  
The 10-item scale had a slightly higher AUC of .85, as well as a higher Youden’s index 
(due to improved specificity).  At the optimal screening cut-off of 3, sensitivity was high 
(.85) and specificity was moderate (.71).  
7.4.3 Comparison with the PCL 
For comparison, accuracy indices were also calculated for the PCL as shown in Tables 
7.3 and 4. The PCL had an AUC in the highly accurate range at .9.  The cut-off of 29 had 
the highest Youden’s index with a sensitivity of .9 and a specificity of .77, demonstrating 
that while the PCL offers the best overall discrimination for 30-day PTSD, both the 9-
item and 10-item physical scales also perform well.  
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Table 7.4 Diagnostic accuracy measures for different screening scales in predicting 30-day DSM-IV PTSD 
Symptoms Cut-off Sens 95% CI Spec 95% CI PPV 95% CI NP
V 
95% CI Youden’s 
Index 


























































































PCL plus items from the 9-item 
































Note: 9-item symptom count: loss of appetite, weight gain, muscle aches, flatulence and burping, shortness of breath at rest, feeling like your bowel 
movements are not finished, faster breathing than normal, rapid heartbeat, pain in the face, jaw, in front of the ear, or in the ear. 10-item physical count: 9-
item count + feeling unrefreshed after sleep.  
PCL: posttraumatic stress check list; Sens: sensitivity; Spec: specificity; CI: confidence interval; PPV positive predictive value; NPV negative predictive 
value. 
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The higher sensitivity and specificity of the PCL (see Table 7.4) will translate into 
comparatively less misclassifications than the physical symptom scales. For example, 
from our sample of 16991, 376 were diagnosed as PTSD-positive by the CIDI.  The 
number of false negatives (those falsely screened as PTSD negative) in this population for 
the PCL was 33, and for both the physical scales 50.  Although the physical symptom 
scales have lower accuracy indices, 25 of the 33 individuals classified as false negatives 
by the PCL were captured as true positives by both the physical symptom scales. 
At optimal cut-offs, both the physical symptom scales and the PCL demonstrated 
excellent NPV of 100%.  The PPVs for both physical symptom scales were 5% and 11% 
for the PCL, indicating a higher false positive rate for the physical symptom scales, and 
indicating that all these tests require follow-up to obtain a more accurate assessment.  
These values fall within two-phase screening process norms (Shapley et al., 2010). 
As the PCL and physical symptom scales measure different symptoms associated with 
PTSD, we also considered using the physical scale and the PCL as a combined screen.  
To do this we added the 9-item physical scale items to the PCL such that the maximum 
possible score was 94 (85 from the PCL plus 9 from the physical symptom scale). Table 
7.4 shows that the addition of physical symptoms to the PCL considerably improved 
sensitivity at .98, with almost no change in the specificity score of .75. 
7.5  Discussion 
Consistent with our hypothesis, this study provides evidence that the presence of two or 
three physical symptoms from our 9-item or 10-item physical symptom scales 
demonstrates value for identifying increased risk for 30-day PTSD. These results support 
the large body of research showing a strong relationship between physical symptoms and 
PTSD (Barrett et al., 2002a; Gupta, 2013), and advance this knowledge by quantifying 
their diagnostic utility.  
Our research found low specificity of individual symptoms, supporting the findings of 
past research that specific physical symptoms do not differentiate between 
psychopathologies (Simon et al., 1996).  However, we identified a cluster of symptoms 
that when considered together provide reasonable diagnostic association with PTSD.  
These findings agree with those of Gulden et al. (2010) and Westermeyer et al. (2010).  
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We further advanced their findings by identifying a wider range of symptoms, using a 
military sample at the population level, and using accepted methods of diagnostic 
validity. 
Feeling unrefreshed after sleep offered the highest AUC if the individual symptoms 
assessed, which may suggest this symptom represents a proxy for sleep disturbance item 
in the PCL.  However, the sensitivity and specificity for this sleep item were low, as 
would be expected as sleep symptoms are common in the presentation of many 
psychological and physical illnesses.  Our nine-item scale had a similar AUC to that for 
the single sleep item, but as it was a combination of items it provided better sensitivity 
and specificity, and therefore better overall utility than a single sleep item, demonstrating 
that such a scale could offer a valuable contribution to PTSD screening.   
Prioritising sensitivity or specificity in determining cut-offs may be considered against 
the perceived costs associated with false diagnosis. In a military setting, a high false 
positive rate (low specificity) may place a burden on mental health services or may 
unnecessarily expose individuals to negative stigma.  Conversely, a high false negative 
rate (low sensitivity) may result in delayed PTSD diagnosis.  Considering that those with 
untreated PTSD more frequently utilise healthcare and generate substantial direct and 
indirect costs (Greenberg et al., 1999), false negatives may be more costly than the 
additional follow-up incurred by false positives.  In two-phase screening, to maximise the 
number of true cases captured, the screening phase should maximise positive 
classifications at the expense of raising false negatives (prioritising sensitivity), as the 
second clinical evaluation phase can correct any misclassification (Newman, Shrout, & 
Bland, 2009).  Consequently, to minimise the number of individuals missed by screening, 
a cut-off that provides a high degree of sensitivity and at least modest specificity would 
be most suitable.  We have demonstrated that physical symptom scales can adequately 
meet these objectives, but the addition of the physical symptom scales to the PCL had the 
best balance of sensitivity to specificity, as supported by the highest Youden’s value. 
While the optimal cut-offs identified for the 9-item and 10-item physical scales in this 
sample demonstrated good utility, it was not as high as the ‘gold standard’ PCL.  As such, 
their stand-alone use cannot match the diagnostic accuracy of the PCL. This is 
unsurprising, given that all 17 PCL items were taken directly from the DSM-IV PTSD 
diagnostic criteria.  That physical scales can perform objectively well despite no specific 
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symptom overlap with DSM-IV defined PTSD is impressive and speaks to the 
demonstrated strong association between PTSD and physical symptoms.  Results from 
our study suggest that the inclusion of both the physical and psychological diatheses of 
distress associated with PTSD may more accurately reflect the true nature of the disease 
for some individuals, and therefore their inclusion may improve screening outcomes. 
Notably, both the 9-item and 10-item physical symptom scales captured two-thirds of 
those misclassified as PTSD-free by the PCL. This finding led us to consider combining 
the two screening tools.  By allowing for both psychological and physical symptom 
presentations, this combined screen was more inclusive.  The addition of the physical 
symptoms from the 9-item scale to the current PCL demonstrated a considerable 
improvement.  However, there were slightly more false negatives than when using the 
PCL alone.  Another possible strategy, if disclosure of psychological symptoms is a 
concern, would be to have participants complete both the physical and psychological 
screens separately but present the physical screen first then follow up with the 
psychological screen.  The impact test ordering could be explored in future research. 
There are a range of pathophysiological mechanisms that may explain the physical 
symptoms we identified. For example, rapid heartbeat and breathing symptoms could be 
due to the DSM-IV PTSD criterion ‘physiological reactivity to trauma stimuli’, comorbid 
depression could explain ‘loss of appetite’, and metabolic disruption ‘weight gain’.  One 
mechanism that symptoms may share is autonomic nervous system dysregulation, which 
is found in individuals with PTSD not only in response to trauma related cues but also at 
rest (Grupe, Wielgosz, Davidson, & Nitschke, 2016; Pole, 2007; Rabellino et al., 2017; 
Thome et al., 2017; van Boxtel et al., 2018).  The physiological profile of individuals with 
PTSD is similar to that seen during the fight-or-flight response, and is thought to be 
coordinated in part by the periaqueductal gray and extended brainstem (Assareh, Sarrami, 
Carrive, & McNally, 2016; Linnman, Moulton, Barmettler, Becerra, & Borsook, 2012).  
Alternatively, rather than these symptoms being proxies for PTSD, it is possible that such 
‘autonomic dysregulation’ (i.e., dysregulation of the automatic, involuntary functions that 
maintain the bodies homeostasis; Sánchez-Manso & Varacallo, 2019) symptoms are 
sequela of trauma, and thus may be a driver of both physical and psychological 
symptomatology (although a bidirectional association between symptomatology and 
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dysregulation could plausibly exist).  Several studies suggest that deployment and/or 
trauma predict dysregulation, independent of psychological disorder.  For example, a 
study of individuals involved in a terrorist bombing found that physiological reactivity 
(measured by Heart rate and systolic, diastolic, and mean arterial blood pressures) was 
elevated seven years after exposure even in those considered psychologically 
resilient (Tucker et al., 2007).  Moreover, longitudinal studies with veterans of World 
War II and the Vietnam War show that combat exposure, regardless of mental health 
status is a risk factor for early mortality, further supporting that exposure to trauma can 
physiologically disrupt normal bodily functioning.  Indeed, while these symptoms were 
more commonly reported by our personnel with PTSD, they were also experienced by a 
sizeable proportion of those without PTSD in our sample, perhaps reflecting that 
physiological reactivity can be a by-product of exposure to trauma. 
7.5.1 Clinical implications 
These findings highlight the importance of physical symptom evaluation in primary care.  
Sleep disturbance in particular has received increased recognition as associated with 
psychological disorder (Baglioni et al., 2016).  Sleep is a primary presenting concern 
among veterans with PTSD and has also been found to be associated with greater 
symptom severity in PTSD (Krakow et al., 2001; Lewis, Creamer, & Failla, 2009).  Our 
study suggests that the presence of two or three physical symptoms offers similar 
diagnostic value as sleep symptoms and therefore their consideration could assist in the 
earlier recognition of PTSD by clinicians.  The advantage of physical symptoms is their 
low face validity, so that groups that may be concerned about the stigma of mental 
disorder may withhold answers to psychological symptom questions but may not sensor 
their results to physical symptom questions.  However, further research is required to test 
this theory testing. 
The co-occurrence of physical symptoms with PTSD has been linked to worse symptom 
severity, poor treatment outcomes, functional disability, and poor quality of life (Clapp, 
Beck, Palyo, & Grant, 2008; Helmer et al., 2009; Meltzer et al., 2012; Outcalt et al., 
2014).  Furthermore, those with untreated PTSD more frequently utilise healthcare and 
generate substantial direct and indirect costs (Greenberg et al., 1999).  Improved 
diagnostic rates may lessen the impact of exposure to trauma on the personnel 
themselves, their families, friends, work colleagues, and the wider community, and as a 
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consequence, may create significant reductions in costs for the Defence forces ( Fear, 
Reed, Rowe, Burdett, Pernet, Mahar, Iversen, Ramchandani, Stein, & Wessely, 2018, Foa 
et al., 2005; Karlin et al., 2010).   
7.5.2 Strengths and limitations 
This study has several key strengths, including the examination of an entire population of 
non-treatment seeking military personnel, and using a diagnostic interview (the CIDI) as 
the diagnostic reference standard rather than self-reported scales.  However, while the 
CIDI has reasonable concordance, it is possible some PTSD cases were missed. Similarly, 
participants were told survey responses were confidential, it is possible that personnel 
underreported symptoms on the CIDI due to fears concerns around career implications 
arising from high scores.   
This study reflects a very specific population; therefore, it is important that these findings 
are explored in other samples to examine their generalisability.  These strengths must be 
weighed against the study limitations particularly that our physical symptom scales were 
constructed post-survey administration, and thus, additional research is required to assess 
their use in situ.  As well, only one psychiatric condition, PTSD, was considered.  Due to 
the known comorbidity and association of physical symptoms with other psychiatric 
conditions such as depression (Bekhuis, Boschloo, Rosmalen, de Boer, & Schoevers, 
2016), it is likely that physical symptoms could also be utilised in the prediction of other 
psychiatric conditions.  Likewise, it is probable that the symptoms we examined are not 
specific to PTSD.  
Adverse post deployment mental and physical health outcomes are the result of many 
individual and combined deployment-related experiences (Vanderploeg et al., 2012).  
Mild traumatic brain (mTBI) injury is of particular interest as there is emerging evidence 
that links mTBI to risk of future physical and psychological morbidity, particularly PTSD 
(Costanzo et al., 2014).  As the examination of the origin of symptoms was beyond the 
scope of this paper we controlled for factors such as injury, disease, and age that may 
impact symptom reporting.  Related to aetiology, some physical symptoms may be more 
prevalent among military compared with civilian samples, which might affect their 
diagnostic utility for predicting PTSD.  We were unable to explore this possibility, and 
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thus generalisability of these results only applies within military spheres.  We were also 
unable to consider frequency of combat exposure the impact of different types of 
traumatic exposures, a factor found to influence health outcomes (Waller et al., 2012).  
Despite these limitations, this study makes an important contribution to the literature as 
the first to examine diagnostic utility measures for physical symptoms in the diagnosis of 
PTSD. 
7.6 Conclusion 
The current study provides strong evidence to support the value of assessing self-reported 
physical symptom scales in screening for 30-day DSM-IV PTSD, particularly through 
their inclusion in current self-report military screening scales.  The findings suggest that 
the presence of two or three physical symptoms provide similar diagnostic utility as 
sleep-related symptoms.  Importantly, these findings underscore the importance of 
screening for both physical and psychological symptoms in patients with a history of 
military deployment.  Considering psychological disorder when addressing non-specific 
physical symptoms may help prevent physical symptoms being treated as isolated, non-
distress related symptoms.  However, more research, particularly longitudinal, is needed 
to disentangle the complex relationship between physical symptoms and psychological 
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8.1 Abstract 
Background: Physical symptoms have a higher prevalence in deployed than non-deployed 
military members. The pathological mechanisms involved are yet to be definitively 
characterised.  As inflammation has been associated with both traumatic deployment 
exposure and physical symptoms, we hypothesised that this may be one mechanism 
involved. Our aim was to explore whether the inflammatory biomarker C-reactive protein 
mediates the relationship between deployment trauma and physical symptoms. 
Methods: Data were from Australian Defence Force (ADF) personnel who were deployed 
to the Middle East Area of Operations (MEAO) from June 2010 to June 2012 (N = 357). 
Self-reported measures of traumatic deployment exposures and physical symptoms as 
well as blood samples were collected approximately four months after members returned 
from deployment. Regression analysis was used to assess the relationship between 
C-reactive protein (CRP) and physical symptoms, and structural equation modelling was 
used to test for mediation. 
Results:  CRP was moderately associated with five physical symptoms: skin infections, 
sore throat, wheezing, low back pain, and tender or painful lymph nodes (unstandardised 
coefficients between 0.18 and 0.46). However, as we found no association between 
trauma and CRP no indirect pathways were significant, and the hypothesised mediation 
was not supported. For the direct pathway, trauma showed a small association with three 
physical symptoms: sore throat, low back pain, and painful lymph nodes (unstandardised 
coefficients between 0.04 and 0.08).  
Conclusion: CRP was associated with a few individual physical symptoms, some of 
which may be indicative of low-grade inflammatory states. 
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8.2  Introduction 
Across most domains, physical symptoms are consistently found to be higher in military 
members deployed to zones of conflict than non-deployed comparison groups (Kelsall et 
al., 2004; McCutchan et al., 2016; Toblin et al., 2012; Unwin et al., 1999; Vanderploeg et 
al., 2012), including after controlling for injury (Vanderploeg et al., 2012). As with 
posttraumatic stress disorder (PTSD), physical symptoms have been associated with 
traumatic deployment exposures (TDEs; de Silva et al., 2013; Graham et al., 2018; 
Hotopf et al., 2006; McAndrew et al., 2013; McCutchan et al., 2016). While these 
associations are likely multifactorial, the biological mechanisms involved are not yet 
definitively characterised. One potential mechanism that has been linked to physical and 
psychological illness as well as trauma is dysregulation of the hypothalamic-pituitary-
adrenal (HPA) axis leading to chronic inflammation (Eraly et al., 2014; Libby, 2007; 
O'Donovan, Neylan, Metzler, & Cohen, 2012; Solomon et al., 2017). The aim of this 
study was to examine direct and indirect associations between TDEs, inflammation, and 
physical symptoms. 
Inflammation can be measured using blood levels of pro-inflammatory cytokines such as 
interleukin – 1 (IL-1), IL-6, tumour necrosis factor-α (TNF-α), or other factors such as C-
reactive protein (CRP), a stress-reactive acute phase protein. CRP is a useful peripheral 
marker of inflammation and innate immune system activation as well as a predictor of 
many chronic physical diseases common in veterans (Gabay & Kushner, 1999; Kushner, 
Rzewnicki, & Samols, 2006; Ridker, 2003; Ridker, Hennekens, Buring, & Rifai, 2000) 
and mortality in healthy individuals, even in the low-normal range (Pepys & Hirschfield, 
2003). CRP is a particularly suitable measure for large epidemiological studies because 
assessment is relatively easy, reference values are known, and CRP concentrations have 
been shown to be stable throughout the day (Meier-Ewert et al., 2001). 
A small number of studies have found a link between trauma and measures of 
inflammation. For example, lifetime trauma exposure has been associated with 
inflammation in civilians even after adjusting for psychological disorder (O'Donovan et 
al., 2012). In military samples, studies have found that military training is associated with 
elevated levels of inflammatory biomarkers (McClung et al., 2013), and Israeli combat 
veterans who were held as prisoners of war (POW) had 1.87 times the risk of having a 
CRP over 3.0mg/L 40 years after the event compared to those in the same cohort who 
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were not POWs (Solomon et al., 2017). Other military studies have explored whether 
inflammation is higher in combat-exposed military members with PTSD than those 
without PTSD but do not directly address the impact of trauma on inflammation (Groer et 
al., 2015; Lindqvist et al., 2017b). Therefore, there is a dearth of research exploring the 
association between inflammation and TDEs in military members independent of 
psychological disorder.   
The association between inflammation and both physical and psychological illness in 
returned veterans is supported by accumulating evidence (Groer et al., 2015; Libby, 2007; 
Lindqvist et al., 2017b; Salum et al., 2011). However, the association between 
inflammation and physical symptoms has received little attention. The high level of 
interrelatedness between these adverse health outcomes can make it difficult to 
differentiate the role of pathophysiological processes such as inflammation. One link 
identified between physical symptoms and inflammation is the ability of pro-
inflammatory cytokines to induce behaviour symptoms that are typically seen in those 
who are unwell (Vollmer-Conna, 2001). For instance, injecting IL-1 and TNF-α into the 
brains of rats was found to induce sickness behaviours, such as social withdrawal, 
reduction of physical activity, fatigue, and cognitive impairment (Dantzer, O'Connor, 
Freund, Johnson, & Kelley, 2008). 
There is some evidence to suggest that CRP may be a measure inflammation and physical 
symptoms. For example, a study by Tak, Bakker, Slaets, and Rosmalen (2009) explored 
the association between CRP and physical symptoms commonly associated with 
functional somatic syndromes. They found that CRP was not associated with a total 
physical symptom count, either cross-sectionally or at a two-year follow-up. However, 
when considering symptom clusters defined by factor analysis, the musculoskeletal 
symptom cluster (back pain, joint pain, pain in extremities, loss of touch or pain 
sensation, muscle weakness, and numbness or tingling sensations) was associated with 
CRP in cross-sectional logistic models adjusted for gender and age (odds ratio [OR] 1.11, 
CI 1.03–1.20), but not following the addition of the covariates BMI, smoking, alcohol 
use, depression, anxiety, and exercise frequency (OR 1.08, CI 0.99–1.17). When this 
cluster was reduced to include only back pain, joint pain, pain in extremities, and muscle 
weakness, the association with CRP was significant in both the model adjusted for gender 
and age (OR 1.14, CI 1.06–1.23) and the fully adjusted model (OR 1.12, CI 1.03–1.21). 
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These results raise the question of how inflammation may relate to individual symptoms 
as opposed to total symptom counts or clusters of symptoms derived by factor analyses. 
Examining individual symptoms may help to explain the relationship between trauma and 
physical symptoms. 
As TDEs appear to be associated with both inflammation and physical symptoms, and 
inflammation appears to be associated with physical symptoms, it is plausible that TDEs 
may be indirectly associated with physical symptoms through inflammation. However, 
there does not appear to be any studies examining the associations between TDEs, 
inflammation, and physical symptoms together in one model. The primary aim of this 
study was to explore the association between the inflammatory biomarker CRP and 
physical symptoms in a sample of combat-exposed Australian Defence Force (ADF) 
members. More broadly, we aimed to examine the direct and indirect associations 
between TDEs, inflammation, and physical symptoms. We hypothesised that all three 
variables would be significantly associated, and that TDEs would be indirectly associated 
with physical symptoms through their association with inflammation. To our knowledge 
such a mediation model has not previously been tested. 
In line with previous research, we hypothesised that CRP would not be associated with a 
total physical symptom count but would be differentially related to some individual 
physical symptoms, most likely those associated with the musculoskeletal system or pain. 
As our symptom list was extensive and varied, including symptoms that may be 
considered psychological ('distressing dreams') or sickness behaviours ('loss of or 
decrease in appetite'), we did not make specific hypotheses about which symptoms would 
be associated with inflammation. Additionally, as the cause of the symptoms explored in 
this study was not known, we have used the broad term ‘physical symptoms’ to 
encompass all symptoms tested. 
The knowledge gained from this study has the potential to advance our mechanistic 
understanding of how experience on deployment increases the risk for physical 
symptoms, and thus inform interventions attempting to prevent such non-specific physical 
symptoms in deployed military members. 
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8.3  Method  
8.3.1 Participants  
The current sample was a subset drawn from the Middle East Area of Operations 
(MEAO) Prospective Study, which assessed the health study of ADF personnel deployed 
to Afghanistan after June 2010 and returning by June 2012. Full details of this study have 
been reported previously (Davy et al., 2012; Searle et al., 2017). Of interest to this study 
is a sub-sample of 1871 (primarily combat personnel) who were invited to provide 
objective health measures including blood samples. At pre-deployment 655 members 
participated, of whom 357 (54.5%) provided post-deployment samples. Training and 
deployment commitments limited the number of personnel available at both time points. 
Samples were collected not more than 4.2 months after returning from deployment. 
This study was approved by the Australian Defence Human Research Ethics Committee 
(ADHREC; Protocol no. 488-07), and the University of Adelaide Human Research Ethics 
Committee (UA HREC; Protocol no. H-064-2008). 
8.3.2 Measures 
8.3.2.1 Traumatic deployment exposures  
A questionnaire adapted for Australian military research from the Deployment Risk and 
Resilience Inventory (King et al., 2006), the King's College Gulf War Survey (Unwin et 
al., 1999), and the Traumatic Stressors Exposure Scale (TSES-R; Swann & Hodson, 
2004) was used to measure the frequency of 27 traumatic deployment exposures from 
participants’ most recent MEAO deployment, rated as: never, once, 2-4 times, 5-9 times, 
10+ times (Dobson et al., 2012).  Two items were excluded from our analysis: ‘Did you 
clear/search caves?’ as this item only related to Afghanistan deployments; and ‘Were you 
present when a loved one was injured or killed?’ as the prevalence rate was less than 1%.  
The items were first dichotomised into ‘no exposure’ or ‘exposed’ then summed to 
provide a count of combat exposure types, as the number of different types of trauma 
rather than the total frequency of exposures has been found to be more strongly associated 
with health outcomes in military studies (Killgore et al., 2006; Kroenke et al., 1998; 
Searle et al., 2017).  
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8.3.2.2 C-reactive protein 
A 40mL whole blood sample was collected in vacuette tubes. C-reactive protein levels 
were assayed at Healthscope (Wayville, South Australia). Analysis was performed by 
ADVIA 2400 (Siemens Healthcare Diagnostics Inc., Tarrytown, NY 10591-5097 USA) 
using latex-enhanced immunoturbidimetric assay. The resulting turbidity was measured at 
571 nm and compared to a six-point standard curve in order to calculate the CRP 
concentration. One-time measurement of CRP is considered a reliable measure over an 
extended period in healthy individuals (Macy, Hayes, & Tracy, 1997).  
8.3.2.3 Physical symptoms 
Members were asked to complete a 67-item health symptom checklist (HSC) adapted 
from the King's College Gulf War Survey (Unwin et al., 1999), and the Australian Gulf 
War Veterans Health Study (Kelsall et al., 2004) for the purposes of Australian military 
research (Dobson et al., 2012). Respondents were asked to indicate the presence or 
absence of these symptoms over the past month, rated as: never, mild, moderate, or 
severe. To provide a count of the number of physical symptoms, symptoms were 
dichotomised into ‘no’ (from ‘never’) or ‘yes’ (from ‘mild’, ‘moderate’, or ‘severe’) then 
summed. Physical symptom count scores have been found to be associated with 
deployment in several veteran samples (de Silva, Jayasekera, & Hanwella, 2013a; Hotopf 
et al., 2006; Kelsall et al., 2004b; Unwin et al., 1999b). This instrument contained 
symptoms that have been reported in veteran populations (Kelsall et al., 2004b), some of 
which could be considered psychological (e.g. ‘loss of concentration’, ‘forgetfulness’) 
and others physical (e.g. ‘headaches’, ‘joint pain’).  
8.3.2.4 Covariates  
An extensive number of demographic, physical, and deployment-related covariates were 
considered for inclusion based on their associations with trauma, inflammation, and 
physical symptoms, as reported in the literature (Fear et al., 2010; Festa et al., 2001; 
Yudkin et al., 2004). However, statistical power was limited by sample size and 
prevalence of symptoms, restricting the number of covariates we could include in our 
model. Therefore, only variables that were found to have more than 10% impact on the 
relationship between each predictor and outcome variable were included. For example, 
although BMI has previously been found to influence CRP (Festa et al., 2001; Yudkin et 
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al., 2004), we found no association here, which could be explained by the homogeneity of 
this relatively young physically fit sample. Considering temporal order, mental health 
variables considered to be an effect of rather than the cause of deployment trauma (e.g. 
depression and posttraumatic stress symptoms) were not included.  
Somatic illness was measured by asking participants ‘Since returning from your last 
MEAO deployment has a medical doctor diagnosed you with or treated you for any of the 
following medical problems or conditions’. The 3-item AUDIT C was used to measure 
alcohol consumption, which classifies consumption with a score of 0 to 12, rated as: 0 = 
no, 1-2 = low, 3-4 = medium, or 5+ = high risk of harm (Council, 2009).  
8.3.2.5 Statistical Analyses  
All independent variables were evaluated for the assumptions of multivariate normality 
and linearity. As expected, total physical symptom count was skewed because most 
members were healthy. This is not unexpected as members undergo extensive mental and 
physical screening before deployment, creating a ‘healthy warrior’ effect common in 
deployed samples (Haley, 1998). CRP was skewed on visual inspection so data were 
normalised with Blom transformation (Blom, 1957). While this improved the distribution, 
CRP still did not meet normality. Skewness is not considered to substantively affect 
analyses with sample sizes of more than 200 (Tabachnick & Fidell, 2007), so the Blom 
transformed variables were used. The non-normal distribution of the mediator combined 
with the dichotomous outcomes and small sample size led us to choose Bayesian analysis 
(Enders, Fairchild, & MacKinnon, 2013; Muthén, Muthén, & Asparouhov, 2017; Yuan & 
MacKinnon, 2009). Initial analyses were conducted using Stata version 15 (StataCorp LP, 
2015b), and all Bayesian analyses were conducted using Mplus version 8.0 (Muthén, 
2017).  
Regression analyses were conducted between CRP and both total physical symptom 
count and individual symptoms while controlling for TDEs to identify any significant 
associations, as a significant direct effect between the independent and dependent 
variables is not required to retain the power to detect a significant mediation effect, and 
significant association between the mediator and the dependent variable is one suggested 
precondition of mediation (Agler & De Boeck, 2017; MacKinnon & Luecken, 2008). 
Structural equation modelling was used to simultaneously test the direct and indirect 
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pathways between TDEs, CRP, and physical symptoms.  The ‘product of coefficients’ 
method was chosen as the ‘difference in coefficients’ method may not hold with 
dichotomous outcomes and estimates with different scales (MacKinnon, Lockwood, 
Hoffman, West, & Sheets, 2002). Using this method, the indirect path reflects the extent 
to which the independent variable changes the mediator (path a) and the extent to which 
the mediator changes the dependent variable (path b), with statistical significance of this 
path ab implying mediation (MacKinnon & Luecken, 2008).  
Model goodness of fit was examined with Bayesian posterior predictive checking using χ2 
95% Bayesian credibility intervals (CI) for the difference between the observed and the 
replicated χ2 values. A posterior predictive p-value of 0.5 and a 95% CI for the difference 
between the observed and the replicated values centred close to zero indicates good 
model fit (Lee & Song, 2012; Muthén & Asparouhov, 2012). Due to the exploratory 
nature of these analyses, we present data without adjusting for multiple comparisons in 
order to more fully represent the data for future hypothesis-testing studies. 
8.4  Results   
Table 8.1 displays demographic characteristics of the study sample. Most participants 
were male, partnered, from the Army, of other ranks, and had a high school education or 
less, with an average age of 27.14 years (SD = 6.80). Most of the sample had no self-
reported doctor diagnosed somatic conditions and their CRP was in the low-risk range of 
less than 1mg/L indicating that this was a predominantly healthy group (Young, Gleeson, 
& Cripps, 1991). However mean alcohol consumption was in the high-risk range, a 
finding that has previously been linked to young age and combat exposure in male 
personnel (Sundin, Forbes, Fear, Dandeker, & Wessely, 2011). The sample had 
experienced a mean of 12.72 different types of traumatic deployment exposures and had a 
mean of 9.88 physical symptoms. both of which are slightly higher than the average 
MEAO deployed of x exposures and y symptoms (Graham et al., 2018).  
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Table 8.1 Demographic characteristics of MEAO-deployed ADF members, n = 357 
Variable MEAO-deployed 
Age – Mean (SE) 27.14 (6.80)  
Sex; Male % 98.6 
Service %  
Army  95.0 
Navy  5.0 
Rank %  
Commissioned officer  5.3 
Non-commissioned officer  30.8 
Other ranks  67.9 
Married/partnered % 63.6 
Highest education level %  
High school or less  66.5 
Post-high school qualification  33.5 
Number of deployments; mean (SD) 1.68 (SD 0.47) 
Number of physical symptoms; mean (SD) 
CRP mg/L; mean (SD) 
Normal CRP range 0.5 – 3.0 mg/L (%) 
9.88 (10.04) 




Table 8.2 provides the results of the regressions with CRP predicting total symptom count 
as well as all the individual symptoms on our health symptom checklist, while controlling 
for TDEs, with unstandardised coefficients, their Bayesian credibility interval and 
statistical significance. Only statistically significant associations are shown as our list of 
symptoms was extensive (full results provided on request). Our hypothesis that 
precondition of CRP would predict total symptom count was not supported, but we found 
five individual symptoms that were significantly related to CRP: skin infections, sore 
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throat, wheezing, low back pain, and tender or painful swelling of lymph glands in the 
neck, armpit or groin (painful lymph glands). The additional symptoms of unexpected 
weight gain > 4kg (B=.31, CI .03, .59, p = .03), muscle aches and pains (B=.01, CI .03, 
.59, p = .04), loss of concentration (B=.04, CI .03, .59, p = .01), and diarrhea (B=.05, CI 
.03, .59, p = .04) were significant b pathways before the covariates somatic illness, age 
and alcohol consumption were considered. 
Table 8.2 Linear regressions of total and individual physical symptoms on CRP after adjusting 
for TDEs, n = 357 
Symptom B (95 % CI) SD p 
Physical symptom count 1.05 (-0.47, 2.58) 0.11 .09 
Wheezing 0.32 (0.06, 0.58) 0.13 .008 
Skin infections 0.46 (0.17, 0.75) 0.15 .001 
Diarrhoea 0.20 (-0.03, 0.42) 0.11 .04 
Sore throat 0.46 (0.22, 0.70) 0.12 <.001 
Loss of concentration 0.18 (-0.03, 0.38) 0.01 .04 
General muscle aches and pains 0.19 (-0.01, 0.39) 0.10 .03 
Low back pain 0.28 (0.08,0.48) 0.10 .003 
Painful lymph glands  0.38 (0.03, 0.71) 0.17 .02 
Note: Only significant results for the individual symptoms are presented. B = unstandardised path 
coefficient, 95% CI = credible intervals, SD = posterior standard deviation, painful lymph 
glands = tender or painful swelling of lymph glands in the neck, armpit or groin. 
Adjusted for somatic disease, age, and alcohol consumption 
 
Separate mediation models were used to explore whether CRP mediated the relationship 
between TDEs and these five individual physical symptoms, which also included the 
covariates age, life trauma, somatic illness, and alcohol consumption, as depicted in 
Figure 8.1. Table 8.3 provides the non-standardised coefficients, their Bayesian 
credibility interval, posterior standard deviation, and significance values. As all the 
hypothesised models displayed good fit to the data (see Table 8.4), we did not conduct 
post-hoc modifications to the models. 
   




Figure 8.1 SEM model illustrating all direct and indirect effects tested between TDEs, CRP, 
and individual physical symptoms, after adjustment for covariate 
 
The association between TDEs and CRP (a pathway) was not statistically significant for 
any of the models. The associations between CRP and the individual physical symptoms 
(b pathways) remained significant for all five symptoms. The indirect effect (ab 
pathways) for all the models tested was nonsignificant. The direct c pathway between 
sore throat, painful lymph glands, and low back pain was significant (see Table 8.4). 
Therefore, while the association between some individual symptoms and trauma 
(unstandardised coefficients of 0.04 to 0.08) and some individual symptoms and 
inflammation (unstandardised coefficients of 0.18 to 0.46) was moderate, these results do 
not support the hypothesised mediation model, suggesting that the relationship between 
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Table 8.3 Path coefficients for indirect effects between TDEs and physical symptoms through CRP 
 
Symptom 
a path b path Indirect (ab) path 
B (95% CI) SD p B (95% CI) SD p B (95% CI) SD p 
Skin infection -.01 (-0.03, 0.01) 0.01 .14 .45 (0.16, 0.75) 0.15 .002 -.004 (-0.014, 0.004) 0.01 .15 
Sore throat -.01 (-0.03, 0.01) 0.01 .14 .47 (0.21, 0.68) 0.12 <.001 -.004 (-0.014, 0.004) 0.004 .16 
Wheezing -.01 (-0.03, 0.01) 0.01 .14 .31 (0.05, 0.58) 0.13 0.01 -.003 (-0.01, 0.003) 0.003 .15 
Low back pain -.01 (-0.03, 0.01) 0.01 .14 .27 (0.07, 0.47) 0.10 .004 -.02 (-.01, .002) 0.003 .14  
Painful lymph 
glands 
-.01 (-0.03, 0.01) 0.01 .14 .36 (0.01, 0.70) 0.17 0.02 -.003 (-0.01, 0.003) .004 .16 
B = unstandardised path coefficient, 95% CI = credible intervals, SD = posterior standard deviation, painful lymph glands = tender or 
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Table 8.4 Total and direct mediation pathways with Bayesian model fit statistics for each of the 
five models 
Symptom Direct c pathway   Model fit statistics 
 b (95% CI) SD p PPI (95% CI χ2) 
Skin infection 0.01 (-0.04, 0.07) 0.03 .31 .552 (-25.29, 20.69) 
Sore throat 0.04 (0.001, 0.09) 0.02 .02 .559 (-25.08, 20.61) 
Wheezing 0.02 (-0.02, 0.07) 0.02 .20 .551 (-24.28, 20.57) 
Low back pain 0.04 (0.01, 0.07) 0.02 .002  .562 (-25.31, 20.32) 
Painful lymph glands 0.08 (0.01, 0.16) 0.04 .01 .569 (-25.31, 21.36) 
 
Note. Each of the physical symptoms was the DV in a separate model. SD = posterior 
standard deviation, PPI = posterior predictive p-value, 95% CI χ2  = 95%  
Bayesian credibility intervals for the difference between the observed and the 
replicated χ2 values 
 
8.5  Discussion 
While both TDEs and CRP were associated with several physical symptoms, TDEs were 
not associated with CRP, and thus, CRP did not mediate the association between TDEs 
and physical symptoms. Previous studies have found a link between inflammation and 
physical and psychological disorders associated with deployment, most notably PTSD, 
cardio-vascular disease, and metabolic disorder (Lindqvist et al., 2017b; O'Donovan et 
al., 2017; Solomon et al., 2017). This study only measured CRP, a general biomarker for 
immunological activation which may not be sufficient to capture all aspects of immune 
function. Exploring a wider range of inflammatory biomarkers may broaden the range of 
identified symptoms. 
The five individual physical symptoms found to be associated with CRP were skin 
infections, sore throat, wheezing, low back pain, and painful lymph glands. CRP is an 
acute phase reactant that increases rapidly in reaction to infection, injury, and 
inflammation to provide early defence that results in proinflammatory signalling and 
activation of the adaptive immune system (Du Clos, 2000). CRP has also been associated 
with chronic health conditions such as cardiovascular disease, diabetes, and metabolic 
syndrome in which low-grade inflammation is thought to play a role (Devaraj, Singh, & 
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Jialal, 2009; Freeman et al., 2002; Lyon, Law, & Hsueh, 2003; Mauvais-Jarvis, 2013; 
Sjöholm & Nyström, 2005). The individual symptoms we identified were suggestive of 
some of these roles of CRP. For example, the association with skin infection, sore throat, 
and painful lymph nodes may relate to the infection and inflammatory roles for which 
CRP is well-recognised, and back pain can be associated with physical illnesses 
associated with inflammation such as obesity, as well as with aging. Therefore, the 
association between these symptoms and CRP may be indicative of chronic low-grade 
inflammatory processes.  
Wheezing may be a sign of many things including infection, smoking, or asthma, all of 
which have been associated with elevated CRP, with the caveat that the association 
appears to be with non-allergic rather than allergic asthma (also labelled broncho spasm) 
(Arif, Delclos, & Colmer‐ Hamood, 2007; Ólafsdóttir et al., 2005; Peltola, Mertsola, & 
Ruuskanen, 2006). As non-allergic asthma often occurs in association with infection, this 
symptom may be indicative of the role of CRP in infection.  It should be remembered that 
chronic stress has been linked to increased susceptibility to infection and disease (Cohen 
et al., 1998; Cohen, Gianaros, & Manuck, 2016; Takkouche, Regueira, & Gestal-Otero, 
2001). Similarly, salivary inflammatory markers have been linked to acute stress (Slavish, 
Graham-Engeland, Smyth, & Engeland, 2015). One tested mechanism is that stress 
causes glucocorticoid receptor resistance which in turn leads to a failure to down-regulate 
the inflammatory response (Cohen et al., 2012). Therefore, it is uncertain whether CRP is 
with these symptoms due to infection only or whether chronic stress from military 
deployment plays a role.  
As some of the symptoms we have associated with CRP may be caused through 
undiagnosed infection, it is possible that the symptoms included on the HSC could be 
divided into subscales to allow more meaningful analysis. However, the complex 
interrelationship between stress and inflammation, and between stress and many health 
symptoms and disease states creates difficulty in determining the best method to create 
symptom subscales. 
While Tak et al. (2009) found that back pain was only associated with CRP within a 
cluster of musculoskeletal symptoms, we found that back pain was associated with CRP, 
and  the relationship was strong enough to be significant as an individual symptom. The 
other musculoskeletal symptom in our checklist that demonstrated an association was 
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muscle aches and pains, but this was no longer significant once covariates were 
considered, suggesting that back pain could have been the driver of the association as 
observed by Tak et al. (2009). This raises the question of whether the source of the 
association is of a musculoskeletal nature or whether it is the mechanisms associated with 
pain. 
Low back pain without a specific underlying cause is a common presentation in primary 
care (Cassidy, Carroll, & Côté, 1998; Qaseem, Wilt, McLean, & Forciea, 2017). CRP has 
been associated with the level of pain in acute low back pain (Gebhardt et al., 2006; 
Stürmer et al., 2005), with one study finding that higher CRP levels were associated with 
patients in higher pain categories (Stürmer et al., 2005). These findings combined with 
those by de Queiroz et al. (2016)  that the inflammatory biomarkers TNF-α and IL-6 were 
positively correlated with measures of pain intensity or severity, suggest that pain may 
play a significant role in the CRP-physical symptom association. 
Another study that identified an association between low back pain and CRP was a large 
cross-sectional analysis (N = 15,322) of the US 1999 to 2004 National Health 
and Nutrition Examination Survey (NHANES). The study found that individuals with 
elevated CRP (>3.0 mg/L) had 1.74 times (95% confidence interval [CI], 1.04–2.91) 
greater odds of reporting lower back pain while obese individuals (≥30kg/m2) with 
elevated CRP had 2.87 times (95% CI, 1.18–6.96) greater odds of reporting lower back 
pain than those without elevated CRP. This study shows that CRP is associated with 
lower back pain, but those with obesity, a condition also associated with chronic low-
grade inflammation, had greater odds (Briggs, Givens, Schmitt, & Taylor, 2013; 
Margioris, 2009; Spyridaki, Avgoustinaki, & Margioris, 2016; Spyridaki et al., 2014). 
Interestingly, none of the symptoms of sickness behaviour, such as fatigue, were 
associated with CRP, suggesting that other inflammatory markers may play a greater role 
in these symptoms. Likewise, none of the symptoms associated with PTSD such as 
‘distressing dreams’, ‘irritability/outbursts of anger’, or ‘feeling distant or cut off from 
others’ shared an association with CRP. This was surprising given that a number of 
studies have found an association between CRP and PTSD in both military and civilian 
samples (Eraly et al., 2014; Lindqvist et al., 2017b; Lindqvist et al., 2014). The lack of 
association with such symptoms suggests the need for an examination of a broader range 
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of biomarkers, such as IL-6 and TNF-α that have been associated with these symptoms 
(Dantzer et al., 2008). 
There are several limitations to consider in this study. First, we did not control for 
multiple comparisons, despite testing for 67 individual symptoms. Therefore, it is 
possible that these results are due to type 1 error and should be interpreted cautiously 
until future research can confirm the association between CRP and physical symptoms.  
Nevertheless, exploratory research offers the valuable role of identifying patterns that can 
be explored more fully in future research. While the data were taken from a cross-
sectional design (limiting causal inferences), our TDEs variable referred to the MEAO 
deployment, which we hypothesised temporally preceded CRP and physical symptoms. 
Further exploration of this model in a prospective study would be valuable. 
The trauma questionnaire and health symptom checklist were self-report measures and 
therefore only represent an estimate of true prevalence and may be subject to recall bias. 
For example, those who are sick may ruminate more on TDEs which creates recall bias 
(McNally, 1997; Vasterling & Hall, 2018).  An advantage of our relatively young and 
currently-serving military sample is that it provides the opportunity to study these 
relationships outside the context of confounding inflammatory-related comorbidity 
associated with aging in older or unwell cohorts. 
In conclusion, deployment has been associated with increased risk for physical and 
psychological disorders that are associated with inflammation (e.g. cardio-vascular 
disease, metabolic syndrome, PTSD and depression). This study furthered these findings 
by identifying an association between individual physical symptoms and inflammation. 
Further research to explore a wider range of inflammatory biomarkers, as well as whether 
physical symptoms could be indicative of individuals at risk of chronic low-grade 
inflammatory states that may have pathophysiological links with poor long-term health 
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This discussion begins with a brief overview of the thesis, and then discusses the key 
findings in a series of five themes. The first theme reflects upon the prevalence of the 
symptom profiles and why physical symptoms are a clinically important presentation; the 
second theme reflects upon the relationship between physical symptoms and trauma; the 
third discusses comorbidity; the fourth discusses the predictive characteristics of trauma; 
and the fifth addresses risk factors. This is followed with a discussion of the clinical 
implications. Finally, the strengths and limitations of the project are considered, as well as 
recommendations for future research.  
9.1 Overview 
This thesis examined the relationship between physical and psychological symptoms as 
independent and comorbid presentations and explored the correlation between TDEs and 
physical symptoms, as well as the role of physical symptoms in the identification of 
PTSD. 
Data used in this thesis were sourced from the Military Health Outcomes Program 
(MilHOP) for Australian Defence Force (ADF) members, specifically those who 
deployed to the Middle East Area of Operations (MEAO) and supporting areas from 2001 
to 2009. Five separate studies were conducted, with the key results summarised below. 
Study 1 (Chapter 4) examined the prevalence of three post-deployment symptom 
profiles: physical symptoms only, psychological symptoms only, and comorbid (physical 
and psychological) symptoms, and found that the prevalence of each profile was similar. 
The comorbid profile had the highest number of symptoms and the strongest association 
with TDEs. Importantly, the physical only profile showed a stronger association with 
TDEs than did the psychological only profile (with this comparison being statistically 
significant but of small effect size), suggesting that physical and psychological symptoms 
are similarly associated with TDEs. The three TDE sub-scales had a similar pattern of 
association with all symptom profiles, with ‘objective’ having the weakest impact and 
‘human death and degradation’ the strongest. 
Study 2 (Chapter 5) involved analyses similar to Study 1, but with a different 
psychological focus, using the created profiles of physical symptoms only, PTSD 
symptoms only, and comorbid symptoms. Results resembled those in Study 1, where the 
   
Page | 184 
prevalence of these three profiles was similar. Moreover, more than half of those with 
probable PTSD experienced comorbidity with physical symptoms (i.e. the PTSD only and 
comorbid groups were similar in size), demonstrating a high prevalence of physical 
symptoms and PTSD co-occurrence. Additionally, associations between TDEs and 
symptom profiles were similar to those in Study 1, where TDEs were a significant 
predictor of belonging to any symptom profile, suggesting that trauma in veterans has a 
similar relationship with all three symptom profiles.  
In Study 3 (Chapter 6), clusters of self-reported physical symptoms were identified using 
the data-driven machine learning approach of self-organised maps, and their association 
with probable PTSD was examined. Two clusters of symptoms were delineated: (1) a 
small cluster (3%) of individuals with high symptom frequency (median 8) and severity; 
and (2) a large cluster with low symptom frequency (median 44) and severity. Most 
(95%) of those in cluster 1 had a PCL score above the screening cut-off of 29, and more 
than two thirds (69%) had a PCL score above the epidemiological cut-off of 53, 
indicating that those with high numbers of severe physical symptoms had a high 
co-occurrence with PTSD.  
Of the 4% of the sample who had probable PTSD (a PCL score above the cut-off of 50), 
about half fell into each cluster, suggesting that there may be sub-types of PTSD 
differentiated by physical symptoms. When examining the association between TDEs and 
cluster membership for only those veterans with probable PTSD, subjective and 
environmental TDEs showed small significant associations with Cluster 1 membership 
compared to Cluster 2, but this was not the case for objective or human degradation 
TDEs, suggesting that appraisal and a malevolent environment are associated with 
Cluster 1. 
Study 4 (Chapter 7) explored whether physical symptoms could be used to predict 
PTSD. The 10 physical symptoms that showed the best utility when combined were: loss 
of or decrease in appetite; unintended weight gain greater than 4kg; general muscle aches 
and pains; flatulence and burping; faster breathing than normal; feeling short of breath at 
rest; rapid heartbeat; feeling that your bowel movement is not finished; pain in the face, 
jaw, in front of the ear, or in the ear; and feeling unrefreshed after sleep.  
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Receiver operating characteristic curve analyses demonstrated that a 10-item physical 
symptom scale showed good diagnostic utility for detecting 30-day PTSD (assessed 
through a gold-standard diagnostic interview). This scale captured an additional two 
thirds of those missed by the PCL screen. The PCL demonstrated good diagnostic validity 
for 30-day PTSD, capturing 333 of the 367 members with PTSD resulting in only 34 false 
positives. However, when the physical symptom scale was used alongside PCL, 
prediction of PTSD was improved, resulting in only eight false positives, but there was an 
increase in false negatives. These results suggest that a screen considering both physical 
and psychological symptoms may improve PTSD screening outcomes.  
In Study 5 (Chapter 8), the involvement of inflammation was explored. Civilian and 
military research has found an association between trauma and elevated peripheral 
pro-inflammatory biomarkers. Similarly, both trauma and inflammation have been linked 
to physical symptoms. Yet it appears that these three factors have not been analysed 
together. This chapter explored whether the pro-inflammatory biomarker C-reactive 
protein (CRP) mediated the relationship between TDE and physical symptoms. 
Relationships between some of the physical symptoms and CRP were identified but these 
relationships did not include physical symptom count. The hypothesised mediation was 
not supported.   
9.2 Theme 1: Profiles of physical symptoms and psychological symptoms 
in a deployed sample 
Results across three of the studies address the existence of the three symptom profiles: 
physical only, psychological/PTSD only, and comorbid, and why it was important to 
identify the physical symptom profile.   
9.2.1 Prevalence of physical and psychological symptoms in a deployed sample   
This thesis identified that the three symptom profiles share a similar prevalence. In Study 
1, where broad psychological distress was measured with the Kessler 10 (K10), 5.0% of 
the sample met the criteria for the physical symptom profile, 9.3% for the psychological 
profile, and 7.5% for the comorbid profile. In Study 2, using a more specific scale 
assessing PTSD, 7.1% met the physical symptom profile, 6.3% the PTSD profile, and 
7.7% the comorbid profile.  
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All the cut-offs used were based on previous physical symptom research or cut-offs used 
in existing psychological screening programs. The mean physical symptom count in the 
‘no symptoms’ groups in Study 1 and Study 2 (4.26 and 4.76, respectively) resembled 
median scores on similar physical symptom counts in the general community (Spitzer et 
al., 1994). However, given the known under-reporting of symptoms in the military, more 
lenient cut-offs may be more appropriate for use in future research, (Hoge et al., 2004).   
Sub-syndromal cut-offs were used for the K10 and PCL as there is evidence in the 
literature that sub-syndromal symptoms are associated with significant distress and 
impairment (Marshall et al., 2001; Stein et al., 1997) and may represent a risk factor for 
delayed onset PTSD (Andrews et al., 2007; Dickstein et al., 2015; Smid et al., 2009; Stein 
et al., 1997). The more stringent physical symptom cut-off was chosen as there is no 
clearly identified recommended cut-off, therefore a high level was chosen to ensure 
validity of concept. The physical symptom profile being marginally smaller than the other 
profiles in Study 1 suggests that the chosen cut-off of 16 physical symptoms was not too 
lenient. Additionally, a meta-analysis of somatic symptoms in primary-care community 
samples found a prevalence range of somatic disorder from 26.2% to 34.8% (Haller et al., 
2015), suggesting the 5% of the physical profile in Study 1 is conservative.  
Results showed that both physical and psychological wellbeing was impacted in the three 
symptom profiles. Study 1 found that all three symptomatic profiles had statistically 
significant lower scores on the mental component summary (MCS) and the physical 
component summary (PCS) of the SF-12 scale than the resilient profile, representing 
poorer self-perceived mental and physical well-being. There were some differences 
between the profiles. The effect size for the physical profile was larger on the PCS but 
smaller on the MCS. The reverse was found for the psychological profile which had a 
smaller effect size for the PCS and a larger one for the MCS. However, the comorbid 
groups were well below the Australian averages on both scales. These results support the 
premise that members suffering with physical symptoms are as worthy of clinical 
attention as those with psychological symptoms. However, treatments for patients with 
physical symptoms are often ineffective, many doctors find these patients challenging and 
doctor-patient relationships are often difficult (Engel et al., 2002; Hartz et al., 2000; 
Stanley, Peters, & Salmon, 2002; Stone, 2014; Wileman, May, & Chew-Graham, 2002; 
Zantinge, Verhaak, Kerssens, & Bensing, 2005). These results confirm that quality of life 
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for military members is impacted by physical symptoms, thus highlighting the need for a 
better understanding of this group’s suffering, which may lead to improved doctor-patient 
relationships and therefore treatment outcomes. 
9.2.2 The importance of identifying a physical symptom only profile 
The findings from the first two studies suggest that while physical and psychological 
symptoms may co-occur, there is a sub-group of ADF MEAO veterans who exhibit 
physical symptoms without psychological distress or PTSD symptoms. Although small, 
the prevalence of this group was similar to that of the psychological only group, which 
receives significant clinical attention. Thus, the prevalence of this physical only 
presentation is worthy of consideration. This profile presents a particular challenge to 
practitioners in diagnosis, as demonstrated by the low clinical use of somatoform 
diagnostic categories (Haller et al., 2015; Rief & Martin, 2014), and the clinical 
management of this presentation is not well developed (McFarlane et al., 2008; olde 
Hartman et al., 2017). Exploring ways to improve clinical management first requires the 
development of a definition for this group that is easily operationalised and widely 
accepted. 
The significance of identifying the physical symptoms profile relates to the limited 
information about the long-term outcomes for this group. The physical only profile may 
be indicative of a significant burden of distress and impairment, although more 
longitudinal research is needed to confirm this. Thus, identifying the prevalence of this 
profile is an important step in characterising a group that needs further investigation in 
terms of the mechanisms of symptom formation and symptom progression. 
9.3 Theme 2: The association between traumatic deployment exposures 
and physical and psychological symptoms  
This section discusses the association of TDEs with symptom profiles and in particular, 
the findings that contest the primacy of psychological mechanisms in the association 
between trauma and symptoms. It is then suggested that physiological reactivity may be a 
pathological mechanism worthy of consideration and that the impact of trauma may be 
better conceived as having a multidimensional (physical and psychological) impact on 
health. 
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9.3.1 Psychological symptoms do not have primacy of association with traumatic 
exposures in a deployed sample 
The findings of this thesis suggest that psychological symptoms do not have a primacy of 
association with TDEs compared with physical symptoms. In fact, one of the key findings 
of this thesis was that there was a stronger association between physical symptoms and 
TDEs than between psychological symptoms and TDEs (Study 1). While this difference 
in association was small, it was statistically significant. In addition, if a parity of 
association is assumed, that is, the likelihood of physical symptoms resulting from TDEs 
is the same as psychological symptoms resulting from TDEs, then military screening in 
those who have deployed, which currently has a psychological focus, should consider 
assessing physical symptoms. Similarly, these findings suggest that military medical 
officers and other mental health clinicians need to be aware that physical symptoms can 
be the result of TDEs and may not have a psychological cause as is often assumed.  
9.3.1.1 Physiological reactivity: A possible shared causal mechanism for both physical and 
psychological symptoms  
Although the data used were cross-sectional and therefore limit causal association, the 
findings of this thesis suggest that trauma could be a shared aetiological mechanism for 
both physical and psychological symptoms. For example, Studies 1 and 2 found that 
TDEs shared a similar relationship with psychological distress, PTSD, and physical 
symptoms. Study 4 found that the high somatic symptom cluster (with high symptom 
count and severity) had higher levels of TDEs than the low somatic symptom cluster, and 
in Study 1 the predictive probabilities demonstrated a dose-response relationship between 
TDEs and all symptom profiles. 
One possible shared mechanism could be physiological reactivity. A study by (Tucker et 
al., 2007) examined physiological reactivity in individuals involved in a terrorist 
bombing, and found that around seven years after the exposure, physiological reactivity 
(measured by heart rate and systolic, diastolic, and mean arterial blood pressures before, 
during and after bombing-related interviews) was higher, even in those considered 
psychologically resilient, than in a comparison group. The researchers concluded that 
physiological reactivity may capture the long-term effects of trauma not identified by 
psychometric measures (Tucker et al., 2007). Similar heightened physiological reactivity 
to traumatic stimuli has long been recognised in military members with PTSD (Bremner 
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et al., 1999; Norrholm et al., 2016). The findings of Tucker et al. (2007) support the 
theory suggested in this thesis that one of the aetiological mechanisms involved in the 
impact of trauma on physical and psychological symptoms could be physiological 
reactivity. 
Our understanding of the long-term impact of such physiological reactivity on individuals 
after exposure to trauma is poor. Longitudinal studies such as those by (Lee et al., 1996) 
and (Elder et al.) with World War II veterans and (Schlenger et al., 2015) with Vietnam 
War veterans show that combat exposure is a risk factor for early mortality, regardless of 
mental health status. These studies highlight the consequence of combat exposure on 
members’ physical health, and further support the theory that trauma can disrupt normal 
physiological functioning. These studies also suggest that veterans with a physical 
symptom profile may experience considerable distress and impairment, thereby 
highlighting the need for more longitudinal research exploring the possible physiological 
mechanisms involved in negative health outcomes for those who experience TDEs. 
Considering such findings, rather than physiological reactivity being a symptomatic 
sequela of PTSD as defined in the DSM-V diagnostic criteria for PTSD ‘B5’ of 
unspecified ‘marked physiological reaction’ (American Psychiatric Association, 2013), it 
may be a driver of both physical and psychological symptomatology. Similarly, there may 
be a bidirectional association between symptoms and physiological reactivity. 
9.3.1.2 The impact of TDEs may be multidimensional  
The finding of this thesis that the outcomes of TDEs can be either psychological, 
physical, or a combination of both allows reconceptualisation of the response to trauma as 
multidimensional and demonstrates the need to not only focus on the psychological 
outcomes of trauma but the physical as well.  Ignoring the physical impact that trauma 
can have may lead to the assumption that the causal mechanisms for all symptoms 
experienced post-deployment are psychological, which has been a common theory in the 
past. However, such theories are difficult to support given there is increasing evidence 
that both physical and psychological health are impacted by bidirectional (‘top-down’ and 
‘bottom-up’) interactions between the brain and peripheral tissues (Taylor, 2010).  
When considering the accumulation of research identifying the complex interplay of 
endocrine, immune, neurochemical, and neurological processes that link physical, 
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behavioural, and cognitive functioning, as well as the negative impact that dysregulation 
of the stress response can have on health, the Descartian mind-body dualism that is still 
commonly used today may be an artificial divide (Alesci et al., 2005; Charmandari, 
Tsigos, & Chrousos, 2005; Chrousos, 2000; Di Benedetto, Mueller, Wenger, Duezel, & 
Pawelec, 2017; Elenkov et al., 2008; Gold et al., 2005; Heim & Nemeroff, 2000; 
McEwen, 1998; McFarlane, 2017; Stapelberg, Neumann, Shum, & Headrick, 2018; 
Vgontzas et al., 2001; Vgontzas et al., 2002; Wong et al., 2000).   
9.4 Theme 3: Associations between physical and psychological 
symptoms in a deployed sample  
This section summarises the findings around comorbidity and considers whether physical 
symptoms could be part of the heterogeneity of PTSD presentation or an expression of a 
sub-type of PTSD. The importance of physical symptoms when considering illness 
severity and the measurement of treatment outcomes is highlighted. Physical symptom 
specificity for PTSD is also discussed, along with a consideration of the broader research 
which suggests that most of these physical symptoms could be associated with autonomic 
nervous system dysregulation.  
9.4.1 What drives what? 
The finding that physical and psychological symptoms are equally related to TDEs 
challenges the assumption that physical symptoms are caused by psychological processes. 
It may be entirely plausible to suggest that physical processes drive the development of 
physical symptoms, or even psychological symptoms, and there may be a bidirectional 
association. The idea that physical processes drive behaviour, emotion, and even 
cognition has long been hypothesised. For example, psychologist William James (1842 – 
1910) and physician and physiologist Carl Lange (1834 – 1900) independently proposed 
similar theories that external stimulus leads to physiological reactions, the interpretation 
of which shape our emotional reaction. This theory came to be known as the James-Lange 
theory of emotion (Lang, 1994).  
More recently, theories such as the somatic marker hypothesis (SMH) of consciousness 
proposed by Damasio (1996) and (Craig, 2004) provide further support for the possibility 
of physically driven psychological symptoms.  The SMH theory postulates that an array 
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of somatic marker signals from the body impact upon emotion and are crucially involved 
in decision-making, attention, and working memory processes.  Such theories continue to 
gain theoretical and evidence-based support and provide plausible explanations for the 
possibility that it is the physical response that may drive the psychological response 
(Domschke, Stevens, Pfleiderer, & Gerlach, 2010; Dunn, Dalgleish, & Lawrence, 2006; 
Singer et al., 2004).  These theories also raise doubt regarding the assumption that 
somatisation is the primary aetiological mechanism in physical symptoms. 
9.4.2 Are physical symptoms a comorbidity or a dimension of PTSD? 
The findings of this thesis support previous research that physical symptoms often co-
occur with PTSD (Andreski et al., 1998; Hoge et al., 2007). Physical symptoms were 
found to co-occur with PTSD in Studies 2, 3, and 4. In Study 2, over half of those with 
PTSD symptoms had high physical symptom counts and this was supported by Study 3 
which found that half of those with probable PTSD were in the cluster with high somatic 
symptom count and severity. In Study 4, the number physical symptoms reported showed 
good diagnostic utility for predicting 30-day PTSD, supporting the strength of the 
association.  
Due to the use of correlational data and analyses in this thesis, the underlying nature of 
this comorbidity cannot be determined here. It is possible that one causes the other, or 
that they are both independent outcomes of a third variable (e.g. trauma, inflammation, or 
physiological dysregulation). Another possibility is that physical symptoms could be part 
of the heterogeneity of symptom presentation in PTSD (Galatzer-Levy & Bryant, 2013).  
One possible reason for the broad heterogeneity seen in PTSD presentations could be the 
existence of subtypes of the illness, as has been found with depression (Baune et al., 
2012; Willeit et al., 2003). The finding of Study 4 of this thesis indicating that those with 
PTSD could be differentiated into two physical symptom clusters, those with high 
physical symptom count and severity and those without, suggests that one subtype of 
PTSD may be a physical symptom subtype.  These different subtypes of PTSD symptom 
presentation may be explained by different underlying pathological processes (McFarlane 
et al., 2017; Pace & Heim, 2011). This suggestion is worthy of further investigation as it 
may point to alternative modes of treatment and help to explain the heterogeneity of 
presentation and treatment response. 
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Treating physical symptoms as a dimension of PTSD rather than as secondary somatic 
complaints should be considered as it may be indicative of the severity of illness. 
Comorbidity among many physical and psychological conditions is a clinically important 
marker of illness severity and presents a significant challenge in treatment management, 
and generally leads to poorer outcomes (Hruska, Irish, Pacella, Sledjeski, & Delahanty, 
2014; Librero, Peiro, & Ordinana, 1999; Poses, McClish, Smith, Bekes, & Scott, 1996; 
Rochon et al., 1996). Similarly, the number of symptoms recruited in PTSD as measured 
by the PCL-5 (using DSM-5 criteria) is seen as a measure of disorder severity (Blevins, 
Weathers, Davis, Witte, & Domino, 2015). If physical symptoms are dismissed as 
secondary or insignificant to PTSD the true severity of a patient’s disorder may be 
overlooked.  
9.4.3 Measuring physical symptoms can improve PTSD screening outcomes 
The association found between PTSD and physical symptoms in Study 2 was marked 
enough to consider questioning whether physical symptoms could be used to predict 
PTSD. If we consider PTSD is underdiagnosed and the diagnostic criteria are still 
evolving, exploring whether including physical symptoms improves diagnostic rates is 
worthy of consideration (Chaumba & Bride, 2010; Grasso et al., 2009; Miele & O'Brien, 
2010; van Zyl, Oosthuizen, & Seedat, 2008).  
Study 4 identified two physical symptom screens (9-item and 10-item versions) that 
demonstrated good utility for identifying those at risk of PTSD. The performance of these 
screens was compared to the posttraumatic stress checklist (PCL) currently used in ADF 
screening. The results of the comparison showed that the physical symptom screens 
demonstrated good utility but did not perform as well as the PCL. Importantly, both 
physical screens captured two-thirds of PTSD-positive individuals who had not been 
captured by the PCL. These results suggest that the PTSD-positive military personnel 
who do not screen positive with the PCL may present predominantly with physical 
symptoms. Another interesting finding of this study was that if the physical symptoms 
were added to the PCL, more PTSD-positive members were identified. This result 
suggests that integrating physical and psychological symptoms into screening is a more 
inclusive approach with the capacity to improve screening utility. 
   DISCUSSION 
 
                                                                                                                                                                                         Page | 193 
9.4.4 Physical symptom specificity for PTSD 
Physical symptoms are recognised as central in a patient’s experience of anxiety disorders 
(Blechert, Michael, Grossman, Lajtman, & Wilhelm, 2007). For example, respiratory 
system dysregulation is recognised as a core feature of panic disorder and is included in 
diagnostic criteria (Abelson, Weg, Nesse, & Curtis, 2001; Papp et al., 1997; Wilhelm, 
Trabert, & Roth, 2001).  Although PTSD is strongly associated with physical symptoms, 
the focus of PTSD diagnostic criteria remains on the psychological symptoms because of 
their assumed specificity (McFarlane et al., 2017). This narrow conceptualisation of 
PTSD has prevented a broader examination of symptomatology (McFarlane et al., 2017).   
Other research has identified the same physical symptoms found in the Study 4 screen for 
PTSD to be concurrently associated with or even predictive of PTSD. Elevated heart rate 
has been viewed as a correlate of PTSD for many years as shown in a study that 
compared Vietnam veterans with age-matched controls (Blanchard, Kolb, Pallmeyer, & 
Gerardi, 1982). Elevated heart rate has also been found to correctly classify current PTSD 
and non-PTSD subjects in a sample of Vietnam veterans  (Keane et al. 1998). Studies in 
civilian samples have identified exaggerated cardiovascular reactivity as a potential 
mechanism for the strong relationship between PTSD and cardio-vascular disease 
(Buckley & Kaloupek, 2001; Hopper, Spinazzola, Simpson, & van der Kolk, 2006; 
Hughes, Dennis, & Beckham, 2007), and PTSD has also been linked to respiratory 
dysfunction (Dobie et al., 2004; Goodwin, Fischer, & Goldberg, 2007; McLeay et al., 
2017; O'Toole & Catts, 2008; Sareen et al., 2007; Seng, Clark, McCarthy, & Ronis, 2006; 
Spiro III, Hankin, Mansell, & Kazis, 2006). Research conducted Bryant et al. (2008) 
found that the combination of elevated heart rate and increased respiratory rate predicted 
the onset of PTSD in a sample of traumatically injured individuals, with baseline 
measures taken when admitted to hospital and follow-up measures taken at three months.  
The studies listed in paragraph above involve heart rate and respiratory function, both of 
which are largely controlled by the sympathetic and parasympathetic systems of the 
autonomic nervous system, the part of the nervous system that supplies the internal 
organs and is responsible for control of involuntary bodily functions. The autonomic 
nervous system responds to incoming bodily and environmental stimuli by either 
stimulating body processes, usually through the sympathetic division, or inhibiting them, 
usually through the parasympathetic division (Buijs & Swaab, 2013). The physical 
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symptoms we identified of ‘faster breathing than normal’, ‘feeling short of breath at rest’, 
and ‘rapid heartbeat’ may also reflect autonomic nervous system dysregulation. Studies of 
PTSD in community samples have also concluded that PTSD is linked with autonomic 
nervous system dysregulation (Blechert, Grossman, & Wihelm, 2007; Cohen, Geva, 
Matar, Kaplan, & Kotler 2000; Streeter, Gerbarg, Saper, Ciraulo, & Brown, 2012; 
Williamson, Porges, Lamb, & Porges, 2015). 
Other symptoms identified in Study 4’s physical symptom screens could be associated 
with the metabolic impact of autonomic arousal, with metabolic dysregulation now 
understood to be an important pathological mechanism in PTSD (McFarlane et al., 2017; 
Mellon, Gautam, Hammamieh, Jett, & Wolkowitz, 2018).  The metabolic symptoms of 
‘unintended weight gain greater than 4kg’, ‘loss of appetite’, and ‘feeling unrefreshed 
after sleep’ in the screens have been linked to PTSD and autonomic dysfunction in 
several studies. For example, a prospective longitudinal military study found that PTSD 
was associated with weight gain and the development of obesity (Vieweg et al., 2006), a 
finding supported by other military research (LeardMann et al., 2015; Maguen et al., 
2013). The researchers theorised that dysregulation of neuroendocrine and autonomic 
nervous systems may directly affect sleep, metabolism, and appetite (Vieweg et al., 
2006). Furthermore, gastrointestinal symptoms such as the ‘flatulence and burping’, and 
‘feeling that your bowel movement is not finished’ may also be linked to autonomic 
nervous system activity, an area of particular interest in irritable bowel syndrome research 
(Aggarwal et al., 1994; Carabotti, Scirocco, Maselli, & Severi, 2015; Heitkemper et al., 
2001; Jarrett et al., 2016; Kolacz & Porges, 2018).  
The symptom of ‘pain in the face, neck or jaw’ is most likely due to bruxism (i.e., 
excessive teeth grinding or jaw clenching), which has a long history of association with 
PTSD and other anxiety disorders (Dharmadhikari et al., 2015). Recent neuroimaging 
studies of bruxism have identified the involvement of the hypothalamic–pituitary–adrenal 
(HPA) axis system, which is also implicated in PTSD. The exact neurochemical 
mechanisms of sleep bruxism is an area of ongoing research interest (Huynh et al., 2006; 
Kato & Lavigne, 2010; Lavigne, Khoury, Abe, Yamaguchi, & Raphael, 2008; Ranjan, P, 
& Prabhu, 2006).  
In summary, the physical symptoms identified in Study 4 have previously been shown to 
be associated with PTSD symptoms, including being able to differentiate PTSD from 
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non-PTSD subjects. These symptoms could be suggestive of pathophysiological 
mechanisms such as autonomic nervous system (ANS) or HPA axis dysregulation. While 
assessing these physical symptoms may aid in the diagnosis of PTSD, they are not 
included in current screens.  
9.4.5 The role of the autonomic nervous system  
Hyperarousal has been found to predict PTSD onset and symptom severity (Breslau & 
Kessler, 2001; Bryant, 2005; Elsesser, Sartory, & Tackenberg, 2005; Schell, Marshall, & 
Jaycox, 2004).  Hyperarousal has a strong physiological component and was seen as a 
core component of PTSD by one of the instigators of the diagnosis (Kolb, 1987). It may 
also be suggestive of underlying mechanisms such as persistent autonomic dysregulation.  
This suggestion is supported by research such as that conducted by Tucker et al. (2007) 
which examined civilians who had been exposed to a bomb blast. Their findings showed 
that participants with PTSD had greater autonomic reactivity (heart rate and systolic, 
diastolic, and mean arterial blood pressures) than the gender-matched trauma-exposed 
controls (Tucker et al., 2007).  
In addition, there is some evidence that autonomic nervous system sympathetic and 
parasympathetic dysfunction in PTSD may be evident through some reactivity paradigms, 
specifically, elevated sympathetic response and attenuated parasympathetic response 
(Blechert et al., 2007; Hauschildt, Peters, Moritz, & Jelinek, 2011; Keary, Hughes, & 
Palmieri, 2009; van Boxtel et al., 2018). For example, PTSD is consistently associated 
with higher elevated mean heart rates but reduced heart rate variability (Blechert et al., 
2007; Delahanty & Nugent, 2006; Hauschildt et al., 2011; Keary et al., 2009). However, 
as cardiovascular changes involve both the sympathetic and parasympathetic nervous 
systems and findings vary, further research is needed on the role of the autonomic 
nervous system in the pathogenesis of PTSD (Berntson, Cacioppo, & Quigley, 1991; van 
Boxtel et al., 2018).  
9.4.6 PTSD and inflammation  
One consequence of chronic autonomic activation has been shown to be dysregulation of 
the hypothalamic–pituitary–adrenal (HPA) axis and the sympathetic–adrenal–medullary 
(SAM) stress axis which may begin a cascade of endocrine and immunological responses 
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increasing allostatic load (Haroon, Raison, & Miller, 2012; Kendall-Tackett, 2000; 
McEwen, 1998; Yehuda, 2009). Extensive research over the last few decades has begun 
to characterise the role of neurobiological dysfunction in the pathophysiology and 
maintenance of PTSD (O'Donovan et al., 2017; O'Donovan et al., 2015; O'Donovan, 
Slavich, Epel, & Neylan, 2013; Yehuda et al., 2015; Yehuda & LeDoux, 2007; Yehuda et 
al., 2014). Burgeoning literature is available on neuroendocrine and immune functioning 
in PTSD, providing insights into additional mechanisms (e.g. pro-inflammatory cytokines 
and other immune biomarkers) that assist in understanding the link between PTSD and 
poor health outcomes (Baker, Nievergelt, & O'Connor, 2012b; Gill, Saligan, Lee, Rotolo, 
& Szanton, 2013; Gola et al., 2013). Many of the chronic somatic disorders associated 
with PTSD have inflammatory mechanisms, most notably cardiovascular disease and 
metabolic disorders (Gander & Känel, 2006; Geracioti Jr et al., 2001; Southwick et al., 
1999; von Känel et al., 2007).  
There are some difficulties with research on biological markers that often result in mixed 
findings (Miller, Sutherland, Hutchison, & Alexander, 2001; Sutherland, Alexander, & 
Hutchison, 2003). Many have found elevated inflammatory markers associated with 
PTSD, such as interleukin-6 (Gill, Vythilingam, & Page, 2008; Maes et al., 1999; 
Sutherland et al., 2003), tumour necrosis factor-α (De Kloet et al., 2007; von Känel et al., 
2007), and C-reactive protein (CRP; Lindqvist et al., 2014; Miller et al., 2001; Solomon 
et al., 2017; Wingenfeld et al., 2011) in PTSD, while others have not (McCanlies et al., 
2011; von Känel et al., 2007). However, it must be noted that many of these studies are 
cross-sectional and therefore the direction of causality could not be argued, demonstrating 
the need for longitudinal research.   
The lack of agreement between studies measuring biomarkers may be explained by 
unique participant characteristics. For example, Sondergaard, Hansson, and Theorell 
(2004) suggested that higher circulating CRP concentrations in their control group 
compared with PTSD patients may have been due to their controls being more likely than 
PTSD patients to have infections. The inconsistencies in inflammatory and neurochemical 
marker research findings demonstrate the difficulties of exploring such relationships in 
humans. Individual differences and experiences at all levels affect these processes, 
making a controlled environment impossible to achieve. However, these findings show 
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promise in helping to discover novel treatment targets for both the psychiatric and 
somatic aspects of PTSD (McFarlane et al., 2017).   
The review of evidence provided in the above two sections covers only a sample of the 
available literature; however, it amply demonstrates that there appears to be considerable 
autonomic, metabolic, and immune involvement in the pathophysiology of PTSD. 
Although advancements in our understanding continue, the research to date strongly 
supports the idea that the mechanism of somatisation is an over-simplification.  
9.5 Theme 4: Comorbidity between PTSD and disease 
This section discusses the association of PTSD with disease, inflammation, and advanced 
aging. The subtle impact of questioning the primacy of psychological processes on one 
current model of the association between PTSD and illness is discussed, as well as 
whether PTSD may be better conceptualised as a systemic illness. 
9.5.1 PTSD and disease 
PTSD has high rates of comorbidity with physical disease; for example, veterans with 
PTSD are significantly more likely to suffer from physical illness and chronic disease 
than the general population or veterans without PTSD (Boscarino, 1997; Boscarino, 2008; 
Britvić et al., 2015; McLeay et al., 2017; O'Toole & Catts, 2008; Pacella, Hruska, & 
Delahanty, 2013; Schnurr, 2015).  A retrospective examination of Vietnam War veterans 
found that those with PTSD had 50% to 150% higher rates of many chronic diseases 
compared to those without PTSD (Boscarino, 1997).  The broad range of chronic medical 
conditions with which PTSD has been linked in both military  and civilian samples 
includes: cardiovascular disease (Bedi & Arora, 2007; Boscarino, 2008; Edmondson, 
Kronish, Shaffer, Falzon, & Burg, 2013; Edmondson et al., 2012; Hovens et al., 1998; 
Jordan, Miller-Archie, Cone, Morabia, & Stellman, 2011; Kibler, 2009; Ouimette et al., 
2004); gastrointestinal disease (McLeay et al., 2017; O'Toole & Catts, 2008; Schnurr et 
al., 2000); respiratory disease (Spitzer et al., 2010b); musculoskeletal, renal and 
autoimmune diseases (Boscarino, 2004; Schnurr et al., 2000); metabolic syndrome 
(Ahmadi, Arora, Vaidya, Yehuda, & Ebrahimi, 2013; Babić et al., 2007; Babić, Maslov, 
Babić, & Vasilj, 2013; Bartoli, Carrà, Crocamo, Carretta, & Clerici, 2013; Heppner et al., 
2012; Jakovljević et al., 2006; Violanti et al., 2006; Weiss et al., 2011; Wolf et al., 
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2015); type 2 diabetes (Miller-Archie et al., 2014; Roberts et al., 2015; Vaccarino et al., 
2014), with PTSD symptom severity correlating with type 2 diabetes severity (Miller-
Archie et al., 2014); insulin resistance in non-diabetics (Rao et al., 2014); rheumatoid 
arthritis (Qureshi, Pyne, Magruder, Schulz, & Kunik, 2009), independent of genetic and 
familial factors (Boscarino, Forsberg, & Goldberg, 2010); psoriasis and thyroid disease 
(Boscarino, 2004); and Alzheimer’s disease (Greenberg, Tanev, Marin, & Pitman, 2014; 
Weiner et al., 2013). Increased risk of cancer has also been identified in Vietnam War 
veterans (Boscarino, 2006; Boscarino, 2008). This high association of PTSD with poor 
health outcomes highlights the high pathophysiological burden of PTSD (McFarlane et 
al., 2017). 
There is some evidence that the relationship of PTSD to physical health is independent of 
age, depression, or other comorbid psychological disorders (Zayfert, Dums, Ferguson, & 
Hegel, 2002). For example, a recent study of a convenience sample of Australian Vietnam 
War veterans found that after controlling for factors known to be associated with chronic 
disease and early mortality, such as higher body mass index, smoking, alcohol 
dependence, anxiety, and depression, the relationship between PTSD, gastrointestinal 
disorders and abnormal respiratory function remained statistically significant (McLeay et 
al., 2017).  Furthermore, (Seng et al., 2006) has described a dose-response association 
between physical comorbidity and the severity and chronicity of PTSD.  
Conceptualising the breadth of association of comorbidities with PTSD allows the 
appreciation of the multiple interacting physiological mechanisms and risk factors 
involved in moving from trauma to ill health.  The significance of these findings and the 
immense cost to the individual is further underscored by longitudinal data showing 
excessive premature mortality associated with PTSD among a cohort of Vietnam veterans 
followed up over 25 years (Schlenger et al., 2015). PTSD is already considered to have a 
heterogeneous presentation, without considering physical symptoms (Galatzer-Levy & 
Bryant, 2013). If the broad range of comorbidities associated with PTSD is also 
considered, presentation becomes even more diverse. 
However, the difficulty in making the link between trauma exposure and adverse health 
outcomes in veterans is that the type of trauma often shows no direct causal link to the 
health outcomes experienced by veterans, and the health outcomes often do not develop 
until many years after the predisposing traumatic exposures (Schnurr, 2015). For 
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example, a study of the prevalence of PTSD and severity of symptoms found an increase 
in prevalence from 5-6% immediately upon return to 24-27% three to six months later 
(Ginsberg, Berry, & Powell, 2010). One prospective study of UK military personnel 
estimated that approximately half of all PTSD cases identified were delayed-onset 
(Goodwin et al., 2012).  
In addition to having an association with disease, PTSD is associated with earlier onset of 
disease. For example, health problems for individuals with PTSD have been found to 
occur earlier in life than in the general population (Dobie et al., 2004; Ouimette et al., 
2004; Seng et al., 2006), and PTSD has been associated with more rapid cellular aging as 
measured by telomere erosion, which could not be explained by health behaviours, 
medical conditions, or trauma type (Roberts et al., 2017).  Results of both studies suggest 
that physical comorbidities may reflect the stage of biological progression of the PTSD, 
that is, as PTSD severity advances it may hasten the time of illness onset.  
9.5.2 Model of the association between trauma and illness 
Schnurr and Green (2004) developed a model of the association between trauma and poor 
health outcomes. The model suggests that the severe persistent distress that can result 
from traumatic exposures recruits maladaptive psychological, behavioural, biological, and 
attentional processes that result in poor health. Their theory, summarised in the model 
depicted in Figure 9.1, shows the flow from trauma to psychological alterations, with 
PTSD as the primary step toward other physical health outcomes. This model 
demonstrates the complexity of factors to be considered in this association.  
Our understanding of the biological impact of trauma is advancing quickly; for example, 
one factor not addressed in the model shown in Figure 9.1 is the impact of genetics and 
epigenetics (Schnurr, 2015). Memory and cognitive changes are also now considered 
central factors in PTSD maintenance but are absent from the model (Dekel, Solomon, & 
Ein-Dor, 2016; Swick, Cayton, Ashley, & Turken, 2017). 
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Figure 9.1 Schnurr and Green (2004, p248) model relating traumatic exposure and PTSD to 
physical health outcomes (in the public domain)  
 
The outcomes of the research conducted for this thesis suggest that biological processes 
(such as allostatic load) may be a primary mechanism involved in the association between 
trauma and poor health outcomes, independent of psychological mechanisms or PTSD. 
As discussed earlier, if the work of (Damasio, 1996) is considered, i.e. that emotions are a 
reaction to the physiological changes induced by the environment, such a proposition 
becomes viable. Therefore, the alterations to be made to the Schnurr and Green (2004) 
model in Figure 9.1 arising from this thesis include the mechanistic link for PTSD 
occurring via biological alterations, rather than these being secondary to PTSD. Hence, 
the model becomes as depicted in Figure 9.2. 
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Figure 9.2 A biological alteration model of the impact of trauma suggesting that exposure to 
trauma activates biological alterations. Cognitive, somatic and affective memories embodied at 
the time of exposure may be involved in driving the maintenance of the biological alterations 
 
It is hypothesised that the biological alterations begin prior to the onset of physical and 
psychological symptoms and that the biological alterations are driving those symptoms. 
This is a major point of difference with the Schnurr and Green (2004) model depicted in 
Figure 9.1 where PTSD or other psychological processes are considered to be the major 
drivers of poor health outcomes arising from exposure to trauma. This new model (Figure 
9.2) hypothesises that PTSD can be a constellation of all the physical and psychological 
symptoms, often resulting in impaired function and health risk behaviours, and that all of 
these components can individually or collectively contribute to and increase risk of 
morbidity and mortality. 
The model in Figure 9.1 suggests that the main pathway from trauma to poor health is via 
PTSD (Schnurr, 2015). However, the research conducted for this thesis identified a group 
who experience physical symptoms without PTSD.  While the data used were cross-
sectional and therefore cannot be used to determine causation, it is theoretically plausible 
for physical symptoms to share a primary association (i.e. not a secondary outcome from 
psychological mechanisms) with trauma via biological alterations. If this is the case, 
physical symptoms may be indicative of altered neurobiological functioning, and the non-
specific symptoms such as those identified in Study 3 may be early indicators of 
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dysregulation and the propensity for later disease development.  This is an area of 
research that would be valuable to pursue. 
While the behavioural manifestations of PTSD are often the focus of researchers and 
clinicians due to their easy discernment, the strong association with physical symptoms 
found in the research for this thesis and supported by others, and the high illness 
association suggests that PTSD is disruptive to functioning on a level that may make it 
more appropriately described as a systemic disorder (Lohr et al., 2015; McFarlane, 2017; 
McFarlane et al., 2017; Mellon et al., 2018; Pacella et al., 2013). However, it is 
acknowledged that further exploration of the underlying biological mechanisms is 
required to justify this description of PTSD.  
Another theory that supports this direction of thinking is embodied cognitive science. 
This is a relatively new theory that uses ecological psychology and dynamical systems 
theory to speculate that psychological function is better understood at the level of the 
whole brain-body-environment system. This theory posits an inseparability of cognitive 
and emotional processing and describes them as taking place in the whole living body of 
an organism as it engages with the environment in relevant possibilities for action or 
action readiness (Frijda & Sundararajan, 2007)that are a priority to the organism at the 
time (Bruineberg & Rietveld, 2014; Rietveld, 2008).  
This theory suggests that affect in the form of action readiness manifests in the body as 
states of arousal and valence (which manifest as changes in the body’s vascular, visceral 
and motor systems) that are either positively or negatively valued. These states orient the 
organism such that it is ready to deal adequately with the affordances of the environment, 
but it does so in large part because of its experience. These states of action readiness are 
tracked by interoceptive processes in the brain, with the salience network likely playing a 
central role in this process (Menon & Uddin, 2010). This coordinated brain-body-
environment process negates the need for a ‘magical’ boundary separating the brain and 
the body   and provides an explanation about how the state of the body at the time of a 
trauma can influence later symptoms, and provides an understanding of PTSD as a 
systemic illness. 
  
   DISCUSSION 
 
                                                                                                                                                                                         Page | 203 
9.5.3 The advantages of categorising PTSD as a systemic illness 
This accumulating field of research in neurobiological changes has the potential to 
expand our view of PTSD from a purely psychological illness to a systemic illness, with 
significant implications for patients’ broader health status.  Changes in how PTSD is 
categorised as well as our explanatory frameworks could greatly improve outcomes for 
veterans. Specifically, it has the possibility to help de-stigmatise this diagnosis, another 
reason why this is worthy of further investment. 
In today’s military there are signs of the influence of past beliefs dating back to WWI 
about the psychological impacts of war (Southwick, Litz, Charney, & Friedman, 2011). 
Documents such as the US Army 2006 combat and operational stress control (Department 
of the Army, 2006) fail to acknowledge the role of combat environment stress as a cause 
of psychological injury or illness. The management strategy for combat stress reactions 
outlined in this US Army document still considers stress from combat as temporary and 
reversible, with the exception being members who are weakened by pre-existing disorders 
of character or mental functioning (Southwick et al., 2011). While vulnerabilities to 
PTSD can include a number of environmental and genetic predispositions, it is feasible 
that stress alone can induce wear and tear or even illness (Charmandari et al., 2005; 
Chrousos & Gold, 1992; Chrousos & Kino, 2007; Franchimont, Kino, Galon, Meduri, & 
Chrousos, 2002; Karalis et al., 1991).  An advantage of conceptualising PTSD as a 
complex systemic illness is that it may help change the view that mental illness is a 
personal failure or weakness.   
9.6 Theme 5: Characteristics of traumatic exposures can impact 
symptoms 
This section includes a discussion of the dose-response effect between trauma and 
physical symptoms and how some trauma types can have more impact than others on 
symptoms. It is suggested that this may be related to physiological reactivity.  
9.6.1 Dose-response effect of traumatic deployment exposure to symptoms  
All the symptom profiles examined in Studies 1, 2, and 4 of this thesis demonstrated a 
dose-response association with TDEs, where higher numbers of TDEs were associated 
with a greater relative risk ratio of symptom profile membership, as shown by the 
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predictive probabilities graph in Study 1 (Figure 4.1 of the supplementary materials in 
Chapter 4). As such, those with comorbid physical and psychological symptoms who 
demonstrated the highest mean number of symptoms had the strongest association with 
TDEs. There is ample evidence for a dose-response association between trauma and 
PTSD (Jakob, Lamp, Rauch, Smith, & Buchholz, 2017; May & Wisco, 2016); however, a 
thorough literature search revealed that there are no studies discussing the dose-response  
relationship between TDEs and physical symptoms.    
Physical and psychological symptoms each demonstrated a dose response association 
with TDEs which suggests that exposure to trauma has a similar relationship with both 
outcomes and further supports that responses to trauma may be multidimensional.  The 
comorbid group had the highest number of symptoms as well as the highest number of 
traumatic exposures, suggesting that symptomatic responses to trauma may be better 
described as a continuum of cumulative distress with comorbid physical and 
psychological or PTSD at the extreme end, rather than a dichotomous ‘present’ or 
‘absent’ diagnosis (Boscarino, 1996; Green & Kimerling, 2004; McFarlane, 2017; 
Ruscio, Ruscio, & Keane, 2002; Schnurr, Friedman, & Bernardy, 2002; Suri & Vaidya, 
2015). The accumulation of physical and psychological symptoms may be the result of 
increased exposure to trauma leading to increased physiologic dysregulation, a theory 
supported by a number of prospective military studies (Minassian et al., 2015; Steudte-
Schmiedgen et al., 2015; van Zuiden et al., 2015; Vermetten, Baker, & Yehuda, 2015).  
The accumulation of physical and psychological symptoms may be the result of increased 
exposure to trauma leading to increased physiologic dysregulation, a theory supported by 
a number of prospective military studies  
9.6.2 Some types of traumatic exposure have a greater impact on symptoms  
Studies 1, 2, and 4 examined subjective (i.e. perceived threat), objective (i.e. measurable 
events), and human death and degradation traumatic exposures, and Study 4 also 
examined environmental exposures. Different types of trauma were examined as research 
has found that some trauma types have stronger associations with physical and PTSD 
symptoms, and military studies have identified that categories of traumatic military 
experiences differentially impact PTSD symptom clusters (Hebenstreit, Madden, & 
Maguen, 2014; Jakob et al., 2017; Maguen et al., 2010; Osorio et al., 2018).  Therefore, it 
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was hypothesised that different types of TDEs may be linked to the different symptomatic 
profiles examined.  
Studies investigating how specific types of TDEs relate to physical compared with PTSD 
symptoms in the same sample are rare, and those that have been conducted do not 
generally distinguish between psychological and physical symptoms. For example, one 
study of ADF members on peacekeeping missions examined emotional distress (K10), 
PTSD (PCL), and health symptom count as independent outcomes in a series of 
regressions. They found that, for those deployed to both East Timor and Bougainville, 
subjective exposures were not related to K10 scores, but showed a small increase in odds 
ratio with PCL scores and health symptom count, while objective exposures were 
unrelated to K10, PCL, and health symptoms in both groups (Waller et al., 2012). Cross 
comparison between this study and the research conducted for this study is difficult due to 
differences in the type of traumas measured as well as conceptual differences in the 
methods of classifying trauma. For example, (Waller et al., 2012) classified exposures to 
dead bodies as objective exposures, whereas due to both civilian and military research 
findings that human death and degradation is highly influential in symptom reporting 
(Butler et al., 1990; Clohessy & Ehlers, 1999; Davidson, Stein, Shalev, & Yehuda, 2004), 
and is a vulnerability factor for suicide (LeBouthillier, McMillan, Thibodeau, & 
Asmundson, 2015; Stanley, Hom, Hagan, & Joiner, 2015),  these types of exposures were 
placed in their own category of human death and degradation in the research conducted 
for this thesis. Interestingly, the findings of both Waller et al. (2012) and the studies 
conducted for this thesis suggest that subjective exposures have a stronger influence on 
symptoms than objective exposures.   
The first two studies in this thesis found that all symptomatic outcomes shared a similar 
pattern of association with the three traumatic exposure types investigated, i.e. subjective, 
objective, and human death and degradation. Human death and degradation had the 
strongest association with all symptom profiles and objective trauma the least. Thus, 
while it was found that some trauma types had a stronger impact, all symptomatic 
outcomes showed similar relationships with these trauma types. Although data are cross-
sectional and therefore causation cannot be determined, these results suggest that all 
symptomatic outcomes may share similar biological mechanisms. While it could be 
argued that physical symptoms are a secondary symptom of psychological distress 
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associated with trauma due to somatisation for example, these findings could similarly be 
used to argue for the impact of trauma being multidimensional.   
Exposure to human death and degradation on deployment has been linked to PTSD (Hoge 
et al., 2004; Phillips et al., 2010), and this connection has been supported by the findings 
of this thesis. This thesis has also identified a link between death and degradation 
exposures and physical symptoms. However, others such as Waller et al. (2012) found no 
association between objective exposures (which included items such as seeing dead 
bodies) and either physical symptoms or PTSD, which the authors suggest may be due to 
repeated exposure to human death and degradation ‘inoculating’ members against 
negative health outcomes (Meicheribaum & Novaco, 1985; Waller et al., 2012). An 
alternative explanation is that responses to repeated trauma change in nature to a more 
physical presentation. For example (Killgore et al., 2006) compared combat-experienced 
soldiers with combat-naive soldiers immediately prior to wartime deployment. The 
researchers found that soldiers with previous combat experience had lower affective 
complaints but greater somatic complaints relative to combat-naive soldiers (Killgore et 
al., 2006). The authors propose that military members learn to repress emotional 
responses and instead present with physical symptoms (Killgore et al., 2006).  It could be 
suggested that physical symptoms are a more culturally acceptable presentation of 
distress than psychological symptoms in a culture that values and respects strength and 
psychological resilience. 
Clearly, the mechanism of symptom development may not simply be the presence or 
absence of somatisation. Presentation type will likely depend on a complex interplay of 
factors; for example, the types of TDEs, members’ and their families’ trauma and 
psychological disorder history, peri-traumatic physiological arousal, and perceived stigma 
within military culture may together be the shared mechanism linking TDEs with both 
physical and psychological symptoms. 
Studies 1 and 2 found that subjective deployment exposures were more strongly 
associated with all outcomes than objective deployment exposures. This finding is not 
unexpected as a person’s subjective feelings at the time of a traumatic exposure is 
associated with psychological disorder (Creamer, McFarlane, & Burgess, 2005). It is also 
possible that physical symptoms are linked to the physical experience at the time of the 
subjective exposure.  That is, these symptoms may represent a somatic memory of 
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combat exposure, reflecting the patterns of arousal the member felt in the combat 
environment. This would explain why subjective appraisal and not objective measures of 
threat were related to all symptom outcomes. This suggestion is supported by a 
prospective study comparing a small sample of Dutch soldiers before and after four 
months’ deployment to a combat zone in Afghanistan with a never-deployed control 
group (van Wingen, Geuze, Vermetten, & Fernandez, 2011). This study used functional 
magnetic resonance imaging to assess amygdala and insula reactivity, a blocked design 
which included an emotion condition with angry and fearful face stimuli.  The amygdala 
is a key brain region involved in threat detection and fear regulation (Stein et al., 2007). 
The insula is involved in interoceptive awareness and is thought to signal internal body 
states (Craig, 2002). The researchers found that combat stress increased amygdala and 
insula reactivity to the stimuli in combat exposed individuals, but amygdala coupling with 
the insula was dependent on perceived threat, suggesting that threat appraisal rather than 
actual combat exposure affects interoceptive awareness (van Wingen et al., 2011).  In 
other words, how an individual perceives a situation (subjective assessment) will 
influence their awareness of sensory information more than exposure to combat 
(objective experience). 
 In addition, it is possible that both non-painful and painful physical symptoms associated 
with war syndromes reflect a state of central nervous system mediated hypersensitivity to 
stimuli or ‘central sensitisation’ (Nijs et al., 2012; Phillips & Clauw, 2011) . With central 
sensitisation, continued stimulation may result in increased neuronal responsivity 
(Baranauskas & Nistri, 1998). In sensitised individuals, symptoms may be influenced not 
only by stimuli for that symptom alone but also the salience of that stimuli which may 
include such factors as context and experience. Therefore, sensitisation offers additional 
support that the experience of ongoing physical symptoms may be shaped by the salience 
of past events.  
Study 3 included the additional trauma category of environmental exposures. This 
analysis found an association between traumatic deployment exposures and physical 
symptom presentation among those with probable PTSD, where a greater number of both 
subjective and environmental (but not objective or human death and degradation) TDEs 
was associated with a higher likelihood of belonging to the high physical symptom 
cluster. There are many possible explanations for this finding. For example, 
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environmental exposures have been linked to physical symptoms in Gulf War veteran 
studies (Hotopf et al., 2000; Kroenke et al., 1998; Wolfe et al., 1998), which is supported 
by this finding. Being a retrospective study design, delays in reporting can create bias; for 
example, those with the worst health ruminate on exposures that may be associated with 
their symptoms and therefore report more exposures (Zakirova et al., 2015). 
Alternatively, it may be that this reflects a group of individuals who found the MEAO 
environment particularly malevolent, which may make the environment exposures they 
experienced more salient (King et al., 1995; Vogt, King, King, Savarese, & Suvak, 2004). 
This feeling of malevolence may also heighten the sense of all TDEs as a threat-to-self, 
resulting in greater physiological arousal associated with these exposures and a greater 
impact on symptom presentation. 
The advantage of an understanding of the impact that a malevolent environment could 
have on members’ sense of threat-to-self is that it suggests there are occupational factors 
that could be modified to reduce their influence on an individual’s risk of post-traumatic 
stress symptoms. Identifying which exposures have the most impact on symptoms may 
enable identification of members who experience these exposures and therefore may be at 
greater risk, or it could be used to inform specific educational and training interventions 
to minimise the impact of malevolence.   
9.7 Clinical implications 
This section first discusses current treatment strategies and considers a shift in approach. 
The issue of contested causation is then discussed, including why the civilian diagnosis of 
functional somatic disorders may not be an appropriate comparison for military 
personnel. This is followed by a discussion of a multidimensional approach to trauma, the 
impact of viewing diagnoses on a continuum, and the importance of identifying and 
intervening on sub-clinical disorder. Finally, the possibility of sub-types of PTSD is 
discussed.  
9.7.1 Current physical symptom treatment strategies 
The lack of understanding of the mechanisms involved in physical symptoms following 
traumatic deployment exposure has resulted in little improvement in available treatments 
or treatment outcomes. There is considerable uncertainty regarding the best management 
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of physical symptoms, with current recommendations including psychological treatments 
such as CBT and antidepressant medication, thereby demonstrating the assumption of 
psychological aetiology (den Boeft, Claassen-van Dessel, & van der Wouden, 2017; 
Kleinstaeuber et al., 2014; Kroenke, 2003; olde Hartman et al., 2017; van Dessel et al., 
2014). The effect sizes for the current treatment recommendations are small, suggesting 
there is a need to explore alternate therapies and causal mechanisms that may suggest new 
treatment targets (Zlotnick, Franklin, & Zimmerman, 2004). The findings of Study 1 that 
physical symptoms can occur independently of psychological symptoms suggests there 
may be value in exploring whether current treatments are as effective for this presentation 
as for a comorbid presentation. Similarly, identifying differences between these two 
presentations may help to determine whether different pathological mechanisms are 
involved. 
When considering the effectiveness of antidepressant medication for physical symptoms, 
the anti-inflammatory effect of some of these medications should be taken into 
consideration. For example, a study of selective serotonin reuptake inhibitor (SSRI) 
treatment for major depressive disorder found a significant drop in C-reactive protein 
concentrations whether or not the depression resolved, indicating that SSRI 
antidepressants induce an anti-inflammatory response independent of antidepressant 
action (O'Brien, Scott, & Dinan, 2006). The finding of Study 5 that inflammation was 
associated with some physical symptoms suggests that antidepressants may be beneficial 
in treating those physical symptoms regardless of psychological disorder. Therefore, 
improvement seen in the physical symptom only patients may give a false impression of 
the true mechanisms involved in symptom development. 
Psychological labels are particularly concerning to military personnel who admire 
strength and are trained to be tough and resilient. Veterans may feel that such a label is a 
way to dismiss or de-legitimise their complaints or imply a ‘weakness of character’,  or as 
negating the unique experiences of deployment to conflict zones; it may also affect 
deployability and career promotion (Iversen et al., 2007; Kilshaw, 2008; Rona et al., 
2004). Considering the difficult history of somatoform disorder in the DSM classification 
(as outlined in the introduction of this thesis) with its implication of psychological cause, 
this diagnosis may carry too much stigma to be used in a group already overly sensitive to 
psychological diagnoses.  
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Our growing understanding of the biological mechanisms involved with physical 
symptoms may help alter how we treat and label these symptoms. Terms such as 
psychosomatic, ‘medically unexplained’, somatisation and somatoform do not offer 
adequate explanations and with improved science they have lost their clinical and 
scientific utility (Crombez, Beirens, Van Damme, Eccleston, & Fontaine, 2009). New 
medical frameworks and nomenclature need to be agreed upon that are easily 
understandable and acceptable to patients, and avoid some of the sterile and judgmental 
language of the past (Bourke et al., 2015).   
Unfortunately, in both military and civilian research there is very little information on the 
long-term outcomes of those suffering with physical symptoms. However, with the new 
trend toward increased surveillance of military personnel, this may change in the future. 
Undoubtedly, aetiological factors will be multifactorial, but the findings of this thesis 
suggest it may be beneficial to consider a move away from assuming a psychological 
primacy of cause and exploring biological mechanisms that may underpin symptoms in 
military personnel; particularly as neuroscience has developed to a point where 
exploration of the alternate mechanism is now possible.   
9.7.2 Contested causation of physical symptoms  
Physical symptoms experienced after war have a history of being invalidated, with 
recognition only occurring following veteran and community discontent (Brown et al., 
2001; Jones & Wessely, 2005b; Kilshaw, 2008). For example, WWI Shell Shock victims 
were denied military pensions and it was community discontent with this decision that 
changed the government’s position (Jones & Wessely, 2005a). Likewise, the recognition 
of PTSD occurred due to community action (Scott, 1990), as did the initiation of research 
into first Gulf War veterans’ ill health (Brown et al., 2001). The strong presence of social 
movements supporting veterans demonstrates the intensity of these disputes over 
causation and illustrates how military syndromes are often positioned at the intersection 
of science, medicine, policy, and public values (Brown et al., 2001; Hotopf & Wessely, 
2005). 
Many of these disputes over physical symptom causation stem from members’ belief that 
physical symptoms are due to environmental TDEs experienced on deployment, while the 
medical profession believe symptoms may be due to stress or psychological disorder. The 
findings of Studies 1 and 2 validate that physical symptoms can occur independently of 
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psychological symptoms and are related to TDEs. Study 4 supports that environmental 
and subjective TDEs impact physical symptoms to a greater degree than objective and 
human death and degradation TDEs.  This contested causation and the lack of adequate 
explanatory frameworks can have considerable impact on veterans including: a sense of 
invalidation; the impression that their experience is being ignored by the medical 
profession; and alternative illness explanations and conspiracy theories which drive 
behaviours including poor treatment choices (Engel et al., 2002; Kilshaw, 2008). 
Improved understanding of physical symptom syndromes can prevent this destructive 
disruption. The failure of the medical profession to develop and communicate 
frameworks of illness that patients can understand and relate to demonstrates that doctors 
focus on diagnosable conditions. 
Doctors and their patients expect that doctors will always provide correct diagnoses and 
treatments (Luther & Crandall, 2011; Quill & Suchman, 1993; Stanley Budner, 1962). 
Such beliefs lead modern medical practitioners to focus on providing diagnoses for which 
they can offer treatment protocols, a focus that at times leads to ignoring the distress and 
anxiety that a lack of or incorrect diagnosis can cause the patient. Ambiguity in the 
medical field is not well tolerated by either clinicians or patients, highlighting the need 
for improved explanatory frameworks for physical symptoms (Domen, 2016). 
9.7.2.1 Functional somatic syndromes 
There has been a trend, especially regarding Gulf War veterans, of equating military 
physical symptom syndromes with civilian syndromes such as multi-chemical sensitivity 
or chronic fatigue syndrome (Halpin et al., 2017; Iversen et al., 2007; Kipen, Hallman, 
Kang, Fiedler, & Natelson, 1999). However, there is research to support the 
inappropriateness of this approach. For example, a large multi-site randomised controlled 
trial conducted with symptomatic US Gulf War veterans compared models of treatment 
established for use in civilian samples with unexplained symptoms and syndromes 
(principally chronic fatigue syndrome; Donta et al., 2003). This study invested over $10 
million to explore the success of cognitive-behavioural therapy (CBT), graded exercise 
therapy, and a combination of both, as used in the treatment of civilians. Results showed 
that, although exercise alone or in combination with CBT improved fatigue, distress, 
cognitive symptoms, and mental health functioning, there was no significant impact on 
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pain (Donta et al., 2003). The researchers concluded that military-specific models may be 
more appropriate (Hotopf & Wessely, 2005; Iversen et al., 2007).  
Civilian functional somatic syndromes have a high comorbidity between physical and 
psychological symptoms, with higher physical symptoms indicating higher psychological 
disorder (Henningsen et al., 2003; Iversen et al., 2007; Thieme, Turk, & Flor, 2004). The 
findings in this thesis support this co-occurrence in military personnel, particularly in 
those with higher levels of TDEs, but it was also found that physical symptoms can be a 
discrete outcome from deployment trauma and are just as strongly associated with 
deployment trauma as are psychological symptoms.  Treating physical symptoms as core 
rather than secondary symptoms could broaden the factors explored as causal in post-
deployment syndromes, most notably physiological dysregulation. Considering the 
unique nature of and increased risk of TDEs in military members as well as the influence 
of training for such exposures, directly equating military syndromes with civilian 
functional syndromes may be inappropriate. However, if our understanding of the TDE 
symptom relationships is improved, findings may enlighten functional somatic syndrome 
research in civilian samples. 
Despite the advances made in DSM diagnostic criteria for somatic symptom disorder, 
Gulf War and other post-war syndromes provide a reminder that this is an area of 
medicine that remains poorly managed. The findings of this thesis that physical 
symptoms may be equally likely to occur with or without psychological comorbidity 
supports phenomenologically-based diagnostic criteria that are compatible with an 
atheoretical approach rather than a psychological label such as somatisation or functional 
somatic syndrome that may stigmatise patients. Such a development could reduce the 
frequency of contested causation. 
9.7.3 The impact of a multidimensional approach to trauma on diagnosis and treatment 
The findings in this thesis that trauma is associated with physical health (with or without 
psychological comorbidity) and subsequent quality of life supports existing research 
which has also shown an increased risk of morbidity and mortality for affected veterans 
(Elder et al., 2009; Lee et al., 1996; Schlenger et al., 2015). Collectively, this evidence 
provides legitimate reasoning for the hypothesis that trauma may disrupt physiological 
homeostasis, and validates the need to explore whether physical symptoms may be an 
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early warning sign of such disruption (Dedert et al., 2009; Lee et al., 1996; Schlenger et 
al., 2015). This hypothesis emphasises the need to recognise trauma in the aetiological 
pathway of physical symptoms as well as the importance of not simply treating physical 
symptoms as a somatic comorbidity of psychological disorder. The finding in this thesis 
that physical symptoms are as likely to be related to trauma as are psychological 
symptoms provides support for this reasoning. 
A move toward a multidimensional understanding of trauma may address a major concern 
identified in the literature that many patients find the labelling of physical symptoms with 
a psychological diagnosis derogatory (Bourke et al., 2015; Kilshaw, 2008; Mayou et al., 
2005; Rief & Martin, 2014). If physical and psychological symptoms are similarly related 
to TDEs and the biological mechanisms are intertwined, examining the degree of 
biological dysregulation may be vital in determining disorder severity and treatment 
planning. Therefore, considering responses to trauma as multidimensional and on a 
continuum could indirectly improve patient outcomes through greater acceptance of 
diagnoses and thus treatments offered. 
9.7.4 Trauma as a continuum   
9.7.4.1 Cumulative effect of trauma 
The findings that higher levels of symptom recruitment occur with higher levels of TDEs 
suggest that responses to trauma may be better assessed on a continuum of symptom 
recruitment. As discussed earlier, the number of symptoms expressed increases with 
exposure to trauma which may be explained by physiological dysregulation also 
increasing with exposure to trauma.  
If the response to trauma is considered to be on a continuum, and the common roots of the 
physical and psychological dimensions of health in trauma-exposed individuals is 
recognised, it may be appropriate to consider a staged approach where treatment is 
prescribed according to degree of physiological dysregulation, as has been suggested for 
the management of both PTSD and medically unexplained symptoms (McFarlane et al., 
2017; olde Hartman et al., 2017). McFarlane et al. (2017) discuss how different stages of 
the progression of PTSD may be defined by the biological progression of the illness, so 
that different therapeutic strategies may be more appropriate depending on the stage of 
progression. Similarly, European physical symptom treatment guidelines recognise the 
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need for a stepped approach with physical symptoms; justification includes factors such 
as the risk of symptoms becoming chronic, severity of symptoms, severity of functional 
impairment, psychological comorbidity, or poor doctor-patient relationship (olde Hartman 
et al., 2013; olde Hartman et al., 2017). The presence of justifications such as severity and 
chronicity could be explained by increasing levels of physiological dysregulation and 
therefore is in keeping with a staged approach being adopted across the management of 
all trauma exposed presentations; physical, psychological, and comorbid. 
Understanding the impact of cumulative trauma may help to better identify risk factors 
such as pre-existing vulnerabilities and cumulative TDEs. This understanding may then 
help in the development of military strategies and tactics to enhance resilience prior to 
deployment, and to tailor post-combat interventions to minimise the impact of trauma on 
members (Rizzo et al., 2012; Price, Gros, Strachan, Ruggiero, & Acierno, 2013). For 
example, checklists of lifetime trauma and TDEs could be used to monitor levels of 
exposure so that guidelines for risk could be developed. This could then allow the 
development of a staged approach to education, training, and intervention by total level of 
trauma. 
An example of where a staged or stepped approach to treatment is already being applied 
is in the management of physical symptoms. The difference being that rather than the 
accumulation of exposures, the Dutch, Danish, and German guidelines assess the 
accumulation of symptoms and impairments (including the quality of the doctor-patient 
relationship), defining three stages of severity (mild, moderate, and severe; Hausteiner-
Wiehle, Sattel, Ronel, Henningsen, 2012;  olde Hartman, Blankenstein, Molenaar, et al., 
2013; olde Hartman et al., 2017). Although there are difference between the three 
countries guidelines, all agree that “the more severe or complex the symptoms and 
limitations, the more intense and complex the treatment needed for patient recovery” 
(olde Hartmen et al., 2017). A similar approach in trauma exposure could examine the 
accumulation of trauma, the type of trauma, and the presence of protective factors such as 
social supports (Gros, Flanagan, Korte, Mills, Brady, & Back, 2016). 
While early detection of those at risk is important, we must consider research which 
indicates that psychological debriefing after traumatic events, popular at the end of last 
century, can be counterproductive (Van Emmerik, Kamphuis, Hulsbosch, & Emmelkamp, 
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2002). Current best practice is to watch and wait for the first month following traumatic 
exposures as described in an article by Greenberg & Wessley (2017). The interesting 
quandary such research presents is what other interventions could be harmful? Could the 
current post-deployment screening strategies utilised by the ADF and many other 
militaries represent a risk (Greenberg & Wessley, 2017; Rona, Hyams, & Wessely, 
2005)?   The research around debriefing suggests any new interventions need to be well 
researched, and consider a broad range of factors including recency of trauma exposure. 
Such research highlights the many aspects that need to be considered in the management 
of trauma exposed individuals and demonstrates the skill required by those working in 
this area as well as the commitment required to stay informed of current research.  
9.7.4.2 Sub-syndromal disorder 
Considering the response to trauma as a continuum not only improves management at the 
severe end of the spectrum but may also improves early intervention.  There is a growing 
body of evidence that sub-syndromal PTSD can result in clinically significant functional 
impairment and distress similar to diagnosed PTSD even when not all diagnostic criteria 
are met (Breslau, Lucia, & Davis, 2004; Cukor et al., 2010; Jakupcak et al., 2007; 
Jakupcak et al., 2011; Marshall et al., 2001; Pietrzak et al., 2009b; Stein et al., 1997; 
Zlotnick et al., 2004). While sub-syndromal PTSD is yet to be well defined in the 
literature (Jakupcak et al., 2007; Jakupcak et al., 2011; Pietrzak et al., 2009a; Shiner et al., 
2012), it has been found that one in four people with sub-syndromal PTSD symptoms go 
on to develop diagnosed PTSD (Cukor et al., 2010; Smid et al., 2009). Many of the 
physiological and immune abnormalities in diagnosed PTSD are also present in the sub-
syndromal form of the disorder, and therefore those with sub-syndromal PTSD are 
potential targets for early intervention (McFarlane et al., 2017). Of interest is the finding 
that low-intensity treatment may be effective in sub-syndromal PTSD but not diagnosed 
PTSD (Shiner et al., 2012), which supports the need for early intervention in minimising 
the economic and resource burden of PTSD on the individual, family, military, and 
community.  
Illness duration has also been identified as having a negative impact on prognosis in many 
psychopathologies including anxiety, major depressive disorder, and obsessive 
compulsive disorder (Altamura et al., 2008; Dell’Osso, Buoli, Hollander, & Altamura, 
2010). Therefore, considering responses to stress as being on a continuum and 
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understanding the benefits of early identification offers potential value in preventing 
progression to full disorder and poorer outcomes.  
The theory that chronic stress and trauma can induce a state of allostatic load supports the 
suggestion made in this thesis that sub-clinical levels of symptomatology, such as non-
specific physical symptoms, may be an early indicator of progression to a state of illness. 
Therefore, early identification of and intervention for physical symptoms may prevent 
chronicity and progression to diagnosable physical disease. Likewise, if physical 
symptoms are maintained by a central sensitisation process (a condition that is yet to have 
clear diagnostic criteria), early intervention may be beneficial (Woolf, 2011). 
9.7.5 PTSD and physical symptoms  
This thesis provides a number of findings that support a strong relationship between 
physical symptoms and PTSD. First, there are some members with PTSD who are likely 
to report predominantly physical symptoms, and thus will be missed by current 
psychologically-based criteria. Second, over half of those with high PTSD symptoms 
have a high physical symptom count. Third, the machine learning clusters used in this 
thesis found that total symptom count and severity delineated those at risk of PTSD. 
Finally, there is no primacy of association of psychological over physical symptoms with 
trauma.  
The focus of PTSD in the various editions of the DSM on the re-experiencing and 
avoidance symptoms of the disorder has resulted in a failure to incorporate physical 
symptoms (McFarlane et al., 2017). The important consequence of this is that biological 
mechanisms involved in physical symptoms, their prevalence, and their relationship with 
later somatic pathology have not been adequately explored (McFarlane et al., 2017). It 
may be timely to reflect upon the early conceptualisations of PTSD by those such as 
Kardiner (1941) and Kolb (1993) who recognised the significant physical experience of 
patients that today’s diagnostic criteria minimises.   
Study 2 found that over half of those with probable PTSD had comorbid physical 
symptoms, thereby highlighting the importance of considering these symptoms. Ignoring 
physical symptoms in PTSD in patient presentation may result in an inaccurate 
understanding of illness severity and treatment outcomes in both research and clinical 
settings (Groll, To, Bombardier, & Wright, 2005). This has been found to be the case in 
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major depressive disorder research which has found that when physical symptoms are not 
considered rates of remission are higher (Trivedi, 2004). This is an area that may be 
particularly challenging for mental health professionals who are often disinclined to 
consider physical symptoms. 
The majority of patients with high physical symptom counts are most likely to seek help 
from their general practitioner (Kilshaw, 2008; Mayou et al., 2005; Simon et al., 1999), 
and as physical symptoms are not included in the diagnostic criteria for PTSD, medical 
practitioners may not consider PTSD when diagnosing these patients. The results of this 
thesis suggest that members who present with physical symptoms may not be diagnosed 
with PTSD, and as such, may undergo unnecessary testing or treatment (Dirkzwager & 
Verhaak, 2007), or the diagnosis may be delayed, allowing their PTSD to become chronic 
and more difficult to treat.  
If the physical symptoms experienced by PTSD patients are not recognised in the 
diagnostic process, the true level of a patient’s suffering may not be addressed. The 
absence of physical symptoms in the diagnostic process has the potential to create a clash 
of illness schemas between doctor and patient and could result in patients placing a 
greater focus on these unaddressed symptoms (McFarlane, Ellis, Barton, Browne, & Van 
Hooff, 2008). 
9.7.6 PTSD sub-types 
The broad heterogeneity of disease progression and the response to treatment suggest that 
there could be sub-types of PTSD that demonstrate different biological responsiveness 
(McFarlane et al., 2017). The findings of Study 3 (Chapter 6) suggest that one sub-type of 
PTSD may be delineated by its association with physical symptoms, which is suggestive 
of mechanistic differences between the two sub-types.  
The existence of PTSD sub-types offers one explanation for poor treatment response 
rates. Exploring possible pathological differences associated with subtypes may lead to 
additional PTSD treatment approaches or improvements in predicting treatment response. 
Considering the current under-detection and poor treatment outcomes for PTSD in 
veterans (Rona et al., 2012; Steenkamp & Litz, 2013), the findings of this thesis and the 
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suggestion of the addition of physical symptoms to current PTSD diagnostic criteria may 
be valuable.  
Research into major depressive disorder suggests that a more chronic course of the 
disease may be due to the involvement of inflammatory and metabolic dysregulation 
(Duivis et al., 2013; Vogelzangs et al., 2014). The high comorbidity of PTSD with 
metabolic and inflammatory conditions is an area worthy of further exploration as it has 
the ability to offer improved understanding and increased treatment targets. The 
involvement of physical symptoms in the subtype suggested in this thesis may be 
suggestive of inflammatory involvement, particularly as the studies in this thesis have 
highlighted relatively higher levels of trauma in this group who were therefore more 
likely to have advanced physiological dysregulation. 
9.7.7 PTSD treatment 
The gold standard for PTSD treatment in both civilian and military settings is cognitive-
behavioural therapy (CBT), incorporating exposure-based therapy (particularly prolonged 
exposure), cognitive therapy (particularly cognitive processing therapy), stress 
inoculation training, and eye-movement desensitization and reprocessing therapy (Rauch, 
Eftekhari, & Ruzek, 2012; Steenkamp & Litz, 2013). Despite the abundance of evidence 
for the efficacy of CBT treatments, symptoms are found to persist in 30–60% of patients 
after treatment (Berger et al., 2009; Bradley, Greene, Russ, Dutra, & Westen, 2005; 
Kessler, Sonnega, Bromet, Hughes, & Nelson, 1995; Steenkamp & Litz, 2013). In 
addition, PTSD treatment often results in partial improvement rather than complete 
remission (Friedman, 2006), and the condition of 50% of those with PTSD take a chronic 
course, while the condition of the other 50% is resolved without treatment (Morina, 
Wicherts, Lobbrecht, & Priebe, 2014). No specific PTSD medications have been 
identified but a number of medications developed for other indications are commonly 
prescribed, with equivocal results (Davis, English, Ambrose, & Petty, 2001; McFarlane et 
al., 2017).  These findings highlight the lack of understanding of the pathological 
mechanisms and the need for improved understanding of the factors that contribute to the 
chronicity and severity of PTSD. The findings also highlight the need to identify 
predictors of treatment response and alternative treatment options.  
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Many PTSD patients are reluctant to seek treatment, or may prematurely discontinue 
treatment (Kehle-Forbes, Meis, Spoont, & Polusny, 2016; Steenkamp et al., 2015; van 
Minnen, Arntz, & Keijsers, 2002).  Hoge and Warner (2014) found that this is particularly 
true in the military where a high percentage of soldiers with PTSD do not access care, do 
not receive adequate treatment, or elect to drop out of treatment. Reported reasons for 
dropping out include soldiers feeling they can manage problems on their own, work 
interference, insufficient time with the mental health professional, stigma, treatment 
ineffectiveness, confidentiality concerns, or discomfort with how the professional 
interacted (Hoge & Warner, 2014). Conditions in trials are often superior to the clinical 
environment as participants often have less severe symptoms and fewer comorbid 
conditions.  Therefore it may be assumed that drop-out and non-responder rates in real 
clinical settings would be significantly higher than those found in research, which 
highlights the possible lack of knowledge of true treatment success (Hoge et al., 2004; 
Najavits, 2015; Schottenbauer, Glass, Arnkoff, Tendick, & Gray, 2008; Spinazzola, 
Blaustein, & van der Kolk, 2005). 
The limited effectiveness of evidence-based psychological interventions in people with 
PTSD, particularly in veteran populations (Steenkamp et al., 2015), highlights the need to 
develop new strategies. This discussion has explored how considering sub-types could 
broaden therapeutic approaches; how considering responses to trauma to be on a 
continuum may lead to the use of staged care models and thereby improve outcomes; how 
broadening diagnostic criteria to include physical symptoms could improve early 
diagnosis as well as assessment of true illness severity; and the need to identify new 
treatment targets by improving our understanding of underlying biological dysregulation. 
These possibilities demonstrate that there are still many avenues to explore and 
improvements to be made in how PTSD in veterans is managed. 
9.8 Recommendations for further research 
The results from this thesis highlight areas for further research on this topic. A major 
impediment to research in this area has been a lack consensus on definition and 
measurement of physical symptoms. Standardising these across disciplines should be a 
research priority to allow direct comparison between studies. These measures need to be 
developed to meet the new DSM-V criteria for somatoform disorder and therefore 
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incorporate both medically unexplained and explained physical symptoms. An improved 
definition of physical symptoms may unify medical specialties and has the potential to 
improve research focus. 
The overwhelming gap in the literature is empirical evaluation and data on physical 
symptoms utilising the new DSM-V definition (olde Hartman et al., 2009). Most 
importantly, longitudinal studies of the physical symptom profile are needed to assess 
which early symptoms are markers for increased severity and chronicity (McFarlane et 
al., 2017), as well as the long-term impact on functioning and wellbeing. Understanding 
the progression of physical symptoms and whether they represent a sub-clinical marker of 
future physical or psychological poor health will allow for consideration of early 
intervention of physical symptoms and prevention of disease progression.  
A comprehensive assessment of physical symptoms may provide understanding of the 
pathological mechanisms involved. The population-based sample used in this thesis was 
largely healthy and therefore may have limited the strength of association with traumatic 
deployment exposures by reducing response variability. Repeating a similar cluster-based 
analysis in a large treatment-seeking sample may identify greater symptom specificity for 
PTSD and result in more meaningful clusters. 
A valuable area of research would be to monitor physical symptoms during PTSD 
treatment and examine whether measuring physical symptoms affects PTSD outcomes 
and remission rates. Limited research has shown that PTSD treatment may improve 
physical health outcomes (Galovski, Monson, Bruce, & Resick, 2009; Shipherd et al., 
2007). This direction in research has the potential to discover whether PTSD can be 
divided into sub-types which could help identify predictors of treatment response and new 
innovative treatments. 
Of importance is an understanding of the neurobiological mechanisms of both PTSD and 
physical symptoms and to identify how these contribute to ill-health. Work on identifying 
biomarkers is an area of current intense interest due to the diagnostic implications. 
The development of a framework for the assessment of physical symptoms in the military 
context could improve research, management, and outcomes. To validate the patients’ 
experiences, as well as explain syndromes to patients, such frameworks need to 
incorporate all dimensions of distress suffered by members as a result of TDEs, and this 
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may help to break down stigma, reduce barriers to care, and improve treatment 
participation.  
Treatment options for physical symptoms need further research, in particular the 
exploration of military treatment protocols. Identifying members who are at risk because 
of military or non-military levels of traumatic exposures should be explored, and effective 
interventions developed. Research around the types or combination of traumatic 
exposures may be informative, as would exploring whether educational interventions can 
reduce the impact of military-specific malevolence.  
These suggestions outline only some areas of interest, however the depth of possible 
research in this field is extensive and includes non-combat deployment experiences such 
as harassment, unit cohesion, the impact on veterans’ families, and many more, as well as 
demographic factors such as sex differences. 
9.9 Strengths and limitations  
A key limitation of this study is that surveys such as this with data collection occurring at 
one point in time, while cost-effective for collecting large quantities of information, limit 
the ability to demonstrate causal associations. Furthermore, the reliance on self-report 
measures introduces a risk of reporting bias. The validity of self-report measures is 
repeatedly questioned, particularly when measures are retrospective and include TDEs 
(McCauley, Joos, Lasarev, Storzbach, & Bourdette, 1999; Wessely et al., 2003). Recall 
bias was discussed in the introduction, including factors such as current ill-health and the 
role of the media.  
PTSD symptoms have been found to influence memory, with research on Gulf War 
veterans showing that traumatic memories are not fixed but can change over time 
(Engelhard, van den Hout, & McNally, 2008; Southwick et al., 1997; Wessely et al., 
2003). Most of the studies in this thesis are retrospective, with participants being recruited 
after their deployment had been completed. Data may have been collected up to ten years 
after the exposures, during which time memories could be reshaped. However, time since 
deployment was controlled for in the analyses for this thesis to reduce the impact of 
delayed collection of data, with results showing that time since deployment did not have a 
significant influence on symptoms. 
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Participation bias is an issue in all survey studies. If the response rate is low, non-
response bias may limit the ability to generalise the study’s results. The response rate for 
the MEAO Census study of 53% is comparable to similar studies (Unwin et al., 1999b). 
Additionally, responses from actively-serving members can be biased; for example, ill 
veterans may censor their responses for fear of jeopardizing their military careers. 
A notable strength of this thesis is the large representative sample of the population of 
interest. Having access to a young and healthy sample avoids some of the complications 
of dealing with older or treatment seeking samples. However, the potential for 
confounding must be considered. Researchers need to be aware of the possibility that 
people with a physical illness may not know of their illness at the time or the illness may 
not be accounted for, and this can create spurious associations.  However, by accounting 
for doctor-diagnosed medical illnesses, the possibility that unmeasured variables may 
offer alternate explanations was minimised. 
A novel contribution made in this thesis is differentiating between physical and 
psychological symptoms on the health symptom checklist. Most symptom measures used 
in military research contain a mix of physical and psychological symptoms, yet the 
symptom counts created from these measures are often assessed against psychological 
measures, resulting in a duplication of symptoms. The strategies used in this thesis were 
an attempt to reduce such confounding.  
9.10 Conclusion  
The findings of this thesis support the concept that post-deployment physical and 
psychological symptoms have a similar prevalence and impact on quality of life, 
indicating that both are equally worthy of clinical concern. TDEs shared a similar dose-
response relationship with both physical and psychological symptoms. As TDEs are well-
accepted in the aetiology of PTSD, it follows that TDEs may have an aetiological role in 
physical symptom pathology. This finding raises doubt about the assumption that 
psychological processes are the primary drivers of physical symptom aetiology associated 
with trauma and suggests that using somatisation to explain physical symptoms is an 
oversimplification that artificially induces a mind-body dichotomy. An alternative is that 
physiological reactivity may be a key causal mechanism in both physical and 
psychological symptom development. 
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This thesis found a strong relationship between PTSD and physical symptoms, with over 
half of those with PTSD having high levels of physical symptoms. Sub-types of PTSD 
may exist, differentiated by the presence or absence of somatic symptoms. These sub-
types may involve different pathological mechanisms which could explain the poor 
treatment outcomes and suggest new directions in treatment intervention.  
Physical symptoms had good utility in PTSD screening and made a valuable addition to 
current psychologically-based PTSD screens, suggesting that the current psychologically 
focused PTSD diagnostic criteria may not reflect the patient experience and may benefit 
from conceptual revision. Recognition of the close relationship between physical and 
psychological dimensions in the spectrum of PTSD may help to avoid under-diagnosis 
and unnecessary and expensive treatment of physical symptoms.  
Greater recognition needs to be given to the heterogeneity of responses to TDEs. It is 
proposed in this thesis that the spectrum of trauma-related pathology may be a systemic 
process, with increasing exposure resulting in increasing levels of physiological 
dysregulation, thereby suggesting the need for a staged approach to trauma treatment. 
These findings suggest it would be appropriate to adopt a more unitary approach rather 
than the traditional mind-body dualism.  
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Health symptom questionnaire (HSC) 
We would like to know about your health in the past month. Please indicate whether or not you have 
suffered any of the following symptoms in the past month, and if so, please indicate whether your 
symptoms were mild, moderate or severe in nature. 
 







2.1 Chest pain  No  Mild  Moderate  Severe 
2.2 Headaches  No  Mild  Moderate  Severe 
2.3 Rapid heartbeat  No  Mild  Moderate  Severe 
2.4 Irritability / outbursts of anger  No  Mild  Moderate  Severe 
2.5. Unable to breathe deeply enough No Mild Moderate Severe 
2.6 Faster breathing than normal  No  Mild  Moderate  Severe 
2.7 Feeling short of breath at rest No Mild Moderate Severe 
2.8 Wheezing No Mild Moderate Severe 
2.9 Sleeping difficulties No Mild Moderate Severe 
2.10 Feeling jumpy / easily startled  No  Mild  Moderate  Severe 
2.11 Feeling unrefreshed after sleep  No  Mild  Moderate  Severe 
2.12 Fatigue  No  Mild  Moderate  Severe 
2.13 Double vision No Mild Moderate Severe 
2.14 Intolerance to alcohol  No  Mild  Moderate  Severe 
2.15 Itchy or painful eyes No Mild Moderate Severe 
2.16 Rash or skin irritation No Mild Moderate Severe 
2.17 Skin infections e.g. boils No Mild Moderate Severe 
2.18 Skin ulcers  No  Mild  Moderate  Severe 
2.19 Shaking No Mild Moderate Severe 
2.20 Tingling in fingers and arms  No  Mild  Moderate  Severe 
2.21 Tingling in legs and toes No Mild Moderate Severe 
2.22 Numbness in fingers / toes No Mild Moderate Severe 
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2.23 Feeling distant or cut off from others No Mild Moderate Severe 
2.24 Constipation  No  Mild  Moderate  Severe 
2.25 Flatulence or burping No Mild Moderate Severe 
2.26 Stomach cramps No Mild Moderate Severe 
2.27 Diarrhoea  No  Mild  Moderate  Severe 
2.28 Indigestion  No  Mild  Moderate  Severe 
2.29 Dry mouth  No  Mild  Moderate  Severe 
2.30 Pain in the face, jaw, in front of the ear, or in the 
ear 
No Mild Moderate Severe 
2.31 Persistent cough  No  Mild  Moderate  Severe 
2.32 Lump in throat No Mild Moderate Severe 
2.33 Sore throat  No  Mild  Moderate  Severe 
2.34 Forgetfulness  No  Mild  Moderate  Severe 
2.35 Dizziness, fainting or blackouts  No  Mild  Moderate  Severe 
2.36 Seizures or convulsions No Mild Moderate Severe 
2.37 Feeling disorientated  No  Mild  Moderate  Severe 
2.38 Loss of concentration No Mild Moderate Severe 
2.39 Difficulty finding the right word  No  Mild  Moderate  Severe 
2.40 Pain on passing urine No Mild Moderate Severe 
2.41 Passing urine more often  No  Mild  Moderate  Severe 
2.42 Burning sensation in the sex organs No Mild Moderate Severe 
2.43 Loss of interest in sex  No  Mild  Moderate  Severe 
2.44 Problems with sexual functioning No Mild Moderate Severe 
2.45 Increased sensitivity to noise  No  Mild  Moderate  Severe 
2.46 Increased sensitivity to light No Mild Moderate Severe 
2.47 Increased sensitivity to smells or odours  No  Mild  Moderate  Severe 
2.48 Ringing in the ears No Mild Moderate Severe 
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2.49 Avoiding doing things or situations  No  Mild  Moderate  Severe 
2.50 Pain, without swelling or redness, in several joints No Mild Moderate Severe 
2.51 Joint stiffness  No  Mild  Moderate  Severe 
2.52 Feeling that your bowel movement is not finished No Mild Moderate Severe 
2.53 Changeable bowel function (mixture of diarrhoea / 
constipation) 
 No  Mild  Moderate  Severe 
2.54 General muscle aches or pains No Mild Moderate Severe 
2.55 Loss of balance or coordination  No  Mild  Moderate  Severe 
2.56 Difficulty speaking No Mild Moderate Severe 
2.57 Low back pain  No  Mild  Moderate  Severe 
2.58 Night sweats which soak the bed sheets No Mild Moderate Severe 
2.59 Feeling feverish  No  Mild  Moderate  Severe 
2.60 Tender or painful swelling of lymph glands in neck, 









2.61 Loss of or decrease in appetite  No  Mild  Moderate  Severe 
2.62 Nausea No Mild Moderate Severe 
2.63 Vomiting  No  Mild  Moderate  Severe 
2.64 Distressing dreams No Mild Moderate Severe 
2.65 Stomach bloating  No  Mild  Moderate  Severe 
2.66 Unintended weight gain greater than 4kg No Mild Moderate Severe 
2.67 Unintended weight loss greater than 4kg  No  Mild  Moderate  Severe 
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Kessler psychological distress scale (K10) 
The following questions inquire about how you have been feeling over the last four (4) weeks. Please read 
each question carefully and then indicate, by shading the circle, the response that best describes how you 


















3.14 In the past four (4) weeks, about how often did 











3.15 In the past four (4) weeks, about how often did 











3.16 In the past four (4) weeks, about how often did 












3.17 In the past four (4) weeks, about how often did 











3.18 In the past four (4) weeks, about how often did 











3.19 In the past four (4) weeks, about how often did 











3.20 In the past four (4) weeks, about how often did 











3.21 In the past four (4) weeks, about how often did 











3.22 In the past four (4) weeks, about how often did 












3.23 In the past four (4) weeks, about how often did 
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Posttraumatic stress checklist (PCL) 
Below is a list of problems and complaints that people sometimes have in response to stressful life 
experiences. Please read each one carefully, then shade the circle to the right to indicate how much 
you have been bothered by that problem in the past month. 
















5.1 Repeated, disturbing memories, 
thoughts or images of a stressful 











5.2 Repeated, disturbing dreams of a 











5.3 Suddenly acting or feeling as if a stressful 
experience from the past were happening 
















5.4 Feeling very upset when something 
reminded you of a stressful experience 











5.5 Having physical reactions (e.g. heart 
pounding, trouble breathing, sweating) 
when something reminded you of a 
















5.6 Avoiding thinking about or talking about a 
stressful experience from the past or 
















5.7 Avoiding activities or situations because 
they reminded you of a stressful 
















5.8 Trouble remembering important parts of a 
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5.11 Feeling emotionally numb or being 
unable to have loving feelings for 











5.12 Feeling as if your future somehow will 
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Traumatic Deployment exposures 












9.1 Were you exposed to smoke from fires / smoke 






















9.3 Were you exposed to an environment where you 
inhaled fine dust or fibres (e.g. driving vehicles, near 











9.4 Were you exposed to others' cigarette smoke in an 




































































9.10 Did you live in an area recently sprayed or 






















9.12 Did you take medication to prevent or suppress 











9.13 Were you close to loud noises and did not have 
hearing protection (e.g. explosions, weapon 
fire)? 
     
9.14 Were you exposed to noise for extended periods 
of time without hearing protection (e.g. 











9.15 Were you bitten by flies, sand flies, fleas, 
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9.16 Did you have close contact with local animals 



































































































9.25 Were you close to sources of non-ionising 




































9.28 Did you enter or come in close proximity to 











9.29 Did you enter or come in close proximity to 
















































9.33 Did you clear / search buildings?      
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9.36 Did you come under guided or directed mortar / 



































































9.42 Did you encounter small arms fire from an 
























9.44 Did you experience a threatening situation where 






















9.46 Did you participate in support convoys (eg. re-











9.47 Were you concerned about yourself or others 
(including allies) having an unauthorised 











9.48 Were you in danger of being killed? 
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9.49 Were you in danger of being injured? 











9.50 Did you handle dead bodies? 











9.51 Did you see dead bodies? 











9.52 Did you hear of a close friend or co-worker who 
had been injured or killed? 











9.53 Were you present when a close friend or co-
worker was injured or killed? 











9.54 Did you fear that you had been exposed to a 
contagious disease, toxic agent or injury? 











9.55 Were you witness to human degradation and 
misery on a large scale? 











9.56 Did you hear of a loved one who had been 























9.58 Do you believe your action or inaction resulted in 
someone being seriously injured? 
e.g. in combat or as a result of rules of engagement or 
















9.59 Do you believe your actions or inaction resulted 
in someone being killed? 
e.g. in combat or as a result of rules of engagement or 

















    
Page | 236 
Short form 12 (SF-12) 
This next set of questions ask for your views about your health. This information will help you to 
keep track of how you feel and how well you are able to do your usual activities. 
 
For each of the following questions, please shade the circle that best describes your answer. 




 Very good  
Good 
 Fair  
Poor 
3.2 The following questions are about activities you might do during a typical day. Does your 
health now limit you in these activities? If so, how much? 
Moderate activities, such as moving 
a table, pushing a vacuum cleaner, 
bowling, or playing golf? 
 
Yes, limited a 
lot 
 
 Yes, limited a little 
 
No, not limited at 
all 
Climbing several flights of stairs? Yes, limited a 
lot 
Yes, limited a little No, not limited at 
all 
3.3 During the past 4 weeks, how much of the time have you had any of the following 













































3.4 During the past 4 weeks, how much of the time have you had any of the following 
problems with your work or other regular daily activities as a result of any emotional 
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3.5 During the past 4 weeks, how much did pain interfere with your normal work (including 
both work outside the home and housework)? 
 Not at all  A little bit  Moderately  Quite a bit  Extremely 
3.6 These questions are about how you feel and how things have been with you during the past 4 
weeks. For each question, please give the one answer that comes closest to the way you have 

































Did you have a lot of energy? 
     











3.7 During the past 4 weeks, how much of the time has your physical health or emotional 
problems interfered with your social activities (like visiting friends, relatives etc.)? 
 All of the time  Most of the time  Some of the time  A little of the time  
None of the time 
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Doctor diagnosed medical conditions 
Since returning from your last MEAO deployment, has a medical doctor diagnosed you with, or 
treated you for any of the following medical problems or conditions? 
 
YES NO 










3.31 Bowel disorder e.g. diarrhoea, constipation, bleeding 
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3.50 Other psychiatric or psychological condition needing treatment or counselling, 
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Appendix B: Consent form 
 
 
MEAO Health Study Consent Form 
I ………………………………………………………………..... give my consent to the 
following parts of the study: (please circle below) 
 Completing the Middle East Area of Operations (MEAO) Health Study 
Questionnaire 
Yes / No 
 *Allowing linkage of information contained in electronic ADF health 
records (e.g. Health-Keys) with the study data 
Yes / No 
 *Allowing linkage of information contained in my electronic ADF 
psychological screening records with the study data 
Yes / No 
 *Allowing linkage to information held in health registries including 
cancer registries and other health registry systems as outlined in the 
Information Sheet 
Yes / No 
 *Being contacted for follow-up studies as outlined in the Information 
Sheet, without any obligation to accept the invitation to participate 
Yes / No 
 *Allowing CMVH to obtain ADF contact details of any listed 
partner/spouse so that (s)he may be invited to participate in a family 
study, if randomly selected, and without any obligation to accept the 
invitation to participate 
Yes / No 
* This action is always subject to CMVH obtaining separate ethics 
approval from the appropriate university/institutional ethics 
committee(s). 
My consent is provided on the following basis: 
 I have read the information sheet provided to me about 
the aims of this research, how it will be conducted and my 
role in it. 
 I understand the risks involved as described in the Information Sheet. 
 I am cooperating in this project on the condition that: 
o My personal information and details will be kept confidential. 
o The information that is collected for this study 
will only be used for the Military Health 
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Outcomes Program or MilHOP research. 
o My participation will be from the commencement 
date to the end date specified on this form, or to 
the end of this project (June 2012). I can elect to 
withdraw from the project at any time. 
 I can discuss my participation at any time with the 
Principal Investigator, a Research Team Member or 
a representative of one of the relevant Ethics 
Committees. 
Continued over page 
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I understand that: 
 There is no obligation to take part in this study. 
 If I choose not to participate there will be no detriment to 
my career, future health care, service pension, DVA 
pension or compensation claims. 
 I am free to withdraw from the study at any time. If I do, 
there is no detriment to my career, future health care, 
service pension, DVA pension or compensation claims. 
 My answers will be completely confidential and any 
personal details, which may identify me in any way, will 
not be passed to the Department of Veterans’ Affairs 
(DVA) or the Department of Defence. My answers will not 
in any way affect my pension, benefits or any health 
services I am entitled to from DVA. 
 I can, at any time, withdraw my consent to participate in 
the project. Should I withdraw my consent, I can do so by 
contacting the study team at the Centre for Military and 
Veterans’ Health on 1800 886 567 (free call) or 
milhop@cmvh.org.au 
 I have kept a copy of the information and consent sheet, signed by me for 
my records. 
 I have also been given a copy of Australian Defence Human Research Ethics 
Committee’s (ADHREC) Guidelines for Volunteers. 
 The study report will be made available to me at my request and any 
published reports of this study will preserve my anonymity. 
Please forward results and findings to: 
 My email address 
 My home address 
Participant Signature:     
 
Name in Full:    
 
Date:    
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Appendix C Australian defence human research ethics committee— guidelines for 
volunteers 
Thank you for taking part in Defence Research. Your involvement is much 
appreciated. This pamphlet explains your rights as a volunteer. 
 
What is the Australian Defence Human Research Ethics Committee? 
 
•ADHREC is the Australian Defence Human Research Ethics 
Committee. It was established in 1988, to make sure that Defence 
complied with accepted guidelines for research involving human 
beings. 
•After World War II (WWII), there was concern around the 
world about human experimentation. The Declaration of 
Helsinki was made in 1964, which provided the basic principles 
to be followed wherever humans were used in research 
projects. 
 
•The National Health and Medical Research Council (NHMRC) in 
Australia has published the National Statement on Ethical 
Conduct in Human Research (NHMRC 2007). This Statement 
describes how human research should be carried out. 
 
•ADHREC follows both the Declaration of Helsinki and the NHMRC 
Statement. 
 
What Australian Defence Human Research Ethics Committee approval means 
•If you are told that the project has ADHREC approval, what that 
means is that ADHREC has reviewed the research proposal and has 
agreed that the research is ethical. 
 
•ADHREC approval does not imply any obligation on commanders 
to order or encourage their Service personnel to participate, or to 
release personnel from their usual workplace to participate. 
Obviously, the use of any particular personnel must have 
clearance from their commanders but commanders should not 
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•As you are a volunteer for this research project, you are under 
no obligation to participate or continue to participate. You may 
withdraw from the project at any time without detriment to your 
military career or to your medical care. 
 
•At no time must you feel pressured to participate or to continue if you do not 
wish to do so. 
 




ld be useful to the researcher to know why, but you are under no 
obligation to give reasons for not wanting to continue. 
 
Informed consent 
•Before commencing the project you will have been given 
an information sheet which explains the project, your role 
in it and any risks to which you may be exposed. 
 
• You must be sure that you understand the information given 
to you and that you ask the researchers about anything of 
which you are not sure. 
 
•If you are satisfied that you understand the information sheet 
and agree to participate, you should initial every page of the 
information sheet and keep a copy. 
 
•Before you participate in the project you should also have 
been given a consent form to sign. You must be happy that the 
consent form is easy to understand and spells out what you are 




• The NHMRC requires that the researcher provide a nominal roll 
of study participants where the study is a clinical trial (eg when 
the researchers are trialling a new treatment or device). For trials 
conducted by large Defence institutions like the Defence Science 
and Technology Organisation, the Submarine and Underwater 
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Medicine or the Centre for Military and Veterans’ Health, this roll 
is kept by them on ADHREC’s behalf. These records will not be 
used to consider your medical employment standard or for 
compensation purposes. 
 
• All ADHREC protocol files are secured in a locked filing cabinet 
and only the Secretariat has access to these. If you do need to be 
traced in the future, ADHREC will do this. ADHREC will not pass 
your contact information to a third party without your permission. 
 
Complaints 
•If at any time during your participation in the project you are worried 
about how the project is being run or how you are being treated, then 
you should speak to the researchers. 
 
•If you don’t feel comfortable doing this, you can contact the 
Executive Secretary of ADHREC. Contact details are: 
Executive Secretary 
Australian Defence Human 
Research Ethics Committee  
Telephone: (02) 6266 3837 




•If you would like to read more about ADHREC, you can look up 
the following references on the Electronic Defence Documents 
(eDocs) or on the Defence 
http://defweb.cbr.defence.gov.au/home/documents/DATA/ADFPU
BS/DIG/GA24_03.PDF Intranet (DEFWEB): 




Health Manual—Human Research in Defence—Instructions 




• Or, visit the ADHREC websites 
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